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Abstract 
A major goal of the synthetic chemists is the development of methods which can be used for 
the synthesis of target molecules from simple building blocks. In this context, annulation 
reactions are considered one of the most efficient methods in organic synthesis due to the 
formation of at least two bonds in a single step. It has been widely used in many fields such as 
pharmaceuticals, materials and natural products synthesis. Among them, oxidative annulation 
via C–H bond functionalization is one of the great interests due to the construction of cyclic 
molecules from non-functionalized precursors. These methods could be utilized in the 
aforementioned fields since they are efficient, mild and step-economic. 
 
In the present study, syntheses of “privileged scaffolds” were described via oxidative 
annulation of C–H bonds functionalization. The main focus of this thesis has been directed 
Abstract 
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towards the development of new methods for the biologically relevant heterocycles and 
carbocycles synthesis employing simple building blocks. The presented work is divided into 
two parts, the first part dealing with metal-free conditions including hypervalent iodine 
reagents and DDQ and the second part with the copper-catalyzed acetophenone 
functionalization.  
To accomplish our goal, iodobenzene catalyzed oxidative annulation of benzamide 
derivatives with alkynes was developed for the synthesis of isoquinolone scaffolds. 
Furthermore, syntheses of pyrido[1,2-a]benzimidazoles and N-heteroaryl anilines were 
achieved using PhI(OAc)2 as oxidant. In addition, methyl group of arenes as a traceless 
directing group in the synthesis of benzo[4,5]imidazo[1,2-a]quinolone derivatives was 
demonstrated. Highly regioselective syntheses of N-oxide imidazopyridines were described 
by annulation of nitrosopyridine derivatives with alkynes and alkenes. Furthermore, an 
oxidative Diels-Alder reaction of alkylbenzenes and electron-deficient alkenes were 
investigated under metal-free conditions. In addition, first time dehydrogenative nitration of 
alkylbenzenes was demonstrated using DDQ as oxidant.  
In the second part of this work, copper(I)-catalyzed syntheses of cyclopropanes via 
oxidative annulation of acetophenones with electron-deficient alkenes were investigated. The 
developed reaction represents copper(I)-catalyzed stereoselective 3-azabicyclo[3.1.0]hexane 
synthesis. The reaction mechanism revealed that cyclopropanation underwent via a novel 
radical addition onto the electron-deficient alkenes. Furthermore, syntheses of strain 
cyclopropanes were demonstrated from three acetophenone derivatives to access fully 
substituted cyclopropanes. It is remarkable that (1+1+1) cyclotrimerization was developed for 
the first time in the synthesis of small saturated carbocycles employing acetophenones. This 
method allowed the straightforward synthesis of strain cyclopropanes. A step forward in this 
direction a copper(I)-catalyzed radical addition of acetophenone to electron-deficient alkynes 
for the synthesis of furans were demonstrated under oxidative reaction conditions. The 
developed method provided polysubstituted furan derivatives from various acetophenones.  
 
All synthesized compounds were submitted to the COMAS for various cell-based 
assays to identify potential inhibitors of the hedgehog signaling pathway, Wnt signaling 
pathway and autophagy. 
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Kurzfassung 
Ein obergeordnetes Ziel von Chemikern ist die Entwicklung neuer Methoden, welche für die 
Darstellung von Zielmolekülen aus einfachen Synthesebausteinen genutzt werden können. 
Bedingt durch die Formierung von wenigstens zwei neuen chemischen Bindungen in einem 
Schritt werden Anellierungsreaktionen in diesem Kontext als ein hoch effizienter Ansatz in 
der organischen Chemie verstanden. Anellierung ist daher eine häufig genutzte Strategie zur 
Darstellung von Naturstoffen und pharmazeutisch relevanten Molekülen. Oxidative 
Anellierungs via C-H Bindungsfunktionalisierung ist von besonderem Interesse, auf Grund 
der Konstruktion cyclischer Moleküle ausgehend von nichtfunktionalisierten Startmaterialien. 
Diese Methoden können in den zuvor genannten Feldern genutzt werden, da sie sich durch 
besonders milde Reaktionsbedingungen, hohe Effizienz und Syntheseschrittökonomie 
auszeichnen. 
 
 
In den vorliegenden Studien wurde die Synthese privilegierter Gerüstmoleküle via oxidativer 
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Anellierung durch C-H Bindungsfunktionalisierung beschrieben. Schwerpunkt lag dabei auf 
der Entwicklung neuer Methoden zur Synthese biologisch relevanter Heterocyclen und 
Carbocyclen ausgehend von einfachen Synthesebausteinen. Die präsentierte Arbeit gliedert 
sich dabei in zwei Teile. Der erste Teil beinhaltet Metall-freie Reaktionen durch den Einsatz 
von hypervalenten Iodreagenzien und DDQ und der zweite Teil die kupferkatalysierte direkte 
C-H Bindungsfunktionalisierung.  
Um dieses Ziel zu erreichen wurde die Iodbenzol katalysierte oxidative Anellierung 
zur Synthese des Isoquinolongerüsts ausgehend von Benzamid und Alkynen entwickelt. 
Darüber hinaus wurde die Synthese von Pyrido[1,2-a]benzimidazolen und N-heteroaryl 
Anilinen durch den Einsatz von PhI(OAc)2 als Oxidationsmittel erzielt. Zusätzlich wurde die 
Methylgruppe von Arenen als spurlose dirigierende Gruppe zur Synthese von 
Benzo[4,5]imidazo[1,2-a]quinolonen demonstriert. Die hoch regioselektive Synthese von 
Imidazopyridin N-Oxiden wurde durch die Anellierung von Nitrosopyridinen mit Alkynen 
und Alkenen erzielt. Weiterhin wurde die Metall-freie oxidative Diels-Alder Reaktion von 
Alkylbenzol und elektronenarmen Alkenen untersucht. Basierend auf den gewonnenen 
Erkenntnissen wurde zusätzlich zum ersten Mal die dehydrogenative Nitrierung von 
Alkylbenzolen doch die Verwendung von DDQ als Oxidationsmittel demonstriert. 
Im zweiten Teil dieser Arbeit wurde die Kupfer(I)-katalysierte Synthese von 
Cyclopropanen via oxidativer Anellierung von Acetophenonen mit elektronenarmen Alkenen 
untersucht. Die entwickelten Reaktionen beinhalten die Kupfer(I)-katalysierte und 
stereoselektive Synthese von 3-Azabicyclo[3.1.0]hexan. Studien des Reaktionsmechanismus 
zeigten, dass die Cyclopropanierung durch radikalische Addition an elektronenarmen Alkene 
erfolgte. Weiterhin wurde die Synthese von gespannten Cyclopropanen ausgehend von drei 
Acetophenonderivaten entwickelt, wodurch hoch substituierte Cyclopropane zugänglich 
wurden. Die (1+1+1) Cyclotrimerisierung repräsentiert das erste Beispiel für die direkte 
Synthese von kleinen, gesättigten Carbocyclen durch den Einsatz von Acetophenonen. Ein 
weiterer Schritt gelang durch die Kupfer(I)-katalysierte radikalische Addition von 
Acetophenonen an elektronenarme Alkyne zur Synthese von Furanen unter oxidativen 
Reaktionsbedingungen. Die neuentwickelte Reaktion erlaubt die Synthese polysubstituierter 
Furanderivate ausgehen von verschiedenen Acetophenonen. 
Alle synthetisierten Verbindungen wurden im COMAS in verschiedenen Zell-
basierten Assays getestet, wodurch verschiedene Inhibitoren des Hedgehog Signalweges, des 
Wnt Signalweges und Autophagie identifiziert wurden. 
 - 1 - 
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1.1 Introduction 
Carbon-carbon or carbon-heteroatom (C–X = N, O, S etc.) bond formation via carbon-
hydrogen (C–H) bond functionalization is one of the greatest interests in modern organic 
chemistry.
[1-4]
 Carbon-hydrogen bonds are ubiquitous in nature.
[5-11] 
Therefore, C–H bond 
functionalization appears to be one of the most powerful routes to install different 
functionalities and emerged as a great tool in the last few decades in many fields such as 
medicinal chemistry, pharmaceutical and natural product synthesis.
[4] 
Among various C–H 
activation pathways, oxidative cross-coupling reactions have found great advantage to enable 
C–C and C–X bond formation. Functionalization of C–H bond is considered to be the most 
challenging and elusive to the synthetic chemists.
[12]
 The oxidative cross-dehydrogenative-
coupling (CDC) reaction became highly attractive method in the synthesis of complex 
architectures.
[7, 13-15] 
There were several breakthrough methods for CDC, which were 
developed by using transition metal (TM) catalysts or under metal-free conditions.
[16]
 It has 
great benefits in the context of non-functionalization of the precursors, step and an atom 
economical processes,
[17]
 and least amount of chemical waste production.
[18-19] 
Due to their 
prime advantages in organic synthesis, the direct construction of C–C and C–heteroatom 
bonds by functionalization of C–H bonds have been extensively studied.[20]  
1.2 Background of Cross-Coupling Reaction 
 
Scheme 1.1. Oxidative C–H bond functionalization vs classic cross-coupling. 
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In general, three types of mechanisms are hypothesized for the oxidative coupling reactions in 
the literature (Scheme 1.1).
[21-24] 
In the type A, first metal insertion takes place with organic 
halide/pseudohalide as coupling partners followed by transmetalation with functionalized 
substrate and a subsequently reductive elimination provides coupling product.
[23]
 For type B, 
reaction proceeds via metal-catalyzed C–H bond activations with organometallic reagents. 
Normally, this type of reaction takes place in three steps: electrophilic substitution, 
transmetalation and reductive elimination. The reaction in type C is oxidative cross-coupling 
between two different C–H bonds. Generally, in this reaction mechanism the radical, radical 
cationic or cationic species were generated via single electron transfer (SET) process followed 
by in-situ oxidation of radical species which reacts with nucleophilic or electrophilic substrate 
to generate coupling product after elimination of hydrogen atom (Scheme 1.1).
[25-26]
  
1.3 Oxidative Cross-Coupling via C–H Bond Functionalization 
In the last century, several cross-coupling reactions were developed in the organic chemistry 
and widely used in many fields.
[27-30]
 However, the major drawback of the cross-coupling 
reactions includes the requirement of functionalized substrates, higher temperatures, additives 
and stoichiometric amount of metal salts. Therefore, the major goal of synthetic chemists has 
been always to minimize the chemical waste in the cross-coupling reaction without 
compromising the efficiency of the process. At the beginning of the 20
th
 century, oxidative C–
H bond functionalization was just a dream to the chemists. Later on, several attractive 
oxidative cross-coupling reactions were slowly emerged using transition metals.
[5]
 
Nevertheless, oxidative coupling reaction was considered as a green process and sustainable 
method due to step-atom economical nature and less amount of chemical waste production.
[4]
 
In the recent years, several types of C–H bond functionalization has been reported such as 
C(sp
3
)–H, C(sp2)–H and C(sp)–H. Among them, functionalization of C(sp3)–H bonds are 
considered to be the most challenging because of its poor acidity in nature and filled high-
energy orbitals which readily interact with empty orbitals of the metal.
[31]
 However, oxidative 
coupling of C(sp
2
)–H or C(sp)–H bond is relatively easier than inert C(sp3)–H bond, since the 
bond dissociation energy (BDE) of C(sp
3
)–H is higher than other types of C–H bond. The 
bond dissociation energy of various types of bonds is highlighted in Scheme 1.2.
[32]
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Scheme 1.2. Bond dissociation energy of various C–H bonds. 
1.4 Oxidants for C–H Bond Functionalization 
In the last few decades, various oxidants were successfully used for the oxidative C–H bond 
functionalization such as 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (15), 2,2,6,6-
tetramethylpiperidine 1-oxyl (16), TEMPO salts (17), peroxides, hypervalent iodine (III) 
reagents
[33]
 such as PhI(OAc)2 (22) and PhI(OCOCF3)2 (23), molecular oxygen
[34]
 and various 
metal salts. They are considered as a milder oxidant in modern synthetic organic synthesis 
(Scheme 1.3).
[35]
 These oxidants are also widely used in the oxidative cross-coupling and 
annulation reactions.
[36-44]
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Scheme 1.3. Various oxidants for C–H bond functionalization. 
1.5 Various Routes of Oxidative Annulation Reaction 
In general, three types of mechanisms of oxidative annulation reactions has been described in 
the literature (Scheme 1.4). In the first step, the radical species 25 or cation species 26 are 
generated via oxidation of C–H bond in the presence of oxidant.[6] Afterwards, the 
nucleophilic or electrophilic addition to the alkene or alkyne affords a radical intermediate 28 
which subsequently undergoes intramolecular cyclization to deliver radical intermediate 29. 
Finally, the oxidation of the radical species followed by hydrogen abstraction provides the 
desired product 30. On the other hand, after the addition of cationic species 26 onto alkene or 
alkyne leads to formation of cationic intermediate 31 which subsequently intramolecular 
cyclization to form the intermediate 32.
[45]
 The intermediate 32 undergoes over oxidation 
followed by hydrogen elimination affording the desired product 30. For the metal-catalyzed 
oxidative annulation, most common mechanism has been shown in Scheme 1.4.
[46]
 Initially, 
the metalocyclic intermediate 33 was generated via C–H activation followed by migratory 
insertion to the alkene or alkyne. Eventually, reductive elimination of metal provides the 
annulated product 30 (Scheme 1.4). The active metal species is regenerated via oxidation.  
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Scheme 1.4. Reaction mechanism of oxidative annulation.  
1.6 TEMPO Salt/ TEMPO Mediated Oxidative Annulation 
Several C–H bond functionalizations have been reported in the last decades using stable N–
oxyl radical as mild oxidant such as TEMPO radical.
[47-50]
 TEMPO radical (18) was first 
reported by Lebedev and Kazarnovskii in 1959 and used as a versatile oxidant in organic 
synthesis. Recently, Carcίa Manchéno and co-workers developed TEMPO oxoammonium salt 
(17) mediated (4+2) oxidative annulation of N-benzylcarbamates (35) with simple olefins (36) 
(Scheme 1.5).
[48]
 According to the proposed reaction mechanism, single-electron oxidation of 
amine followed by hydrogen atom abstraction generates iminium ion intermediate (35a). 
Afterwards, iminium ion (35b) undergoes electrophilic addition to the olefin to furnish the 
carbocation intermediate 38 which is trapped by nucleophilic oxygen of carbamate to produce 
the desired product 37. 
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 Scheme 1.5. Oxidative annulation of N-benzylcarbamate with alkene. 
In 2015, Carcίa Manchéno and co-workers reported first 2,2,6,6-tetramethylpiperidine 1-oxyl 
(16) mediated C(sp
3
)–H bond functionalization for the oxidative annulation.[47] The 
annulation reaction of alkyne (41) and maleimide (43) underwent through the nitrone 
intermediate (40) which was generated from alkyl, allyl or benzyl N-carbamoyl N-
hydroxylamine in the presence of TEMPO as oxidant (Scheme 1.6). 
 
Scheme 1.6. Oxidative annulation of alkene. 
Very recently, Han and co-workers disclosed an elegant TEMPO (16) mediated 
intermolecular oxidative aza-Diels-Alder reaction via functionalization of ketohydrazone 
(Scheme 1.7).
[51]
 According to the mechanism proposed by the authors, 2 equivalents of 
TEMPO (16) required for transformation to achieve the desired product 49. At the beginning 
the radical species 45a was formed by hydrogen atom abstraction from 45 by TEMPO radical. 
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Scheme 1.7. Oxidative aza-Diels-Alder reaction. 
It was found that the intermediate 45a was stabilized via resonance to generate the 
intermediate 45b. The intermediate 48a was formed via oxidation of the intermediate 45b 
with 1 equivalent of TEMPO and subsequently undergoes [4+2] cycloaddition with 46 to 
provide the product 49. 
1.7 DDQ Mediated Oxidative Annulation  
 
Scheme 1.8. Oxidative annulation of phenol with alkene. 
In the last decades, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (15) was successfully used for 
the oxidative annulation reactions.
[52-58]
 Recently, the group of Lei described a novel FeCl3-
catalyzed oxidative annulation of phenol derivatives (50) with olefins (51) employing DDQ 
(15) as oxidant (Scheme 1.8).
[53]
 Based on their mechanistic studies, the authors proposed a 
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plausible reaction mechanism of DDQ mediated oxidative alkene annulation with phenol. 
First, DDQ reacted with phenol to form radical species (50a) which led to furnish the 
intermediate 50b. Afterwards, the intermediate 50b could react with alkene to generate the 
intermediate 53 which undergoes oxidation with 15a to produce the target product 52.  
 
Scheme 1.9. Oxidative annulation of 2-naphthol with alkyne. 
In 2016, Liu et al. reported the first successfully DDQ (15) mediated oxidation annulation of 
2-naphthol derivative (54) with terminal alkyne (55) under metal-free conditions (Scheme 
1.9). The reaction was found to be extremely versatile with various 2-naphthols and alkynes. 
The mechanistic studies suggested that a novel radical oxidative annulation underwent via C–
C coupling and C–O intramolecular cyclization under developed reaction conditions.[54] First, 
2-naphthol was oxidized by DDQ to form 2-naphthol radical in the presence of BF3. 
Afterwards, the 2-naphthol radical was attacked to generate the vinyl radical of alkyne which 
undergoes cyclization via oxygen atom and followed by oxidation of radical species providing 
the product 56. 
 
Scheme 1.10. Oxidative annulation of prenyl derivative with alkene. 
Later, in 2015 Zhou and co-workers reported the DDQ (15) mediated dehydrogenative 
Diels-Alder reaction of prenyl derivative (57) under metal-free conditions (Scheme 1.10).
[52]
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The developed reaction tolerated under oxidative annulation of various prenyl derivatives 
with DDQ. The mechanistic studies indicated that the dehydrogenative Diels-Alder reaction 
underwent through isoprene intermediate which was generated via oxidation of prenyl 
derivative in the presence of DDQ. 
1.8 Peroxide Mediated Oxidative Annulation 
Recently, various peroxides were used for the oxidative annulation to build diverse annulated 
products including furan, oxazole and nitrogen-based heterocycles.
[59-67]
 In 2009, Li and co-
workers described the synthesis of polysubstituted benzofurans (62) through Fe-catalyzed 
tandem oxidative annulation between phenols (60) and β-ketoester derivatives (61) using 
DTBP (20) as oxidant (Scheme 1.11).
[68]
 Proposed reaction mechanism has been shown in the 
Scheme 1.11. The intermediate 63 was formed after reaction of FeCl3 with phenol and β-
ketoester which produce the intermediate 64 after reductive elimination of iron species. The 
intermediate 64a could be formed via tautomerization of intermediate 64. Subsequently, the 
product 62 was formed by condensation of the intermediate 64a.  
 
Scheme 1.11. Oxidative annulation of phenol with alkene. 
In 2010, Jiang and co-workers disclosed oxidative annulation of easily accessible 
benzylamine derivatives (66) with alkenes (65) in the synthesis of oxazole derivatives (67) 
employing tert-butyl hydroperoxide (19) as oxidant in combination with molecular iodine 
(Scheme 1.12).
[60]
 The proposed reaction mechanism of the oxazole synthesis has been 
described in the Scheme 1.12. Mechanistically, it was proposed that the intermediate 65a was 
formed in the presence of I2 in combination with TBHP. The intermediate could undergo 
oxidation to generate the intermediate 65b. Upon reaction with benzylamine, produce the 
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intermediate 68. After attacking of the lone pair of oxygen to the imine intermediate furnish 
the substrate 68a. Afterward, oxidation of the intermediate 68a provided the target product 
67.  
 
Scheme 1.12. Oxidative annulation of benzylamine with alkene. 
In 2016, Antonchick and Song published an elegant oxidative annulation between tertiary 
anilines (71) and alkenes (72) employing tetrabutylammonium iodide (TBAI) as a catalyst 
and tert-butyl hydroperoxide (21) as oxidant under metal-free conditions (Scheme 1.12).
[66]
 
The reported method showed functionalization of diverse tertiary anilines with different 
alkenes to build a wide range of substrate scopes. The mechanistic studies suggested that the 
oxidative annulation reaction proceeded via the formation of α-aminoalkyl radical. It is 
formed by tert-butoxyl radical which generates in-situ reaction between tert-butyl 
hydroperoxide and iodide ion. The α-aminoalkyl radical could attack the alkene to form 
radical intermediate followed by cyclization and hydrogen abstraction providing the product 
70. 
 
Scheme 1.13. Oxidative annulation of tertiary aniline with alkene. 
In the recent years several Povarov type oxidative annulation has been developed using 
various oxidant via C–H bond functionalization.[69-73] Very recently, Seidel and co-workers 
established copper(I) bromide catalyzed oxidation [4+2] cycloadditions of N-aryl amines with 
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alkenes to achieve polycyclic amines derivatives (Scheme 1.14).
[74]
 According to the 
described mechanism by the authors, the reaction underwent via iminium ion intermediate 
which was formed by oxidation of N-aryl amines with tert-butyl hydroperoxide in the 
presence of copper(I) bromide.  
 
Scheme 1.14. Oxidative Povarov type annulation in synthesis of polycyclic amine. 
1.9 Hypervalent Iodine (III) Mediated Oxidative Annulation 
Application of hypervalent iodine (III) reagents has seen explosive growth in the last few 
decades due to its versatile oxidizing ability, easy availability and environmentally benign 
nature.
[75-76]
 Hypervalent iodine (III) reagents have found great success in the development of 
novel methods and widely used for oxidative amination, cross-dehydrogenative coupling 
(CDC) reaction and various oxidation processes.
[77-91]
 Recently, Antonchick group developed 
several oxidative intramolecular and intermolecular amination reactions employing 
hypervalent iodine (III) reagents from simple building blocks.
[79, 87, 89-90]
 
 
Scheme 1.5. Oxidative annulation of phenol with alkene. 
In 2013, the group of Minakata and Takeda first developed hypervalent iodine (III) mediated 
oxidative annulation of o-phenyldiamines (74) with electron-deficient alkynes (41) in the 
synthesis of quinoxaline derivatives (Scheme 1.15).
[92]
 According to authors proposed 
reaction mechanism, o-phenyldiamine (74) could react with electron-deficient alkyne to 
generate three probable intermediates 76a, 76b or 76c which subsequently undergoes 
intramolecular cyclization followed by oxidation, providing the desired product 75 (Scheme 
1.16). 
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Scheme 1.16. Proposed mechanism of quinoxaline synthesis. 
In 2009, Kita and co-workers reported an oxidative trimerization of catechol (78) to 
hexahydroxytriphenylene (79) using hypervalent iodine (III) reagents as oxidant (Scheme 
1.17).
[93]
 The reaction proceeded under mild reaction conditions and resulted in the formation 
of useful hexahydroxytriphenylene (79).  
 
Scheme 1.17. Hypervalent iodine (III) mediated oxidative annulation of catechol. 
In 2013, Hadjiarapoglou and co-worker published a novel method for the synthesis of fused 
dihydrofuran (82) from 1,3-cyclohexanedione (80) and alkene (81) using iodobenzene 
diacetate (22) under photochemical activation (Scheme 1.18).
[94]
 The reaction mechanism 
suggested that a tandem cycloaddition underwent via C–C bond formation and C–O bond 
cyclization under the developed reaction conditions. In the proposed mechanism for 
PhI(OAc)2 mediated oxidative annulation, first 1,3-cyclohexanedione reacted with PhI(OAc)2 
to form the intermediate 80a which led to produce the intermediate 80b after losing acetic 
acid. The intermediate 80b could be reacted with alkene to generate the intermediate 80c 
followed by reductive elimination of iodobenzene proving the desired product 82 (Scheme 
1.18).  
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Scheme 1.18. Hypervalent iodine (III) mediated (3+2) oxidative annulation. 
Very recently, Zhdankin and co-workers developed a catalytic aziridination of alkene (86) 
using hypervalent iodine (III) reagents (85) (Scheme 1.19).
[95]
 It could be utilized as a nitrene 
precursors based on ortho-alkoxyiodobenzene for aziridine (87) synthesis. 
Alkoxyphenyliminoiodanes reagent were generated from hypervalent iodine (III) reagents. 
 
Scheme 1.19. Aziridination of alkene. 
1.10 Molecular Oxygen as Oxidant for Oxidative Annulation 
Recently, the application of molecular oxygen has attracted great attention as oxidant for the 
oxidative coupling reaction due to its green nature and abundance compared to the metal 
oxidants or peroxides.
[35]
 Oxidative coupling reaction using molecular oxygen as oxidant has 
not much explored due to poor reactivity and less selectivity. Albeit, there are some methods 
for oxidative annulation reaction using molecular oxygen as oxidant.
[96-97]
 In 2012, the group 
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of Jia and Wang reported the synthesis of substituted quinolines (89) between glycine 
derivatives (88) and styrenes (65a) or alkynes (55) in combination with tris(4-
bromophenyl)aminium hexachloroantimonate (90) as a catalyst under oxygen atmosphere 
(Scheme 1.20).
[98]
  
 
Scheme 1.20. Oxygen mediated oxidative annulation. 
According to the proposed mechanism by the authors, first oxygen could react with TBPA
+• 
to 
produce the peroxide intermediate (Scheme 1.21). The peroxide intermediate abstracts 
hydrogen atom from glycine derivative to generate intermediate 88a and TBPA
+• 
was 
regenerated after fragment of peroxide. The intermediate 88b was generated via oxidation of 
 
Scheme 1.21. Proposed mechanism of oxygen mediated oxidative annulation. 
the intermediate 88a which undergoes Povarov type reaction with alkene to furnish the 
intermediate 88c. Finally, the desired product 89 was formed via rearrangement of 
intermediate 88c followed by oxidation of intermediated 88d.  
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In 2016, Hua and co-workers disclosed double oxidative dehydrogenative annulation between 
glycine derivatives (88) and dioxane (91) under oxygen atmosphere (Scheme 1.22).
[99]
 
Quinoline derivatives could be obtained from various glycine derivatives. According to the 
proposed reaction mechanism by the authors, first bromine radical was formed after 
nucleophilic attacks of PPh3 to CBr4 (Scheme 1.22). The bromine radical abstracts hydrogen 
atom from the glycine derivative to form the radical intermediate 88a which undergoes over 
 
Scheme 1.22. Oxidative annulation of glycine derivative with dioxane. 
oxidation in the presence of oxygen, giving an intermediate 88b. Similarly, 2,3-dihydro-1,4-
dioxine (91b) was formed after reaction of dioxane (91) with bromine radical and followed by 
oxidation of radical species with molecular oxygen. The intermediate 88b undergoes [4+2] 
cycloaddition with intermediate 91b to afford intermediate 93 which producing the 
intermediate 93a after acidic ring-opening. Finally, aromatization of intermediate 93a in 
presence of oxidant provided the target product 92. 
In 2015, Ackermann and co-workers reported as unprecedented ruthenium-catalyzed 
oxidative annulation of benzoic acid derivative (93) and alkyne (94) with molecular oxygen as  
Chapter 1. General Introduction 
- 17 - 
the sole oxidant (Scheme 1.23).
[100]
 According to the mechanism proposed by the authors, 
acetic acid is crucial for the re-oxidation of Ru(0) by the molecular oxygen. 
 
Scheme 1.23. Oxidative annulation benzoic acid with alkyne. 
In 2013, Rueping and co-workers reported an elegant oxidative annulation of alkene (97) and 
aryl tertiary aniline derivative (96) with combination of molecular oxygen and visible-light 
photoredox catalysis (Scheme 1.24).
[101]
 In the absence of oxygen, only intermolecular radical 
addition onto the electron-deficient alkene took place and observed liner product 98 
formation. In contrast, intermolecular annulation occurred in the presence of molecular 
oxygen, and provided the desired annulated product 99. The mechanistic investigations 
suggested that reaction underwent through radical intermediate and molecular oxygen 
promoted the cyclization via oxidation of radical species (Scheme 1.24). On the other hand, in 
absence of oxygen acyclic product 99 was formed. 
 
Scheme 1.24. Photocatalyzed oxidative annulation. 
1.11 Directing Groups as Internal Oxidants for Oxidative Annulation 
In the last few decades, several transition-metals catalyzed oxidative annulation were 
developed employing directing groups as internal oxidants (Scheme 1.25). In 2010, Fagnou 
and co-workers discovered the pioneering work of alkyne (94) annulations with using amides 
directing groups as internal oxidants through C–H bond activation and N–O bond 
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cleavages.
[102-104]
 Afterwards, Fagnou groups as well as Glorius and Rovis groups reported 
Rh(III)-catalyzed oxidative annulation of benzamide derivative (101) with alkyne (94) or 
alkene (89a) with oxidizing directing groups as internal oxidant (Scheme 1.25).
[105-106]
 In 
2011, Ackermann group as well as Li and Wang groups developed ruthenium-catalyzed an 
oxidative annulation between benzamide derivative (101) and alkyne (94) using directing 
group as internal oxidant.
[107-108]
 
 
Scheme 1.25. Oxidative annulations using directing groups as internal oxidants. 
The catalytic cycle of Rh(III)-catalyzed oxidative alkyne annulations using directing groups 
as internal oxidants has been shown in the Scheme 1.26. Initially, the metallocycle 
intermediate was generated via C–H activation of benzamide (101c). The intermediate (103) 
undergoes the alkyne insertion to form seven-member rhodium complex (104). Afterwards, 
reductive elimination and N–O bond cleavage in the presence of acid, delivering the product 
(102b) and recycling Rh (III) catalyst.
[109]
  
Chapter 1. General Introduction 
- 19 - 
 
Scheme 1.26. Proposed mechanism of Rh-catalyzed oxidative alkyne annulation.  
1.12 Metal Salt as Oxidants for Oxidative Annulation 
The combination of late transition-metal complexes as catalyst and metal salts as oxidants was 
widely used in the field of C–H activation (Scheme 1.27) In this context, several novel  
 
Scheme 1.27. Oxidative annulation of alkyne in the presence metal oxidant 
methods have been reported in the last decades for the oxidative annulation of alkyne with 
benzoic acid, amine or amide derivatives.
[110-115]
 In 2007, Satoh and co-workers reported 
rhodium-catalyzed oxidative annulation of benzoic acid with alkyne using Cu(OAc)2∙H2O as 
Chapter 1. General Introduction 
- 20 - 
oxidant.
[112]
 Later, groups of Ackermann, Satoh, Miura and Cramer independently 
demonstrated transition metal catalyzed oxidative annulation of alkyne 94 with various 
substrates in the presence of metal salt as oxidant.
[111, 114-115]
  
 
Scheme 1.28. Ru(II)-catalyzed oxidative annulation of alkyne.  
Recently, Ackermann and co-workers reported several elegant oxidative annulation methods 
employing ruthenium(II)-catalysts for oxidative annulation of alkynes (Scheme 1.28).
[115]
 
Later, Wang and co-workers also disclosed ruthenium(II)-catalyzed oxidative annulation of 
alkynes with benzamides.  
 
Scheme 1.29. Proposed mechanism for Ru-catalyzed oxidative alkyne annulation. 
Thus, the catalytic cycle of Rh-catalyzed alkyne annulation has been shown in the Scheme 
1.29. Irreversible cycloruthenated complex (110) was generated in the presence of acetate. 
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Intermediate (110) undergoes the alkyne insertion to form seven-member ruthenium complex 
(111), which upon reductive elimination producing the desired isoquinolone 109e.
[115]
 
 
Scheme 1.30. Cu(OAc)2 mediated oxidative annulation. 
In 2014, Maiti and co-workers reported as unprecedented oxidative annulation between aryl 
ketones (112) and aromatic olefins (89) using Cu(OAc)2 as oxidant (Scheme 1.30).
[110]
 
According to authors proposed mechanism, the reaction underwent via aryl ketone radical 
(112a) pathway. The reaction was followed by a novel oxidative annulation via radical C–C 
formation and C–O cyclization to achieve 2,3-dihydrofurans derivatives 113. 
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2.1 Overview of the Projects 
Selective C–H bond functionalization for the construction of novel carbon–carbon or carbon–
heteroatom bond is one of the most challenging tasks.
[116-117]
 In the recent years, direct C–H 
bonds functionalization are considered as a mild, efficient and step-economic method using 
non-prefunctionalized coupling partners. Therefore, development of novel methods for the 
synthesis privileged scaffolds using simple building blocks would be highly interesting 
methods. Among them, oxidative annulation reaction via C–H bond functionalization is of 
great interest due to the formation of cyclic molecules from at least two acyclic molecules in 
single process.
[116, 118]
 These methods could be used in the synthesis of biologically relevant 
compounds since they are efficient and step economic method.  
The aim of this work is the development of new methods for the “privileged scaffolds” 
syntheses using hypervalent iodine (III) reagents, metal-free conditions and copper catalyst 
via C–H bonds functionalization. The nitrogen-containing heterocycles such as isoquinolones 
and pyrido[1,2-a]benzimidazoles and N-arylated pyridine scaffolds could be synthesized 
using hypervalent iodine (III) reagents. Further, various carbocycles such as 1,4-
phenanthraquinones and cyclopropanes could be developed employing novel C–H bonds 
functionalization. Furthermore, synthesis of furan derivatives was subjected under oxidative 
conditions via acetophenones functionalization. 
2.2 Hypervalent Iodine (III) Mediated Oxidative Annulation 
Hypervalent iodine (III) mediated C–H bond functionalization has emerged over the last few 
decades as an attractive tool in synthetic organic chemistry.
[119]
 One of the potential uses of 
this class of reagents is the construction of heterocycles via oxidative C–H bond 
functionalization.
[120]
 Nitrogen-containing heterocycles are ubiquitous in natural products and 
drug molecules. Therefore, synthesis of nitrogen-based heterocycles under metal-free 
conditions is highly desirable. I(III) reagents were used to generate nitronium ion intermediate 
with protected amines for oxidative amination. Our approach to generate the aforementioned 
heterocycles is to generate a nitronium ion in-situ from the corresponding amines followed by 
trapping of these intermediates with suitable nucleophiles. Our hypothesis could be 
investigated with different aminopyridines or protected amides and various nucleophiles such 
as simple arenes or alkynes under hypervalent iodine (III) mediated in the synthesis of 
nitrogen-based heterocycles (Scheme 2.1).  
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Scheme 2.1. Hypervalent iodine (III) mediated oxidative annulation and amination. 
In the course of these studies, we were also interested to develop a new method for the 
synthesis of pyridobenzimidazoles under metal-free conditions since pyridobenzimidazoles 
represents important scaffolds for biologically studies and drug molecules. Therefore, 
synthesis of pyridobenzimidazole derivatives would be highly demanding under mild and 
efficient metal-free conditions (Scheme 2.2). 
 
Scheme 2.2. Synthesis of pyridobenzimidazole scaffold. 
2.3 Metal-Free Oxidative Dehydrogenative Diels-Alder Reaction  
Carbon-hydrogen (C–H) bonds functionalization represents one of the most fundamental and 
efficient methods in organic synthesis. In the last decades, the construction C–C bond via  
functionalization of C–H has attracted great attention due the employment of simple building 
blocks.
[121]
 In this regards, we moved to oxidative dehydrogenative Diels-Alder (DDA) 
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reaction of alkylbenzenes with alkenes via C(sp
3
)–H bond functionalization. Over the last few 
decades, Diels-Alder reaction has found utilizing of diene-dienophile chemistry to obtain 
unsaturated carbocycles. Despite its importance in organic synthesis, dehydrogenative 
Diels-Alder (DDA) reactions paid great attention recently due to atom economy. 
Nevertheless, the synthesis of carbocycles by functionalization of unactivated C–H bonds 
remains a prime challenge to the chemists. Therefore, the development of new methods in this 
direction would be highly desirable.
[122]
 
 
Scheme 2.3. Dehydrogenative Diels-Alder reaction. 
However, metal-free dehydrogenative Diels-Alder reactions of alkylbenzenes with electron-
deficient alkenes have never been investigated. We envisioned that dehydrogenative 
Diels-Alder reaction of simple alkylbenzenes might lead to interesting heterocycles and 
carbocycles. 
2.4 Copper-Catalyzed Oxidative Annulation of Acetophenones 
Finally, we were curious about the oxidative annulation of acetophenones with alkenes and 
alkynes that might be used for the synthesis of cyclopropanes and furans. Cyclopropanes
[123]
 
and furans
[124]
 are among the most versatile and important classes of compounds and present 
in many natural products and biologically active drug molecules.
[125]
 Traditionally, 
cyclopropanes are synthesized through the Simmon-Smith reaction
[126-131]
, Michael-initiated 
ring closure reaction
[132-135]
 and metal-carbene intermediates employing various transition 
metal or metal-free conditions.
[136]
 In addition prior methods employed prefunctionalized 
precursors and drastic reaction conditions. Therefore, the development of cyclopropanes using 
mild conditions and user friendly chemicals would be a highly desirable. During studies on 
cyclopropanation, it was found that cyclopropanes were formed via acetophenones radical 
addition to the alkenes intermediate. From these studies, we envisaged that the new route to 
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multisubstituted furans via acetophenone radical addition to alkynes would be highly 
 
Scheme 2.4. Synthesis of cyclopropanes and furans. 
interesting route. To the best of our knowledge, synthesis of furan derivatives via direct 
annulation of simple acetophenones with alkynes has never investigated. Moreover, an 
efficient method for the synthesis of polysubstituted furans via acetophenones 
functionalization would be highly demanded.
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3.1 Introduction  
C–H bond amination has emerged over the last few decades and became an attractive field to 
build molecular diversities employing simple starting materials.
[137-138]
 They are extensively 
used in the synthesis of biologically relevant drug molecules
[139-140]
 and natural products 
synthesis.
[141]
 In the last century, syntheses of nitrogen-containing heterocycles were well 
established by transition metal (TM) catalysts using prefunctionalized precursors.
[142]
 
Nevertheless, metal-free methods in the synthesis of heterocycles are becoming more 
interesting field due to atom economic and environmentally friendly nature in modern 
chemistry. However, the development of new method for the synthesis of nitrogen-based 
heterocycles such as isoquinolone employing cheaper and user friendly hypervalent iodine 
(III) reagents via C–H bond amination is highly demanded.[119] 
 
Scheme 3.1. Transition metal catalyzed directed quinolones synthesis. 
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In the last decades, several methods to isoquinilones synthesis were reported using transition 
metal catalyst such as Rh, Ru, Ni and Pd applying different approaches (Scheme 3.1). 
[102-108, 
115, 143]
 First, Fagnou and co-workers were initiated the annulation of benzamides with alkynes 
for the synthesis of isoquinolone derivatives employing Rh-catalyst via direct C–H bond 
activation using directing group as an internal oxidant.
[102-104]
 Very recently, Ackermann and 
co-workers disclosed Ru-catalyzed an efficient approach to annulation of N-
hydroxybenzamides, N-methoxybenzamides, N-methylbenzamides and alkynes for the 
demonstration of isoquinolines.
[108, 115]
 Pd-catalyzed synthesis of isoquinolines was developed 
by Huang and co-workers employing atmospheric oxygen as an external oxidant for this 
transformation.
[144]
 Chatani and co-workers independently developed first nickel catalyzed 
chelation-assisted cycloaddition of benzamides with alkynes for the synthesis of 
isoquinolones scaffolds where alkyne was used as an internal oxidant in this 
transformation.
[145]
 However, reported methods require higher temperature, external oxidant 
or internal oxidant and longer reaction time in the synthesis of isoquinolone scaffolds. It is 
notable that metal-free method for isoquinolones synthesis has never been investigated. 
Therefore, a mild, efficient and organocatalytic conditions for the synthesis of isoquinolone 
scaffolds would be highly desirable.  
3.2 Results and Discussion 
3.3 Studies on the Optimization of Reaction Conditions  
We initiated our optimization studies with N-methoxybenzamide (136a) and commercially 
available diphenylacetylene (134a) in the presence of PhI(OAc)2 (22) as oxidant in HFIP as a 
solvent at room temperature for 12 h and the desired product 137a was obtained in 40% yield 
(Table 3.3.1). Encouraged by the initial result, we then started the optimization of 
isoquinolone scaffold synthesis with iodobenzene (138) as a catalyst and 3-chloroperbenzoic 
acid as oxidant. We found that the catalytic amount of iodobenzene (138) was effective for 
this transformation. After screening several oxidants for in-situ generation of hypervalent 
iodine (III) with PhI (138), we found that peracetic acid was to be the best oxidant to provide 
the desired product 137a in 68% yield. Later, we examined the oxidative annulation with 
PhI(OCOCF3)2 (23) instead of 138 and peracetic acid to obtain good conversion. We did not 
obtain our target product 137a in the presence of stoichiometric amounts of PhI(OCOCF3)2 
(23). Afterwards, we tested different solvents for the oxidative annulation. Pleasingly we 
found that HFIP was to be the best solvent and provided the desired product 137a in 68% 
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yield (Table 3.3.1, entry 3). The annulated product 137a was not observed in MeOH, EtOAc, 
CHCl3 or DCE as a solvent. After screening several solvents, various iodobenzene 
Table 3.3.1. Optimization of reaction conditions for isoquinolone synthesis.
[a]
 
 
Entry Solvent ArI (mol%) Oxidant Yield (%) 
1
[b,c]
 HFIP - PhI(OAc)2,  40 
2
[d]
 HFIP PhI (138) mCPBA 52 
3 HFIP 138 AcOOH 68 
4 HFIP 138 DTBP n.d. 
5 HFIP 138 H2O2 n.d. 
6 CF3CH2OH 138 AcOOH 44 
7 HFIP - PhI(OCOCF3)2  n.d. 
8 HFIP:DCM (1:1) 138 AcOOH 41 
9 CHCl3 138 AcOOH n.d. 
10 MeOH 138 AcOOH 44 
11 DCE 138 AcOOH n.d. 
12 HFIP 4-MeOC6H4I (138b) AcOOH 5 
13 HFIP 4-MeC6H4I (138c) AcOOH 20 
14 HFIP 4-NO2C6H4I (138d) AcOOH n.d. 
15
[e]
 HFIP 138 AcOOH 64 
16
[f]
 HFIP 138 AcOOH 78 
17
[g]
 HFIP 138 AcOOH 73 
18
[h]
 HFIP 138 AcOOH 55 
 [a] Reaction conditions: 136a (0.15 mmol), 134a (0.18 mmol), ArI (10-20 mol%) in solvent (0.25 M) for 30 
min. [b] Reactrion was carried out for 12 h. [c] PhI(OAc)2 (2 equiv) used. [d] m-CPBA (1.5 equiv) used. [e] 
catalyst 138e (2,2’,6.6’-tetramethylbiphenyl) 10 mol% was used. [f] Peracetic acid was added portion wise. [g] 
1.5 equiv AcOOH was used. [h] 15 mol% catalyst was used. HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol. DCE = 
1,2-dichloroethane. n.d. = not detected. 
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derivatives were anticipated in combination with peracetic acid at ambient temperature in 
HFIP solvent to achieve the best yield. The iodobenzene (138) was found to be the best 
catalyst and provided the desired product 137a in 73% yield. Dramatically yield was 
increased to 78% while 1.5 equivalents peracetic acid was added by portion wise. Notably, 
improvement of yield did not observe when the amount of peracetic acid was increased or 
decreased under the same reaction conditions. 
3.4 Scope of Iodobenzene-Catalyzed Oxidative Annulation  
With the optimal reaction conditions in hand, we next explored the scope of reaction with 
various substituted alkynes 134 with N-methoxybenzamide derivatives 136 (Table 3.4.1). We 
found that the reaction was very facile and provided the desired products in good to excellent 
yield. The reaction of alkyne bearing electron-withdrawing as well as electron-donating  
Table 3.4.1. Scope of different alkynes.
[a] 
 
Entry R
1
 R
2
 R
3
 R
4
 Product Yield (%) 
1 H H Ph Ph 137a 78 
2 OMe OMe 4-MeC6H4 4-MeC6H4 137b 82 
3 H H 3-MeC6H4 3-MeC6H4 137c 60 
4
[b]
 OMe OMe Ph 4-CF3C6H4 137d 53 
5
[b]
 H H Ph 4-CF3C6H4 137e 71 
6
[c]
 OMe OMe Ph 4-FC6H4 137f 61 (2:1) 
7
[c]
 H H Ph 4-FC6H4 137g 53 (2:1) 
8
[b]
 H H Ph 4-NO2C6H4 137h 50 
9
[d]
 OMe OMe 4-MeOC6H4 Ph 137i 50 
10 H H Ph H 137j n.d. 
11 H H CH2Cl CH2Cl 137k n.d. 
12 H H Cycloheyl H 137l n.d. 
[a] Reaction conditions: 137 (0.15 mmol), 134 (0.18 mmol), 20 mol% 139 in HFIP (0.25 M) at RT for 30-120 
min. [b] 25 mol% catalyst loading. [c] Yield of mixture of isomers were shown in the table. [d] PhI(OAc)2 (1.5 
equiv) used instead of catalytic conditions. n.d. = not detected. 
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groups at the para-position on the aryl part of diphenylacetylene were well tolerated and 
afforded cyclized products in good yield. Various functional groups such as trifluoromethyl, 
fluoro, nitro and methoxy on the aryl part were tolerated under mild reaction conditions and 
delivered the desired products (137b-137h) in good to moderate yield. With para substituted  
Table 3.4.2. Scope of different benzamides.
[a] 
 
Entry R
1
 R
2
 R
3
 R
4
 Product Yield (%) 
1 H H H C6H17 139a 81 
2 H H H nBu 139b 85 
3 H H H 
i
Pr 139c 76 
4
[b]
 H H H PhCH2 139d 56 
5 H H H 2-Methylallyl 139e 75 
2 H OMe OMe Me 139f 64 
9 Me H H Me 139g 68 
10
[c]
 H Me H Me 139h 65 (3:1) 
6 H H Me Me 139i 74 
7 H H 
t
Bu Me 139j 69 
8 H H Ph Me 139k 65 
11
[c]
 H OCF3 H Me 139l 54 (5:4) 
12 H H H Ph 139m n.d. 
13 H H H Me 139n n.d. 
14 H H OMe Me 139o n.d. 
15 H H SMe Me 139p n.d. 
[a] Reaction conditions: 136 (0.15 mmol), 134a (0.18 mmol), 20 mol% PhI 138 in HFIP (0.25 M) at RT for 30-
120 min. [b] 10 mol% 138e catalyst, 5 equiv TFA and 2 equiv AcOH were used and run up to 4 h.  [c] Major 
isomer has shown in the Table. n.d. = not detected. 
unsymmetrical alkynes such as methoxy, nitro and trifluoromethyl group; regioselectively 
delivered single isomer and the structures were established based on NOE analysis. Notably, 
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methyl group in the meta and para-position of diphenylacetylene worked well and afforded 
the isoquinolone derivatives (137b and 137c) in moderate to good yields.  
After explored the scope of alkynes, a wide range of N-alkoxy group of benzamide derivatives 
were also investigated with simple diphenylacetylene (134a) under developed reaction 
conditions (Table 3.4.2). We observed long chain aliphatic groups such as octane and n-
butane could be produced the annulated products 139a and 139b under organocatalytic 
reaction conditions in excellent yield. The reaction of 134a with N-isopropyloxy benzamide 
also provided the desired product 139c in 76% yield without any difficulty. The 
benzyloxybenzamide as a substrate was also investigated and obtained the desired product 
139d in 56% yield. N-((2-Methylallyl)oxy)benzamide produced the desired product 139e in 
75% yield without oxidation of terminal alkene. We next turned our attention to the different 
benzamide derivatives for the synthesis of isoquinolone scaffolds. The electron-rich 3,5-
methoxybenzamide selectively reacted with 134a under our optimal reaction condition and 
provided the corresponding product 139f in 64% yield. Notably, the reaction of 
diphenylacetylene (134a) with methyl substituted benzamideamides led to form target 
products 139h and 139i in moderate to good yield. Pleasingly, we found that para-substituted 
electron-rich benzamides reacted smoothly with diphenylacetylene (134a) and afforded the 
desired isoquinolones 139i-139k in good yield. para-Substituted methoxy and thiomethyl 
groups of N-methoxybenzamide did not gave the desired product under developed reaction 
conditions. Phenyl substituted benzamide slowly reacted to give corresponding isoquinolone 
139k in 65% yield. Unfortunately, strong electron-withdrawing benzaamide derivatives did 
not give the desired product. N-Methylbenzamide and N-phenylbenzamide did not give yield 
under developed reaction conditions. 
3.5 Determination of the Regioisomers 
3.5.1 1-D NOE Experiments for Product 137i 
NOE experiment was performed to identify regioisomer of product 137i (Figure 3.1). 
According to the NOE analysis, H
b
 correlated with proton H
a 
and proton H
c 
after irradiation 
of proton H
b
. Proton H
b
 on irradiation shows no correlation with OMe
a
 which indicated that 
H
b 
is far from
 
OMe
a 
group. After irradiation of proton H
c
, there was correlation with proton 
H
b
 and OMe
b 
and no correlation observed with OMe
a
. NOE experimental result suggested 
that Ph group close to N–OMe group. 
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Figure 3.1. Identification of regioisomer of product 137i by NOE experiments. 
3.5.2 1-D NOE Experiments for Product 137d 
Similarly, NOE experiment was carried out for product 137d (Figure 3.2) to identify 
regioisomer. Upon irradiation of proton H
a
 which correlated with proton H
b 
and OMe
a
. 
Proton H
d
 on irradiation does not correlation with proton H
c 
which indicated that H
c 
is close 
to H
d
 of 4-methoxybenzene group. Upon irradiation of proton OMe
a 
which shows correlation 
with proton H
a 
and no correlation with proton H
d
. NOE studies suggested that Ph group far to 
N–OMe group. 
 
Figure 3.2. Identification of regioisomer of product 137d by NOE experiments. 
3.6 Mechanism 
Based on our preliminary investigation and experimental studies, a plausible mechanism has 
been shown in Scheme 3.2. The active species 22 was generated via in-situ oxidation of 
iodobenze 138 in the presence of peracetic acid. Afterwards, the intermediate 140 produced 
via the ligand exchange of N-methoxybenzamide 136a after reacting with the intermediated 
22. Then nitrenium intermediate 141 was generated through reductive elimination of 
intermediated 140 which subsequently trapped by alkyne 134a to give probable intermediate 
141a. Finally, isoquinolone 139 was formed followed by hydrogen abstraction by acetate 
anion and the producing acetic acid as byproducts. 
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Scheme 3.2. Proposed mechanism for organocatalyzed annulation. 
3.7 Synthetic Application of Product 137a 
To apply follow up reaction, we examined N–O bond cleavage to N–H bond by applying 
reported method (Scheme 3.3).
[146]
 N-H bond formation could be applied using NaH by the 
reduction of N–O bond. Finally, we anticipated compound 137a with 2 equivalents of NaH in 
DMF at 120 ºC to afford 142 in 83% yields. 
 
Scheme 3.3. N–O bond cleavage of product 137a. 
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3.8 Identification of Biological Activity of Isoquinolones 
According to our plan, we synthesized compound libraries of isoquinolone derivatives. 
Afterwards, we submitted all compound to COMAS (Compound Management and Screening 
Centre) in Dortmund to find the biological activity. Several cell-based assays such as 
hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. After 
screening different assays, four compounds 137a, 137b, 137h and 139e inhibited the 
hedgehog signaling pathway in the low micro molar range (Table 3.8.1). 
Table 3.8.1. Results of hedgehog signaling pathway.  
Entry Product IC50 [µM] Viability [µM] 
1 
                             137a 
5.52 ± 0.38 inactive 
2 
      137b  
4.69 ± 0.21 inactive 
3 
               137h 
4.31± 0.56 inactive 
4 
                 139e 
5.10 ± 0.46 inactive 
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(Part of this result already published: S. Manna, K. Matcha, A. P. Antonchick, Angew. Chem. 2014, 126, 8302-
8305; Angew. Chem. Int. Ed, 2014, 53, 8163-8166).
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4.1 Introduction 
Hypervalent iodine (III) mediated oxidative C–N bond formation is one of the most 
fascinating reactions in organic chemistry due to its efficient and cost reliable to build up 
diverse compound libraries.
[78] 
 It has been used in many fields such as pharmaceutical, 
biological relevant molecules development and natural products synthesis.
[147-152] 
One of the 
key objectives of this method is the utilization of readily available starting materials to get a 
wide range of molecular diversities under simple reaction conditions. Utilization of I(III) 
reagents has seen explosive growth in modern organic synthesis due to its easily available and 
user friendly.
[153]
 Nevertheless, the synthesis of nitrogen-containing heterocycles such as 
pyridoimidazoles and pyridobenzimidazoles via oxidative annulation approaches without 
prefunctionalized building blocks would be highly desirable transformation.  
 
Scheme 4.1. Various routes in the synthesis of pyrido[1,2-a]benzimidazoles. 
In the recent years, several methods for intramolecular pyridobenzimidazoles synthesis were 
developed using hypervalent iodine (III) reagents from prefunctionalized feedstocks.
[88, 91, 154-
155] 
Synthesis of pyridobenzimidazole of N-aryl-2-aminopyridines was disclosed by Zhu and 
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co-workers employing copper(II) and iron(III) as catalyst (Scheme 4.1).
[156] 
Later, Zhu and 
co-workers developed hypervalent iodine (III) mediated pyrido[1,2-a]benzimidazoles with N-
aryl-2-aminopyridines and N-benzylpyridin-2-amines (Scheme 4.1).
[81, 157]
 However the 
reported methods are only intramolecular approaches (Scheme 4.1). Synthesis of pyrido[1,2-
a]benzimidazoles via intermolecular way has never been reported.
[158]
 In this context, it would 
be a significant advantage to discover a direct intermolecular annulation of 2-aminopyridines 
with non-prefunctionalized arenes. In the continue of our studies, we were interested to 
develop PhI(OAc)2 (22) mediated oxidative annulation of 2-aminopyridine derivatives 144 
with simple arenes 149 for the synthesis of the pyrido[1,2-a]benzimidazole scaffolds.  
4.2 Results and Discussion 
4.3 Studies on the Optimization of Reaction Conditions 
Having interests from our previous studies on the annulation of benzamides with alkynes, we 
were motivated to develop a new method for oxidative annulation of 2-aminopyridine (144a) 
with non-functionalized arene under metal-free conditions. We began our initial studies with 
2-aminopyridine (144a) and para-xylene (159a) as model substrates to examine the 
annulation by employing hypervalent iodine (III) reagents. While the reaction was carried out 
with 2-aminopyridine (144a) and para-xylene (149a) in the presence of two equivalents 
PhI(OAc)2 (22) as oxidant at room temperature in HFIP, the desired product pyrido[1,2-
a]benzimidazoles derivative (151a) was isolated in 63% yield. Afterwards, we tested different 
temperature for the annulation reaction. To our delight, when reaction was performed at 70 
⁰C, the desired product formation decreased to 19% yield. Changing the reaction temperature 
to 40 ⁰C, formation of the desired product 151a was increased to 74% yield. After screening 
different solvents, we found that HFIP was to be the best solvent in this transformation. We 
did not obtain target product 151a while dichloromethane, 1,2-dichloroethane, 2,2,2-
trifluoroethanol or toluene were used as a solvent. The solvent combination with HFIP and 
dichloromethane (1:1) did not give promising results. Later, we investigated the application of 
various hypervalent iodine (III) reagents for oxidative annulation reaction. Surprisingly, 
highly reactive PhI(OCOCF3)2 (23) did not provide the desired product 151a. Less reactive 
PhI(OCO
t
Bu)2 (22a) was able to produce the desired product 151a in 33% yield. Notably, the 
yield was decreased with increase or decrease the amount of PhI(OAc)2 (22) instead of 2 
equivalents reagents. Finally, we found that 2 equivalents of PhI(OAc)2 (22) was to be the 
best reagent for this transformation. However, increasing the amount of the arene did not give 
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the benefit for the oxidative annulation reaction (Table 4.3.1, entry 16), but decreasing 
amount of arene provided lower yield (Table 4.3.1, entry 15). 
Table 4.3.1. Optimization of oxidative annulation reaction conditions.
[a]
 
 
Entry Solvent (0.25M) I(III) reagent (equiv) Temp (
o
C) Yield (%) 
1 HFIP PhI(OAc)2 (2) RT 63 
2 HFIP PhI(OAc)2 (2) 40 74 
3 HFIP PhI(OAc)2 (2) 70 19 
4 DCM PhI(OAc)2 (2) 40 n.d. 
5 HFIP:DCM (1:1) PhI(OAc)2 (2) 40 31 
6 CF3CH2OH PhI(OAc)2 (2) 40 n.d. 
7 Toluene PhI(OAc)2 (2) 40 n.d. 
8 DCE PhI(OAc)2 (2) 40 n.d. 
9 HFIP PhI(OCOCF3)2 (2) 40 n.d. 
10 HFIP PhI(OCO
t
Bu)2 (2) 40 33 
11 HFIP PhI(OAc)2 (1.5) 40 48 
12 HFIP PhI(OAc)2 (1.75) 40 63 
13 HFIP PhI(OAc)2 (2.5) 40 68 
14 HFIP PhI(OAc)2 (3) 40 44 
15
[c]
 HFIP PhI(OAc)2 (2) 40 55 
16
[d]
 HFIP PhI(OAc)2 (2) 40 75 
17 DCM PhI(OCOCF3)2 (2) 40 n.d. 
[a] Reaction conditions: 144a (0.2 mmol), 149a (1.0 mmol), I(III) reagent (equiv) in solvent (0.25 M) and 
temperature for 12 h. [b] 149a (0.4 mmol) used. [c] 149a (2.0 mmol) used. DCE = 1.2-Dichloroethane.  n.d. = 
not detected. 
4.4 Substrate Scope of PhI(OAc)2 Mediated Oxidative Annulation 
With the optimized reaction conditions in hand, we moved to explore the oxidative annulation 
reaction. At first, a series of simple arenes were examined for the annulation (Table 4.4.1). To 
our delight, the reaction was found to be very facile with various electron- rich arenes. 
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Table 4.4.1. Scope of oxidative annulation of different arenes.
[a] 
 
[a] Reaction conditions: 144 (0.2 mmol), 149 (1.0 mmol), PhI(OAc)2 (0.4 mmol) in HFIP (0.25 M) at 40 °C for 
12 h. [b] 149 (0.6 mmol) used. [c] After 12 h, PhI(OAc)2 (0.2 mmol) was added and the reaction continued for 
24 h. [d] 4-bromo-2-aminopyridine was used. [e] Major isomer is shown, minor isomer is indicated with star and 
the yields were reported for mixtures. [f] 4-Me-2-aminopyridine was used. n.d. = not detected. 
Simple electron-rich arenes such as anisole (149a) and diphenyl ether (149b) provided the 
corresponding products 151b and 151c in excellent yields. After successfully established 
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monosubstituted arenes, we then examined multisubstituted arenes and found disubstituted 
arenes were well tolerated under optimal reaction conditions and provided products in good to 
excellent yield (Table 4.4.1, entries 4, 7-10). Various disubstituted arenes also were well 
tolerated and provided the desired products with excellent to moderate yields 151g-151j. 
Naphthalene derivatives 149e was investigated in the metal-free annulation reaction and 
obtained the desired products 151e in 67% yield with regioisomer in 5:1 ratio. Furthermore, 
toluene (149f) also provided the desired annulation products in acceptable yields. 
Tetrahydronapthalene (149j) worked well and gave a mixture of regioisomers with 1.3:1 ratio. 
Interestingly, less electron-deficient iodobenzene (138) also provided the desired product 
151k in 49% yield. An electron-deficient arenes such as nitrobenzene, chlorobenzene and 
Table 4.4.2. Scope of oxidative annulation of different 2-aminipyridines.
[a]
 
 
Entry R
1
 R
2
 R
3
 R
4
 Product Yield (%) 
1 H H Br H 152a 86 
2 H H F H 152b 59 
3 H H Me H 152c 75 
4 H Me H H 152d 72 
5 H H H Me 152e 72 
6 H Me H Br 152f 76 
7 Br H Br H 152g 57 
8 H Me Br Me 152h 87 
9 OAc H H Me 152i 80 
[a] Reaction conditions: 144 (0.2 mmol), 149a (1.0 mmol), PhI(OAc)2 (0.4 mmol) in HFIP at 40 
o
C for 12 h. [b] 
152b (0.6 mmol) used. [b] After 12 h PhI(OAc)2 (0.2 mmol) was added and the reaction continued for 24 h. [c] 
Obtained from product 152e by adding additional PhI(OAc)2  (0.2 mmol) and reaction time of 24 h. 
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fluorobenzene did not provide the desired product under optimized conditions. Phenol and 
benzene did not yield the desired product under develop reaction conditions. 
Having established the scope of different arenes, we next investigated the scope of various 2-
aminopyridine derivatives in the metal-free oxidative annulation reaction conditions (Table 
4.4.2). We found that various functionalized 2-aminopyridine derivatives worked very well 
and provided the corresponding desired products (152a-152i) in good to excellent yield. We 
observed that the oxidative annulation was very facile with 2-aminopyridines bearing 
electron-donating as well as electron-withdrawing groups at various position of pyridines. 
Further, disubstituted 2-aminopyridines were investigated and obtained the corresponding 
products 152f-152g in moderate to good yields. Disubstituted electron-withdrawing 2-
aminopyridine worked well and provided the desired product 152h in 57% yield. 
Trisubstituted 2-aminopyridine also provided the desired product 152g in excellent yield. It is 
notable that product 152i could be directly obtained using excess amount of PhI(OAc)2 (22) in 
the one-pot reactions with product 152e. 
Table 4.4.3. Scope of oxidative annulation of 2-aminoquinolines.
[a] 
 
[a] Reaction conditions: 153 (0.2 mmol), 149 (1.0 mmol), PhI(OAc)2 (0.6 mmol was added in 3 portions every 6 
h) in HFIP (0.25 M) at 40 °C for 18 h.  
Later, we found interesting demethylated benzo[4,5]imidazo[1,2-a]quinolinee derivative 
formation while 2-aminoquinoline (153a) was used instead of 2-aminopyridine (144a) with 
para-xylene (Table 4.4.3). Afterwards, we were interested to expand the scope of 
demethylation of arene for the demonstration of biologically relevant benzo[4,5]imidazo[1,2-
a]quinolinee scaffolds. In this context, 2-aminoquinoline and para-xylene (149a) were 
subjected to our optimized reaction conditions and obtained the corresponding product 154a 
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in 60% yield. Then, we examined the generality of this unprecedented oxidative annulation 
under developed reaction conditions. To our delight, 4-iodotoluene also provided the desired 
annulation product 154b in 45% yield. 6-Fluro-2-aminoquinoline worked well under 
developed conditions and provided the desired product 154c in 57% yield. 
4.5 Determination of the Regioisomers 
4.5 1-D NOE Experiments for Product 151i 
NOE experiment was carried out for product 151i (Figure 3.2) to identify regioisomer. Upon 
irradiation of proton H
a
 which shows the correlation with proton H
b 
and Me
a
 but there is no 
correlation between H
a
 with proton H
c
. Upon irradiation of proton H
c 
which shows 
correlation with proton H
d 
but there is no correlation with H
b
. NOE experimental result 
suggested that Et group in 6
th
 position of product 151i. 
 
Figure 4.1. Identification of regioisomer of product 151i by NOE experiments. 
4.6 Studies on Reaction Mechanism 
Further, we performed several experimental studies to gain insight into the reaction 
mechanism. We thought that reaction underwent through N-arylpyridine intermediate. 
According to our hypothesis, we have prepared the probable intermediates and conducted the 
control experiments in our standard protocol. 
4.6.1 Reaction with Probable Intermediate 155 
 
Scheme 4.2. Control experiment with the intermediate 155 
The intermediate 155 was investigated under standard protocol for oxidative annulation. We 
found that the intermediate 155 provided the desired product 151a in 95% yield (Scheme 4.2). 
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This result suggested that the reaction of 2-aminopyridine (144a) underwent via the 
intermediate 155. 
4.6.2 Reaction with Probable Intermediate 156 
Later, we thought that annulation of 2-aminoquinoline occurred similar type of 2-
aminopyridine intermediate. Afterwards, we tested our standard protocol with probable 
intermediate 156 (Scheme 4.3). We obtained product 157 instead of product 154a with 
excellent yield under standard reaction conditions.  
 
Scheme 4.3. Control experiment with the intermediate 156. 
After this experiment, we were confirmed that the reaction of 2-aminoquinoline did not 
undergo through intermediate 156. From this experiment, we hypothesized that reaction 
underwent via benzylamine intermediate.  
4.6.3. Reaction with Probable Intermediate 156a 
 
Scheme 4.4. Control experiment with the intermediate 156a. 
Additionally, we performed control experiment with benzylamine intermediate 156a under 
optimized reaction conditions and obtained the desired product 154a in 80% yield (Scheme 
4.4). This result suggested that the annulation reaction of 2-aminoquinoline underwent 
through benzylamine intermediate. 
Chapter 4. PhI(OAc)2 Mediated Oxidative Annulation 
- 48 - 
 
4.6.4 Kinetic Isotope Effect Study of 2-Aminopyridine
[159]
 
After intermediate studies, we conducted a kinetic isotope effect experiment of p-xylene 
(149a) and deuterated p-xylene (149b) with 2-aminopyridine (144a) under our optimal 
reaction conditions (Scheme 4.5). We observed small kinetic isotope effect (kH/KD = 1.4). 
This result suggested that the abstracting of hydrogen is not rate-limiting step in the oxidative 
annulation reaction. 
  
Scheme 4.5. Kinetic study of p-xylene (149a) and deuterated p-xylene (149b). 
4.6.5 Kinetic Isotope Effect Study of 2-Aminoquinoline 
Further, we set up a kinetic isotope effect experiment of 2-aminoquinoline (153a) with p-
xylene (149a) and deuterated p-xylene (149b) and obtained kinetic isotope effect equal to 
1.4 (Scheme 4.6). This result suggested that the hydrogen abstraction of p-xylene is not rate-
limiting step. 
 
Scheme 4.6. Kinetic study of p-xylene (149a) and deuterated p-xylene (149b). 
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4.7 Mechanism 
Based on our experimental studies and literatures reports, a plausible mechanism for oxidative 
annulation of 2-aminopyridine derivative with p-xylene (149a) has showed in Scheme 4.7.  
 
Scheme 4.7. Proposed mechanism for 2-aminopyridine. 
 
The intermediate 160 was formed after reacting with PhI(OAc)2 (22) and 2-aminopyridine 
derivative (159) via ligand exchange of acetate. Then, the intermediate (160) led to generate 
the nitrenium ion (161) via reductive elimination of the intermediate 160 which subsequently 
trapped by arene (149a) and provided N-arylated-2-aminopyridine 162. Following oxidation 
of the intermediate 162 with one equivalent of PhI(OAc)2 (22) produced nitrenium ion 164. 
The intermediate 164 could be stabilized via resonance which generated the more stable ion 
165. The intermediate 165 readily underwent intramolecular cyclization to form intermediated 
166. Finally, aromatization of intermediate 166 followed by hydride abstraction in the 
presence of acetate anion provided the annulated product 152c. 
In the case of 2-aminoquinoline (153a), initially the intermediate 167 was generate by the 
oxidation of methyl group of the 144a through successive single-electron transfer from 
PhI(OAc)2 (22) to generate the benzylic carbocation 167a.
[84]
 The carbo cation was readily 
attacked by 2-aminoquinoline (153a) to form the intermediate 168 (Scheme 4.8). Then, the  
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Scheme 4.8. Proposed mechanism for 2-aminoquinoline. 
intermediate 168a was formed by reacting with one equivalent of PhI(OAc)2 (22), which 
underwent oxidative degradation through an ipso-attack to form the cationic species 168b. 
The tertiary amine intermediate 169 was generated by the aziridine ring opening through 
attacking of HFIP molecules. Afterwards, attacks of HFIP lead to cleavage of the carbon-
nitrogen bond of the intermediate 169a which represents the formal loss of a methyl group 
from the arene substrate. This step initiates the intramolecular cyclization to form the cationin 
species 171, which rearomatizes to provide the final product 172.  
4.8 Identification of Biological Activity of Pyrido[1,2-a]benzimidazole Derivatives 
According to our plan, we synthesized compound libraries of pyrido[1,2-a]benzimidazole 
derivatives. Afterwards, we submitted all compound to COMAS (Compound Management 
and Screening Centre) in Dortmund to find the biological activity. Several cell-based assays 
such as hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. 
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After screening different assays, compounds 151i inhibited the hedgehog signaling pathway 
in the low micro molar range (Figure 4.8). 
 
 
Figure 4.8. Results of hedgehog signaling pathway. 
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5.1 Introduction 
Metal-free carbon-nitrogen (C–N) bond formation is highly attractive method from the atom-
economic point of view, least amount of chemical waste and sustainable green process.
[160-161]
 
In the last few decades, hypervalent iodine (III) reagents have found very important roles in 
organic synthesis. In this context, hypervalent iodine (III) mediated C–H bond amination is 
becoming an attractive field because of many advantages such as the simplicity of this method 
and efficiency. Nevertheless, hypervalent iodine (III) mediated oxidative amination has 
emerged as a prime topic in organic chemistry for the construction of C–N bond without 
prefunctionalized building block. N-Arylated heteroaryl amines represents in many natural 
products and biologically active drug molecules.
[77, 162-164]
 Despite their importance in organic 
synthesis, the discovery of a new method for the practically valuable N-aryled heteroaryl 
amines synthesis with non-prefunctionalized arenes under metal-free conditions would be 
highly attractive method.  
 
Scheme 5.1. Oxidative amination of arene. 
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Reported synthetic routes to N-aryl amines require harsh reaction conditions and higher 
temperature.
[165-167]
 Recently, several attractive methods to N-arylamines synthesis employing 
non-prefunctionalized arenes were developed using protected amines.
[78, 83, 168]
 Antonchik and 
co-workers disclosed hypervalent (III) mediated oxidative aminations of simple arenes 
[Scheme 5.1, (a), (c) and (d)].
[79, 90, 169-170]
 Very recently, Chang and Deboef group reported 
hypervalent iodine (III) mediated amination of simple arene with protected amine [Scheme 
5.1, (b)].
[83-84]
 During our studies on metal-free intermolecular amination of 2-aminopyridine 
with simple arene employing hypervalent iodine (III) reagents for the synthesis of 
pyridobenzimidazoles, we envisaged that development of oxidative amination of 
heteroarylamines with non-prefunctionalized arenes would be highly attractive method. 
Animation of heteroarylamines with unactivated arene has never been investigated. Therefore, 
we were interested in the development of a novel method for the N-arylated heteroaromatic 
amines synthesis with simple arenes under metal-free conditions. 
5.2. Results and Discussion 
5.3. Studies on the Optimization of Reaction Conditions 
We began our studies by the investigation of oxidative amination of 2-aminopyridine (144a) 
with mesitylene (177a) in the presence of PhI(OAc)2 (22) as oxidant in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP) at room temperature and the desired product was obtained in 
86% yield. Afterwards, Ms. Polina O. Serebrennikova optimized the reaction conditions along 
with me. Having fully optimization reaction conditions in hand, we next explored the 
substrate scope with various 3-aminopyridine derivatives having differently functional groups 
with mesitylene (177a). Part of this project was included in this thesis.  
5.4 Substrate Scope of PhI(OAc)2 Mediated Oxidative Amination 
Having optimized reaction conditions in hand, we next explored the substrate scope with 
various pyridine derivatives with mesitylene (177a). We were pleased to find out that various 
heteroaromatic amine derivatives could be transferred into the oxidative aminated products in 
moderate to good yields (Table 5.4.1). Electron-withdrawing groups onto the heterocycles 
were well tolerated and provided the corresponding product 178a-178c in excellent yield. 
Interestingly, highly substituted pyrimidine derivative could be efficiently converted into the 
corresponding desired product 178a in 93% yield. Afterwards, various substituted 3-
aminopyridine were tested and obtained excellent yield. It was noteworthy that 1-
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aminoquinoline (176e) and 2-aminoquinoline (176f) also gave the corresponding products 
178f and 178g in 48% and 85% yield. 
Table 5.4.1. Scope of oxidative aminations.
[a]
 
 
[a] Reaction conditions: 176 (0.25 mmol), mesitylene 177 (2.5 mmol), PhI(OAc)2 (1.1 equiv) in HFIP (0.25 M). 
[b] Reaction was carried out at 0 ˚C. 
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5.5 Organocatalytic Oxidative Amination 
Having motivation of PhI(OAc)2 (22) mediated oxidative amination of heteroaromatic amine 
derivatives with simple arenes, we were interested to develop organocatalytic oxidative 
amination of nonfunctionalized arenes to minimize the least amount of side product. 
Afterwards, we initiated the optimization studies between 3-aminopyridine (176d) and anisole 
(177a) with a catalytic amount of iodobenzene (138) in combination with peracetic acid as 
oxidant (Table 5.5.1). We found that catalytic amount of iodobenzene (138) was effective in 
this transformation and provided the desired product 178a in 45% yield. After screening of 
several oxidants, solvents and catalysts for the N-arylated heteroaromatic amines synthesis, 
finally we found that peracetic acid was to be the best oxidant for oxidative amination and 
provided the desired product 178a in 60% yield. 
Table 5.5.1. Optimization of oxidative amination reaction conditions.
[a]
 
 
Entry Solvent ArI (mol%) Oxidant (equiv) Yield (%) 
1 HFIP 138 (25) AcOOH (3) 45 
2 HFIP 138 (25) AcOOH (5) 60 
3 HFIP 138e (10) AcOOH (3) 30 
4 HFIP 138 (25) m-CPBA (2) 45 
5 DCE 138 (25) AcOOH (5) n.d. 
6 DCE 138e (10) AcOOH (2) n.d. 
7 HFIP - PhI(OAc)2  (2) 56 
8 CHCl3 - PhI(OAc)2 (2) trace 
9 HFIP - PhI(OCOCF3)2 (2) n.d. 
10 DCE - PhI(OCOCF3)2 (2) n.d. 
[a] Reaction conditions: 176d (0.25 mmol), arene 177a (2.5 mmol), ArI (x mol%), AcOOH (y equiv), added 
portion wise in 6 h) in HFIP (0.25 M). DCE = 1,2-Dichloroethane.  n.d. = not detected.  
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We did not obtain our target product 178a while PhI(OCOCF3)2 (23) was used for 
optimization. To our delight, HFIP was found considerably better solvent to give in 60% yield 
of the desired product 178a. The aminated product 178a was not obtained in CHCl3 or DCE 
as a solvent. 
Table 5.5.2. Scope of oxidative aminations.
[a] 
 
Entry R
1
 R
2
 R
3
 R
4
 R
5
 R
6
 R
7
 Product Yield (%) 
1 H H H H H OMe H 180a 60 
2 Cl H H Cl H OMe H 180b 58 
3 H CF3 H Cl H OMe H 180c 65 
4 H Br H H H OMe H 180d 54 
5 Me H H H Me H Me 180e 75 
6 Cl H H Cl Me H Me 180f 78 
7 H H H H H H OH 180g n.d. 
8 H H H H H H NH2 180h n.d. 
9 H H H H H H Cl 180i n.d. 
[a] Reaction conditions: 176 (0.25 mmol), arene 177 (2.5 mmol), PhI (25 mol%), AcOOH (5 equiv, added 
portion wise in 6 h) in HFIP (0.25 M). n.d. = not detected. 
Pleasingly, we found that a wide array of 3-aminopyridine derivatives were well tolerated 
under organocatalytic conditions and provided the corresponding desired products in 
moderates to good yields (Table 5.5.2). Various electron-withdrawing groups such as chloro, 
bromo, and trifluoromethyl onto the pyridines were able to yield the corresponding desired 
products 180b-180d and 180f. Electron-donating group onto the pyridine also worked well 
and delivered the desired product 180e in 75% yield. Electron-withdrawing arene such as 
chlorobenzene as well as electron-donating arene such as phenol and aniline were not 
tolerated under organocatalytic conditions.  
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5.6 Kinetic Isotope Effect (KIE) Study 
In addition, we conducted kinetic isotope effect (KIE) experiment between p-xylene (149a) 
and deuterated p-xylene (149b) with 3-aminopyridine (176d) under optimized reaction 
conditions and obtained kinetic isotope effect equal to 1 (kH/kD ≈ 1). This result suggested that 
the hydrogen abstraction from arene is not rate-determine step (Scheme 5.2).  
 
Scheme 5.2. Kinetic isotope effect (KIE) experiment. 
5.7 Mechanism 
On the basis of our experimental studies, a plausible mechanism has been described in the 
Scheme 5.3. The intermediate 182 could be obtained after reacting 3-aminopyridine (176d) 
with hypervalent iodine (III) reagent (22) via ligand exchange. After nucleophilic attacks of  
 
Scheme 5.3. Proposed mechanism for oxidative amination. 
mesitylene (177a) to the intermediate 182 which produced the intermediate 182a. 
Iodobenzene (138) and acetate anion was generated as a side product after reductive 
elimination of the intermediated 182. Afterward, rearomatization of intermediate 182a in the 
presence of acetate anion and provided the desired product 178e. 
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5.8 Synthesis of Carboline Scaffold
[171]
 
 
Scheme 5.4 Synthesis of Carboline. 
We were interested in the synthesis of the important carboline scaffold from the N-arylated 
heteroaromatic amine. Palladium catalyzed C–H activation was applied in the synthesis of 
carboline derivative (183). The desired product 183 was obtained in 53% yield from N-
arylated heteroaromatic amine 178h.  
5.9 Identification of Biological Activity of N-Arylated Heteroaromatic Amines 
According to our plan, we synthesized compound libraries of N-arylated heteroaromatic 
amines. Afterwards, we submitted all compound to COMAS (Compound Management and 
Screening Centre) in Dortmund to find the biological activity. Several cell-based assays such 
as hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. After 
screening different assays, compounds 178f inhibited the hedgehog signaling pathway and 
compound 178d inhibited autophagy in the low micro molar range (Table 5.9.1). 
Table 5.9.1. Results of hedgehog signaling pathway and autophagy. 
Entry Product Pathway IC50 [µM] Viability [µM] 
1 
  178f 
hedgehog 
signaling 
1.63±0.07 inactive 
2 
            178d 
autophagy 0.50±0.21 inactive 
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6.1 Introduction 
During the studies on oxidative annulation of 2-aminopyridines with arenes under metal-free 
conditions,
[172]
 we were motivated to develop a novel oxidative annulation of 2-
aminopyridines with alkynes in the synthesis of imidazopyridine derivatives. Unfortunately, 
we did not obtain our target product due to instability of alkyne under oxidative conditions in 
the presence of hypervalent iodine reagents. Despite huge importance of pyridoimidazole in 
biological studies, the development of an efficient method for pyridoimidazole scaffolds 
under metal-free conditions would be highly desirable.
[173-174]
  
 
Scheme 6.1. Annulation of nitrosopyridine. 
Over the past few decades, the strategy based on cycloaddition of nitrosoarene has emerged as 
a new route to construct heterocyclic compounds.
[175-176]
 Transition-metal catalyst has played 
a leading role in these fields for the transformation of cyclic compounds. Recently, the groups 
of Yamato and Studer disclosed nitrosopyridine
[47]
as a dienophile for nitroso Diels-Alder 
(NDA) reactions employing copper catalyst.
[48] 
Recently, Liu and co-workers independently 
demonstrated gold-catalyzed [3+3] cycloaddition of nitrosoarenes with alkenyldiazo 
esters.
[177]
 Arguably, the annulation of nitrosoarene require lower temperature and transition 
metal catalyst. However, the annulation of nitrosopyridine with various alkynes under metal-
free conditions for the synthesis of pyridoimidazole has never been investigated. Therefore, a 
mild and efficient metal-free condition for the synthesis of pyridoimidazole scaffolds is highly 
demanded. 
6.2 Results and Discussion 
6.3 Studies on the Optimization of Reaction Conditions 
We initiated our investigation with 2-nitrosopyridine (184a) and diphenylacetylene (134a) as 
a model substrate to explore annulation in acetonitrile without oxidant and catalyst (Table 
6.3.1). Initially, we obtained our desired product 189a in 20% yield. Encouraged by the initial 
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result, next various solvents were screened for the annulation reaction. We observed that 
acetonitrile, dichloromethane or chloroform were less effective to produce annulated product  
Table 6.3.1. Optimization of metal-free annulation reaction conditions.
[a]
 
 
Entry Solvent (1 mL) Additive (equiv) Time (h) Yield (%) 
1 MeCN - 24 20 
2 CH2Cl2 - 24 45 
3 CHCl3 - 12 65 
4 H2O - 12 n.d. 
5 MeOH - 12 n.d. 
6 CF3CH2OH - 24 40 
7 HFIP - 12 86 
8 EtOAc - 12 n.d. 
9 EtOH - 12 n.d. 
10 PhH - 12 n.d. 
11
[b]
 HFIP - 12 70 
12 HFIP: CH2Cl2 (1:1) CF3CO2H (2) 12 50 
13 MeOH CH3CO2H (2) 12 n.d. 
14 CHCl3 CF3CO2H (2) 12 20 
15 CHCl3 CF3CO2H (2) 12 15 
16 HFIP CF3CO2H (2) 12 54 
[a] Reaction conditions: 184a (0.25 mmol), 134a (0.28 mmol) in solvent (0.25 M) at 40 °C for 12 h. [b] Reaction 
was carried out at ambient temperature. n.d. = not detected. HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol 
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189a under catalyst and additive free reaction conditions. Protic solvents such as MeOH or 
EtOH did not provide the desired product 189a. While reaction was performed in nonpolar 
solvents such as benzene or 1,2 dichloroethane (DCE), we did not obtain the corresponding 
product 189a. After screening various solvents, we found that HFIP was to be the best solvent 
to provide (3+2) annulated product 189a in 70% yield at room temperature. Afterward, we 
tested 2,2,2-trifluoroethanol (TFE) for annulation and found the reaction is less effective, 
resulting the desired product in 40% yield. In the presence of additive, we did not get 
promising yield. Finally, the changing of temperature to 40 ºC, obtained the best result in 86% 
yield after 12 h. 
6.3.1 Structure Determination of Imidazo[1,2-a]pyridine 1-oxide 
The structure of the imidazo[1,2-a]pyridine 1-oxide was confirmed by X-ray single crystal 
structural analysis (Figure 6.1).  
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Figure 6.1. Crystal structure of product 194f. 
6.4 Scope of Annulation with Nitrosopyridines and Alkynes  
With fully optimized reaction conditions in hand, we then started to explore the scope of 
annulation reaction with symmetrical alkynes (Table 6.4.1). Various functional groups onto 
the alkynes were well tolerated under optimized conditions. To our delight, the alkyne bearing 
electron-donating groups as well as electron-withdrawing groups were able to produce the 
desired products in good to excellent yields (Table 6.4.1). Reactions of nitrosopyridine with 
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functionalized alkynes found to be facile to deliver the desired product. Simple, para-
substituted electron-donating alkynes such as methyl, methoxy and tert-butyl group onto the  
Table 6.4.1. Scope of metal-free annulation of alkynes.
[a] 
 
Entry R
1
 R
2
 R
3
 Product Yield (%) 
1 H Ph Ph 189a 86 
2 H 4-
t
BuC6H4 4-
t
BuC6H4 189b 95 
3 H 4-MeC6H4 4-MeC6H4 189c 88 
4 Me 4-MeOC6H4 4-MeOC6H4 189d 87 
5
[b]
 H 4-CF3C6H4 4-CF3C6H4 189e 77 
6
[b]
 Me 4-FC6H4 4-FC6H4 189f 91 
7 H thiophen-2-yl thiophen-2-yl 189g 86 
8 H Ph 4-NO2C6H4 189h 84 
9 H 4-MeOC6H4 Ph 189i 85 
10 Me 4-MeOC6H4 4-CNC6H4 189j 86 
[a] Reaction conditions: 184 (0.25 mmol), 94 (0.28 mmol) in HFIP (0.25 M) at 40 ºC for 12 h. [b] The reaction 
was performed at 60°C. 
aryl part provided corresponding products 189b-189d in excellent yields. To our delight, 
para-substituted electron-withdrawing alkynes such as trifluoromethyl and fluoro group also 
provided the desired product 189e-189f in excellent yields. Notably, 1,2-di(thiophen-2-
yl)ethyne reacted smoothly and delivered the corresponding product 189g in 92% yield. 
Having established scope of symmetrical alkynes, we next examined the scope of 
unsymmetrical diphenylacetylene derivatives under optimal conditions (Table 6.4.2, entries 8-
10). Pleasingly, we found that the reactions of unsymmetrical alkynes with nitrosopyridine 
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also were well tolerated. Pleasingly, an excellent yields were obtained when alkynes having 
various functional  
Table 6.4.2. Scope of metal-free annulation of alkynes.
[a]
 
 
[a] Reaction conditions: 184 (0.25 mmol), 190 (0.28 mmol) in HFIP (0.25 M) at 40 ºC for 12 h. [b] 2-Nitroso-5-
methyl-pyridine (2 equiv) was used, yield is given for a mixture of di- and mono adduct with ratio 8:1. n.d. = not 
detected.  
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group such as methoxy, nitro and cyano at the para-positions onto the aryl part of 
diphenylacetylene and provided the corresponding products 191h-191j.Notably, one side 
electron-donating group and other side electron-withdrawing group at the para-position of 
unsymmetrical diphenylacetylene derivative provided regioselectively single isomer 191j in 
86% yield under standard conditions. One side attached with aliphatic chain in the arylalkynes 
were examined under developed reaction conditions and obtained the desired products 191k-
191m excellent yield with regioselectively single isomer (Table 6.4.2, entries 1-4). Notably, 
steroid-derived complex molecule 190d was investigated under annulation conditions, and 
obtained the corresponding product 191d in 85% yield. Further, conjugate bis-alkyne 190e 
was employed and found to be facile to provide the desired product 191e in 63% yield. 
Table 6.4.3. Scope of metal-free annulation of various terminal alkynes.
[a]
 
  
Entry R
1
 R
2
 Time (h) Product Yield (%) 
1
[b]
 H 
 63a 
3  192a 76 (2:1) 
2
[b]
 H 
63b 
4 192b 78 (5:1) 
3
[b]
 Me 
63c 
5 192c 65 (3:1) 
4 Me 
63d 
2 192d 74 
5 H 
63e 
2 192e 87 
6 H 
 63f 
12 192f n.d. 
[a] Reaction conditions: 184(a-b) (0.25 mmol), 63 (0.28 mmol) in HFIP (0.25 M). [b] Major isomer is shown, 
and the yields were reported for mixtures. n.d. = not detected.  
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Having described internal alkynes, next we investigated the scope of various terminal alkynes 
under annulation reaction conditions (Table 6.4.3). Interestingly, we found that a wide range 
of functional groups onto the aryl part of terminal alkynes were tolerated and afforded the N–
oxideimidazo[1,2-a]pyridine derivatives in good to excellent yield. The election-rich 
disubstituted phenyl acetylene derivative (63d) produced the corresponding product 192d 
with selectively single isomer in 74% yield. The terminal alkyne of naphthalene derivative 
(63e) provided the desired product 192e with selectively single isomer in 87% yield. 
Unfortunately, aliphatic terminal alkyne did not provide the desired product. 
Table 6.4.4. Scope of metal-free annulation of various nitrosopyridines.
[a] 
 
Entry R
1
 R
2
 R
3
 R
4
 Product Yield (%) 
1 H Me H H 194a 67 
2 H H Me H 194b 82 
3 H H NO2 H 194c 96 
4 Cl H CF3 H 194d 64 
5 Br H Br H 194e 81 
6 H H Br H 194f 95 
7 H H H Me 194g 87 
[a] Reaction conditions: 193 (0.25 mmol), 134a (0.28 mmol) in HFIP (0.25 M) at 40 ºC for 12 h. 
Later, we sought to evaluate 2-nitrosopyridine derivatives 193 for annulation with 
symmetrical alkynes (Table 6.4.4). We were interested to expand the scope of various 
nitrosopyrines with diphenylacetylene 134a. To our gratification, various functional groups 
such as chloro, bromo, trifluoromethyl, methyl and nitro on the nitrosopyridine, provided the 
corresponding annulated products 194a-194g in good to excellent. Nitrosopyridine bearing 
electron-withdrawing groups such as nitro, trifluoromethyl, chloro and bromo were well 
tolerated and provide annulated products 194c-194f in excellent yield. Furthermore, electron-
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rich nitrosopyridines were investigated under developed reaction conditions and obtained the 
corresponding products 194a-194b and 194g in good to excellent yields.  
 
6.5 Determination of the Regioisomers 
6.5.11-D NOE Experiments for Product 189i 
NOE experiment was carried out for product 189i (Figure. 6.1) to identify regioisomer. Upon 
irradiation of proton H
a
 which correlated with proton H
b 
and Me group. Upon irradiation of 
Me group which shows correlation with proton H
a 
and H
d 
and there was no correlation with 
proton H
c
. After irradiation of proton H
b
 which showed correlated with proton H
a
 and OMe. 
NOE experimental result suggested that 4-methoxybenzene group close to Me group. 
 
Figure 6.1. Identification regioisomer of product 189i by NOE experiments. 
6.5.2 1-D NOE Experiments for Product 191c 
NOE experiment was carried out for product 191c (Figure 6.2) to identify regioisomer. Upon 
irradiation of proton H
a
, which correlated with proton H
b 
and H
c.
. There was no correlation 
between proton H
a
 and proton H
d
. Upon irradiation of proton H
c
 which shows correlation 
with proton H
a 
only
 
but there was no correlation between H
c
 and H
d
. NOE experimental result 
suggested that 4-nitrobenzene group close to proton H
c
. 
 
Figure 6.2. Identification regioisomer of product 191c by NOE experiments. 
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6.6 Scope of Annulation with Nitrosopyridines and Alkenes 
Having described the scope of alkynes, we further explored the scope of alkenes under 
optimal reaction conditions (Scheme 6.2). To our delight, we found that nitrosopyridine 
reacted with α methylstyrene to give the product 198 via ene-reaction.[178-179] Notably, the  
 
Scheme 6.2. Reaction of nitrosopyridines with alkenes. 
reaction between 4-methyl-6-nitrosopyridine and cis-stilbene, obtained product 194a which 
underwent through annulation and over oxidation with most probable dissolved oxygen of air. 
Furthermore, α-phenylstyrene was employed for the annulation reaction with nitrosopyridine 
and the target product 199 was isolated in 85% yield. Unfortunately, aliphatic alkene such as 
cyclohexene and butene did not give the desired product under developed reaction conditions. 
6.7 Scope of Deoxygenation of Imidazo[1,2-a]pyridine 1-oxide 
Further, we were interested to explore the cleavage of N–O bonds to obtain biologically 
important imidazo[1,2-a]pyridines scaffolds (Table 6.4.5).
[180]
 We were delighted to find that 
N–oxides of imidazo[1,2-a]pyridines could be deoxygenated under heating conditions. 
Notably, 2,3-diphenylimidazo[1,2-a]pyridine could be obtained from 189a upon heating at 
125 ºC. 3-Phenylimidazo[1,2-a]pyridine 1-oxide 192a was used for deoxygenation and 
obtained the target product 201b in 86% yield. Alkyl-substitution at C2 position of 
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imidazo[1,2-a]pyridine 1-oxide also provided the deoxygenated product 201c in 65% yield 
under heating conditions.  
Table 6.4.5. Scope of deoxygenations. 
 
Reaction conditions: 0.25 mmol N–oxide-imidazopyridines in solvent (0.5 M). [a] In MeCN at 125°C for 6 h, [b] 
In MeCN at 140°C for 12 h. [c] In EtCN at 150°C for 12 h. 
 6.8 Studies on Reaction Mechanism 
6.8.1 Radical Inhibition Test 
 
Scheme 6.3. Reaction with radical scavenger.  
In addition, we performed radical inhibition test with 2 equivalents of 2,2,6,6-
tetramethylpiperidine 1-oxyl (16) under standard reaction conditions (Scheme 6.3). We 
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observed formation the desired product only in 40 % yield after 12 h. Unfortunately, we did 
not observe any TEMPO (16) adduct product. Hence, reaction did not undergo via radical 
mechanism. 
6.8.2 Competition Study 
 
Scheme 6.4. Competition experiment.  
Furthermore, a competition experiment was carried out between electron-rich alkyne 95c and 
electron-deficient alkyne 95f with nitrosopyridine (184a) under standard reaction conditions 
(Scheme 6.4). We found that reaction of the electron-rich alkyne much faster than electron-
deficient alkyne. This result indicated that annulation reaction underwent through nucleophilic 
addition and followed by intramolecular cyclization.  
6.9 Mechanism 
 
Scheme 6.5. Proposed mechanism for metal-free annulation. 
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A plausible mechanism for (3+2) annulation has been described in Scheme 6.5. The nitroso 
group of pyridine (184e) was activated by HFIP solvent through the hydrogen bonding and it 
led nitrenium ion intermediate 202 formation which was subsequently trapped by alkyne 134a 
to form the intermediate 203. Then the vinyl cationic species was attacked by nucleophilic 
nitrogen of pyridine to generate intermediate 204. Afterwards, the rearrangement of nitrogen 
lone pair provided the desired produce 194a. 
6.10 Identification of Biological Activity of Imidazo[1,2-a]pyridine 1-oxides 
According to our plan, we synthesized compound libraries of imidazo[1,2-a]pyridine 1-oxide 
derivatives. Afterwards, we submitted all compound to COMAS (Compound Management 
and Screening Centre) in Dortmund to find the biological activity. Several cell-based assays 
such as hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. 
After screening different assays, three compounds 189b, 189e and 194e inhibited the 
hedgehog signaling pathway in the low micro molar range (Table 6.9.1). 
Table 6.9.1. Results of hedgehog signaling pathway. 
Entry Product IC50 [µM] Viability [µM] 
1 
      189b 
5.24 ± 0.39 inactive 
2 
      189e 
7.93 ± 0.29 inactive 
3 
             194e 
≥ 10 inactive 
 
 
 - 74 - 
 
  
 - 75 - 
 
 
 
 
 
 
 
Chapter 7 
Metal-Free Oxidative Dehydrogenative Diels-Alder 
Reaction of Alkylarenes with Electron-Deficient  
Alkenes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (This part already publish: S. Manna, A. P. Antonchick, Chem. Eur. J. 2017, 23, 7825-7829.) 
 
Chapter 7. Metal-Free Dehydrogenative Diels-Alder Reaction 
 
- 76 - 
 
7.1 Introduction 
Cross-dehydrogenative coupling (CDC) has become an attractive method due to their inherent 
economic and environmentally benign nature. 
[121, 181]
 In the last decades, CDC represents an 
efficient, atom economic and sustainable green methods for the construction of C–C bond and 
occupy an important space of modern chemistry.
[182]
 Several synthetic routes to cross-
dehydrogenative coupling reactions were developed under metal-free conditions.
[118]
 Notably, 
oxidative CDC reaction represents state of arts in organic synthesis. In this regard, metal-free 
cross-dehydrogenative coupling are highly interesting method for the functionalization of 
C(sp
3
)–H bonds.[183] Among them, metal-free CDC reactions were also applied for oxidative 
Diels-Alder reaction employing low cost and easy handling reagent.
[184-185]
 Diels-Alder 
reactions represent one of the most fundamental, atom-economic, and efficient reactions in 
organic synthesis and used in many fields such as the natural products synthesis,
[186]
 materials 
and biologically relevant molecules synthesis.
[187]
 Over the last few decades, Diels-Alder 
reactions were developed employing diene and dienophile to obtain unsaturated carbocycles. 
Despite its importance in organic synthesis, development of the dehydrogenative Diels-Alder 
(DDA) reactions paid great attention nowadays.
[122]
 Therefore, syntheses of carbocycles by 
functionalization of unactivated C–H bonds are highly interesting method to the chemists.  
 
Scheme 7.1 Palladium catalyzed dehydrogenative Diels-Alder reactions. 
Interestingly, dehydrogenative Diels-Alder reactions with electron-deficient dienophiles were 
first developed by the group of White
[188]
 and Stahl
[189]
 employing palladium catalyzed via - 
 
Scheme 7.2 Metal-free dehydrogenative Diels-Alder reaction. 
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C–H bonds activation (Scheme 7.1). Very recently, metal-free dehydrogenative Diels-Alder 
reaction has been developed by Zhang and co-workers employing DDQ as oxidant (Scheme 
7.2).
[58]
 Similarly Yao and co-workers developed oxidative Diels-Alder reaction of 3-
ethylindoles using excess amount of 1,4-benzoquinones.[190] However, this method only was 
applied to electron-rich indole scaffolds. It is notable that metal-free dehydrogenative 
Diels-Alder reaction of alkylbenzene with electron-deficient alkene has never been studied. 
Therefore, a mild and metal-free dehydrogenative Diels-Alder reaction of simple 
alkylbenzenes would be a significant advance for the synthesis of phenanthraquinone and 
isoindolone scaffolds.
[191]
 
7.2 Results and Discussion 
7.3 Studies on the Optimization of Reaction Conditions 
To test our hypothesis, p-cymene (212a) was treated with 1,4-benzoquinone (210a) and 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (15) as oxidant in the presence of acetic acid in 
chlorobenzene as solvent at 110 °C under argon (Table 7.3.1). We obtained dehydrogenative 
Diels-Alder product 213a in 42% isolated yields after 24 h. Encouraged by the initial result, 
Table 7.3.1. Optimization of reaction conditions with different additives.
[a]
 
 
Entry Additive (x equiv) Solvent (2 mL) Yield (%) 
1 - PhCl trace 
2 CH3CO2H (2) PhCl 42 
3 CF3CO2H (2) PhCl trace 
4 4-NO2C6H4CO2H (2) PhCl 45 
5 2-FC6H4CO2H (2) PhCl 20 
6 4-CNC6H4CO2H (2) PhCl 15 
7 PhCO2H (2) PhCl 46 
8 Ac2O (2) PhCl 38 
9 Ac2O (1.5) PhCl 35 
10 Ac2O (3) PhCl 22 
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Continuation of Table 7.3.1 
11 Tetrafluorophthalic anhydride (1.5) PhCl 25 
12 (CF3CO)2O (2) PhCl trace 
13 BOP (2) PhCl trace 
14 HFIP (5) PhCl 30 
15 DDQ (3)+ AcOH (2) PhCl 50 
16
[b]
 PhOH (2) PhCl 65 
[a] Reaction conditions: 210a (1.25 mmol), 212a (0.25 mmol), DDQ (2 equiv), additive (x equiv) in solvent 
(0.125 M) at 110 °C for 12-24 h under argon [b] Additive and 1,4-benzoquinone were added after 4h. 
we next tested various additives for dehydrogenative Diels-Alder reaction. To our delight, 
various additives were examined under oxidative reaction conditions. Notably, we found that 
annulation reaction was proceeded very smoothly. After the screening various additives, we 
did not observe the improvement of the yield (Table 7.3.1, entries 3-7). We envisioned that 
acidic anhydride as additive could be accelerated the yield of the desired product 213a instead 
of acid derivatives. Unfortunately, various acidic anhydride as additives did not give 
improvement of yield (Table 7.3.1, entries 8-12). To our delight, the yield was increased to 
65% while phenol used as additive. 
Afterwards, we examined different phenolic derivatives as additive. We observed that 
phenolic additives were very effective to increase the yield of the desired product 213a (Table 
7.3.2, entries 1-5). After screening of various phenolic derivatives, we found that benzenediol 
were effective to provide a good yield under oxidative reaction conditions. Remarkably, the 
desired product 213a was obtained in 72% yield when 2 equivalents of hydroquinone were 
used instead of catechol and resorcinol. The yield was decreased while the reaction was 
carried out at 90 °C instead of 110 °C. The increasing of the temperature, the yield of the 
desired product 213a did not increase. Afterwards, we moved to screen different polar as well 
as non-polar solvents for oxidative Diels-Alder reaction. Finally, we found that chlorobenzene 
was to be the best solvent to achieve the corresponding product 213a in 72% yield. We did 
not observe the desired product formation when reaction was carried out in polar solvents 
such as MeCN, 
t
BuOH or DMF. Later, we found that aromatic halogenated solvents were 
suitable for metal-free oxidative annulation reaction. Among them, PhCl was found to be the 
best solvent for the dehydrogenative Diels-Alder reaction. 
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Table 7.3.2. Optimization of reaction condition with phenolic additives and solvents.
[a] 
 
Entry ArOH (2 equiv) Solvent (2 mL) Yield (%) 
1[
b]
 4-NO2C6H4OH  PhCl 25 
2
[b]
 PhOH  PhCl 65 
3
[b]
 1,2-Dihydroxybenzene  PhCl 70 
4
[c]
 1,3-Dihydroxybenzene  PhCl 44 
5
[c]
 Hydroquinone  PhCl 72 
6
[c]]
 Hydroquinone  DCE trace 
7
[c]]
 Hydroquinone  PhF 44 
8
[c]
 Hydroquinone  PhBr 65 
9
[c]
 Hydroquinone  MeCN trace 
10
[c]
 Hydroquinone  DMF trace 
11
[c]
 Hydroquinone  PhH 15 
12
[c]
 Hydroquinone  
t
BuOH trace 
13
[c,d]
 Hydroquinone  PhCl 60 
14
[e]
 Hydroquinone  PhCl 50 
15
[f]
 Hydroquinone  PhCl 70 
[a] Reaction conditions: 210a (1.25 mmol), 212a (0.25 mmol), oxidant (2 equiv), additive (2 equiv) in solvent 
(0.125 M) at 110 °C for 12-24 h under argon [b] Additive and 1,4-benzoquinone were added after 4h. [d] 
Reaction was carried out with 1.5 equiv hydroquinone [e] Reaction was carried out at 90 °C. [f] Reaction was 
performed at 120 °C. 
7.4 Scope of Oxidative Dehydrogenative Diels-Alder Reaction 
With the optimized reaction conditions in hand, we next explored the substrate scope of 
metal-free oxidative dehydrogenative Diels-Alder reactions. We investigated the scope of 
metal-free dehydrogenative Diels-Alder reaction of different arenes with p-benzoquinone 
(210a) under optimal reaction conditions (Table 7.4.1). Various substituted arenes were well 
tolerated under developed reaction conditions. It was notable that a wide array of arenas were 
able to yield the corresponding desired products (213a-213f) in moderate to good yield. 3,5-
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Dimethylisopropylbene was employed under developed reaction conditions and obtained the 
corresponding desired product 213c in 46% yield under developed reaction conditions. It is  
Table 7.4.1. Substrate scope of different arenes.
[a] 
 
[a] Reaction conditions: 210a (0.25 mmol), 212 (1.25 mmol), DDQ (0.5 mmol) and hydroquinone (0.5 mmol) in 
PhCl (0.125 M) at 110 ˚C for 24 h under argon. n.d. = not detected. 
notable that selectively mono annulated product was obtained when 1,4-diethylbenzene was 
used for oxidative annulation reaction. Unfortunately, electron-rich alkene, alkyne such as 
diphenylacetylene, phenylacetylene and stilbene were not working under optimal conditions. 
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Table 7.4.2. Substrate scope of different maleimides.
[a]
 
 
Entry R
1
 R
2
 Product Yield (%) 
1 Me Me 214a 64 
2 Me C2H4NO2 214b 64 
3 Me H 214c 46(61
b
) 
4
[c]
 Me Br 214d 43 
5 Me 2-tolyl 214e 48 
6 nBu Me 214f 72 
7 CH2CF3 Me 214g 78 
8 Ph Me 214h 56 
9 4-BrC6H4 Me 214i 62 
10 4-ClC6H4 Me 214j 53 
11 4-NO2C6H4 Me 214k 66 
[a] Reaction conditions: 206 (0.25 mmol), 212 (1.25 mmol), DDQ (0.5 mmol) and hydroquinone (0.5 mmol) in 
PhCl (0.125 M) at 110 ˚C for 24 h under argon. [b] Reaction was performed without hydroquinone. [c] Reaction 
carried out at 120˚C for 24 h. 
Further, various arenes were investigated with N-methylmaleimide (213a) and obtained good 
to moderates yield of the corresponding products 214a-214d. Selectively single product 214b 
was obtained when 1-isopropyl-4-(2-nitroethyl)benzene was used under optimal conditions. 
Furthermore, electron-withdrawing group onto the para-positions were compatible under the 
developed reaction conditions and provided the desired products 214d and 214e in 43% and 
48% yield. Afterwards, different N-substituted maleimide derivatives were examined under 
oxidative annulation reaction conditions. We observed that various maleimide derivatives 
afforded the corresponding products (214f-214k) in moderate to good yields. Later, electron-
donating maleimide was investigated and obtained the corresponding product 214e in 72% 
yield. To our delight, different para substituted N-arylmaleimides also well examined and 
obtained the desired products 214h-214j without any difficulty under developed reaction 
conditions.  
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7.4.1 Determination of the Diastereoisomer of Product 214i 
NOE experiment was carried out for product 214i (Figure 7.1) to identify diastereomer. Upon 
irradiation of proton H
a
 which correlated with proton H
b 
and Me
a
. Proton H
c
 shows nice 
correlation with proton H
b 
and H
d
. NOE experimental result suggested that H
b
 and H
c
 are cis 
-configuration. 
 
Figure 7.1. Identification diastereoisomer of product 214i by NOE experiments. 
7.5 Scope of Dehydrogenative Nitration 
Having established dehydrogenative Diels-Alder reaction between alkylbenzenes and 
electron-deficient alkenes, next we investigated dehydrogenative nitration of simple arene for 
nitrostyrene synthesis. Generally, nitrostyrenes are synthesized using aldehydes and ketones  
 
Scheme 7.3. Reaction conditions: 215 (0.5 mmol), DDQ (2 equiv), AgNO2(2 equiv), 50 mg Ȧ molecular sieve 
in 1,2-dichloroethane (2.0 mL) at 80 °C for 10 h under argon. 
with nitroalkanes under basic mediated condensation at higher temperature.
[192]
 Recently. 
Maiti and co-workers developed synthesis of nitroolefins from different building blokes using 
metal nitrate or tert-butylnitrate.
[193-194]
 It is notable that the metal-free dehydrogenative 
nitration of ethylbenzene have never investigated. Nevertheless, we were interested to develop 
new method for dehydrogenative nitrostyrene synthesis from alkylbenzene. We investigated 
nitrostyrenes synthesis employing silver nitrate as a nitrating reagent with DDQ 15 (Scheme 
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7.3). We observed that the nitrostyrene derivatives (216a-216b) were formed selectively in 
trans-isomer in good yield. Furthermore, isopropyl group of benzene was investigated and 
obtained nitrated product with (1:1) mixtures of 216c and 216c’ in 68% yield. 
7.6 Studies on Reaction Mechanism 
 
Scheme 7.4. Reaction conditions: 210a (0.25 mmol), 217 (1.25 mmol), additive (x mmol) in PhCl (0.125 M) 
at 110 ˚C for 12 h under argon. 
In order to gain insight into the reaction mechanism of dehydrogenative Diels-Alder reaction, 
we conducted several control experiments (Scheme 7.4). First, we did control experiment with 
possible intermediate 217 which formed by the oxidation of cumene (212c).
[195]
 When the 
reaction was performed between cumene (212c) and DDQ (15) without 210a, observed the 
formation of probable intermediate 217 (Scheme 7.4, entry a). The reaction between 210a and 
217 with 1 equivalent of DDQ (15), the desired product was not obtained (Scheme 7.4, entry 
c). Afterwards, control experiment was carried out with intermediate 217 in the presence 
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quinhydrone (218). The desired product 215b was obtained in 60% yield (Scheme 7.4. d). 
After understanding the role of quinhydrone (218), we set out the reaction with 1:1 DDQ 15 
and hydroquinone and obtained the desired product 215b in 38% yields (Scheme 7.4 entry e). 
Finally, we conducted the cycloaddition reaction between 210a and 217 with 2 equivalents of 
hydroquinone, found the desired products 215b formation in 72% yield (Scheme 7.4, entry f). 
Mechanistic studies revealed that dehydrogenative Diels-Alder reaction underwent via styrene 
intermediate via acid promoted cycloaddition.
[196]
  
7.7 Mechanism 
 
Scheme 7.5. Proposed mechanism for dehydrogenative Diels-Alder reaction. 
Based on our mechanistic studies, a proposed reaction mechanism of metal-free Diels-Alder 
reaction has been shown in the Scheme 7.5. Initially, the complex 219 was formed by a 
single-electron transfer from p-cymene (212a) to electron-deficient DDQ (15) which led to 
generate radical cation species of arene.
[197]
 Afterwards, the intermediate 220 was formed 
after abstraction of hydrogen atom from radical cationic species of p-cymene by radical anion 
of DDQ (15). Subsequently the anion species 221 abstract hydrogen atom from the benzyl 
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cation species 220 to form intermediate 217a. In the presence of hydroquinone, the complex 
intermediate 218 could be generated through hydrogen bonding of hydroxy groups which are 
well known in literature for activation of quinone 210a through hydrogen bonding of hydroxy 
group.
[198]
 Then styrene derivative facilitated the Diels-Alder reaction with intermediate 218 
to lead intermediate 222. In the next step, intermediate 223 could be obtained from the 
intermediate 222 via rearrangement. Finally, oxidation of the intermediate 223, provided the 
desired product 213a. 
7.8 Identification of Biological Activity of 1,4-Phenanthraquinone Derivatives 
According to our plan, we synthesized compound libraries of 1,4-phenanthraquinone 
scaffolds. Afterwards, we submitted all compound to COMAS (Compound Management and 
Screening Centre) in Dortmund to find the biological activity. Several cell-based assays such 
as hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. After 
screening different assays, two compounds 213d, and 213f inhibited the autophagy signaling 
pathway in the low micro molar range (Table 7.8.1). 
Table 7.8.1. Results of autophagy pathway inhibition. 
Entry Product IC50 [µM] Viability [µM] 
1 
   213d   
≥ 10 inactive 
2 
      213f 
≥ 10 inactive 
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8.1 Introduction 
Cyclopropanes represents one of the most useful molecules and have found many 
applications
[199-201]
 in organic synthesis due to its unique reactivity and ring strain.
[202-205]
 This 
small molecule is widely used in many fields such as natural products,
[200, 206-207]
 biologically 
relevant compound and materials.
[208-211]
 Traditionally cyclopropanes were synthesized by 
Simmon-Smith reaction
[212]
 employing diiodomethane and zinc copper with alkene.
[126-131]
 
Recent years, transition metal catalyst such as Rh
[213]
, Ru
[214]
, Fe
[215-216]
, Co
[217]
, Cu
[218-219]
, 
Ir
[220-222]
, Pd
[223]
, Au
[135]
 and Ni
[131]
 played important roles in the novel cyclopropane 
synthesis. Among them, metal carbene has been used for cyclopropane synthesis using diazo 
compound with alkene. It is notable that metal-free method for cyclopropanation also was 
established applying ylide precursors.
[136]
 Simmon-Smith method, Michael-initiated ring 
closure reaction
[129, 224-227]
 and diazo compounds with metal catalysis are the most useful and 
valuable synthetics route for cyclopropane synthesis. Though, these methods are useful for the 
synthesis of cyclopropanes, drastic reaction conditions and explosive nature of many 
chemicals open room for further development. Therefore, the development of new method for 
cyclopropane synthesis under mild conditions is in high demand. 
 
Scheme 8.1. Cyclopropanation via C–H bond functionalization. 
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In the recent years, development of cyclopropanes via C–H bond functionalization have been 
reported employing transition metal-catalyst. Very recently, the group of Rovis disclosed 
cyclopropanation of alkenes with phenyl-N-enoxyphthalimide (225) via rhodium-catalyzed 
C–H activation (Scheme 8.1).[228] The group of Monopoli and Nacci developed palladium 
catalyzed cyclopropanation of alkene with acetophenone (Scheme 8.1).
[223]
 Although, a  
variety of cyclopropane synthesis have been reported using functionalized precursors, the 
development of a novel method for the synthesis of cyclopropane via C–H bond 
functionalization is still high demand. We were interested in developing cyclopropane though 
acetophenones functionalization with electron-deficient alkenes. 
8.2. Results and Discussion 
8.3. Studies on the Optimization of Reaction Conditions 
We began our optimization studies of cyclopropanation with 2-acetylnaphthalene (228a) and 
N-methylmaleimide (227a) under oxidative conditions. Initially, the optimization was started  
Table 8.3.1. Optimization of cyclopropanation with different ligands and oxidants.
[a] 
 
Entry Ligand (10 mol%) Oxidant (3 equiv) Yield (%) 
1 1,10-Phenanthroline (L1) DTBP 52 
2 2,9-Dimethyl-1,10-phenanthroline (L2) DTBP trace 
3 3,4,7,8-Tetramethyl-1,10-phenanthroline (L3) DTBP 35 
4 2,2'-Bipyridine (L4) DTBP 63 
5 4,4'-Di-tert-butyl-2,2'-bipyridine (L5) DTBP 64 
6 4,4'-Dimethoxy-2,2'-bipyridine (L6) DTBP 49 
7 Picolinic acid (L7) DTBP 0 
8 L4 TBHP trace 
9 L4 PhI(OAc)2 n.d. 
10
[b]
 L4 H2O2 n.d. 
11 L4 K2S2O8 n.d. 
[a] Reaction conditions: 227a (0.25 mmol), 228a (0.5 mmol), in PhCl (2.0 mL) for 24 h under argon. [b] 
Reaction carried out at 80 °C. DTBP = Di-tert-butyl peroxide. TBHP = tert-Butyl hydroperoxide. n.d. = not 
detected. 
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with 20 mol% CuI as catalyst in combination with 10 mol% 1,10-phenanthrolene (L1) as 
ligand in the presence of di-tert-butylperoxide (20) as oxidant in chlorobenzene at 100 ºC for 
24 h and obtained the desired product 229a in 52% yield.
[229]
 Encouraged by the initial result, 
we further tested different nitrogen-based ligands under oxidative reaction conditions (Table 
8.3.1, entries 1-7). We observed that the cyclopropanation reaction was highly ligand 
dependent. After screening of several ligands, we found 2,2′-bipyridine (L4) and 4-4′-
dimethoxy-2-2′-bipyridine (L6) ligands were to be optimal to provide the desired product 
229a in 63% and 65% yields. Later, we screened different oxidants. After testing various  
Table 8.3.2. Optimization of cyclopropanation with different additives and Cu-catalysts.
[a]
 
 
Entry Cu-salt (20 mol%) Additive (x equiv) Yield (%) 
1 CuI - 66 
2
[b]
 CuI - 72 
3 CuBr - 65 
4 CuCl - 62 
5 CuBr·SMe2 - 42 
6 Cu(OAc)2 - 35 
7
[c]
 CuI - 83 
8 CuI KI (0.2) n.d. 
9 CuI I2 (0.2) trace 
10 CuI DBU (0.5) n.d. 
11 CuI Et3N (1) n.d. 
12 CuI MS (50 mg, 4 Ȧ) 45 
13
[d]
 CuI - trace 
[a] Reaction conditions: 227a (0.25 mmol), 228a (0.5 mmol), in solvent (2.0 mL) for 24 h under argon. [b] 30 
mol% L4 was used. [c] Reaction was carried out with 5 equiv DTBP. [d] Reaction was performed under oxygen 
atmosphere MS = Molecular sieve. n.d. = not detected. 
oxidants, DTBP was found to be the best oxidant to provide cyclopropane 229a in 64% 
yields. We did not observe the desired product formation while tert-butyl-hydroperoxide (19), 
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Table 8.3.3. Optimization of cyclopropanation with different temperature and solvents.
[a] 
 
Entry Solvent (2 mL) Temp (ºC) Yield (%) 
1 Toluene 110 trace 
2 p-Xylene 110 trace 
3 DMSO 110 n.d. 
4 DMF 110 n.d. 
5 H2O 110 n.d. 
6 PhCl 110 83 
7 PhBr 110 72 
8 PhF 110 41 
9 tert-Amyl alcohol 110 n.d. 
10 NMP 110 n.d. 
11 EtCN 110 n.d. 
12 PhCl 90 63 
13 PhCl 100 65 
14 PhCl 110 83 
15 PhCl 120 68 
16
[b]
 PhCl 110 45 
[a] Reaction conditions: 227a (0.25 mmol), 228a (0.5 mmol), in solvent (2.0 mL) for 24 h under argon. [b] 10 
mol% CuI was used. DTBP = Di-tert-butyl peroxide. [b] 10 mol% catalyst was used. n.d. = not detected. 
hydrogen peroxide (H2O2) or PhI(OAc)2 (22) were used as oxidant (Table 8.3.1, entries 8-11). 
After screening various copper catalysts, next we moved to examine various additives for 
oxidative cyclopropanation reaction. We did not observe cyclopropane formation when KI, I2, 
DBU or NEt3 were used as additives (Table 8.3.2, entries 8-11). In the presence of molecular 
sieve, the desired product formation decreased to 45 % yield. The desired cyclopropane did 
not obtain while reaction was carried out under oxygen atmosphere (Table 8.3.2, entry 13). In 
order to investigate copper-catalyzed oxidative annulation of acetophenone, a series of copper 
salts were tested (Table 8.3.2, entries 1-6). However, the yield was slightly decreased while 
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CuBr or CuCl were used instead of CuI. It is notable that lower yield was obtained when 
copper(II) diacetate was used (Table 8.3.2, entry 6). After screening of various copper 
catalysts, 72% yield of the desired product 229a was obtained using 30 mol% of CuI in the 
present of 3 equivalents of DTBP. To our delight, after increase the amount of oxidant, the 
yield of the desired product 229a also increased to 83%. Further, we examined various 
solvents (Table 8.3.3). We did not observe the formation of the desired product while reaction 
was carried out in H2O, DMSO or DMF. Only trace amount of product 229a was obtained in 
non-polar solvent such as toluene or p-xylene. Yield was increased by using halogenated 
solvents such as PhCl, PhBr or PhF. Notably, chlorobenzene was found to be the best solvent 
to achieve corresponding product 229a in 83% yield. When the amount of copper catalyst was 
decreased to 10 mol%, the yield of 229a dramatically decreased to 45%. While the reaction 
was carried out below 100 ºC, surprisingly the yield of product 229a was decreased to 65% at 
90 ºC. Finally, we found that 110 ºC was the best temperature for oxidative cyclopropanation. 
8.4 Scope of Oxidative Cyclopropanation 
Table 8.4.1. Substrate scope with different acetophenone derivatives.[a] 
 
Entry R
1
 R
2
 R
3
 R
4
 Product Yield (%) 
1 H NO2 H H 229b 62 
2 H CO2Me H H 229c 82 
3
[b]
 H Ac H H 229d 56 
4 H F H H 229e 72 
5 H 3-ClC6H4 H H 229f 62 
6 H H H H 229g 65 
7 H Br H H 229h 78 
8 H Me H H 229i 52 
9 H Cl H H 229j 76 
10 H H Br H 229k 76 
11 H H CN H 229l 84 
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Continuation of Table 8.4.1 
12 H H CF3 H 229m 82 
13 H Br NO2 H 229n 69 
14 H Cl H Cl 229o 48 
15 F H H F 229p 76 
16
[c]
 2-Acylpyridine 229q 62 
[a] Reaction conditions: 227a (0.25 mmol), 228 (0.5 mmol), 5 equiv DTBP, CuI 20 mol%, bipy (L4) 30 mol% in 
PhCl (2.0 mL) at 110 ºC for 16 h. [b] Methyl aryl ketone was use 3 equiv. [c] 10 mol% 1,10-phen (L1) and 4 
equiv DTBP were used. All products were formed with d.r. >20:1. 
 
 
With the optimization reaction conditions in hand, we then started investigation the scope of 
the cyclopropanation reaction of acetophenone derivatives with N-methyl maleimide (Table 
8.4.1). Various functional groups such as nitro, bromo, chloro, fluoro, acetyl, ester, 
trifluoromethyl and also protected phenol (R
2 
= 3-ClC6H4CO2) on the acetophenones were 
well tolerated under standard reaction conditions. Notably, both electron-rich as well as 
electron-deficient aryl groups were found to be compatible for the cyclopropanation reaction. 
Further, various functional groups onto the para-position of acetophenone were investigated 
and obtained the corresponding products (229b-229g and 229h-229j) in good to excellent 
yield. Selectively mono-addition product 229c was obtained in 56% yield when 1,4-
diacetylbenzene was employed under optimal conditions. Furthermore, various functional 
groups such as nitro, bromo, cyano and trifluoromethyl group on the meta-position of 
acetophenone derivatives were investigated under the developed reaction conditions and 
obtained the corresponding desired products (229k-229n) in good yield. Next, we focused on 
cyclopropanation of di-substituted aryl methyl ketone under developed reaction conditions 
(Table 8.4.1, entries 13-15). The desired product 229n was obtained when 2,4-
dichlroacetophenone was employed. Interestingly, 3,5-difluoroacetophenone provided 
corresponding product 229p in 69% yield. To our delight, 2-acetylpyridine was used and 
found the desired product 229q in 62% yield. It is notable that all desired products were 
obtained single and trans isomer which was confirmed by NOE studies. 
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Table 8.4.2. Substrate scope with different maleimide derivatives.
[a] 
 
Entry R R
1
 Product Yield (%) 
1 n-Pr 4-BrC6H4 231a 63 
2 n-Hexyl 4-BrC6H4 231b 86 
3 c-Hexyl 4-BrC6H4 231c 77 
4 CH2CF3 4-BrC6H4 231d 56 
5 but-3-en-1-yl 4-CO2MeC6H4 231e 59 
6
[b]
 CH2Ph 4-CO2MeC6H4 231f 72 
7 (R)-1-(1-phenylethyl) 4-CO2MeC6H4 231g 87 
8 (R)-1-(1-cyclohexylethyl) 4-BrC6H4 231h 60 
9 H 4-BrC6H4 231i n.d. 
 [a] Reaction conditions: 227 (0.25 mmol), 230 (0.5 mmol), 5 equiv DTBP, CuI  20 mol%, bipy L4 30 mol% in 
PhCl (2.0 mL) at 110 ºC for 16 h. [b] Reaction time was 12 h. [c] using  CuI 10%, L4 (20 mol%), DTBP (3 
equiv),  methacrylate (10 equiv). Reaction was performed at 100 °C. n.d. = not detected. All products were 
formed with d.r. >20:1. 
Encouraged by the acetophenone scopes, we further explored the scope of cyclopropanation 
reaction with a series of N-substituted maleimide 227 under our standard reaction conditions 
(Table 8.3.2). Various substituted maleimide derivatives were investigated and found good 
compatible for cyclopropanation. N-Alkylsubstituted electron-rich maleimides were found to 
be facile for the products formation (231a-231c). Importantly, N-substituted terminal alkene 
maleimide gave the desired product 231e in 59% yield under radical reaction conditions 
without radical species addition of terminal alkene (Table 8.3.2, entry 231e). N-
Benzylmaleimide underwent smoothly conversion to give the desired product 231f in 72% 
yield. Afterwards, N-substituted chiral maleimides were examined and found excellent yield 
of the corresponding products 231g and 231h. Maleimide did not give the desired product 
under developed reaction conditions. 
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Table 8.4.3. Substrate scope with different alkenes.[a] 
 
Entry R
1
 R
2
 R
3
 Product Yield (%) 
9 CN H 4-CO2MeC6H4 231j 35 
10
[b]
 CO2Me H 4-CNC6H4 231k 70 
11 4-ClC6H4CO 4-ClC6H4CO 4-CO2MeC6H4 231l 61 
12 CO2Me CO2Me 4-BrC6H4 231m n.d. 
[a] Reaction conditions: 232 (0.25 mmol), 230 (0.5 mmol), 5 equiv DTBP, CuI 20 mol%, bipy L4 30 mol% in 
PhCl (2.0 mL) at 110 ºC for 16 h. using CuI 10%, L5 (20 mol%), DTBP (3 equiv), methacrylate (10 equiv). 
Reaction was performed at 100 °C. n.d. = not detected. All products were formed with d.r. >20:1. 
Having described scope of maleimides and acetophenone derivatives, next we investigated the 
scope of various internal and terminal alkenes in the cyclopropane synthesis (Table 8.4.3). 
Interestingly, we found that various alkenes were very facile to provide cyclopropane (231j-
231l) in moderate to good yield. Cyclopropane 231k was obtained in good yield under 
developed conditions. Internal alkene such as (E)-1,4-bis(4-chlorophenyl)but-2-ene-1,4-dione 
well tolerated and provide the corresponding cyclopropane 231l in 61% yield. Unfortunately, 
methyl fumarate did not provide the desired product. 
8.4.1 Determination of the Stereoisomer 
 
Figure 8.1. Identification of stereoisomer of product 229j by NOE experiments. 
NOE experiment was performed to identify stereoisomer of product 229j (Figure 8.1). 
According to the NOE analysis, proton H
a
 correlated with proton H
b 
and Me
 
group. Proton 
H
b
 on irradiation did not shows strong correlation with proton H
a
 which indicated that proton 
H
a
 and H
b 
are tran configuration.  
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8.5 Studies on Reaction Mechanism 
8.5.1 Control Experiments 
Next we turned out our attention to understand the reaction mechanism of copper-catalyzed 
cyclopropanation. In this regards, we conducted several experimental studies with the 
probable intermediate (Scheme 8.2). Initially, we were wondering whether cyclopropanation 
reaction proceeds via in-situ formation of α-halocarbonyl intermediate 233 or different 
pathway. While the reaction was performed between 233 and 227a under optimized reaction 
conditions, did not observe any desired product formation. While the reaction was carried out  
 
Scheme 8.2. Control experiment with probable intermediate 
without ligand or without catalyst with probable intermediate 233, we did not obtain target 
product 229a. This result indicated that cyclopropanation did not undergo via α-halocarbonyl 
intermediate. Afterwards, we thought that cyclopropanation underwent different pathway. 
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Finally, we examined our standard reaction condition with probable intermediate 234. 
Unfortunately, we did not observe any desired product formation under developed reaction 
conditions. 
8.5.2 Reaction of 2,2,2-[
2
H3]-1-Phenylethan-1-one with Maleimide 
In order to gain insight into the reaction mechanism, we conducted the control experiment 
with 2,2,2-[
2
H3]-1-phenylethan-1-one under developed reaction conditions (Scheme 8.3). 
Pleasingly, we obtained target product 236 in 41% yield with deuterium incorporation greater 
than 95%. This result suggested that deuterium and hydride exchange not occurred under 
radical reaction conditions. 
 
Scheme 8.3. Reaction of deuterated acetophenone. 
8.5.3 Kinetic Isotope Effect (KIE) Study 
Subsequently, a kinetic isotope effect experiment was performed between 235 and 235a with 
N-methylmaleimide under developed reaction conditions and obtained kinetic isotope effect 
equal to 2.45 (Scheme 8.4). Hence, abstraction of both hydrogen atom is not rate-limiting 
step. 
 
Scheme 8.4. Kinetic isotope effect (KIE) experiment. 
 
Chapter 8. Copper(I)-Catalyzed Oxidative (2+1) Annulation 
 
- 98 - 
 
8.5.4 Radical Trapping Experiment with TEMPO 
Furthermore, a radical trapping experiment was performed with TEMPO (16) as a radical 
scavenger. The yield of the desired product 229a dramatically decreased in the presence of 
TEMPO (Scheme 8.5). This result suggested that the reaction proceeded through radical 
pathway. 
 
Scheme 8.5. Radical trapping experiment. 
8.6 Mechanism 
 
Scheme 8.6. Proposed mechanism for Cu-catalyzed cyclopropanation. 
Based on our mechanistic studies and literature reports, a plausible reaction mechanism has 
been proposed in the Scheme 8.6. First, tBuO-[CuII] species was formed by the oxidation of 
Cu(I) with DTBP.[230] In the next step, intermediate 237 was formed via enolization of 
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acetophenone. After oxidation of the intermediate 237 with Cu(II) species to yield the 
intermediate 238 which attack the electron-deficient maleimide 227a to form intermediate 
239. The intermediate 239 could be stabilized by resonance to generate the intermediate 239’. 
Upon reaction of r Cu(II) species with the intermediate 239, generate the intermediate 240. 
The intermediate 241 could be obtained via enolization of keto group of 240 and ligand 
exchange and followed by cyclization. The cyclic intermediate 241 determined the stereo-
selectivity of developed annulation. Finally, reductive elimination of Cu(I) provided the final 
product 229g. The Cu(II) species was regenerated in the presence of DTBP via oxidation of 
Cu(I) species. 
8.7 Products Derivatization 
8.7.1 Reduction of Product 229h 
Further, we were interested to reduce the amide bonds of cyclopropane scaffolds.
[231]
 
Importantly, cyclopropane 229h could be transferred into product 242 upon reduction of 
amide and carbonyl groups in the presence of LiAH4 (Scheme 8.6). The desired product 242 
was obtained in 75% isolated yield.  
 
Scheme 8.6. Reduction of product 229h. 
8.7.2 Ring Opening of the Product 229h 
 
Scheme 8.7. Ring opening of the product 229h. 
In addition, we investigated the ring opening of obtained product 229h (Scheme 8.7).
[232]
 
Ester derivative of cyclopropane 243 could be obtained from product 229h in 61% yield, upon 
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hydrolysis of amide followed by esterification of the hydrolyzed product in one-pot.
[233]
 
Further, unsymmetrical ring opening of obtained cyclopropane was applied in the presence of 
K2CO3 and the desired product 244 was isolated in 53% yield.
[234]
 
 
Scheme 8.8. Unsymmetrical ring opening of the product 229h. 
8.8 Identification of Biological Activity of 3-Azabicyclo[3.1.0]hexane-2,4-diones 
According to our plan, we synthesized compound libraries of 3-azabicyclo[3.1.0]hexane-2,4-
dione scaffolds. Afterwards, we submitted all compound to COMAS (Compound 
Management and Screening Centre) in Dortmund to find the biological activity. Several cell-
based assays such as hedgehog signaling pathway and Wnt signaling pathway and autophagy 
were tested. After screening different assays, we did not obtain biological result.  
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9.1 Introduction 
During studies on cyclopropanation of acetophenones with electron-deficient alkenes under 
oxidative conditions, we envisaged that the development of a novel method for the oxidative 
cyclopropanation through C–H bond functionalization without alkene would be highly 
desirable transformation (Scheme 9.1). It is notable that synthesis of small carbocycles via 
three C(sp
3
)–H bonds functionalization has never been reported. Therefore, discovery of a 
new method for the synthesis of strain cyclopropane without prefunctionalized starting 
material would be a significant advantage. Moreover, a mild and efficient method via C–H 
bond functionalization is in high demand. 
 
Scheme 9.1. Oxidative Cyclopropanation of acetophenone. 
Cyclotrimezation reactions were applied for the synthesis of polysubstituted benzenes using 
acetophenones in the recent years.
[235-237]
 The development of cyclopropane from 
acetophenone via oxidative cyclotrimerization has never been reported. In this regard, we 
were interested to demonstrate the first catalytic approach for the synthesis of strained 
cyclopropanes by an unprecedented (1+1+1) cyclotrimerization of simple aryl methyl ketones 
under oxidative conditions.  
9.2 Result and Discussion  
9.3 Studies on the Optimization of Reaction Conditions 
We initiated our optimization studies on the oxidative cyclopropanation of 4-
fluoroacetophenone (228e) as model substrate. We started our exploration of the reaction with 
10 mol% CuI in combination with 20 mol% bipy (L4) as ligand and 3 equivalents of DTBP as 
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oxidant in PhCl as solvent at 100 °C for 12 h under argon (Table 9.3.1). At the beginning, the 
desired cyclopropane (245a) was isolated in 41% yield. Encouraged by the initial result of 
oxidative (1+1+1) annulation, we further tested different ligands (Table 9.3.1). Pleasingly, we 
found that 4,4′-ditertbutyl-2-2′-bipyridine (L5) was to be  the best ligand for the copper(I)-
catalyzed annulation of 4-fluoroacetophenone (228e) and could be obtained the desired  
Table 9.3.1. Optimization of cyclopropanation with different ligands.
[a]
 
 
[a] Reaction conditions: 228e (0.5 mmol), DTBP (3 equiv), CuI (10 mol%), ligand (20 mol%) in PhCl (2.0 mL) 
at 100 °C for 12 h under argon. n.d. = not detected 
product 245a in 73% yield using ligand L5. Unfortunately, 1,10-phenanthroline derivatives 
(L1-L3) and aliphatic nitrogen-based ligands (L8-L9) did not give promising yield of the 
desired product 245a under oxidative conditions. After screening various ligands, next we 
examined various oxidants for cyclopropanation (Table 9.3.2). To our delight, the desired 
product 245a was isolated in 73% yield using 3 equivalents of DTBP. Formation of 
cyclopropane was decreased when tert-butyl hydroperoxide or di-cumylperoxide were 
employed (Table 9.3.2 entries 2-3). We did not observe the desired product 245a formation 
when hydrogen peroxide, benzoyl peroxide or PhI(OAc)2 (22) were used as oxidant (Table 
9.3.2 entries 4-8).  
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Table 9.3.2. Optimization of cyclopropanation with different oxidants.[a] 
 
Entry Oxidant (x equiv) Yield (%) Entry Oxidant (x equiv) Yield (%) 
1 DTBP (3) 73 6 K2S2O8 (2) n.d. 
2 DCP (3) 55 7 PhI(OAc)2 (2) n.d. 
3 TBHP (3) 15 8 H2O2 (4) n.d. 
4 TBPB (3) trace 9 DTBP (2) 55 
5 BPO (3) n.d. 10 DTBP (4) 70 
[a] Reaction conditions: 228e (0.5 mmol), oxidant (x equiv), CuI (10 mol%), dtbpy L5 (20 mol%) in PhCl (2.0 
mL) at 100 °C for 12 h under argon. BOP = Benzoyl peroxide. DCP = Dicumyl peroxide. TBPB = tert-Butyl 
peroxybenzoate. TBHP = tert-Butyl hydroperoxide. n.d.= not detected. 
Table 9.3.3. Optimization of cyclopropanation with different copper-salts.
[a]
 
 
Entry Cu-salt Yield (%) Entry Cu-salt Yield (%) 
1 CuCl 72 5 CuCl2 34 
2 CuBr 68 6 Cu(OAc)2 trace 
3 CuI 73 7 Cu(OSO2CF3)2 trace 
4 CuBr
.
SMe2 56 8
[b]
 CuI 86 
[a] Reaction conditions: 228e (0.5 mmol), DTBP (3 equiv), Cu-salt (10 mol%), dtbpy L5 (20 mol%) in PhCl (2.0 
mL) at 100 °C for 12 h under argon. [b] Reaction was carried out at 90 °C for 8 h. 
To identify the best catalyst, various copper salts were examined for oxidative 
cyclopropanation and finally CuI was found to be the best catalyst for the transformation 
(Table 9.3.3). However, the yield of the desired product was slightly decreased when CuBr or 
CuCl were used. When Cu(OAc)2 or Cu(OTf)2 were employed, the desired product was not 
obtained under optimal reaction conditions.  
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Table 9.3.4. Optimization of cyclopropanation with different solvents.
[a]
 
 
Entry Solvent ( 2 mL) Yield (%) Entry Solvent ( 2 mL) Yield (%) 
1 Benzene trace 9 PhCl 86 
2 Toluene trace 10 PhBr 74 
3 p-Xylene trace 11 PhF 68 
4 ClCHCHCl trace 12 PhNO2 10 
5 DMSO trace 13 NMP n.d. 
6 DMF 43 14 
t
AmOH n.d. 
7 DMF(1mL) 51 15 EtCN 15 
8 H2O n.d. 16
[b]
 PhCl 48 
 
[a] Reaction conditions: 229e (0.5 mmol), DTBP (3 equiv), CuI (10 mol%), dtbpy L5 (20 mol%) in different 
solvent (2.0 mL) at 90 °C for 8 h under argon. [b] Reaction was carried out with 5 mol% CuI. n.d.= not detected. 
After screening different catalysts, we next tested different solvents as well (Table 9.3.4). We 
did not observe the formation of target product 245a in protic solvent such as H2O, 
t
AmOH. 
Trace amount of the desired product was obtained when non-polar solvents such as benzene, 
toluene or p-xylene were used. Finally, we found that aromatic halogenated solvents such as 
PhCl, PhBr or PhF were suitable for the copper-catalyzed oxidative cyclopropanation. After 
that, chlorobenzene was found to be the best solvent for the discovery of oxidative 
cyclopropanation of methyl aryl ketone. The effect of temperature was examined under 
copper-catalyzed cyclopropanation reaction (Table 9.3.5). The best yield of oxidative 
cyclopropanation could be obtained at 90 °C using 3 equivalents of DTBP. Increasing or 
decreasing of temperature, formation of the desired product 245a also was decreased instead 
of 90 °C (Table 9.3.5, entries 1 and 5). The formation of the desired product 245a drastically 
decreased under atmospheric conditions. 
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Table 9.3.5. Optimization of cyclopropanation with different temperature.
[a]
 
 
Entry Temp (ᵒC) Yield (%) Entry Temp. (ᵒC) Yield (%) 
1 70 54 5 110 45 
2 80 78 6
[b]
 90 48 
3 90 85 7
[c]
 90 86 
4 100 83 8
[d]
 90 n.d. 
[a] Reaction conditions: 228e (0.5 mmol), DTBP (3 equiv), CuI (10 mol%), dtbpy L5 (20 mol%) in PhCl (2.0 
mL) at different temperatures for 12 h under argon. [b] Reaction was carried out with 5 mol% CuI; [c] Reaction 
time 8 h. [d] Reaction was carried out in oxygen. n.d.= not detected. 
 
9.4 Scope of Cu(I)-Catalyzed Oxidative (1+1+1) Annulation of Acetophenones 
With the optimal reaction conditions in hand, we next explored the substrate scope of the 
copper-catalyzed oxidative cyclopropanation of methyl aryl ketone derivatives (Table 9.4.1). 
We found that various acetophenone were well tolerated and obtained the corresponding 
products in moderate to good yields. Interestingly, various functional groups such as fluoro, 
chloro, bromo, ester, sulphonamide, methyl and trifluoromethyl on the acetophenones were 
tolerated under standard conditions. To our delight, various electron-withdrawing groups such 
as fluoro, chloro, bromo, cyano, ester, sulphonamide and trifluoromethyl on the para-position 
of acetophenones provided the desired products 245a-245j smoothly. Afterwards, we tested 
electron-donating group on the acetophenone and obtained the desired products 245j, 245o in 
moderate yield. Substituents at meta-positions of acetophenones were well tolerated and 
provided the corresponding desired products 245l-245m in good to moderate yield. 
Furthermore, polysubstituted acetophenones were employed for the cyclopropane synthesis 
under oxidative conditions (Table 9.4.1, 15 and 16). 3,4-Dimethylacetophenone was well 
tolerated and provided the desired product 245o in 53% yield. After that, we assessed the 
potential of this (1+1+1) cycloaddition of 2-acetylnaphthalene moiety that could be formed 
three member strained ring without any difficulty. It is remarkable that heterocyclic derivative 
was found to give the desired product 245t in 52% yield under developed conditions. 
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Electron-donating groups such as hydroxyl and anino onto the acetophenone did not provide 
the desired product under optimized reaction conditions. 
Table 9.4.1. Scope of acetophenones.
[a]
 
 
Entry Ar Time (h) Product Yield (%) 
1 
  
8 245a 86 
2 
 
8 245b 66 
3 
 
8 245c 73 
4 
 
8 245d 88 
5 
 
8 245e 65 
 
6 
 
6 245f 43 
7 
 
5 245g 79 
8 
 
6 245h 62 
9 
 
8 245i 35 
10 
 
8 1245j 43 
11
[b]
 
 
12 245k 69 
12 
 
8 245l 46 
13 
 
7 245m 68 
14 
 
8 245n 77 
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Continuation of Table 9.4.1 
15
[c]
 
 
18 245o 53 
16 
 
18 245p 43 
17 
 
8 245q 65 
18
[b]
 
 
12 245r 46 
19 
 
8 245s 41 
20 
 
8 245t 52 
21 
 
12 245u n.d. 
22 
 
12 245w n.d. 
[a] Reaction conditions: 228 (0.5 mmol), DTBP (3 equiv), CuI (10 mol %), L5 (20 mol%) in PhCl (2.0 mL) at 
90 °C for 5-8 h under argon. All products were formed with d.r. >20:1. [b] CuI (20 mol %), L5 (30 mol %) were 
used at 75 °C for 12 h under argon. [c] Reaction was carried out in 1 mL DMF for 18 h. n.d. = not detected. 
9.5 Studies on Reaction Mechanism 
In order to gain insight into the reaction mechanism of copper-catalyzed oxidative 
cyclopropanation, we conducted several control experiments for understanding the reaction 
mechanism. We hypothesized that reaction underwent step-wise mechanism. In this context, 
we prepared several potential intermediates to examine oxidative cyclopropanation under 
developed reaction conditions. 
9.5.1. Reaction with Probable Intermediate 246 
In addition, we performed annulation reaction with probable intermediate 246 with 228c 
under optimized reaction conditions and obtained the desired product in 64% yield (Scheme 
9.2). This result suggested that annulation reaction proceeded through intermediate 246. 
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Scheme 9.2. Reaction with the intermediate 246. 
9.5.2 Reaction with Probable Intermediate 246 without 228c 
When the control experiment was carried out with intermediate 246 without 228c under 
optimal conditions, we observed the formation of (E)-1,4-bis(4-chlorophenyl)but-2-ene-1,4-
dione 247 in 92% yield (Scheme 9.3). This result indicated that reaction underwent via 
probable intermediate 247.  
 
Scheme 9.3. Reaction with the intermediate 246 without 228c. 
9.5.3 Reaction with Probable Intermediate 247 
  
Scheme 9.4. Reaction with the intermediate 247 without 228c. 
Afterwards, we performed the annulation reaction between 228c and (E)-1,4-bis(4-
chlorophenyl)but-2-ene-1,4-dione (247) (Scheme 9.4). We observed the desired product 
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formation in 82% yield under optimal reaction conditions. This result supported that the 
reaction underwent via intermediate 247. 
9.5.4 Radical Inhibition Test 
Radical inhibition test was conducted in the presence of radical scavenger TEMPO (16). 
Formation of the desired product was suppressed under optimized reaction conditions in the 
presence TEMPO (Scheme 9.5). This experimental result supported that cyclopropanation 
reaction proceeded via methyl radical species of acetophenone. 
 
Scheme 9.5. Radical inhibition test.  
9.5.5 Reaction with 2,2,2-[
2
H3]-1-Phenylethan-1-one 
Interestingly, when reaction was carried out with deuterated acetophenone (235a) under 
oxidative reaction conditions, the desired product 248 was obtained in 55% yield with 
deuterium incorporation ≥ 95% (Scheme 9.6). 
 
Scheme 9.6. Synthesis of product trideuterated product (248). 
9.5.6 Kinetic Isotope Effect (KIE) Study 
Additionally, kinetic isotope effect experiment was performed between 235 and 235a under 
standard conditions (Scheme 9.7). The value of kH/kD was equal to 1.4 which suggesting that 
the hydrogen abstraction process from acetophenone is not rate-limiting step. 
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Scheme 9.7. Kinetic isotope effect experiment. 
9.6 Mechanism 
 
Scheme 9.8. Proposed mechanism for Cu-catalyzed trimerization.  
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Based on our experimental results, a proposed mechanism has been shown in the Scheme 9.8. 
We described the mechanism for the synthesis of cyclopropane through triple C(sp
3
)–H 
functionalization. First, Cu(II) species was generated in the presence of DTBP via oxidation 
of Cu(I) species. The radical species 250 was formed by oxidation of intermediate 249. 
Afterwards, two radical species 250 dimerized to generate the intermediate 251. The 
intermediate 253 could be generated from the intermediate 251 via oxidation with Cu(II)-
species which generated the intermediate 254 after addition of copper(II) species. The 
intermediate 254 lead to form 255 which could react with 250 and produced the intermediate 
256. Afterwards, the intermediate 257 was formed from the intermediate 256 after addition of 
Cu(II) species which could be genrated intermediate 258 via enolization. The intermediate 
258 could be led to form the intermediate 259 via ligand exchange of copper centre. Finally, 
product 245k was generated by reductive elimination of Cu(I) from 259. Cu(II) species was 
regenerated by the oxidation of Cu(I) in the presence of DTBP. 
9.7 Identification of Biological Activity of Cyclopropane Derivatives 
According to our plan, we synthesized compound libraries of cyclopropane derivatives. 
Afterwards, we submitted all compounds to COMAS (Compound Management and Screening 
Centre) in Dortmund to find the biological activity. Several cell-based assays such as 
hedgehog signaling pathway and Wnt signaling pathway and autophagy were tested. After 
screening different assays, we did not obtain biological results. 
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10.1 Introduction 
Oxygen containing heterocycles represents one of the most important classes of 
compounds.
[238-242]
 Among them, furans are ubiquitous structural motif found in many natural 
products, agrochemicals, pharmaceuticals and biologically active drug molecules.
[124-125, 243]
 
Multisubstituted furans have found a widespread application in organic synthesis as building 
blocks.
[240-241, 244-247]
 In this regard, several attractive methods for the synthesis of furans were 
developed using various transition-metal catalyst and under metal-free conditions employing 
functionalized feedstocks.
[57, 248-252]
  
 
 
Scheme 10.1. Metal catalyzed furan synthesis. 
Conventionally furan derivatives are synthesized by Paal-Knorr method which relies upon 
acid catalyzed cyclization of 1,4-dicarbonyl compound.
[248, 251]
 Multisubstituted furans are 
prepared intermolecular approach using Feist-Benary method from α-haloketones and β-
dicarbonyl.
[253-254]
 In the recent years, transition-metal catalyzed intramolecular approaches to 
the synthesis of multisubstituted furan derivatives have been reported employing allenyl 
Chapter 10. Copper(I)-Catalyzed (3+2) Oxidative Annulation 
 
- 115 - 
 
ketone.
[255-261]
 Very recently, Zhang and co-workers developed the synthesis of furans with 
alkynes and α-diazocarbonyls through Co-catalyzed metalloradical cyclization.[262] Lei and 
co-workers disclosed a novel silver mediated an efficient method to furans using alkynes and 
1,3-diketones compounds.
[263]
 Recently, palladium-catalyzed synthesis of furans has been 
developed by Yoshikai and co-workers employing imine derivatives of acetophenones and 
alkynylbenziodoxolones.
[264-265]
 However, reported methods require prefunctionalized 
precursors, stoichiometric amount of metals and longer reaction time. It is notable that 
synthesis of multisubstituted furan employing acetophenone with electron-deficient alkyne 
has never investigated. Therefore, development of a novel method to multisubstituted furans 
via C–H bond functionalization would be highly attractive method in organic synthesis. In 
this regards, we were interested to develop a novel strategy for copper(I)-catalyzed oxidative 
(3+2) annulation of acetophenones with electron-deficient alkynes to access multisubstituted 
furan derivatives. 
10.2 Result and Discussion 
10.3 Studies on the Optimization of Reaction Conditions  
During the study on oxidative annulation of acetophenones with maleimides for the synthesis 
of cyclopropanes, we envisaged that synthesis of furan derivatives by employing aryl methyl 
ketones with electron-deficient alkynes would be significant advantage.
[266]
 To test our 
hypothesis, the reaction was initiated with 4-bromoacetophenone (228h) and diethyl 
acetylenedicarboxylate (265a) in the presence of CuI (20 mol%), 2,2'-bipyridine (30 mol%) 
and 3 equivalents of di-tert-butylperoxide (DTBP) in PhCl at 110 ºC for 12 h (Table 10.3.1). 
Interestingly, the desired product 266a was isolated in 45% yield under oxidative conditions. 
Encouraged by the initial result, we first examined different ligands. Pleasingly, 2,2'-
bipyridine (L4) was found to be the best ligand in this transformation and the yield could be 
obtained in 64% using CuI as a pre-catalyst. It was notable that while reaction was performed 
at higher or lower temperature resulted in a lower yield (Table 10.3.1 entries 4 and 20). 
Afterwards, various solvents were tested and the reaction showed strongly solvent dependent 
(Table 10.3.1, entries 7-14). We observed that chlorinated solvent such as PhBr, PhCl, PhF or 
1,2-dichloroethane were efficient solvents to deliver the desired product 266a. Finally, 1,2-
dichloroethane was found to be the best solvent for the annulation of 228h with 265a to 
obtain product 266a in 64% yield (Table 10.3.1, entry 14). 
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Table 10.3.1. Optimization of reaction conditions.
[a] 
 
Entry Solvent 
(2 mL) 
Oxidant 
(equiv) 
Metal salt 
(mol%) 
Temp 
(°C) 
Ligand 
(mol%) 
Yield 
(%) 
1 PhCl DTBP (3) CuI (15) 110 30 42 
2 PhCl DTBP (3) CuI 30) 110 30 40 
3 PhCl DTBP (3) CuI (20) 110 30 45 
4 PhCl DTBP (3) CuI (20) 110 40 34 
5 DCE DTBP (3) CuI (20) 80 30 47 
6 DCE DTBP (3) CuI(20) 60 30 25 
7 MeCN DTBP (3) CuI (20) 75 30 trace 
8 PhNO2 DTBP (3) CuI (20) 75 30 25 
9 PhF DTBP (3) CuI (20) 75 30 39 
10 PhBr DTBP (3) CuI (20) 75 30 46 
11 PhH DTBP (3) CuI (20) 75 30 trace 
12 DCE DTBP (3) CuI (20) 75 30 45 
13 2-
i
PrOH DTBP (3) CuI (20) 75 30 n.d. 
14
[b,c]
 DCE DTBP (3) CuI (20) 75 30 64 
[a] Reaction conditions: 288h (0. 75 mmol), 265a (0. 25 mmol), DTBP (3 equiv), CuI (20 mol%), 2,2'-bipyridine 
L4 (30 mol%) in DCE (2.0 mL) at 75 °C for 5-8 h under argon. [b] Solid starting mixture was degassed by 
freezing it in liquid nitrogen, replacing the atmosphere with argon and allowing it to warm to room temperature 
(repeated two times). [c] Reaction time 8 h. DCE = 1,2-dichloroethane. n.d.= not detected. 
After screening different solvents, we next screened different copper salts such as CuBr, CuI, 
CuCl, Cu2O, CuF2 or CuBr∙SMe2 as a catalyst. Notably, CuBr
.
SMe2 was to be the best 
catalyst for oxidative furan synthesis and desired produce product 266a was isolated in 70% 
yield (Table 10.3.2, entry 9). Furthermore, we examined various oxidants for multisubstituted 
furan synthesis. Several oxidants, such as TBHP, BPO or H2O2 were failed to produce the 
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desired annulated product 266a (Table 10.3.2, entries 12-14). Interestingly, di-cumyl-peroxide 
(DCP) and di-tert-butylperoxide (20) were suitable to produce the product 266a under  
Table 10.3.2. Optimization of reaction condition with different catalysts and oxidants.
[a] 
 
Entry Oxidant (equiv) Cat. (mol%) Yield (%) 
1 DTBP (3) CuCl (20) 32 
2
[b]
 DTBP (3) CuBr (20) 53 
3 DTBP (3) CuCN (20) trace 
4 DTBP (3) CuF2 (20) n.d. 
5 DTBP (3) Cu2O (20) trace 
6 DTBP (3) Fe(acac)3 (20) n.d. 
7
[c,d]
 DTBP (3) CuI (20) 64 
8
[c,d]
 DTBP (3) CuBr (20) 68 
9
[c,d]
 DTBP (3) CuBr·SMe2 (20) 70 
10
[b,d]
 DTBP (5) CuBr (20) 44 
11
[b,d]
 DTBP (4) CuBr (20) 65 
12 BPO (3)  CuI (20) trace 
13 H2O2 (3) CuI (20) trace 
14 TBHP (3) CuI (20) trace 
15 DCP (3) CuI (20) 55 
16
[e]
 DTBP (3) CuBr (20) 44 
17 DTBP (3) CuI (20) trace 
[a] Reaction conditions: 288h (0. 75 mmol), 265a (0. 25 mmol), DTBP (3 equiv), CuI (20 mol%), 2,2'-bipyridine 
L4 (30 mol%) in DCE (2.0 mL) at 75 °C for 8 h under argon. [b] Fresh degassed DCE was used. [c] Solid 
starting mixture was degassed by freezing it in liquid nitrogen, replacing the atmosphere with argon and 
allowing it to warm to room temperature (repeated two times). [d] Reaction time 8 h. [e] 1 equiv SMe2 was used. 
DTBP = Di-tert-butyl hydrogen peroxide. TBHP = tert-Butyl hydrogen peroxide. BPO = Dibezyl peroxide. DCP 
= Dicumyl peroxide. 
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oxidative conditions. The temperature effect of furan synthesis was examined. The best yield 
was obtained while reaction was conducted at 75 ºC. The formation of product 266a 
drastically decreased under atmospheric condition. 
10.4 Scope of Copper(I)-Catalyzed Oxidative Furans Synthesis 
With fully optimized reaction conditions in hand, a wide range of aryl methyl ketones were 
then examined with 265a under copper(I)-catalyzed annulation reaction conditions (Table 
10.4.1). The formations of multisubstituted furan derivatives were observed with various 
functionalized acetophenones. We were pleased to find that various acetophenones could be 
transferred into the corresponding products in moderate to good yield. To our delight, meta-  
Table 10.4.1. Scope of Aryl methyl ketones.
[a] 
 
Entry R
1
 R
2
 Product Yield (%) 
1 
 
Et 266a 70 
2 
 
Et 266b 75 
3 
 
Et 266c 45 
4 
 
Et 266d 76 
5 
 
Et 266e 66 
6 
 
Et 266f 67 
7 
 
Et 266g 78 
8 
 
Et 266h 65 
9 
 
Et 266i 56 
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Continuation of Table 10.4.1 
10 
 
Et 266j 72 
11 
 
Et 266k 56 
12 
 
Et 266l 70 
13 
 
Et 266m 61 
14 
 
Et 266n 48 
15  
Me 266o 66 
16  
Me 266p n.d. 
17  
Me 266q n.d. 
18  
Me 266r n.d. 
[a] Reaction conditions: 228 (0. 75 mmol), 265 (0. 25 mmol), DTBP (3 equiv), CuBr∙Me2S (20 mol%), bipy L4 
(30 mol%) in DCE (2.0 mL) at 75 °C for 5-8 h under argon. [b] 4 Equiv aryl methyl ketone was used. n.d. = not 
detected. 
substituted acetophenones were well tolerated and the desired products (266i-266j) proceeded 
in moderate to good yield. Various functional groups on the aryl part were compatible with 
oxidative conditions and annulation reaction afforded the desired products (266k-266m) 
smoothly. Gratifyingly, 2-acetylthiophene provided the corresponding desired product 266n  
in 48 % yield efficiently under developed reaction conditions. Unfortunately, electron-
donating groups such as hydroxyl, methoxy and amino onto the acetophenone were not 
tolerated under optimal conditions. 
After successfully established the scope of acetophenones, we further explored the scope of 
the copper(I)-catalyzed oxidative furans synthesis with a series of alkyl acetylenedicarboxlate 
under developed reaction conditions (Table 10.4.2). To our delight, various alkyl substituted  
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Table 10.4.2. Scope of different alkynes.
[a] 
 
Entry R
1
 R
2
 R
3
 Product Yield (%) 
1 
 
CO2n-Pr CO2n-Pr 266s 76 
2 
 
CO2n-Hex CO2n-Hex 266t 72 
3 
 
CO2allyl CO2allyl 266u 51 
4[b] 
 
CO2(+)-menthol CO2(+)-menthol 266v 80 
5[b] 
 
CO2(+)-borneol CO2(+)-borneol 266w 47 
6 
 
Ph CO2H 266x n.d. 
7 
 
Me CO2H 266y n.d. 
8 
 
CO2H CO2H 266z n.d. 
9 
 
Ph Ph 266ab n.d. 
10 
 
Ph H 266ac n.d. 
[a] Reaction conditions: 228 (0. 75 mmol), 267 (0. 25 mmol), DTBP (3 equiv), CuBr∙Me2S (20 mol%), L4 (30 
mol%) in DCE (2.0 mL) at 75 °C for 5-8 h under argon. [b] 4 equiv arylmethylketone were used. n.d. = not 
detected. 
esters of acetylenedicarboxylic acid provided the corresponding furan derivatives (226s-
226w) under oxidative reaction conditions. Long-chain-aliphatic substituted 
acetylenedicarboxylate ester derivatives were anticipated and observed formation of products 
226s-226u in good yield. Interestingly, diallyl but-2-ynedioate well tolerated under radical 
reaction conditions and obtained the desired product 266u in 51% yield. Gratifyingly, an ester 
derivative of (+)-menthol and (+)-borneol of but-2-ynedioic acid, gave the desired products 
266v and 266w smoothly in moderate to good yield. Ethylpropiolate, phenylacetylene and 
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diphenylacetylene derivatives did not give the desired products under optimized reaction 
conditions. 
10.5 Studies on Reaction Mechanism 
10.5.1 Kinetic Isotope Effect (KIE) Study 
In order to gain insight into the reaction mechanism of the copper-catalyzed furan synthesis, 
we performed several experimental studies. We next conducted kinetics isotope effect (KIE) 
experiment between 228e and 268 under optimal reaction condition. We observed large 
kinetic isotope effect equal to 4.5 (kH/kD ≈ 4.5). This study suggested that the hydrogen 
abstraction from the acetophenone derivative is not the rate-determining step. 
 
Scheme 10.2. Kinetics isotope effect (KIE) experiment.  
10.5.2 Radical Inhibition Studies 
Initially, we were wondering whether the annulation reaction underwent via radical pathway 
or other reaction pathway. In this regards, we have performed radical trapping experiment 
under our optimized reaction conditions using radical scavenger. In the presence of radical 
scavenger such as TEMPO (16), (Z)-N-tert-butyl-1-phenylmethanimine oxide (270) and 2,6-
di-tert-butylphenol (271), we did not observe the desired product formation. These result 
suggested that reaction proceeded via radical intermediate. 
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Table 10.5.1. Reaction with different radical scavengers.
[a]
 
 
Entry Additive Yield (%) 
1 none 68 
2 TEMPO (16)  
3 (Z)-N-tert-butyl-1-phenylmethanimine oxide (270) n.d. 
4 2,6-di-tert-butylphenol (271) n.d. 
[a] Reaction conditions: 268h (0.75 mmol), 265a (0. 25 mmol), DTBP (3 equiv), CuBr∙Me2S (20 mol%), bipy 
L4 (30 mol%), additive (2 equiv) in DCE (2.0 mL) at 75 °C for 12 h under argon. 
10.6 Mechanism 
 
Scheme 10.3. Proposed mechanism for furan synthesis. 
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Based on our previous studies and preliminary experimental results, a plausible mechanism 
has been proposed in the Scheme 10.3. At the beginning, the copper (II) species was 
generated from cupper(I) species by oxidation with DTBP.[230] Then, the reaction of enol form 
of acetophenone (228) with copper(II) species could be generated the intermediate 273 which 
reacted with electron-deficient alkyne (265a) to form the intermediate 274. Afterwards, the 
intermediate 275 was formed from the intermediate 274 after addition of copper(II) species 
which could be formed intermediate 276. The intermediate 276 could be led to form 
intermediate 277 via ligand exchange of copper center of intermediate 276. Finally, product 
279 was produced by reductive elimination of copper(I) from 277. Alternative way of product 
279 could be formed via oxidation of intermediate 274 to lead the intermediate 278 which C–
O cyclized followed by oxidation. The Cu(II) species was regenerated by oxidation of Cu(I) 
with DTBP. 
10.7 Identification of Biological Activity of Furan Derivatives 
According to our plan, we synthesized compound libraries of furan derivatives. Afterwards, 
we submitted all compound to COMAS (Compound Management and Screening Centre) in 
Dortmund to find the biological activity. Several cell-based assays such as hedgehog signaling 
pathway and Wnt signaling pathway and autophagy were tested. After screening different 
assays, two compounds 266f, and 266j inhibited the hedgehog signaling pathway in the low 
micro molar range (Table 10.7.1). 
Table 10.7.1. Results of hedgehog signaling pathway.  
Entry Product IC50 [µM] Viability [µM] 
1 
266f 
6.01±0.44 inactive 
2 
        266j 
6.51±0.38 inactive 
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11 Summary 
In the present work, emphasis is given on the synthesis of biologically relevant compound 
libraries via oxidative annulation of non-prefunctionalized precursors. The thesis is mainly 
focused on the development of new methods for the synthesis of nitrogen, oxygen-containing  
 
Figure 11.1. Summary of oxidative annulation via C–H bond functionalization in the 
syntheses of biologically relevant compounds. 
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heterocycles and carbocycles under annulation conditions. The “privileged scaffolds” were 
obtained employing metal-free conditions and copper catalyst. In the first part of this work, 
the focus was oriented in the synthesis of isoquinolones, pyrido[1,2-a]benzimidazoles and N-
arylated pyridine scaffolds using hypervalent iodine (III) reagents. Furthermore, synthesis of 
imidazo[1,2-a]pyridine 1-oxide derivatives were described via annulation of various 
nitrosopyridines with alkynes and alkenes. In the second part of the work, oxidative 
annulations via C(sp
3
)–H bond functionalization were investigated. In this respect, a novel 
dehydrogenative Diels-Alder reaction of alkylbenzenes and electron-deficient alkenes and 
dehydrogenative nitration of alkyl benzenes were demonstrated using DDQ as oxidant. 
Development of novel methods for the syntheses of fully substituted cyclopropanes and 
furans via functionalization of acetophenones were described.  
11.1 Hypervalent Iodine (III) Mediated Oxidative Annulations  
In the first project, organocatalyzed regioselective oxidative annulation of N-
alkoxybenzamides (101c) with readily available alkynes (94) was described. The iodobenzene 
as a simple catalyst in combination with peracetic acid as oxidant was employed for the 
synthesis of biologically important isoquinolone scaffolds under mild reaction conditions. The 
developed method was applied in the annulation of various symmetric as well as 
unsymmetrical alkynes with different substituted benzamide derivatives. Unsymmetrical 
alkynes provided regioselectively single isomer which was confirmed by NOE and COSY 
analysis. The yields of this methodology ranged from moderate to excellent with very short 
reaction time. Furthermore, N–O bond cleavage of alkoxyisoquinolone was carried out to 
obtain the corresponding isoquinolone scaffold. 
 
Scheme 11.1. Organocatalyzed isoquinolone synthesis. 
In the second project, a novel (3+2) annulation of 2-aminopyridine and 2-aminoquinoline 
derivatives with simple arenes were demonstrated under oxidative conditions employing 
PhI(OAc)2 (22) as oxidant. The developed method tolerated a broad range of diversely 
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functionalized 2-aminopyridine derivatives to access biologically important pyrido[1,2-
a]benzimidazole scaffolds under mild reaction conditions. In addition, the methyl group of 
arenes as a traceless directing group in the synthesis of benzo[4,5]imidazo[1,2-a]quinolone 
derivatives were developed.  
 
Scheme 11.2. Hypervalent iodine (IIII) mediated pyrido[1,2-a]benzimidazole and 
benzo[4,5]imidazo[1,2-a]quinolone synthesis. 
In the third project, metal-free amination of heteroarylamines with non-prefunctionalized 
arenes were established. This process realized pharmaceutically useful scaffolds of N-arylated 
heteroaromatic amines using PhI(OAc)2 (22) as oxidant. Various 3-aminopyridine derivatives 
bearing differently functional groups were well tolerated and the yields of amino compounds 
were excellent in these conditions. Further, the development of an organocatalytic version of 
aforementioned reaction was developed. The oxidative amination reaction was successful 
under organocatalytic conditions and the corresponding products were obtained in moderate 
to good yields.  
 
Scheme 11.3. Hypervalent iodine (III) in oxidative amination. 
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11.2 Metal-free Regioselective Annulation of Nitrosopyridines with Alkynes 
In the course of these studies, effort was also put to develop a new method for the synthesis of 
imidazo[1,2-a]pyridines under metal and reagents free conditions (Scheme 11.4). This was 
achieved through a metal-free regioselective (3+2) annulation of nitrosopyridines with 
alkynes and alkenes. According to our knowledge, for the first time regioselective annulation 
of nitrosopyridines was developed under both catalyst and additive free conditions. In the 
annulation reaction, various functional groups were well tolerated and provided imidazo[1,2-
a]pyridine 1-oxide derivatives in good to excellent yield. Furthermore, N–oxides products 
could be deoxygenated under heating condition to obtain imidazo[1,2-a]pyridine motifs. 
 
Scheme 11.4. Metal free imidazo[1,2-a]pyridine 1-oxide synthesis. 
11.3 Oxidative Annulation of Alkylarenes with Electron-Deficient Alkenes  
Carbon-hydrogen (C–H) bonds are ubiquitous in nature and have found many significant 
advantages to utilize C–H bond functionalization for the construction C–C bond in an atom 
and the step economical way. In this regards, oxidative dehydrogenative Diels-Alder (DDA) 
reaction and nitration of alkylarenes via C–H bond functionalization were studied in details. 
DDQ (15) mediated oxidative dehydrogenative Diels-Alder reaction of alkylarenes and  
 
Scheme 11.5. Oxidative dehydrogenative Diels-Alder reaction and nitration. 
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electron deficient alkenes was developed (Scheme 11.5). The process was carried out with 2 
equivalents of DDQ (15) as oxidant, 2 equivalents of hydroquinone as additive in 
chlorobenzene under argon atmosphere and the synthesis of 1,4-phenanthraquinone and 
isoindolone scaffolds were realized. The reaction showed tolerance to various substituted 
arenes yielding the corresponding desired product. Mechanistic studies suggested that 
oxidative annulation reaction underwent via styrene intermediate with in-situ formation of 
quinhydrone. Furthermore, a dehydrogenate stereoselective nitroalkenes synthesis from 
alkylbenzenes was also developed employing AgNO2 as nitrating agent (Scheme 11.5). 
11.4 Oxidative Annulation of Acetophenones via C(sp
3
)–H Bond Functionalization 
Furthermore, the investigations of acetophenones for the oxidative annulation via C–H bond 
functionalization were described. In the sixth project, a novel Cu(I)-catalyzed oxidative (2+1) 
cyclopropanation of aryl methyl ketones with electron-deficient alkenes were demonstrated 
using 20 mol% CuI in combination with 30 mol% 2,2'-bipyridine (L4) as ligand in the 
presence of DTBP as oxidant in chlorobenzene (Scheme 11.6). Diverse ranges of 
acetophenones and maleimide derivatives were tolerated under such mild reaction conditions. 
Interestingly, the method allowed stereoselectively (2+1) annulation of acetophenones with 
electron-deficient alkenes and provided the straightforward way in the synthesis of strain 
cyclopropanes. Mechanistic studies revealed that the reaction underwent via a novel radical 
oxidative pathway. 
 
Scheme 11.6. Synthesis of cyclopropane via (2+1) annulation. 
In the seventh project, Cu(I)-catalyzed (1+1+1) oxidative annulation of acetophenone 
derivatives without alkenes was also developed for the synthesis of fully substituted 
cyclopropanes (Scheme 11.7). The process was developed using 10 mol% CuI in combination 
of 20 mol% 4,4'-di-tert-butyl-2,2'-bipyridyl (L5) as ligand in the presence of DTBP as oxidant 
in chlorobenzene at 90 ºC. Wide ranges of functional groups were tolerated under mild 
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conditions and good to excellent yield was achieved. The process is highly practical and a 
wide array of acetophenones could be used in the stereoselective synthesis of cyclopropanes. 
  
 
Scheme 11.7. Oxidative (1+1+1) cyclotrimerization in cyclopropane synthesis. 
During the studies on oxidative cyclopropanation, we envisaged that a new route to 
multisubstituted furans via acetophenone radical addition to alkynes would be highly 
interesting method from simple starting materials. In an attempt towards this direction a 
Cu(I)-catalyzed (3+2) annulation of acetophenone derivatives with alkyl 
acetylenedicarboxylates was demonstrated under oxidative reaction conditions (Scheme 11.8). 
The method was developed using CuBr
.
SMe2 as catalyst, bipy (L4) as ligand and DTBP as 
oxidant under radical reaction conditions. The developed method provided polysubstituted 
furan derivatives with various substituted acetophenones in moderate to good yield. 
Mechanistic studies revealed that reaction underwent a novel a radical addition to the 
electron-deficient alkynes. The developed reaction is highly practical because readily 
available starting materials were used without prefunctionalization. 
 
Scheme 11.8. Cu(1)-catalyzed oxidative furan synthesis. 
After establishing several interesting reaction methodologies, they were used for the 
synthesis of biologically relevant compound collections. Finally, all developed compounds 
were submitted to the COMAS for various cell-based assays which resulted in identifying of 
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some analogous as inhibitors of the hedgehog signaling pathway, Wnt signaling pathway and 
autophagy. 
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11 Zusammenfassung 
In der vorgelegten Arbeit wurde die Synthese von biologisch relevanten Substanzbibliotheken 
durch oxidative Anellierung von nicht-funktionalisierten Startmaterialien durch C-H 
Bindungsfunktionalisierung adressiert. Dabei fokussierten sich die Studien in dieser Arbeit 
auf die Entwicklung neuer Methoden zur Synthese von Stickstoff- und Sauerstoff- 
 
Abbildung 11.1. Zusammenfassung der oxidativen Anellierung durch C-H 
Bindungsfunktionalisierung zur Synthese biologisch relevanter Verbindungen. 
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haltigen Heterocyclen als auch von Carbocyclen unter Anellierungsbedingungen. Die 
privilegierten Gerüstmoleküle wurden unter Metall-freien Reaktionsbedingungen und 
Kupferkatalyse erhalten. Im ersten Teil dieser Arbeit lag der Fokus auf der Synthese von 
Isoquinolonen, Pyrido[1,2-a]benzimidazolen, und N-arylierten Pyridinen unter Verwendung 
von hypervalenten Iod(III) Reagenzien. Darüber hinaus wurde die Synthese von 
Imidazopyridin N-Oxide durch Anellierung verschiedener Nitrosopyridine mit Alkinen und 
Alkenen beschrieben. Im zweiten Teil dieser Arbeit wurde eine neue dehydrogenative Diels-
Alder Reaktion von Alkylbenzolen und elektronenarmen Alkenen als auch die 
dehydrogenative Nitrierung von Alkylbenzol durch den Einsatz von DDQ als 
Oxidationsmittel beschrieben. Des Weiten wurde die Entwicklung neuer Methoden zur 
Synhese vollständig substituierter Cyclopropane und Furane durch Funktionalisierung von 
Acetophenonen beschrieben. 
11.1 Hypervalentes Iod(III) vermittelte oxidative Anellierungen  
Im ersten Projekt wurde die organokatalytische regioselektive oxidative Anellierung von N-
Alkoxybenzamiden (101c) mit leicht zugänglichen Alkinen (94) beschrieben (Abbildung 
11.2). Iodbenzol als einfacher Katalysator in Verbindung mit Peressigsäure als 
Oxidationsmittel wurde zur Synthese des biologisch wichtigen Isoquinolon-Gerüsts unter 
milden Reaktionsbedingungen verwendet. Die entwickelte Methode wurde zur Anellierung 
verschiedenster symmetrischer und asymmetrischer Alkine mit unterschiedlich substituierten 
Benzamid-Derivaten genutzt. Asymmetrische Alkine lieferten ein einziges Regioisomer, was 
durch NOE und COSY-NMR Analyse bestätigt wurde. Diese neue Methode erzielte gute bis 
ausgezeichnete Ausbeuten in kurzen Reaktionszeiten. Darüber hinaus wurde die N-O 
Bindungsspaltung der Alkoxyisoquinolone zu den entsprechenden Isoquinolonen 
demonstriert. 
 
Abbildung 11.2. Organokatalytische Isoquinolon-Synthese. 
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Im zweiten Projekt wurde eine neue (3+2) Anellierung von 2-Aminopyridinen und 2-
Aminoquinolinen mit einfachen Arenen unter oxidativen Reaktionsbedingungen durch die 
Verwendung von PhI(OAc)2 (22) als Oxidationsmittel demonstriert (Abbildung 11.3). Die 
entwickelte Methode tolerierte ein breites Spektrum an funktionalisierten 2-Aminopyridinen 
zur Synthese des biologisch relevanten Pyrido[1,2-a]benzimidazol-Gerüsts unter milden 
Reaktionsbedingungen. Zusätzlich wurde der Einsatz der Methylgruppe von Arenen als 
spurlose dirigierende Gruppe in der Synthese von Benzo[4,5]imidazo[1,2-a]quinolone-
Derivaten entwickelt. 
 
Abbildung 11.3. Hypervalentes Iod(III) vermittelte Synthese von Pyrido[1,2-
a]benzimidazolen und Benzo[4,5]imidazo[1,2-a]quinolonen. 
Im dritten Projekt wurde die Metall-freie Aminierung von Heteroaryl-Aminen mit nicht-
prefunktionalsierten Arenen etabliert. Dieser Prozess realisierte die Synthese von 
pharmazeutisch nützlichen N-arylierten heteroaromatischen Aminen durch Verwendung von 
PhI(OAc)2 (22) als Oxidationsmittel (Abbildung 11.4). Eine Vielzahl an 3-Aminopyridin-
Derivaten mit verschiedenen funktionellen Gruppen wurde unter den Reaktionsbedingungen 
mit exzellenten Ausbeuten toleriert. Die oxidative Aminierung wurde darüber hinaus 
erfolgreich unter organokatalytischen Bedingungen durchgeführt, wobei die entsprechenden 
Produkte in moderaten bis guten Ausbeuten erhalten wurden. 
 
Abbildung 11.4. Hypervalent iodine (III) in oxidative amination. 
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11.2 Metal-freie regioselektive Anellierung von Nitrosopyridinen mit Alkinen 
Im weiteren Verlauf dieser Arbeit wurde die Entwicklung einer neuen Methode zur Synthese 
von Imidazo[1,2-a]pyridinen unter Metall-freien Bedingungen und ohne den Einsatz von 
weiteren Reagenzien erzielt (Abbildung 11.5). Diese Transformation wurde durch die Metall-
freie und regioselektive (3+2) Anellierung von Nitrosopyridinen mit Alkinen und Alkenen 
erreicht. Nach unserem Wissen wurde damit zum ersten Mal die regioselektive Anellierung 
von Nitrosopyridinen ohne Verwendung von Katalysatoren oder Additiven beschrieben. In 
der Annellierungsreaktion wurden verschiedene funktionelle Gruppen gut toleriert und lieferte 
Imidazopyridin N–Oxide in guten bis ausgezeichneten Ausbeuten. Zusätzlich wurden die 
N-Oxide durch Erhitzen desoxygeniert, wodurch die entsprechenden Imidazo[1,2-a]pyridine 
erhalten wurden. 
 
Abbildung 11.5. Metal-freie Synthese von Imidazopyridin N–Oxiden. 
11.3 Oxidative Anellierung von Alkylarenen mit elektronenarmen Alkenen 
Kohlenstoff-Wasserstoff (C-H) Bindungen sind allgegenwertig in der Natur und es finden 
sich viele signifikante Vorteile C-H Bindungen zu nutzen, um neue C-C Bindungen in einer 
Atom- und syntheseschrittökonomischen Weise zu konstruieren. Im diesem Kontext wurde 
die oxidative dehydrogenative Diels-Alder (DDA) Reaktion und Nitrierung von Alkylarenen 
durch C-H Bindungsfunktionalisierung im Detail studiert. Mit diesem Ziel wurde die DDQ 
(15) vermittelte oxidative und dehydrogenative Diels-Alder Reaktion von Alkylarenen und 
elektronenarmen Alkenen entwickelt (Abbildung 11.6). 
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Abbildung 11.6. Oxidative dehydrogenative Diels-Alder Reaktion und Nitrierung. 
Dieser Prozess wurde mit zwei Äquivalenten DDQ (15) als Oxidationsmittel, zwei 
Äquivalenten Hydrochinon als Additiv in Chlorbenzol unter Argonatmosphäre durchgeführt, 
wodurch 1,4-Phenanthrachinone und Isoindole erhalten wurden. Die Reaktionsbedingungen 
zeigten gute Toleranz gegenüber verschieden substituierter Arene, welche die gewünschten 
Produkte in guten Ausbeuten lieferten. Mechanistische Studien legten nahe, dass die oxidative 
Anellierungsreaktion über ein Styrol-Intermediat und die in situ Bildung von Quinhydrone 
verläuft. Zusätzlich wurde die dehydrogenative und stereoselektive Synthese von 
Nitroalkenen ausgehend von Alkylbenol durch den Einsatz von AgNO2 als 
Nitrierungsreagenz beschrieben (Abbildung 11.5). 
11.4 Oxidative Anellierung von Acetophenonen durch C(sp
3
)–H 
Bindungsfunktionalisierung 
Des Weiteren wurde die oxidative Annelierung durch C(sp
3
)–H Bindungsfunktionalisierung 
beschrieben. In diesem 6. Projekt wurde eine neue Cu(I)-katalysierte oxidative (2+1) 
Cyclopropanierung von Acetophenon-Derivaten mit elektronenarmen Alkenen durch den 
Einsatz von 20 mol% CuI in Verbindung mit 30 mol% 2,2‘-Bipyridin (L4) als Liganden in 
der Anwesenheit von DTBP als Oxidationsmittel in Chlorbenzol demonstriert (Abbildung 
11.7). Ein vielseitiges Spektrum an Acetophenonen und Maleimid-Derivaten wurde unter den 
milden Reaktionsbedingungen toleriert. Interessanterweise erlaubte die Methode die 
stereoselektive (2+1) Anellierung von Acetophenonen mit elektronenarmen Alkenen und 
ermöglichte dadurch die Synthese gespannter Cyclopropane. Mechanistische Studien deckten 
auf, dass die Reaktion durch einen neuen oxidativ radikalischen Weg erfolgte.  
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Abbildung 11.7. Synthesis von Cyclopropanen via (2+1) Anellierung. 
Im 7. Projekt wurde die Cu(I)-katalyiserte oxidative (1+1+1) Anellierung von Acetophenon-
Derivaten ohne die Verwendung von Alkenen zur Synthese vollständig substituierter 
Cycopropanen entwickelt (Abbildung 11.8). Dieser Prozess wurde durch Verwendung von 
10 mol% CuI in Kombination mit 20 mol% 4,4'-di-tert-Butyl-2,2'-bipyridin (L5) als Ligand 
in Gegenwart von DTBP als Oxidationsmittel in Chlorbenzol bei 90 °C verwirklicht. Ein 
breites Spektrum an funktionellen Gruppen wurde unter den milden Reaktionsbedingungen 
toleriert und erzielte gute bis ausgezeichnete Ausbeuten. Dieser Prozess ist von hohem 
praktischem Nutzen, da eine Vielzahl an Acetophenonen für die stereoselektive Synthese von 
Cyclopropanen eingesetzt werden konnte. 
 
  
 
Abbildung 11.8. Oxidative (1+1+1) Cyclotrimerisierung in der Synthese von Cyclopropanen. 
Während der Studien zur oxidativen Cyclopropanierung postulierten wir eine neue Route für 
multisubstituierte Furane durch Acetophenon-Radikaladdition an Alkine als hoch interessante 
Methode ausgehend von einfachen Startmaterialien. Mit dem Ziel diesen Ansatz zu 
verwirklichen wurde die Cu(I)-katalyiserte (3+2) Anellierung von Acetophenon-Derivaten 
mit elektronenarmen Alkinen unter oxidativen Reaktionsbedingungen demonstriert 
(Abilldung 11.9). Die Methode wurde durch den Einsatz von CuBr
.
SMe2 als Katalysator, bipy 
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(L4) als Ligand und DTBP als Oxidationsmittel unter radikalischen Reaktionsbedingungen. 
Die entwickelten Reaktionsbedingungen lieferten polysubstituierte Furan-Derivate mit 
verschieden substituierten Acetophenonen in moderaten bis guten Ausbeuten. Mechanistische 
Studien deckten auf, dass die Reaktion über die radikalische Addition von Acetophenon an 
elektronenarme Alkine erfolgte. Die entwickelten Reaktionsbedingungen erwiesen sich als 
äußert praktisch, da einfache Startmaterialien ohne Prefunktionalisierung genutzt werden 
konnten. 
 
Abbildung 11.9. Cu(1)-katalysierte oxidative Furansynthese. 
Nach der Etablierung mehrerer Reaktionsmethoden, wurden diese zur Synthese 
biologisch relevanter Substanzbibliotheken genutzt. Letztendlich wurden alle erhaltenen 
Verbindungen im COMAS in verschiedenen Zell-basierten Assays untersucht, was die 
Identifikation mehrerer Analoga mit inhibitorischer Aktivität in den Hedgehog und Wnt 
Singalwegen als auch gegen Autophagie erzielte. 
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12.1 Materials and methods 
12.2 General Remarks 
Unless otherwise noted, all commercially available compounds were used as provided without 
further purification. Solvents for chromatography were technical grade. Dry solvents were 
purified by the Solvent Purification System Glovebox Technology M‐BRAUN SPS‐800.  
12.2.1 Nuclear Magnetic Resonance Spectroscopy (NMR) 
1
H‐NMR and 13C‐NMR were recorded on Varian Mercury (200 MHz), Bruker DPX400 (300 
MHz), Bruker DRX400 (400 MHz), DRX500 (500 MHz) or DRX600 (600 MHz) spectrometers 
in CDCl3. Data are reported in the following order: chemical shift (d) in ppm; multiplicities 
are indicated s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet); coupling constants 
(J) are given in Hertz (Hz). 
12.2.2 Chromatography 
Analytical thin‐layer chromatography (TLC) was performed on Merck silica gel aluminium 
plates with F‐254 indicator, visualized by irradiation with UV light. Column chromatography 
was performed using silica gel Merck 60 (particle size 0.040‐0.063 mm). Solvent mixtures are 
understood as volume/volume. 
 
12.2.3 High resolution mass spectra (HRMS) 
HRMS were recorded on a LTQ Orbitrap mass spectrometer coupled to an Accela HPLC-
System (HPLC column: Hypersyl GOLD, 50 mm × 1 mm × 1.9 μm). Mass spectra (MS-EI, 
70 eV) were collected using a GC-MS (GC system 7890A equipped with 5975C detector) 
produced by Agilent Technologies (column: HP-5MS, 30 m × 0.250 mm × 0.25μm).  
 
12.2.4 Fourier transform infrared spectroscopy (FT-IR)  
IR spectra were obtained with a Bruker Tensor 27 spectrometer (ATR, neat) and are reported 
in terms of frequency of absorption (cm
-1
).  
11.2.5 Optical rotations 
Optical rotation [𝛼] was measured in a Schmidt + Haensch Polartronic HH8 polarimeter in 
cuvettes with a path length of 10 cm at ambient temperature. The concentration is given as 
g/100 mL 
 
Experimental Section 
- 141 - 
 
12.2.6 Reagents 
Chemicals were brought form commercial sources with purity above 97% which used without 
further purification. Nitrosopyridine derivatives were taken from Dr. Rishikesh Narayan and 
benzamide derivatives were taken from Dr. Rajarshi Samanta for substrate scope.  
12.3 General Procedure for A-J 
General Procedure A: Synthesis of N‑Methoxyisoquinolone Derivatives  
 
To a screw capped reaction vial containing benzamide (1 equiv, 0.25 mmol) 
diphenylacetylene derivative (1.2 equiv, 0.3 mmol), iodobenzene (0.2 equiv) in 1 mL 
1,1,1,3,3,3-hexafluoro-2-propanol (0.25 M), and peracetic acid (1.5 equiv; 0.75×2) were 
added portion-wise (second portion was added after 15 min) at room temperature under air. 
After stirring 30-50 min, the reaction mixture was diluted with mesitylene (2 mL) and the 
crude reaction mixture was concentrated under reduced pressure until almost evaporation of 
HFIP. Crude reaction mixture was subsequently purified by flash column chromatography 
over neutral alumina using petroleum ether/ethyl acetate as an eluent system. 
General Procedure B: Synthesis of Pyrido[1,2-a]benzimidazoles Derivatives  
 
To a screw cap reaction vial 2-aminopyridine derivatives (1 equiv, 0.25 mmol), phenyliodine 
diacetate (2 equiv, 0.5 mmol), arene (3-5 equiv, 0.75-1.25 mmol) and HFIP (0.25 M) were 
added. The reaction mixture was heated to 40 
o
C and stirred until completion. The crude 
reaction mixture was concentrated under reduced pressure and subsequently purified by flash 
column chromatography over silica gel using petroleum ether/ethyl acetate as an eluent 
system. 
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General Procedure C: Synthesis of N-Arylated Heteroaromatic Amines 
 
To a screw capped reaction vial containing heteroaromatic amine (0.25 mmol), arene (2.5 
mmol, 10 equiv) and HFIP (0.25 M) were added. Then PhI(OAc)2 (0.257-0.375 mmol) was 
added to the reaction mixture and the reaction was stirred at room temperature under air until 
completion. The crude reaction mixture was concentrated under reduced pressure and 
subsequently purified by flash column chromatography over silica gel using petroleum 
ether/ethyl acetate as eluent system. 
General Procedure D for Organocatalytic Amination 
 
To a screw capped reaction vial containing heteroaromatic amine (0.25 mmol), arene (2.5 
mmol, 10 equiv), iodobenzene (25 mol % ) in 1 mL HFIP (0.25 M) and peracetic acid (5 
equiv; 39% solution in acetic acid) was added portion-wise (3 equiv was added initially and 
second portion 2 equiv was added after 6 h) at room temperature under air and the reaction 
mixture was stirred at room temperature under air until completion. The crude reaction 
mixture was concentrated under reduced pressure and subsequently purified by flash column 
chromatography over silica gel using petroleum ether/ ethyl acetate as eluent system.  
General Procedure E: Synthesis of N–Oxide-imidazopyridines  
 
To a screw cap reaction vial 2-nitrosopyridine derivatives (0.25 mmol, 1 equiv), alkyne (0.28 
mmol, 1.1 equiv), and HFIP (0.25 M) were added under air. The reaction mixture was stirred 
vigorously at RT-60 
o
C until completion. The crude reaction mixture was concentrated under 
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reduced pressure and subsequently purified by flash column chromatography over silica gel 
using dichloromethane/methanol as an eluent system. 
General Procedure F: Synthesis of Oxidative Diels-Alder Reaction 
 
To a screw cap reaction vial charged with a magnetic stir-bar, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (0.5 mmol, 2 equiv) was added. Then the reaction tube was evacuated and 
back-filled with argon. The evacuation/backﬁll sequence was repeated three additional times. 
Under a counter flow of argon, 2 mL chlorobenzene (0.125 M) and arene (1.25 mmol, 5 equiv 
were added and the reaction was allowed to warm to 110-120°C. After 6 h, hydroquinone (0.5 
mmol, 2 equiv) and maleimide or quinone (0.25 mmol, 1 equiv) were added. The reaction 
mixture was stirred vigorously for completion of reaction (12 h). Afterwards, the reaction 
mixture was cooled to room temperature. Acetone (4 mL) was added and subsequently the 
reaction mixture was concentrated in vacuo and purified by column chromatography using 
silica gel (100-200 mesh) and petroleum-ether/acetone/ethyl acetate as eluent. 
 
General Procedure G: Synthesis of Nitroolefins 
 
To a screw cap reaction vial charged with a magnetic stir-bar, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (0.25 mmol, 2 equiv) was added. Then the reaction tube was evacuated and 
back-filled with argon. The evacuation/backﬁll sequence was repeated three additional times. 
Under a counter flow of argon, 2 mL of 1,2-dichloroethane (0.25 M) and arene (0.25 mmol, 1 
equiv were added and the reaction was allowed to warm to 80 °C. After 4 h, AgNO2 (0.5 
mmol, 2 equiv) was added. The reaction mixture was stirred vigorously for completion of 
reaction (6 h). Afterwards, the reaction mixture was cooled to room temperature. Acetone (4 
mL) was added and subsequently the reaction mixture was concentrated in vacuum and 
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purified by column chromatography using silica gel (100-200 mesh) and petroleum-ether/ 
ethyl acetate as eluent. 
General Procedure H: Synthesis of Cyclopropanes  
 
To a screw cap reaction tube charged with a magnetic stir-bar, maleimide (0.25 mmol), 
acetophenone (0.5 mmol), CuI (20 mol%) and 2,2'-bipyridine (30 mol%) were added. The 
tube was then evacuated and back-filled with argon. This evacuation/backﬁll sequence was 
repeated three additional times. Under a counter flow of argon, solvent (2 mL of degased 
chlorobenzene) and di-tert-butyl peroxide (5 equiv) were added. The reaction mixture was 
allowed to warm up to 110 °C and stirred vigorously for completion of reaction (12-24 h). 
Then the reaction mixture was cooled to room temperature. Dichloromethane (4 mL) and 
ethyl acetate (2 mL) were added and the reaction mixture was filtered through Celite. 
Afterwards, the reaction mixture was concentrated and purified by column chromatography 
using silica gel (100-200 mesh) and petroleum-ether/ acetone as eluent. 
General Procedure I: Synthesis of Cyclopropane from Acetophenones 
 
To a screw cap reaction vial charged with a magnetic stir-bar, acetophenone derivative (0.5 
mmol), CuI (10 mol%), dtbpy L5 (20 mol%) were added. The vial was then evacuated and 
back-filled with argon. This evacuation/back-fill sequence was repeated three additional 
times. Under a counter flow of argon, 2 mL (0.25 M) of degassed solvent and DTBP (3 equiv) 
were added by syringe. The reaction mixture was allowed to warm up to 80-90 °C and was 
stirred vigorously for completion of reaction. Then the reaction mixture was cooled to room 
temperature. To the reaction mixture was added dichloromethane (20 mL), washed with HCl 
(1M) for two times, dried over Na2SO4 and evaporated in vacuum to afford the crude 
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product, which was purified by column chromatography using silica gel (100-200 mesh) and 
petroleum-ether/ acetone as the eluent. 
General Procedure J: Synthesis of Furan Derivatives  
 
To a screw cap reaction tube with septum charged with a magnetic stir-bar, 
acetylendicarboxylic acid ester (0.25 mmol, if it is solid), aryl methyl ketone (0.75 mmol, if it 
is solid), CuBr.SMe2 (20 mol%) and bipy L4 (30 mol%) were added. The tube was then 
evacuated and back-filled with argon. This evacuation/backﬁll sequence was repeated three 
additional times. Under a counter flow of argon, solvent (2 mL of degased 1,2-
dichloroethane) was added. The resulting mixture was then degassed by freezing in liquid 
nitrogen, replacing the atmosphere with argon and allowing warming to room temperature 
(repeated two times). Then liquid samples (acetylendicarboxylica acid ester and aryl methyl 
ketone) and DTBP (3 equiv) were added. The reaction mixture was allowed to warm to 75 °C 
and stirred vigorously for completion of reaction (5-8 h). Afterwards, the reaction mixture 
was cooled to room temperature. Dichloromethane (4 mL) and ethyl acetate (2 mL) were 
added and the reaction mixture was filtered through celite. Subsequently, the reaction mixture 
was concentrated and purified by column chromatography using silica gel (100-200 mesh) 
and petroleum-ether/ acetone/ethyl acetate as eluent. 
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12.4 Experimental Part for Iodobenzene-Catalyzed Oxidative Annulation of Benzamide 
Derivatives with Alkynes 
 
12.4.1 Characterization of Isoquinolone Derivatives (137a-139l) 
2-Methoxy-3,4-diphenylisoquinolin-1(2H)-one (137a) 
Compound 137a was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (10:90 v/v); the product was 
obtained as brown amorphous solid in 78% yield. 
 
1
H NMR (400 MHz, CDCl3) δ 8.59 (dd, J = 7.9, 1.2 Hz, 1H), 7.59 
– 7.50 (m, 2H), 7.29 – 7.20 (m, 9H), 7.12 – 7.06 (m, 2H), 3.73 ppm (s, 3H). 
 
13
C NMR (101 MHz, CDCl3) δ 158.27, 140.06, 136.61, 135.53, 133.03, 132.40, 131.71, 
130.78, 128.40, 128.22, 127.90, 127.62, 127.28, 126.89, 126.48, 125.87, 118.45, 63.60 ppm. 
 FT‐IR: ṽ = 3027, 2934, 1757, 1604, 1444, 1419, 1277, 1174, 1025 cm-1. 
 HRMS: calc. for [M+H]
+
 C22H18O2N: 328.13305found: 328.13321. 
 
2,6,7-Trimethoxy-3,4-di-p-tolylisoquinolin-1(2H)-one (137b) 
Compound 137b was obtained by using the general 
procedure A and product was isolated by column 
chromatography with neutral alumina. Eluent: 
EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as brown amorphous solid in 82% yield. 
1
H NMR (500 MHz, CD2Cl2) δ 7.90 (s, 1H), 7.21 – 7.17 
(m, 2H), 7.12-7.10 (m, Hz, 4H), 7.06 (d, J = 7.9 Hz, 2H), 
6.60 (s, 1H), 4.04 (s, 3H), 3.72 (s, 3H), 3.70 (s, 3H), 2.35 ppm (s, 6H). 
 
13
C NMR (126 MHz, CD2Cl2) δ 157.79, 153.90, 149.90, 139.20, 138.55, 137.31, 133.63, 
132.79, 131.96, 131.18, 129.98, 129.35, 128.70, 120.94, 118.08, 107.96, 106.91, 63.82, 56.67, 
56.19, 21.59, 21.50 ppm.  
FT‐IR: ṽ = 3015, 2958, 1771, 1656, 1503, 1422, 1181, 1020 cm-1. 
HRMS: calc. for [M+H]
+
 C26H26O2N: 416.18563 found: 416.18553. 
 
2-Methoxy-3,4-di-m-tolylisoquinolin-1(2H)-one (137c) 
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Compound 137c was obtained by using the general procedure A 
and product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (10:90 v/v); the product 
was obtained as brown amorphous solid in 60% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.53 (d, J = 7.6 Hz, 1H), 7.62 – 
7.53 (m, 2H), 7.24 (d, J = 8.1 Hz, 1H), 7.18 – 7.14 (m, 2H), 7.13-
7.06 (m, 3H), 7.00-6.96 (m, 2H), 3.76 (s, 3H), 2.31 (s, 3H), 2.29 ppm (s, 3H). 
13
C NMR (101 MHz, CD2Cl2) δ 158.38, 140.73, 138.24, 137.75, 137.31, 136.05, 132.86, 
132.61, 132.41, 131.75, 129.44, 129.17, 128.36, 128.30, 128.11, 127.85, 127.79, 127.07, 
126.98, 126.35, 118.60, 63.91, 21.55 ppm. 
 FT‐IR: ṽ = 3015, 2958, 1771, 1656, 1503, 1422, 1181, 1020 cm-1. 
 HRMS: calc. for [M+H]
+
 C24H22O2N: 356.16451 found: 356.16461. 
 
6,7-Dimethoxy-4-phenyl-3-(4-(trifluoromethyl)phenyl)isoquinolin-1(2H)-one (137d) 
Compound 137d was obtained by using the general 
procedure A and product was isolated by column 
chromatography with neutral alumina. Eluent: 
EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as brown amorphous solid in 53% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 7.87 (s, 1H), 7.50 (d, J = 
8.0 Hz, 2H), 7.41 (d, J = 8.0 Hz, 2H), 7.28-7.23 (m, 3H), 7.16 – 7.08 (m, 2H), 6.57 (s, 1H), 
4.01 (s, 3H), 3.69 (s, 3H), 3.66 ppm(s, 3H). 
 
13
C NMR (101 MHz, CD2Cl2) δ 157.56, 153.97, 150.17, 143.96, 139.13, 137.40, 136.74, 
135.85, 132.74, 132.16, 132.01, 131.87, 130.49, 130.16, 128.82, 127.96, 126.57, 124.97, 
124.93, 124.90, 124.86, 121.14, 118.56, 107.90, 106.79, 63.94, 56.67, 56.16 ppm. 
 FT‐IR: ṽ = 3040, 2934, 1661, 1605, 1555, 1506, 1324, 1271, 1172, 1091 cm-1. 
HRMS: calc. for [M+H]
+
 C25H21O4NF3: 456.14172 found: 456.14150. 
 
2-Methoxy-4-phenyl-3-(4-(trifluoromethyl)phenyl)isoquinolin-
1(2H)-one (137e) 
Compound 137e was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as brown amorphous solid in 71% yield. 
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1
H NMR (500 MHz, CD2Cl2) δ 8.52 (dd, J = 7.9, 1.4 Hz, 1H), 7.61 – 7.54 (m, 2H), 7.52 (d, J 
= 8.1 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 7.29 – 7.23 (m, 4H), 7.12 (dd, J = 7.3, 1.7 Hz, 2H), 
3.72 ppm (s, 3H). 
 
13
C NMR (126 MHz, CD2Cl2) δ 158.33, 139.12, 137.03, 136.35, 135.59, 132.94, 132.16, 
131.81, 131.10, 130.50, 129.75, 128.86, 128.08, 128.06, 127.68, 127.35, 126.50, 125.68, 
125.10, 125.07, 125.04, 125.01, 119.09, 64.04 ppm. 
FT‐IR: ṽ = 3031, 2923, 1736, 1647, 1605, 1567, 1448, 1389, 1316, 1172, 1069 cm-1. 
HRMS: calc. for [M+H]
+
 C23H17O2NF3: 396.12059 found: 396.11938. 
 
3-(4-Fluorophenyl)-2,6,7-trimethoxy-4-phenylisoquinolin-1(2H)-one (137f) and 4-(4-
fluorophenyl)-2,6,7-trimethoxy-3-phenylisoquinolin-1(2H)-one (137f’) (2:1) 
Mixture of compounds 137f and 
137f’ were obtained by using the 
general procedure A and products 
were isolated by column 
chromatography with neutral 
alumina. Eluent: 
EtOAc/petroleum ether (15:85 
v/v); the product was obtained as brown amorphous solid in 61% yield. 
 
1
H NMR (400 MHz, CD2Cl2) δ 7.87 (s, 1H), 7.25 (s, 5H), 7.13-7.10 (m, 2H), 7.00 – 6.90 
(m, 2H), 6.55 (s, 1H), 4.00 (s, 3H), 3.70 (s, 3H), 3.68 ppm (s, 3H). 
13
C NMR (101 MHz, CD2Cl2) δ 164.04, 163.54, 163.07, 161.58, 161.10, 157.66, 153.94, 
149.94, 139.41, 137.96, 136.32, 135.57, 133.86, 133.78, 133.30, 133.22, 132.56, 132.54, 
132.50, 132.34, 132.26, 132.05, 131.20, 128.73, 128.69, 128.08, 127.72, 120.88, 115.69, 
115.47, 115.13, 114.91, 107.91, 107.86, 106.69, 106.41, 63.88, 63.80,73, 53.46 ppm. 
FT‐IR: ṽ = 3068, 2935, 1791, 1606, 1503, 1396, 1351, 1271, 1115, 1015 cm-1. 
HRMS: calc. for [M+H]
+
 C24H21O4NF: 406.14491 found: 406.14426. 
 
3-(4-Fluorophenyl)-2,6,7-trimethoxy-4-phenylisoquinolin-1(2H)-one (137g) and 4-(4-
fluorophenyl)-2-methoxy-3-phenylisoquinolin-
1(2H)-one (137g’) (2:1) 
Mixture of compounds 137g and 137g’ were 
obtained by using the general procedure A and 
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products were isolated by column chromatography with neutral alumina. Eluent: 
EtOAc/petroleum ether (15:85 v/v); the product was obtained as brown amorphous solid in 
53% yield.  
1
H NMR (500 MHz, CD2Cl2) δ 8.52 – 8.50 (m, 1H), 7.61 – 7.56 (m, Hz, 1H), 7.55 – 7.51 (m, 
1H), 7.31 – 7.25 (m, 5H), 7.22 (t, J = 8.7 Hz, 1H), 7.15 – 7.09 (m, 2H), 6.95 (t, J = 8.8 Hz, 
2H), 3.72 ppm (s, 3H). 
 
13
C NMR (126 MHz, CD2Cl2) δ 166.30, 163.97, 163.44, 162.00, 161.48, 158.42, 158.40, 
141.14, 140.69, 139.67, 137.49, 137.18, 137.10, 136.79, 136.07, 135.13, 134.00, 133.93, 
133.24, 133.18, 132.84, 132.81, 132.43, 132.21, 131.12, 128.90, 128.77, 128.20, 128.09, 
128.03, 127.81, 127.39, 127.34, 127.22, 127.15, 126.36, 126.10, 118.99, 117.50, 115.68, 
115.51, 115.24, 115.07, 63.98, 63.90, ppm. 
FT‐IR: ṽ = 3035, 2940, 1660, 1604, 1508, 1326, 1219, 1155, 1015 cm-1. 
HRMS: calc. for [M+H]
+
 C22H17O2NF: 346.12378 found: 346.12380. 
 
2-Methoxy-8-methyl-3-(4-nitrophenyl)-4-phenylisoquinolin-1(2H)-one (137h) 
Compound 137h was obtained by using the general procedure 
A and product was isolated by column chromatography with 
neutral alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); 
the product was obtained as brown amorphous solid in 46% 
yield. 
1
H NMR (300 MHz, CD2Cl2) δ 8.48 (dd, J = 6.6, 2.6 Hz, 1H), 
8.05 (d, J = 8.8 Hz, 2H), 7.47 – 7.42 (m, 2H), 7.40 – 7.36 (m, 
2H), 7.18 – 7.13 (m, 3H), 7.09 (dd, J = 6.6, 3.1 Hz, 2H), 3.74 (s, 3H), 1.77 ppm (s, 3H). 
13
C NMR (75 MHz, CD2Cl2) δ 158.31, 147.75, 139.71, 138.78, 138.62, 137.31, 136.54, 
134.66, 132.84, 132.45, 132.20, 129.13, 128.66, 128.44, 127.98, 127.63, 126.80, 125.16, 
123.05, 118.89, 64.02, 24.12 ppm. 
FT‐IR: ṽ = 3051, 2943, 1661, 1586, 1515, 1343, 1103, 1016 cm-1. 
HRMS: calc. for [M+H]
+
 C23H19O4N2: 342.14886 found: 342.14888. 
 
2,6,7-Trimethoxy-4-(4-methoxyphenyl)-3-phenylisoquinolin-1(2H)-one (137i) 
Compound 137i was obtained by using the general procedure A and product was isolated by 
column chromatography with neutral alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the 
product was obtained as brown amorphous solid in 50% yield. 
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1
H NMR (500 MHz, CD2Cl2) δ 7.86 (s, 1H), 7.26 (s, 5H), 7.04 (d, 
J = 8.4 Hz, 2H), 6.77 (d, J = 8.4 Hz, 2H), 6.60 (s, 1H), 4.00 (s, 
3H), 3.75 (s, 3H), 3.69 (s, 3H), 3.68 (s, 3H) ppm. 
13
C NMR (126 MHz, CD2Cl2) δ 159.19, 157.79, 154.65, 153.99, 
149.99, 146.90, 139.28, 133.21, 133.00, 132.94, 131.36, 128.57, 
128.03, 120.94, 117.88, 114.97, 114.06, 107.99, 106.89, 63.88, 
56.69, 56.24, 55.65 ppm. 
FT‐IR: ṽ = 3038, 2939, 1655, 1603, 1248, 1216, 1156, 1031 cm-1. 
HRMS: calc. for [M+H]
+
 C25H24O5N: 418.16490 found: 418.16477. 
 
2-(Octyloxy)-3,4-diphenylisoquinolin-1(2H)-one (139a) 
Compound 139a was obtained by using the general procedure A 
and product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (3:97 v/v); the product 
was obtained as brown amorphous solid in 81% yield. 
1
H NMR (300 MHz, CD2Cl2) δ 8.53 – 8.43 (m, 1H), 7.59 – 7.47 
(m, 3H), 7.26 (tdd, J = 7.0, 5.1, 2.3 Hz, 8H), 7.17 – 7.11 (m, 2H), 3.95 (t, J = 6.3 Hz, 2H), 
1.35-1.04 (m, 12H), 1.02-0.85 ppm (m, 3H). 
13
C NMR (75 MHz, CD2Cl2) δ 158.53, 144.12, 141.05, 137.18, 136.29, 132.59, 132.24, 
131.36, 130.37, 128.69, 128.57, 127.92, 127.59, 127.09, 126.21, 125.24, 118.34, 76.35, 54.72, 
32.25, 29.71, 29.57, 28.20, 25.84, 23.19, 14.42 ppm. 
FT‐IR: ṽ = 3061, 2923, 1658, 1603, 1465, 1322, 1271, 1106, 1027 cm-1. 
HRMS: calc. for [M+H]
+
 C29H32O2N: 426.24276 found: 426.24265. 
 
2-Butoxy-3,4-diphenylisoquinolin-1(2H)-one (139b) 
Compound 139b was obtained by using the general procedure 
A and product was isolated by column chromatography with 
neutral alumina. Eluent: EtOAc/petroleum ether (5:95 v/v); 
the product was obtained as brown amorphous solid in 85% 
yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.50 (dd, J = 7.8, 1.2 Hz, 1H), 7.59 – 7.49 (m, 2H), 7.25 (dt, 
J = 10.5, 7.9 Hz, 9H), 7.16 – 7.11 (m, 2H), 3.95 (t, J = 5.8 Hz, 2H), 1.32 – 1.25 (m, 2H), 1.02 
– 0.93 (m, 2H), 0.68 ppm (t, J = 7.4 Hz, 3H). 
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13
C NMR (101 MHz, CD2Cl2) δ 158.52, 141.03, 137.17, 136.28, 132.58, 132.24, 132.07, 
131.35, 130.36, 129.07, 128.65, 128.56, 127.93, 127.89, 127.59, 127.09, 127.06, 126.20, 
118.33, 75.99, 30.21, 19.07, 13.99 ppm. 
FT‐IR: ṽ = 3058, 2952, 16461, 1602, 1552, 1478, 1444, 1320, 1175, 1060 cm-1. 
HRMS: calc. for [M+H]
+
 C25H24O2N: 370.18016 found: 370.18019. 
 
2-Isopropoxy-3,4-diphenylisoquinolin-1(2H)-one (139c) 
Compound 139c was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (5:95 v/v); the product was 
obtained as brown amorphous solid in 76% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.49 (dd, J = 7.7, 1.2 Hz, 1H), 7.58-
7.50 (m, 2H), 7.27 – 7.19 (m, 9H), 7.13 (d, J = 5.8 Hz, 2H), 4.39 (sep, 6.3 Hz, 1H), 0.94 (s, 
3H), 0.92 ppm (s, 3H). 
 
13
C NMR (101 MHz, CD2Cl2) δ 159.46, 141.78, 137.15, 136.52, 132.97, 132.52, 132.33, 
132.05, 130.78, 129.22, 129.06, 128.98, 128.55, 128.46, 128.07, 127.61, 127.54, 127.07, 
126.98, 126.17, 118.27, 79.38, 54.54, 54.27, 54.00, 53.73, 53.46, 20.74 ppm. 
FT‐IR: ṽ = 3057, 2977, 2923, 1647, 1606, 1491, 1445, 1372, 1175, 1071 cm-1. 
HRMS: calc. for [M+H]
+
 C24H22O2N: 356.16451 found: 356.16466. 
 
2-(Benzyloxy)-3,4-diphenylisoquinolin-1(2H)-one (139d) 
Compound 139d was obtained by using the general procedure A 
and product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the product 
was obtained as brown amorphous solid in 56% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.56 (d, J = 7.6 Hz, 1H), 8.09 (d, 
J = 8.1 Hz, 1H), 7.62 – 7.48 (m, 3H), 7.32 -7.23 (m, 10H), 7.19 – 7.14 (m, 2H), 6.84 (d, J = 
7.6 Hz, 2H), 4.93 ppm (s, 2H). 
13
C NMR (101 MHz, CD2Cl2) δ 158.64, 140.88, 137.23, 136.13, 134.21, 134.09, 132.76, 
132.60, 132.21, 131.48, 130.52, 130.16, 129.37, 129.02, 128.89, 128.83, 128.78, 128.74, 
128.60, 128.10, 128.00, 127.67, 127.26, 127.04, 126.31, 77.88 ppm. 
FT‐IR: ṽ = 3031, 2925, 1655, 1602, 1443, 1210, 1173, 1105, 1028 cm-1. 
HRMS: calc. for [M+H]
+
 C28H22O2N: 404.16451 found:404.16405. 
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2-(2-Methylallyl)oxy)-3,4-diphenylisoquinolin-1(2H)-one (139e) 
Compound 139e was obtained by using the general procedure 
A and product was isolated by column chromatography with 
neutral alumina. Eluent: EtOAc/petroleum ether (10:90 v/v); 
the product was obtained as brown amorphous solid in 75% 
yield. 
1
H NMR (300 MHz, CD2Cl2) δ 8.55 – 8.46 (m, 1H), 7.54 (m, 
3H), 7.28 – 7.21 (m, 8H), 7.16 – 7.11 (m, 2H), 4.83 – 4.74 (m, 2H), 4.37 (s, 2H), 1.31 ppm (s, 
3H). 
13
C NMR (101 MHz, CD2Cl2) δ 158.56, 140.93, 139.63, 137.19, 136.18, 132.67, 132.50, 
132.21, 131.40, 128.73, 128.57, 128.45, 128.16, 128.01, 127.94, 127.62, 127.31, 127.17, 
127.03, 126.25, 118.47, 116.44, 79.69, 69.91, 19.55 ppm. 
FT‐IR: ṽ = 3059, 2928, 1658, 1491, 1444, 1319, 1173, 1105, 1024 cm-1. 
HRMS: calc. for [M+H]
+
 C25H22O2N: 368.16451 found: 368.16493. 
 
2,6,7-Trimethoxy-3,4-diphenylisoquinolin-1(2H)-one (139f)
[267]
 
Compound 139f was obtained by using the general procedure 
A and product was isolated by column chromatography with 
neutral alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); 
the product was obtained as brown amorphous solid in 64% 
yield. 
1
H NMR (500 MHz, CDCl3) δ 7.94 (s, 1H), 7.26 – 7.18 (m, 
8H), 7.12 – 7.08 (m, 2H), 6.60 (s, 1H), 4.05 (s, 3H), 3.73 (s, 3H), 3.70 ppm (s, 3H) 
 
13
C NMR (126 MHz, CDCl3) δ 157.67, 153.44, 149.42, 138.67, 135.94, 132.07, 131.97, 
131.65, 130.94, 128.28, 128.26, 127.58, 127.32, 120.56, 118.03, 107.83, 106.24, 63.62, 56.47, 
55.95 ppm. 
FT‐IR: ṽ = 3040, 2941, 1660, 1603, 1508, 1444, 1249, 1173, 1094, 1015 cm-1. 
HRMS: calc. for [M+H]
+
 C24H22O2N: 388.15433 found: 388.15502.  
2-Methoxy-8-methyl-3,4-diphenylisoquinolin-1(2H)-one (139g) 
Compound 139g was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the product 
was obtained as brown amorphous solid in 68% yield. 
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1
H NMR (300 MHz, CD2Cl2) δ 8.51 – 8.42 (m, 1H), 7.43 – 7.38 (m, 2H), 7.23 – 7.14 (m, 
5H), 7.17 – 7.08 (m, 5H), 3.73 (s, 3H), 1.74 ppm (s, 3H). 
13
C NMR (75 MHz, CD2Cl2) δ 158.44, 141.17, 139.51, 137.01, 136.17, 135.49, 135.11, 
133.01, 132.65, 131.00, 130.32, 129.59, 128.42, 128.35, 127.99, 127.82, 127.36, 127.00, 
126.68, 118.42, 63.83, 54.72, 54.36, 54.00, 53.64, 53.28, 24.13 ppm. 
FT‐IR: ṽ = 3000, 2940, 1655, 1584, 1488, 1442, 1310, 1094, 1026 cm-1. 
HRMS: calc. for [M+H]
+
 C23H20O2N: 342.14886 found: 342.14883. 
 
2-Methoxy-7-methyl-3,4-diphenylisoquinolin-1(2H)-one (139h) and 2-methoxy-8-methyl-
3,4-diphenylisoquinolin-1(2H)-one (139h’) (3:1) 
Mixture of compounds 139h and 
139h’were obtained by using the general 
procedure A and products were isolated by 
column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether 
(10:90 v/v); the product was obtained as 
brown amorphous solid in 65% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.32 (s, 1H), 7.44 – 7.38 (m, 2H), 7.31 – 7.18 (m, 10H), 7.12 
(dd, J = 8.0, 3.6 Hz, 4H), 3.70 (s, 3H), 2.51 ppm (s, 3H). 
13
C NMR (101 MHz, CD2Cl2) δ 158.29, 139.64, 137.59, 137.01, 136.32, 134.84, 134.20, 
132.65, 132.59, 132.17, 131.23, 131.00, 128.65, 128.52, 127.98, 127.81, 127.55, 127.50, 
126.94, 126.20, 63.81, 21.60 ppm. 
FT‐IR: ṽ = 3058, 2937, 1656, 1491, 1442, 1333, 1213, 1174, 1073 cm-1. 
HRMS: calc. for [M+H]
+
 C23H20O2N: 342.14886 found: 342.14888. 
 
2-Methoxy-6-methyl-3,4-diphenylisoquinolin-1(2H)-one (139i) 
Compound 139i was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (10:90 v/v); the product 
was obtained as brown amorphous solid in 74% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.32 (s, 1H), 7.40 (dd, J = 8.4, 1.8 Hz, 1H), 7.28 – 7.21 (m, 
8H), 7.13 – 7.10 (m, 3H), 3.70 (s, 3H), 2.51 ppm (s, 3H). 
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13
C NMR (101 MHz, CD2Cl2) δ 158.29, 139.65, 137.59, 136.32, 134.84, 134.20, 132.59, 
132.17, 131.23, 128.65, 128.52, 127.97, 127.54, 127.50, 126.94, 126.20, 118.51, 63.81, 21.60 
ppm. 
FT‐IR: ṽ = 3058, 2937, 1656, 1602, 1495, 1441, 1334, 1214, 997 cm-1. 
HRMS: calc. for [M+H]
+
 C23H20O2N: 342.14886 found: 342.14878. 
 
6-(tert-Butyl)-2-methoxy-3,4-diphenylisoquinolin-1(2H)-one (139j) 
Compound 139j was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the product 
was obtained as brown amorphous solid in 69% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.50 (d, J = 2.1 Hz, 1H), 7.64 (dd, J 
= 8.6, 2.2 Hz, 1H), 7.28 – 7.21 (m, 8H), 7.16 (d, J = 8.6 Hz, 1H), 7.14 – 7.10 (m, 2H), 3.70 (s, 
3H), 1.41 ppm (s, 9H). 
13
C NMR (101 MHz, CD2Cl2) δ 158.52, 150.74, 139.88, 136.32, 134.85, 132.60, 132.16, 
131.22, 130.78, 129.06, 128.66, 128.53, 127.98, 127.56, 126.69, 126.12, 123.73, 118.38, 
63.81, 35.43, 31.54 ppm. 
FT‐IR: ṽ = 3057, 2960, 1654, 1588, 1491, 1442, 1332, 1176, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C26H26O2N: 384.19581 found: 384.19660. 
 
2-Methoxy-3,4,6-triphenylisoquinolin-1(2H)-one (139k) 
Compound 139k was obtained by using the general procedure A and 
product was isolated by column chromatography with neutral 
alumina. Eluent: EtOAc/petroleum ether (15:85 v/v); the product 
was obtained as brown amorphous solid in 65% yield. 
1
H NMR (400 MHz, CD2Cl2) δ 8.76 (d, J = 2.1 Hz, 1H), 7.84 (dd, 
J = 8.5, 2.1 Hz, 1H), 7.77 – 7.74 (m, 2H), 7.49 (t, J = 7.6 Hz, 3H), 7.41 (d, J = 7.4 Hz, 1H), 
7.30 – 7.24 (m, 8H), 7.18 – 7.14 (m, 2H), 3.73 ppm (s, 3H). 
13
C NMR (75 MHz, CD2Cl2) δ 158.49, 140.63, 140.21, 139.87, 136.16, 134.94, 132.67, 
132.47, 132.20, 131.50, 131.19, 129.51, 129.00, 128.80, 128.64, 128.39, 128.05, 127.70, 
127.41, 127.19, 126.97, 125.83, 123.56, 118.46, 63.93 ppm. 
FT‐IR: ṽ = 3057, 2960, 1654, 1609, 1491, 1442, 1332, 1265, 1176, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C28H22O2N: 404.16451 found: 404.16405. 
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2-Methoxy-3,4-diphenyl-7-(trifluoromethoxy)isoquinolin-1(2H)-one (139l) and 2-
methoxy-3,4-diphenyl-8-(trifluoromethoxy)isoquinolin-1(2H)-one (139l’) (5:4) 
Mixture of compounds 139l and 
139l’ were obtained by using the 
general procedure A and products 
were isolated by column 
chromatography with neutral 
alumina. Eluent: EtOAc/petroleum 
ether (15:85 v/v); the product was obtained as brown amorphous solid in 54% yield. 
1
H NMR (300 MHz, CD2Cl2) δ 8.35 (d, J = 1.2 Hz, 1H), 7.43 – 7.39 (m, 1H), 7.29 – 7.22 (m, 
9H), 7.14 – 7.08 (m, 2H), 3.72 ppm (s, 3H). 
13
C NMR (126 MHz, CD2Cl2) δ 157.65, 148.16, 141.33, 135.94, 135.78, 135.50, 132.16, 
131.13, 130.37, 129.63, 129.01, 128.80, 128.73, 128.30, 128.16, 127.96, 125.99, 119.33, 
118.10, 64.06 ppm. 
FT‐IR: ṽ = 3058, 2944, 1662, 1593, 1491, 1254, 1212, 1158, 1022 cm-1. 
HRMS: calc. for [M+H]
+
 C23H17O3NF3: 412.11550 found: 412.11532. 
 
12.4.2 Synthesis of 3,4-Diphenylisoquinolin-1(2H)-one (142) 
 
 
To a screw capped reaction vial containing compound 139a (0.25 mmol), NaH (2 equiv) and 
DMF (2 ml) were added and the reaction was allowed to warm to 120 °C for 2 h. After 
completing, the reaction mixture was allowed to cool down to room temperature, and 
saturated aqueous Na2S2O3 (20 mL) was added, extracted with CH2Cl2 (10 mL x 2). The 
combined organic layer was dried over anhydrous Na2SO4, concentrated under reduced 
pressure. The crude reaction mixture was concentrated under reduced pressure and 
subsequently purified by flash column chromatography over silica gel using petroleum 
ether/ethyl acetate as eluent system (80:20 v/v). 
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3,4-Diphenylisoquinolin-1(2H)-one (142) 
1
H NMR (500 MHz, CDCl3) δ 9.35 (s, 1H), 8.47 (d, J = 7.9 Hz, 1H), 
7.59 (t, J = 7.6 Hz, 1H), 7.50 (t, J = 7.4 Hz, 1H), 7.35 (d, J = 8.2 Hz, 
1H), 7.33 – 7.27 (m, 3H), 7.27 – 7.21 (m, 5H), 7.18 – 7.16 ppm (m, 
2H). 
13
C NMR (126 MHz, CDCl3) δ 138.82, 135.74, 135.11, 132.88, 
131.92, 129.31, 128.79, 128.51, 128.49, 127.57, 127.47, 126.82, 125.84, 117.63 ppm. 
FT‐IR: ṽ = 3048, 2922, 1715, 16444, 1554, 1514, 11315, 1155, 114, 1016 cm-1. 
HRMS: calc. for [M+H]
+
 C21H16ON: 298.12264 found: 298.12222. 
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12.5 Hypervalent Iodine (III) Mediated Oxidative Annulation of 2-Aminopyridines with 
Arenes 
 
12.5.1. Characterization of Pyrido[1,2-a]benzimidazole Derivatives (151a-154a) 
6,9-Dimethylpyrido[1,2-a]benzimidazole (151a) 
Compound 151a was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. Eluent: 
EtOAc/petroleum ether (20:80 v/v); the product was obtained as light 
yellow amorphous solid in 75% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.74 (d, J = 7.2 Hz, 1H), 7.74 (d, J = 9.3 Hz, 1H), 7.36 (ddd, J 
= 9.3, 6.6, 1.2 Hz, 1H), 7.19 (d, J = 7.3 Hz, 1H), 6.98 (d, J = 7.3 Hz, 1H), 6.77 (d, J = 6.9, 1.2 
Hz, 1H), 2.85 (s, 3H), 2.73 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 148.04, 143.79, 128.59, 127.55, 127.30, 127.19, 125.44, 
123.31, 120.67, 118.12, 110.41, 19.67, 17.08 ppm. 
FT‐IR: ṽ = 3034, 2914, 1819, 1749, 1508, 1319, 1279, 1209 cm-1. 
HRMS: calc. for [M+H]
+
 C13H13N2: 197.1073 found: 197.1075. 
 
8-Methoxypyrido[1,2-a]benzimidazole (151b) 
Compound 151b was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (20:80 v/v); the product was obtained 
as brown solid in 77% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 6.9 Hz, 1H), 7.84 (d, J = 9.0 Hz, 1H), 7.67 (d, J = 
9.0 Hz, 1H), 7.48 – 7.31 (m, 1H), 7.30 (d, J = 6.9 Hz, 1H), 7.19 (dd, J = 9.0, 2.4 Hz, 1H), 6.82 
(t, J = 6.9 Hz, 1H), 3.94 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 155.56, 147.91, 138.59, 128.77, 128.50, 124.82, 120.47, 
118.05, 116.19, 110.45, 93.34, 56.12 ppm. 
FT‐IR: ṽ = 3072, 2956, 2834, 2282, 1758, 1487, 1359, 1283, 1207, 1027 cm-1. 
HRMS: calc. for [M+H]
+
 C12H11ON2: 199.0868 found: 199. 0865. 
 
8-Phenoxypyrido[1,2-a]benzimidazole (151c) 
Compound 151c was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Experimental Section 
- 158 - 
 
Eluent: EtOAc/petroleum ether (20:80 
v/v); the product was obtained as brown 
solid in 80% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.29 (d, J 
= 6.9 Hz, 1H), 7.90 (d, J = 9.0 Hz, 1H), 
7.70 (d, J = 9.0 Hz, 1H), 7.50 (d, J = 2.2 Hz, 1H), 7.43 – 7.28 (m, 4H), 7.11 (m, 1H), 7.03 (d, 
J = 6.9 Hz, 2H), 6.82 ppm (t, J = 6.9 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 158.31, 151.99, 148.71, 140.43, 129.94, 129.36, 128.84, 
125.17, 123.20, 120.73, 119.43, 118.36, 118.13, 110.75, 101.08 ppm. 
FT‐IR: ṽ= 3067, 2923, 2325, 1585, 1434, 1219, 1160 cm-1. 
HRMS: calc. for [M+H]
+
 C17H13ON2: 261.1025 found: 261.1022.  
 
6,8-Dimethylpyrido[1,2-a]benzimidazole (151d) 
Compound 151d was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (15:85v/v); the product was obtained as light yellow 
amorphous solid in 62% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 6.8 Hz, 1H), 7.74 (d, J = 9.3 Hz, 1H), 7.46 (s, 
1H), 7.42 – 7.27 (m, 1H), 7.15 (s, 1H), 6.78 (m, 1H), 2.73 (s, 3H), 2.52 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.58, 141.32, 131.39, 129.16, 128.93, 128.23, 127.92, 
125.12, 117.89, 110.47, 107.64, 21.90, 17.22 ppm. 
FT‐IR: ṽ = 3015, 2913, 2854, 1693, 1640, 1497, 1464, 1355, 1174, 1099 cm-1. 
HRMS: calc. for [M+H]+ C13H13N2: 197.1073 found: 197.1075. 
 
5-Methylnaphtho[1',2':4,5]imidazo[1,2-a]pyridine (151e) and 6 methylnaphtho[2',3':4,5] 
-imidazo [1,2-a]pyridine (151e’) 
Mixture of compounds 151e and 151e’ were obtained by using the general procedure B and 
products were isolated by column chromatography with silica gel. Eluent: EtOAc/petroleum 
ether (20:80 v/v); the product was obtained as light yellow amorphous solid in 75% yield.  
Prepared according to the general procedure using PIDA (2 equiv) and the product was 
obtained as amorphous solid in 67% yield;  
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1
H NMR (400 MHz, CDCl3) δ 8.85 (d, J = 8.1 Hz, 1H), 8.36 (d, J = 6.8 Hz, 1H), 8.07 (d, J = 
8.1 Hz, 1H), 7.84 – 7.79 (m, 1H), 7.71 (t, J = 7.4 Hz, 1H), 7.67 – 7.60 (m, 2H), 7.38 – 7.31 
(m, 1H), 6.86 (t, J = 6.4 Hz, 1H), 2.78 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 146.92, 140.14, 131.81, 129.19, 128.12, 127.59, 127.00, 
126.77, 126.29, 125.35, 124.57, 123.80, 121.66, 118.96, 118.09, 111.58, 110.51, 20.79 ppm. 
FT‐IR: ṽ= 3070, 2929, 1732, 1526, 1349, 1323, 1263 cm-1. 
HRMS: calc. for [M+H]+ C16H13N2: 233.1075 found: 233.1073. 
 
3-Bromo-8-methylpyrido[1,2-a]benzimidazole (151f)
[268]
 
Compound 151f was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (15:85 v/v); the prod-uct was 
obtained as light yellow amorphous solid in 43% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.56 (d, J = 1.1 Hz, 1H), 7.83 (d, J = 8.4 Hz, 1H), 7.67 (d, J = 
9.4 Hz, 2H), 7.48 (dd, J = 9.4, 1.8 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 2.59 pmm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 145.81, 141.31, 133.00, 132.77, 128.62, 128.26, 125.44, 
119.41, 118.46, 110.34, 105.17, 22.03 ppm. 
FT‐IR: ṽ=3052, 2919, 1498, 1454, 1383, 1256, 1217, 1073 cm-1. 
HRMS: calc. for [M+H]
+
 C12H10
79
BrN2: 261.0029 found: 261.0022.; HRMS: calc. for 
[M+H]
+
 C12H10
81
BrN2: 263.0002 found: 263.0001. 
 
6,8-Diisopropylpyrido[1,2-a]benzimidazole (151g) 
Compound 151g was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (10:90 v/v); the product was 
obtained as light yellow amorphous solid in 52% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 6.8 Hz, 1H), 7.72 (d, 
J = 9.2 Hz, 1H), 7.55 (s, 1H), 7.35 (dd, J = 5.1, 4.0 Hz, 1H), 7.28 (s, 1H), 6.78 (t, J = 6.8 Hz, 
1H), 3.96 – 3.68 (m, 1H), 3.13 (dt, J = 13.8, 6.9 Hz, 1H), 1.46 (d, J = 6.9 Hz, 6H), 1.37 ppm 
(d, J = 6.9 Hz, 6H). 
13
C NMR (101 MHz, CDCl3) δ 147.67, 142.88, 141.08, 140.20, 128.63, 125.10, 121.05, 
118.08, 110.12, 107.85, 104.59, 34.75, 29.20, 24.74, 23.35 ppm. 
FT‐IR: ṽ= 3073, 2957, 2868, 1639, 1507, 1422, 1356, 1229, 1146 cm-1. 
HRMS: calc. for [M+H]
+
 C17H21N2: 253.1626 found: 253.253.1703.  
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2-(8-Methoxybenzo[4,5]imidazo[1,2-a]pyridin-6-yl)acetonitrile (151h) 
Compound 151h was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. Eluent: 
EtOAc/petroleum ether (25:75v/v); the product was obtained as light 
yellow amorphous solid in 68% yield (ratio = 2.1:1).  
1
H NMR (500 MHz, CDCl3) δ 8.35 (d, J = 6.8 Hz, 1H), 7.68 (d, J = 
9.3 Hz, 1H), 7.40 (dd, J = 8.4, 6.8 Hz, 1H), 7.31 (s, 1H), 7.27 (d, J = 1.9 Hz, 1H), 6.86 (t, J = 
6.8 Hz, 1H), 4.30 (s, 2H), 3.95 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 155.64, 155.25, 129.00, 125.05, 122.22, 118.28, 117.77, 
115.07, 110.93, 93.44, 56.35, 19.69 ppm. 
FT‐IR: ṽ= 3075, 2923, 2835, 2249, 1643, 1500, 1462, 1349, 1230, 1206, 1079 cm-1. 
HRMS: calc. for [M+H]
+
 C14H12ON3: 238.0977 found: 238.0975. 
 
6-Ethyl-8-methylpyrido[1,2-a]benzimidazole (151i) 
Compounds 151i and 151i’ were obtained by using the general 
procedure B and products were isolated by column chromatography 
with silica gel. Eluent: EtOAc/petroleum ether (10:90 v/v); the 
product was obtained as light yellow amorphous solid in 73% yield 
(2.1:1 ration).  
Major product:
 1
H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 6.8 Hz, 1H), 7.73 (d, J = 9.2 Hz, 
1H), 7.52 (s, 1H), 7.37 (dd, J = 8.4, 7.4 Hz, 1H), 7.20 (s, 1H), 6.81 (t, J = 6.7 Hz, 1H), 2.84 
(q, J = 7.6 Hz, 2H), 2.76 (s, 3H), 1.34 ppm (t, J = 7.6 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.98, 141.61, 135.84, 131.64, 128.90, 126.20, 118.42, 
110.46, 107.96, 106.67, 24.75, 22.34, 15.15 ppm. 
FT‐IR: ṽ = 3074, 2964, 2928, 1639, 1506, 1458, 1356, 1206, 1051 cm-1. 
HRMS: calc. for [M+H]
+
 C14H15N2: 211.1231, found 211.1229. 
 
6-Methyl-8-ethylpyrido[1,2-a]benzimidazole (151’) 
Minor product: 
1
H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 6.8 Hz, 
1H), 7.75 (d, J = 9.2 Hz, 1H), 7.54 (s, 1H), 7.39 (dd, J = 8.4, 7.4 Hz, 
1H), 7.22 (s, 1H), 6.83 (t, J = 6.7 Hz, 1H), 2.86 (q, J = 7.6 Hz, 2H), 
2.79 (s, 3H), 1.36 ppm (t, J = 7.6 Hz, 3H). 
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13
C NMR (101 MHz, CDCl3) δ 148.01, 142.14, 138.30, 129.71, 129.10, 128.63, 127.12, 
125.51, 118.35, 110.64, 106.69, 29.65, 17.59, 16.71 ppm. 
HRMS: calc. for [M+H]
+
 C14H15N2: 211.1231, found 211.1229. 
 
1,2,3,4-Tetrahydronaphtho[1',2':4,5]imidazo[1,2-a]pyridine (151j) 
Compounds 151j and 151j’ were obtained by using the general 
procedure B and products were isolated by column chromatography 
with silica gel. Eluent: EtOAc/petroleum ether (15:85 v/v); the 
product was obtained as light yellow amorphous solid in 82% yield 
(ratio = 1.3:1).  
 Major product:
 1
H NMR (400 MHz, CDCl3) δ 8.43 (d, J = 6.8 Hz, 
1H), 7.79 (d, J = 9.2 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.49 – 7.36 (m, 1H), 7.13 (d, J = 8.4 
Hz, 1H), 6.87 (t, J = 6.8 Hz, 1H), 3.29 (t, J = 5.9 Hz, 2H), 2.98 (t, J = 5.8 Hz, 2H), 2.07 – 1.82 
ppm (m, 4H). 
13
C NMR (126 MHz, CDCl3) δ 147.70, 134.60, 129.08, 128.31, 126.10, 125.17, 123.31, 
117.86, 110.68, 109.73, 107.43, 29.91, 24.82, 23.51, 22.81 ppm. 
FT‐IR: ṽ = 3074, 2925, 1726, 1642, 1503, 1356, 1195, 1049 cm-1. 
HRMS: calc. for [M+H]+ C15H15N2: 223.1232 found: 223.1229.  
 
7,8,9,10-Tetrahydronaphtho[2',3':4,5]imidazo[1,2-a]pyridine (151j’) 
Minor product:
 1
H NMR (400 MHz, CDCl3) δ 8.41 (d, J = 6.8 
Hz, 1H), 7.77 (d, J = 9.2 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.43 
– 7.37 (m, 1H), 7.10 (d, J = 8.4 Hz, 1H), 6.85 (t, J = 6.8 Hz, 
1H), 3.27 (s, 2H), 3.04 – 2.84 (m, 2H), 2.01 – 1.86 ppm (m, 4H). 
13
C NMR (126 MHz, CDCl3) δ 148.08, 136.81, 136.57, 132.10, 
129.82, 125.29, 118.40, 117.46, 110.76, 109.82, 31.03, 30.39, 
30.36, 23.47, 23.37 ppm. 
 
3-Methyl-8-iodopyrido[1,2-a]benzimidazole (151k) 
Compound 151k was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. Eluent: 
EtOAc/petroleum ether (20:80 v/v); the product was obtained as light 
yellow amorphous solid in 49% yield.  
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1
H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 7.0 Hz, 1H), 8.17 (s, 1H), 7.74 (dd, J = 8.6, 1.1 
Hz, 1H), 7.64 (d, J = 8.6 Hz, 1H), 7.43 (s, 1H), 6.70 (d, J = 7.0 Hz, 1H), 2.46 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 149.10, 143.85, 141.94, 134.45, 130.23, 124.29, 121.33, 
119.49, 116.09, 114.06, 82.96, 22.10 ppm.  
FT‐IR: ṽ = 3050, 2958, 1651, 1609, 1258, 1036 cm-1. HRMS: calc. for [M+H]+ C12H10IN2: 
308.9885found: 308.9883. 
HRMS: calc. for [M+H]
+
 C12H10IN2: 308.9885found: 308.9883. 
 
2-Bromo-6,9-dimethylpyrido[1,2-a]benzimedazole (152a) 
Compound 152a was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (15:85v/v); the product was 
obtained as light yellow amorphous solid in 86% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.80 (d, J = 0.8 Hz, 1H), 7.64 (d, J = 9.7 Hz, 1H), 7.40 (dd, J 
= 9.7, 0.8 Hz, 1H), 7.19 (d, J = 7.3 Hz, 1H), 6.99 (d, J = 7.3 Hz, 1H), 2.82 (s, 3H), 2.72 ppm 
(s, 3H).  
13
C NMR (126 MHz, CDCl3) δ 146.08, 143.82, 131.93, 127.61, 127.52, 127.10, 125.92, 
124.11, 120.67, 118.77, 104.61, 19.54, 17.04 ppm. 
FT‐IR: ṽ = 3031, 2926, 1692, 1588, 1514, 1450, 1423, 1371, 1279, 1113. cm-1. 
HRMS: calc. for [M+H]
+
 C13H12
79
BrN2: 275.0186 found: 275.0178. HRMS: calc. for [M+H]
+
 
C13H11
81
BrN2: 277.0159 found: 277.0158. 
 
2-Fluoro-6,9-dimethylpyrido[1,2-a]benzimidazole (152b) 
Compound 152b was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as light yellow amorphous solid in 59% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.66 (dd, J = 3.9, 2.4 Hz, 1H), 7.77 – 7.70 (m, 1H), 7.42 – 
7.27 (m, 1H), 7.19 (d, J = 7.3 Hz, 1H), 6.99 (d, J = 7.3 Hz, 1H), 2.83 (s, 3H), 2.72 ppm (s, 
3H). 
13
C NMR (126 MHz, CDCl3) δ 151.60 (d, J = 235.8 Hz), 145.63, 144.59, 127.99, 127.75, 
125.52, 123.67, 120.89 (d, J = 26.0 Hz), 120.51, 118.55 (d, J = 8.6 Hz), 113.93 (d, J = 40.9 
Hz), 19.29, 17.02 ppm. 
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FT‐IR: ṽ =3013, 2926, 1659, 1533, 1514, 1439, 1308, 1204, 1103, 1037 cm-1. 
HRMS: calc. for [M+H]
+
 C13H12N2F: 215.0982 found: 215.0979.  
 
2,6,9-Trimethylpyrido[1,2-a]benzimidazole (152c) 
Compound 152c was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (15:85 v/v); the prod-uct 
was obtained as light yellow amorphous solid in 72% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 7.67 (d, J = 9.3 Hz, 1H), 7.21 (dd, J = 9.3, 1.4 
Hz, 1H), 7.15 (d, J = 7.3 Hz, 1H), 6.94 (d, J = 7.3 Hz, 1H), 2.83 (s, 3H), 2.72 (s, 3H), 2.36 
ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.16, 143.74, 131.83, 127.16, 126.99, 125.07, 124.88, 
123.05, 120.60, 119.87, 117.31, 19.75, 18.54, 17.08 ppm. 
FT‐IR: ṽ = 3026, 2967, 2921, 1650, 1511, 1417, 1347, 1251, 1105 cm-1. 
HRMS: calc. for [M+H]
+
 C14H15N2: 211.1233 found: 211.1229. 
 
3,6,9-Trimethylpyrido[1,2-a]benzimidazole (152d)  
Compound 152d was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as light yellow amorphous solid in 72% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.55 (d, J = 7.2 Hz, 1H), 7.48 (s, 1H), 7.14 (d, J = 7.3 Hz, 
1H), 6.92 (d, J = 7.3 Hz, 1H), 6.58 (d, J = 7.2 Hz, 1H), 2.79 (s, 3H), 2.70 (s, 3H), 2.41 ppm (s, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 148.45, 143.44, 140.15, 127.05, 126.65, 126.50, 125.32, 
122.91, 120.38, 115.83, 113.32, 21.76, 19.50, 17.07 ppm. 
FT‐IR: ṽ = 3027, 2920, 2867, 1649, 1554, 1536, 1459, 1418, 1376, 1260, 1037 cm-1. 
HRMS: calc. for [M+H]
+
 C14H15N2: 211.1233 found: 211.1229. 
 
1,6,9-Trimethylpyrido[1,2-a]benzimidazole (152e) 
Compound 152e was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (10:90v/v); the product was obtained as 
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light yellow amorphous solid in 72% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.60 (d, J = 6.9 Hz, 1H), 7.17 (d, J = 7.3 Hz, 1H), 7.13 (d, J = 
6.9 Hz, 1H), 6.95 (d, J = 7.3 Hz, 1H), 6.66 (dd, J = 6.9, 6.9 Hz, 1H), 2.82 (s, 3H), 2.78 (s, 
3H), 2.71 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 148.68, 143.80, 127.85, 127.73, 127.27, 126.66, 125.14, 
125.03, 123.07, 120.48, 110.11, 19.61, 17.88, 17.12 ppm.  
FT‐IR: ṽ = 3016, 2962, 2915, 1831, 1634, 1557, 1518, 1382, 1356, 1252, 1084 cm-1. 
HRMS: calc. for [M+H]
+
 C14H15N2: 211.1232 found: 211.1229. 
 
1-Bromo-3,6,9-trimethylpyrido[1,2-a]benzimidazole (152f)  
Compound 152f was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (10:90 v/v); the product was 
obtained as light yellow amorphous solid in 76% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.49 (s, 1H), 7.52 (s, 1H), 7.18 (d, J = 7.3 Hz, 1H), 6.98 (d, J 
= 7.3 Hz, 1H), 2.83 (s, 3H), 2.78 (s, 3H), 2.37 ppm (s, 3H).  
13
C NMR (101 MHz, CDCl3) δ 144.93, 144.01, 133.97, 128.37, 128.04, 125.62, 124.55, 
123.93, 120.61, 119.69, 111.46, 19.59, 18.23, 16.84 ppm. 
FT‐IR: ṽ = 2917, 1522, 1489, 1380, 1342, 1257, 1159, 1048 cm-1. 
HRMS: calc. for [M+H]
+
 C14H14
79
BrN2: 289.0341 found: 289.0335. HRMS: calc. for [M+H]
+
 
C14H14
81
BrN2: 291.0313 found: 291.0314. 
 
2,4-Dibromo-6,9-dimethylpyrido[1,2-a]benzimidazole (152g) 
Compound 152g was obtained by using the general procedure B and 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (5:95 v/v); the product was obtained 
as light yellow amorphous solid in 57% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.82 (d, J = 1.5 Hz, 1H), 7.73 (d, J = 1.5 Hz, 1H), 7.22 (d, J = 
7.3 Hz, 1H), 7.03 (d, J = 7.3 Hz, 1H), 2.83 (s, 3H), 2.77 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 144.27, 144.09, 133.22, 128.60, 128.28, 126.73, 126.14, 
124.82, 120.68, 112.60, 103.01, 19.49, 17.06
. 
ppm. 
FT‐IR: ṽ = 3074, 2964, 1727, 1485, 1374, 1335, 1274, 1196 cm-1. 
HRMS: C13H11
79
Br2N2 [M+H]
+ 
calc.: 352.9298 found: 352.9283; C13H11
79
Br
81
BrN2 [M+H]
+ 
calc.: 354.9270 found: 354.9263, C13H11
81
Br2N2 [M+H]
+ 
calc.:356.9244 found : 356.9242 
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2-Bromo-1,3,6,9-tetramethylpyrido[1,2-a]benzimidazole (152h) 
Compound 152h was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (10:95 v/v); the product was 
obtained as light yellow amorphous solid in 87% yield.  
1
H NMR (400 MHz, CDCl3) δ 7.64 (s, 1H), 7.27 (d, J = 7.3 Hz, 1H), 7.08 (d, J = 7.3 Hz, 
1H), 3.03 (s, 3H), 2.74 (s, 6H), 2.54 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 148.23, 141.50, 137.58, 129.68, 126.51, 126.40, 125.29, 
121.66, 114.11, 113.87, 25.85, 24.36, 24.18, 17.18 ppm. 
FT‐IR: ṽ =3031, 2956, 2918, 1644, 1531, 1374, 1346, 1299, 1195 cm-1. 
HRMS: calc. for [M+H]
+
 C15H16
79
BrN2: 303.0499 found: 303.0491. HRMS: calc. for [M+H]
+
 
C15H16
81
BrN2: 305.0474 found: 305.0471. 
 
3-Acetoxy-1,6,9-trimethylpyrido[1,2-a]benzimidazole (152i) 
Compound 152i was obtained by using the general procedure B 
and product was isolated by column chromatography with silica 
gel. Eluent: EtOAc/petroleum ether (15:85 v/v); the product was 
obtained as light yellow amorphous solid in 80% yield.  
1
H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 9.1 Hz, 1H), 7.29 (dd, J = 6.8, 2.1 Hz, 1H), 7.09 
(s, 1H), 6.56 (d, J = 6.6 Hz, 1H), 2.89 (s, 3H), 2.75 (s, 3H), 2.53 (s, 3H), 2.39 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 170.11, 151.29, 144.06, 142.98, 128.93, 127.57, 120.40, 
115.80, 113.84, 112.62, 24.28, 20.87, 17.29, 17.07 ppm. 
FT‐IR: ṽ = 3063, 30178, 2921, 2230, 1760 1519, 1350, 1058 cm-1. 
HRMS: calc. for [M+H]
+
 C16H17O2N2: 269.1288 found: 269.1284. 
 
10-Methylbenzo[4,5]imidazo[1,2-a]quinolone (154a) 
Compound 154a prepared according to the general procedure B using 
PIDA (3 equiv PIDA was added in 3 portions every 6 h and reaction 
continued for 18 h) and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum ether (25:75 v/v); the product was 
obtained as light yellow amorphous solid in 60% yield. 
1
H NMR (400 MHz, CDCl3) δ 8.52 
(d, J = 8.5 Hz, 1H), 8.13 (s, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.79 (dd, J = 7.8, 1.0 Hz, 1H), 7.77 
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– 7.68 (m, 1H), 7.60 (q, J = 9.5 Hz, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.35 (d, J = 8.2 Hz, 1H), 
2.64 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 147.99, 142.72, 135.79, 132.83, 131.15, 130.84, 129.61, 
129.54, 126.20, 124.17, 123.58, 119.96, 117.85, 115.36, 114.06, 22.44 ppm. 
FT‐IR: ṽ = 2930, 2855, 1605, 1560, 1525, 1415, 1225 cm-1. 
HRMS: calc. for [M+H]
+
 C16H13N2: 233.1073 found: 233.1069.  
 
10-Iodobenzo[4,5]imidazo[1,2-a]quinolone (154b) 
Compound 154b prepared according to the general procedure B using 
PIDA (3 equiv PIDA was added in 3 portions every 6 h and reaction 
continued for 18 h) and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum ether (20:80 v/v); the product was 
obtained as brown amorphous solid in 45% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.71 (s, 1H), 8.43 (d, J = 8.5 Hz, 1H), 7.86 (d, J = 7.5 Hz, 
1H), 7.84 – 7.78 (m, 2H), 7.77 (dd, J = 9.0, 4.6 Hz, 2H), 7.67 (d, J = 9.5 Hz, 1H), 7.53 (t, J = 
7.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 148.02, 143.13, 134.94, 133.45, 131.99, 131.78, 130.16, 
129.84, 124.87, 123.40, 122.59, 121.67, 116.94, 115.24, 86.04 ppm. 
FT‐IR: ṽ = 3040, 2945, 2856, 1575, 1520, 1403, 1340, 1170, 1109 cm-1. 
HRMS: calc. for [M+H]
+
 C15H10N2I: 344.9882. found: 344.9883.  
 
2-Fluoro-10-methylbenzo[4,5]imidazo[1,2-a]quinolone (154c) 
Compound 154c prepared according to the general procedure B using 
PIDA (3 equiv PIDA was added in 3 portions every 6 h and reaction 
continued for 18 h) and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum ether (25:75 
v/v); the product was obtained as brown amorphous solid in 57% yield.  
1
H NMR (400 MHz, CDCl3) δ 8.49 (dd, J = 8.8, 4.4 Hz, 1H), 8.06 (s, 1H), 7.89 (d, J = 8.3 
Hz, 1H), 7.67 (d, J = 9.5 Hz, 1H), 7.59 (d, J = 9.5 Hz, 1H), 7.46 (dt, J = 8.3, 2.8 Hz, 2H), 7.36 
(d, J = 8.3 Hz, 1H), 2.64 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 158.83 (d, J = 245.4 Hz), 147.08, 141.61, 133.53, 132.11, 
130.36, 130.33, 126.68, 125.07 (d, J = 8.5 Hz), 119.86, 118.72, 117.46 (d, J = 24.0 Hz), 
117.02 (d, J = 8.3 Hz), 114.72 (d, J = 22.5 Hz), 113.73, 22.46 ppm. 
FT‐IR: ṽ = 3050, 2955, 2850, 1630, 1550, 1490, 1380, 1220, 1113 cm-1. 
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HRMS: calc. for [M+H]
+
 C16H12N2F: 251.0979 found: 251.0973.  
 
8,11-Dimethylbenzo[4,5]imidazo[1,2-a]quinoline (157)
[81]
 
Compound 157 prepared according to the general procedure B using 
PIDA (1 equiv) and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum ether (25:75 
v/v); the product was obtained as light yellow amorphous solid in 83% 
yield.  
1
H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.77 (dd, J = 7.8, 1.2 Hz, 1H), 7.66 
–7.57 (m, 3H), 7.43 – 7.37 (m, 1H), 7.28 – 7.24 (m, 1H), 7.14 (d, J = 7.4 Hz, 1H), 2.78 ppm 
(s, 6H). 
13
C NMR (101 MHz, CDCl3) δ 148.65, 144.95, 135.66, 130.84, 130.58, 128.55, 128.03, 
127.24, 126.09, 125.18, 124.11, 124.02, 120.73, 119.79, 118.06, 23.25, 17.02 ppm. 
MS-EI: m/z (%): 246.1 (100); 231.1 (41); 115.1 (8). 
 
12.5.2 Synthesis of N-Heteroarylamines
[269]
 
 
To the seal tube, 2-aminopyridine 144a (1 mmol), CuI (0.5 mmol) and K2CO3 (2.0 mmol) 
were added, magnetic stir bar and septum. The seal tube was evacuated and back filled with 
nitrogen gas three times. Dioxane (5 mL), 2-iodo-1,4-dimethylbenzene (1.5 mmol) and 
DMEDA (0.5 mmol) were added by syringe at room temperature. The reaction mixture was 
stirred at 100 °C for 12 h. Upon completion the reaction, cooled down to room temperature. 
Saturated ammonium chloride (25 mL) added, and the mixture was extracted with ethyl 
acetate (3×10 mL). The crude reaction mixture was concentrated under reduced pressure and 
subsequently purified by flash column chromatography over silica gel using petroleum 
ether/ethyl acetate as an eluent system. The product was obtained as yellow solid in 45% 
yield. 
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1
H NMR (400 MHz, CDCl3) δ 7.50 (t, J = 6.3 Hz, 1H), 7.21 (s, 1H), 7.13 (d, J = 7.7 Hz, 1H), 
6.90 (d, J = 7.6 Hz, 1H), 6.82 (t, J = 48.5 Hz, 3H), 2.32 (s, 3H), 2.23 ppm (s, 3H) 
13
C NMR (101 MHz, CDCl3) δ 138.10, 137.57, 136.61, 130.95, 128.72, 125.97, 125.48, 
123.97, 21.16, 17.76. 
 
 
To the seal tube, 2-aminoquinoline 153a (1 mmol), CuI (0.5 mmol) and K2CO3 (2.0 mmol) 
were added, magnetic stir bar and septum. The seal tube was evacuated and back filled with 
nitrogen gas three times. Dioxane (5 mL), 2-iodo-1,4-dimethylbenzene (1.5 mmol) and 
DMEDA (0.5 mmol) were added by syringe at room temperature. The reaction mixture was 
stirred at 100 °C for 12 h. Upon completion the reaction, cooled to room temperature. 
Saturated ammonium chloride (25 mL) added, and the mixture was extracted with ethyl 
acetate (3×10 mL). The crude reaction mixture was concentrated under reduced pressure and 
subsequently purified by flash column chromatography over silica gel using petroleum 
ether/ethyl acetate as an eluent system. The product was obtained as yellow solid in 33% 
yield. 
1
H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 9.0 Hz, 1H), 7.72 (s, 1H), 7.63 (t, J = 8.3 Hz, 1H), 
7.57 (ddd, J = 8.4, 7.0, 1.4 Hz, 1H), 7.37 (s, 1H), 7.31 – 7.26 (m, 1H), 7.16 (d, J = 7.8 Hz, 
1H), 6.95 (d, J = 7.8 Hz, 1H), 6.86 (d, J = 9.0 Hz, 1H), 2.35 (s, 3H), 2.27 ppm (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 155.71, 147.78, 138.08, 136.72, 130.98, 129.98, 129.63, 
127.62, 127.23, 126.18, 125.95, 124.61, 124.12, 122.95, 110.72, 21.21, 17.81 ppm. 
 
12.5.3 Procedure for probable Intermediate 155 Test 
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To a screw cap reaction vial N-(2,5-dimethylphenyl)pyridin-2-amine 155 (0.20 mmol, 1 
equiv), PhI(OAc)2 (0.20 mmol, 1 equiv) and HFIP (1 mL) were added. The reaction mixture 
was heated to 40 
o
C for 3 h. The crude reaction mixture was concentrated under reduced 
pressure and subsequently purified by flash column chromatography over silica gel using 
petroleum ether/ethyl acetate or acetone as an eluent system. The product was obtained as 
yellow solid in 95% yield 
 
12.5.4 Procedure for Probable Intermediate 156 Test 
To a screw cap reaction vial N-(2,5-dimethylphenyl)quinolin-2-amine (0.20 mmol, 1 equiv), 
PhI(OAc)2 (0.20 mmol, 1 equiv)  and HFIP (1 mL) were added. The reaction mixture was 
heated to 40 
o
C for 3h. Then the reaction mixture was analysis by GC-MS and only 8,11-
dimethylbenzo[4,5]imidazo[1,2-a]quinoline was obtained. The crude reaction mixture was 
concentrated under reduced pressure and subsequently purified by flash column 
chromatography over silica gel using petroleum ether/ ethyl acetate or acetone as an eluent 
system. The product was obtained as yellow solid in 83% yield 
 
 
8,11-Dimethylbenzo[4,5]imidazo[1,2-a]quinoline (157)
 
1
H NMR (400 MHz, CDCl3) δ 8.07 (d, J = 8.4 Hz, 1H), 7.77 (dd, J = 7.8, 1.2 Hz, 1H), 7.66 – 
7.57 (m, 3H), 7.45 – 7.37 (m, 1H), 7.30 – 7.22 (m, 1H), 7.14 (d, J = 7.4 Hz, 1H), 2.78 ppm (s, 
6H). 
13
C NMR (101 MHz, CDCl3) δ 148.65, 135.66, 130.84, 130.58, 128.55, 128.03, 127.24, 
126.09, 125.18, 124.11, 124.02, 120.73, 119.79, 118.06, 23.25, 17.02 ppm. 
 
12.5.5. Procedure for Kinetic Isotope Experiment Study with 2-Aminopyridine  
To a screw cap reaction vial 2-aminopyridine (0.5 mmol, 1 equiv), PhI(OAc)2 (0.20 mmol, 1 
equiv), p-xylene (3 equiv), deuterated p-xylene (3 equiv) and HFIP (1.5 mL) were added. The 
reaction mixture was heated to 40 
o
C for 12 h. The crude reaction mixture was concentrated 
under reduced pressure and subsequently purified by flash column chromatography over silica 
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gel using petroleum ether/ethyl acetate or acetone as an eluent system. Ratio was calculated 
by 
1
H NMR analysis and kH/kD is equal to 1. 
 
12.5.6 Procedure for Kinetic Isotope Effect Study with 2-Aminoquinoline 
 
To a screw cap reaction vial 2-aminopyridine (0.5 mmol, 1 equiv), PhI(OAc)2 (0.20 mmol, 1 
equiv), p-xylene (3 equiv), deuterated p-xylene (3 equiv) and HFIP (1.5 mL) were added. The 
reaction mixture was heated to 40 
o
C for 12 h. The crude reaction mixture was concentrated 
under reduced pressure and subsequently purified by lash column chromatography over silica 
gel using petroleum ether/ethyl acetate or acetone as an eluent system. Ratio was calculated 
by 
1
H NMR analysis and KH/KD is equal to1.42. 
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12.5.7 Reaction of N-Benzylamine Intermediate  
 
 
To a screw reaction vial N-(4-methylbenzyl)quinolin-2-amine (0.20 mmol, 1 equiv), 
PhI(OAc)2 22 (0.4 mmol, 2 equiv) and HFIP (1 mL) were added. The reaction mixture was 
heated to 40 
o
C for 3 h and the reaction mixture was monitored by TLC and GC-MS analysis. 
The crude reaction mixture was concentrated under reduced pressure and subsequently 
purified by flash column chromatography over silica gel using petroleum ether/ethyl acetate 
or acetone as an eluent system. The product was obtained as yellow solid in 90% yield. 
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12.6 Hypervalent Iodine (III) Mediated Oxidative Amination of Arenes with 
Heteroaromatic Amines 
 
12.6.1. Characterization of N-Arylated Heteroaromatic Amines (189a-194g) 
4,6-Dichloro-N-mesityl-2-methylpyrimidin-5-amine (178a) 
Compound 178a was obtained by using the general procedure C 
and the product was isolated by column chromatography with 
silica gel. Eluent: EtOAc/petroleum ether (5:95 v/v); The 
product was obtained as brown solid in 93% yield. 
1
H NMR (300 MHz, CDCl3) δ 6.86 (s, 2H), 5.48 (s, 1H), 2.59 (s, 3H), 2.28 (s, 3H), 2.11 ppm 
(s, 6H). 
13
C NMR (75 MHz, CDCl3) δ 156.64, 146.66, 136.43, 135.52, 134.48, 133.08, 129.10, 
24.43, 21.03, 19.00 ppm. 
FT-IR: ṽ = 3265, 2918, 2854, 1610, 1508, 1482, 1434, 1370, 1292, 1186, 1028 cm-1. 
HRMS: calc. for [M+H]
+
 C14H16
35
Cl2N3: 296.07158 found: 296.07167; calc. for [M+H]
+
 
C14H16Cl
37
ClN3: 298.06863 found: 298.06869; calc. for [M+H]
+
 C14H16
37
Cl2N3: 300.06568 
found: 300.06534. 
 
2-Chloro-N-mesityl-5-(trifluoromethyl)pyridin-3-amine (178b)  
Compound 178b was obtained by using the general procedure C and 
the product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (5:95 v/v); The product was obtained 
as light yellow solid in 94% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 2.0 Hz, 1H), 7.00 (s, 2H), 6.55 (d, J = 2.0 Hz, 
1H), 5.90 (s, 1H), 2.33 (s, 3H), 2.14 ppm (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 139.82, 139.75, 137.66, 136.13, 133.57 (q, J = 4.4 Hz), 
132.24, 129.91, 127.01 (d, J = 32.9 Hz), 123.37 (q, J = 272.8 Hz), 114.65 (q, J = 3.5 Hz), 
21.09, 18.04 ppm. 
FT-IR: ṽ = 3265, 2918, 2854, 1508, 1482, 1434, 1370, 1292, 1186, 1028, 1011 cm-1. 
HRMS: calc. for [M+H]
+
 C15H15
35
ClF2: 315.0804 found: 315.08797; [M+H]
+
 C15H15
37
ClF: 
317.08409 found: 317.08487. 
 
5-Bromo-N-mesityl-3-amonopyridine (178c) 
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Compound 178c was obtained by using the general procedure C 
and the product was isolated by column chromatography with 
silica gel. Eluent: EtOAc/petroleum ether (20:80 v/v); The 
product was obtained as brown crystals in 89% yield. 
1
H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 2.1 Hz, 1H), 7.95 (d, J = 2.1 Hz, 1H), 6.96 (s, 
2H), 6.76 (t, J = 2.1 Hz, 1H), 5.50 (s, 1H), 2.31 (s, 3H), 2.15 ppm (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 144.27, 139.31, 136.85, 136.12, 134.41, 133.26, 129.67, 
121.39, 121.10, 21.04, 18.22 ppm. 
FT-IR: ṽ = 3204, 2673, 1698, 1575, 1443, 1323, 1004 cm-1. 
HRMS: calc. for [M+H]
+
 C14H16
79
BrN2: 291.04914 found: 291.05045; [M+H]
+
 
C14H16
81
BrN2: 293.04709 found: 293.04827. 
 
N-Mesityl-2-aminopyridine (178d) 
Compound 178d was obtained by using the general procedure C and 
the product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (40:60 v/v); The product was obtained 
as light brown amorphous solid in 86% yield. 
1
H NMR (300 MHz, CDCl3) δ 8.09 (d, J = 4.4 Hz, 1H), 7.43 – 7.31 (m, 1H), 6.95 (s, 2H), 
6.69 (s, 1H), 6.60 (dd, J = 6.6, 5.6 Hz, 1H), 6.01 (d, J = 8.4 Hz, 1H), 2.31 (s, 3H), 2.19 ppm 
(s, 6H). 
13
C NMR (75 MHz, CDCl3) δ 157.99, 147.72, 138.25, 136.65, 136.55, 133.69, 129.34, 
113.34, 105.98, 21.06, 18.36 ppm. 
FT-IR: ṽ = 3155, 2920, 1716, 1684, 1593, 1454 cm-1. 
HRMS: calc. for [M+H]
+
 C14H17N2: 213.13863 found: 213.13909. 
 
N-Mesityl-3-aminopyridine (178e) 
Compound 178e was obtained by using the general procedure C and 
the product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (20:80 v/v); The product was obtained 
as light brown amorphous solid in 97% yield. 
1
H NMR (200 MHz, CDCl3) δ 8.02 (d, J = 2.6 Hz, 1H), 7.95 (d, J = 4.6 Hz, 1H), 7.03 (dd, J 
= 8.3, 4.6 Hz, 1H), 6.95 (s, 2H), 6.65 (ddd, J = 8.3, 2.6, 1.3 Hz, 1H), 5.46 (s, 1H), 2.30 (s, 
3H), 2.15 ppm (s, 6H). 
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13
C NMR (126 MHz, CDCl3) δ 143.18, 138.65, 136.12, 136.00, 135.99, 134.24, 129.37, 
123.83, 118.83, 20.90, 18.13 ppm. 
FT-IR: ṽ = 3229, 2968, 2916, 1579, 1480 cm-1. 
HRMS: calc. for [M+H]
+
 C14H17N2: 213.13863 found:213.13909. 
 
N-Mesitylisoquinolin-1-amine (178f) 
Compound 178f was obtained by using the general procedure C and 
the product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (40:60 v/v); The product was obtained 
as light brown amorphous solid in 47% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.14 (d, J = 8.4 Hz, 1H), 7.69 – 7.39 
(m, 3H), 7.25 – 7.20 (m, 2H), 6.99 (s, 2H), 2.37 (s, 3H), 1.93 ppm (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 155.69, 137.98, 137.64, 136.69, 135.28, 132.45, 131.86, 
128.41, 126.96, 125.34, 124.01, 123.01, 21.23, 20.46 ppm. 
FT-IR: ṽ = 3395, 2915, 1663, 1610, 1505, 1454, 1284, 1025 cm-1. 
HRMS: calc. for [M+H]
+
 C18H19N2: 263.15428 found: 263.15431. 
 
4-Bromo-N-mesitylquinolin-3-amine (178g) 
Compound 178g was obtained by using the general procedure C 
product was isolated by column chromatography with silica gel. 
Eluent: EtOAc/petroleum ether (10:90 v/v); The product was 
obtained as brown solid in 85% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.97-7.95 (m, 2H), 7.57 (ddd, J = 
8.4, 7.0, 1.1 Hz, 1H), 7.48 (ddd, J = 8.4, 7.0, 1.3 Hz, 1H), 7.00 (s, 2H), 5.89 (s, 1H), 2.34 (s, 
3H), 2.20 ppm (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 142.88, 139.40, 137.99, 137.13, 136.58, 133.73, 129.70, 
129.58, 128.44, 128.26, 125.80, 124.73, 112.97, 21.12, 18.30 ppm. 
FT-IR: ṽ = 3347, 2946, 2853, 1592, 1479, 1407, 1340, 1239, 1215, 1029 cm-1. 
HRMS: calc. for [M+H]
+
 C17H16BrN2: 327.04914 found: 327.05006; [M+H]
+
 C17H16
81
BrN2: 
329.04709 found: 329.04786. 
 
N-(4-Methoxyphenyl)pyridin-3-amine (180a) 
Compound 180a was obtained by using the general procedure D 
and the product was isolated by column chromatography with 
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silica gel. Eluent: EtOAc/petroleum ether (30:70 v/v); The product was obtained as brown 
amorphous solid in 60% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.25 (d, J = 2.6 Hz, 2H), 8.05 (d, J = 4.6 Hz, 2H), 7.22 – 7.17 
(m, 2H), 7.11 – 7.09 (m, 1H), 7.08 (d, J = 8.9 Hz, 2H), 6.88 (d, J = 8.9 Hz, 2H), 5.70 (s, 2H), 
3.80 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 156.10, 141.97, 140.42, 138.24, 134.45, 123.86, 122.91, 
121.39, 115.00, 55.70 ppm. 
FT-IR: ṽ = 3247, 3176, 3041, 2923, 2852, 1505, 1324, 1246, 1030 cm-1. 
HRMS: calc. for [M+H]
+
 C12H13N2O: 201.09832 found: 201.10224. 
 
2,4-Dichloro-N-(4-methoxyphenyl)pyridin-3-amine (180b) 
Compound 180b was obtained by using the general procedure D 
and the product was isolated by column chromatography with 
silica gel. Eluent: EtOAc/petroleum ether (20:80 v/v); The 
product was obtained as brown amorphous solid in 58% yield. 
1
H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 2.2 Hz, 1H), 7.13 (d, J = 8.8 Hz, 2H), 7.08 (d, J = 
2.2 Hz, 1H), 6.94 (d, J = 8.8 Hz, 2H), 6.03 (s, 1H), 3.83 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 158.07, 140.56, 136.40, 135.38, 131.87, 131.76, 126.35, 
119.25, 115.57, 55.95 ppm. 
FT-IR: ṽ = 3369, 3005, 2938, 2838, 1592, 1509, 1417, 1286, 1246, 1112, 1060, 1036 cm-1. 
HRMS: calc. for [M+H]
+
  C12H11
35
Cl2N3: 269.02429 found: 269.02505; calc. for [M+H]
+
 
C12H11Cl
37
ClN3: 271.02134 found: 271.02180; calc. for [M+H]
+
 C11H12
37
Cl2N3: 273.01839 
found: 273.01863. 
 
2-Chloro-N-(4-methoxyphenyl)-5-(trifluoromethyl)pyridin-3-amine (180c) 
Compound 180c was obtained by using the general 
procedure D and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum 
ether (15:85 v/v); The product was obtained as brown 
amorphous solid in 65% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.01 (s, 1H), 7.25 (d, J = 2.0 Hz, 1H), 7.14 (d, J = 8.8 Hz, 
2H), 6.96 (d, J = 8.8 Hz, 2H), 3.84 ppm (s, 3H). 
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13
C NMR (126 MHz, CDCl3) δ 157.98, 140.27, 139.88, 134.15 (d, J = 4.5 Hz), 131.17, 
126.74 (d, J = 33.0 Hz), 126.13, 124.42, 123.34 (d, J = 272.9 Hz), 115.56 (d, J = 3.5 Hz), 
115.43, 55.67 ppm. 
FT-IR: ṽ = 3314, 2915, 2838, 1654, 1514, 1453, 1340, 1243, 1117, 1068, 1033 cm-1. 
HRMS: calc. for [M+H]
+
 C13H11
35
ClN2F3: 303.05065 found: 303.05143; calc. for [M+H]
+
 
C13H11Cl
37
N2F3: 305.04770 found: 305.04818. 
 
5-Bromo-N-(4-methoxyphenyl)pyridin-3-amine(180d) 
Compound 180d was obtained by using the general 
procedure D and the product was isolated by column 
chromatography with silica gel. Eluent: EtOAc/petroleum 
ether (20:80 v/v); The product was obtained as brown amorphous solid in 54% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.17 (s, 1H), 8.07 (s, 1H), 7.31 (t, J = 1.9 Hz, 1H), 7.10 (d, J 
= 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 5.82 (s, 1H), 3.82 ppm(s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 156.98, 146.33, 140.04, 135.57, 132.94, 124.24, 123.01, 
115.20, 55.72 ppm. 
FT-IR: ṽ = 3238, 3002, 2929, 1566, 1505, 1439, 1246, 1178, 1033, 1006 cm-1. 
HRMS: calc. for [M]
+
 C12H12O
79
BrN2: 279.01275 found: 279.01382; calc. for [M+H]
+
 
C12H12O
81
BrN2: 281.01071 found: 281.01131. 
 
N-(2,5-Dimethylphenyl)-4-methylpyridin-3-amine (180e) 
Compound 180e was obtained by using the general procedure D and 
product was isolated by column chromatography with silica gel. Eluent: 
EtOAc/petroleum ether (15:85 v/v); The product was obtained as brown 
amorphous solid in 75% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.24 (s, 1H), 8.14 (d, J = 3.8 Hz, 1H), 7.12 – 7.07 (m, 2H), 
6.76 (d, J = 7.6 Hz, 1H), 6.72 (s, 1H), 5.11 (s, 1H), 2.25 (s, 6H), 2.23 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 142.72, 141.04, 140.79, 139.05, 136.79, 136.58, 130.89, 
125.54, 124.75, 123.00, 119.10, 21.20, 17.40, 17.36 ppm. 
FT-IR: ṽ = 3236, 3027, 1600, 1585, 1481, 1395, 1310, 1289, 1213, 1120, 1004 cm-1. 
HRMS: calc. for [M+H]
+
 C13H15N2O: 213.13863 found: 213.13860. 
 
2,4-Dichloro-N-(2,5-dimethylphenyl)pyridin-3-amine (180f) 
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Compound 180f was obtained by using the general procedure D and the 
product was isolated by column chromatography with silica gel. Eluent: 
EtOAc/petroleum ether (25:75 v/v); The product was obtained as brown 
amorphous solid in 75% yield. 
1
H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 2.2 Hz, 1H), 7.19 (d, J = 7.8 Hz, 1H), 7.03 (s, 
1H), 7.01 (d, J = 7.8 Hz, 1H), 6.90 (d, J = 2.2 Hz, 1H), 5.92 (s, 1H), 2.34 (s, 3H), 2.19 ppm (s, 
3H). 
13
C NMR (126 MHz, CDCl3) δ 139.72, 137.34, 136.88, 136.23, 135.35, 131.66, 131.50, 
130.38, 127.34, 125.61, 119.39, 21.09, 17.44 ppm. 
FT-IR: ṽ = 3329, 2920, 1567, 1473, 1424, 1364, 1251, 1196, 1112, 1061 cm-1. 
HRMS: calc. for [M+H]
+
 C13H13
35
Cl2N2: 267.04503 found: 267.04517; calc. for [M+H]
+
 
C13H13Cl
37
ClN2: 269.04208 found: 269.04196; calc. for [M+H]
+
 C13H13
37
Cl2N2: 271.03913 
found: 271.03857. 
 
12.5.1 Procedure for Kinetic Isotope Experiment of 3-Aminopyridine 
 
To a screw capped reaction vial containing, 3-aminopyridine 176d (1 equiv.), p-xylene 149a 
(5 equiv.), deuterated p-xylene 149b and HFIP (0.25 M) were added. Then 1.1 equiv 
(diacetoxy)iodobenzene 22, was added to the reaction mixture and was stirred at room 
temperature under air for 4 h. The crude reaction mixture was concentrated under reduced 
pressure and subsequently purified by flash column chromatography over silica gel using 
petroleum ether/ethyl acetate as an eluent system. KIE (KH/KD ≈ 1) was determined from 
1
H 
NMR. 
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12.6.2 Synthesis of Compound 183 
 
In a seal tube equipped with a magnetic stirring bar, were added dry dioxane (3 mL), 
Pd(OAc)2 (40 mol %), P(
t
Bu)3 (30 mol %), then 2-chloro-N-(2,5-dimethylphenyl)pyridin-3-
amine and finely ground K3PO4 (7 equiv) under argon atmosphere. The mixture was heated 
under argon atmosphere for 24 h at 12 °C. After cooling ethyl acetate was added and the 
mixture was filtered. The crude reaction mixture was concentrated under reduced pressure and 
subsequently purified by flash column chromatography over silica gel using petroleum 
ether/ethyl acetate as an eluent system. 
 
6,9-dimethyl-5H-pyrido[3,2-b]indole 
1
H NMR (600 MHz, CDCl3) δ 8.56 (dd, J = 4.6, 1.4 Hz, 1H), 7.72 (dd, J 
= 8.3, 1.3 Hz, 1H), 7.26 (dd, J = 8.3, 4.6 Hz, 1H), 7.19 (d, J = 7.3 Hz, 1H), 
6.98 (d, J = 7.3 Hz, 1H), 3.03 (s, 3H), 2.52 ppm(s, 3H). 
13
C NMR (151 MHz, CDCl3) δ 141.66, 139.79, 133.06, 132.93, 132.35, 
128.12, 121.56, 119.25, 117.56, 117.50, 117.31, 19.70, 16.37 ppm. 
FT‐IR: ṽ = 3015, 2913, 2854, 1693, 1640, 1497, 1464, 1355, 1174, 1099 cm-1. 
HRMS: calc. for [M+H]
+
 C13H13N2: 197.10732 found: 197. 1080. 
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12.7 Regioselective Annulation of Nitrosopyridine with Alkynes and Alkenes in the 
Synthesis of N–Oxide-imidazopyridines 
 
12.7.1. Characterization of N–Oxide-imidazopyridine derivatives (189a-194g) 
2,3-Diphenylimidazo[1,2-a]pyridine 1-oxide (189a)  
Compound 189a was obtained by using the general procedure E and the 
product was isolated by column chromatography with silica gel. Eluent: 
MeOH/DCM (5:95 v/v); The product was obtained as light yellow solid in 
86% yield. This reaction was carried out in 4 mmol scale and the pure product 
was obtained; 75% yield. 
 
1
H NMR (400 MHz, CDCl3) δ 8.01 – 7.91 (m, 2H), 7.75 – 7.68 (m, 2H), 7.49 – 7.42 (m, 
3H), 7.39 – 7.32 (m, 2H), 7.32 – 7.27 (m, 3H), 7.20 (ddd, J = 9.1, 6.7, 0.8 Hz, 1H), 6.78 ppm 
(td, J = 6.9, 1.1 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 133.97, 132.91, 130.51, 130.13, 129.75, 129.71, 128.98, 
128.26, 126.72, 126.50, 124.92, 122.60, 117.28, 114.48, 112.87 ppm. 
FT‐IR: ṽ = 3015, 2926, 1630, 1506, 1514, 1450, 1423, 1371, 1279, 1113 cm-1. 
HRMS: calc. for [M+H]
+
 C19H15N2O: 287.11789 found: 287.11743. 
 
2,3-Bis(4-(tert-butyl)phenyl)imidazo[1,2-a]pyridine 1-oxide (189b) 
Compound 189b was obtained by using the general procedure 
E and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (5:95 v/v); the product was 
obtained as light yellow solid; yield 95%. 
1
H NMR (200 MHz, CDCl3) δ 8.01 – 7.87 (m, 2H), 7.76 – 7.64 
(m, 2H), 7.54 – 7.45 (m, 2H), 7.39 – 7.28 (m, 4H), 7.20 (ddd, J 
= 9.4, 6.7, 0.9 Hz, 1H), 6.83 – 6.72 (m, 1H), 1.36 (s, 9H), 1.29 
ppm(s, 9H). 
13
C NMR (50 MHz, CDCl3) δ 152.92, 151.88, 133.92, 132.90, 130.29, 129.73, 126.64, 
125.29, 124.69, 123.86, 123.67, 122.78, 117.19, 114.24, 112.82, 35.02, 34.85, 31.35, 31.33 
ppm. 
FT‐IR: ṽ = 2962, 2915, 1605, 1492, 1363, 1283, 1177, 1089 cm-1. 
HRMS: calc. for [M+H]
+
 C27H31N2O: 399.24310 found: 399.24309. 
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2,3-Di-p-tolylimidazo[1,2-a]pyridine 1-oxide (189c) 
Compound 189c was obtained by using the general procedure E 
and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (5:95 v/v); the product was 
obtained as light yellow solid; yield 88%. 
1
H NMR (300 MHz, CDCl3) δ 8.00 (d, J = 7.0 Hz, 1H), 7.96 
(d, J = 9.2 Hz, 1H), 7.65 (d, J = 8.2 Hz, 2H), 7-317.28 (m, 4H), 
7.26 – 7.21 (m, 1H), 7.17 (d, J = 8.0 Hz, 2H), 6.86-8.81 (m, 6.9, 1H), 2.45 (s, 3H), 2.35 
ppm(s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 139.84, 138.92, 133.83, 132.75, 130.36, 130.30, 129.89, 
128.95, 124.97, 123.60, 123.50, 122.62, 117.19, 114.32, 112.59, 21.47, 21.44 ppm. 
FT‐IR: ṽ =2988, 2921, 1620, 157, 1407, 1360, 1232, 1110 cm-1. 
HRMS: calc. for [M+H]
+
 C21H19N2O: 315.14919 found: 315.15023. 
 
2,3-Bis(4-methoxyphenyl)-5-methylimidazo[1,2-a]pyridine 1-oxide (189d) 
Compound 189b was obtained by using the general procedure 
E and the product was isolated by column chromatography 
with silica gel. Eluent: MeOH/DCM (5:95 v/v); the product 
was obtained as light yellow solid; yield 87%. 
1
H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 9.1 Hz, 1H), 7.54 
(d, J = 8.8 Hz, 2H), 7.26 (d, J = 8.9 Hz, 2H), 7.08 (d, J = 8.8 
Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 6.73 (t, J = 8.8 Hz, 2H), 
6.48 (d, J = 6.8 Hz, 2H), 3.80 (s, 3H), 3.69 (s, 3H), 2.04 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 160.62, 159.66, 136.43, 135.16, 134.22, 133.57, 131.38, 
124.81, 121.42, 118.94, 117.75, 115.51, 113.49, 113.46, 110.55, 55.35, 55.15, 21.51 ppm. 
FT‐IR: ṽ = 2996, 2837, 1609, 1519, 1494, 1395, 1293, 1247, 1160, 1027 cm-1. 
HRMS: calc. for [M+H]
+
 C22H21N2O3: 361.15467 found: 361.15525. 
 
2,3-Bis(4-(trifluoromethyl)phenyl)imidazo[1,2-a]pyridine 1-oxide 
(189e)Compound 189e was obtained by using the general procedure E 
and the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v); the product was obtained as light 
yellow solid; yield 77%. 
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1
H NMR (300 MHz, CDCl3) δ 8.00 (d, J = 8.6 Hz, 2H), 7.85 (d, J = 8.1 Hz, 2H), 7.78 (d, J = 
8.2 Hz, 2H), 7.61 (d, J = 8.2 Hz, 2H), 7.54 (d, J = 8.1 Hz, 2H), 7.32 (dd, J = 9.5, 6.8 Hz, 1H), 
6.91 ppm (t, J = 7.4 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 134.73, 132.33, 132.18, 131.89 (q, J =31.02 Hz), 131.41 (q, J 
=30.68 Hz), 130.97, 130.51, 130.03, 129.67, 127.02 (q, J = 3.6 Hz), 126.16, 125.53 (q, J =3.7 
Hz), 122.12 (q, J =271.09 Hz), 121.82 (q, J =272.35 Hz), 116.30, 115.55, 113.31 ppm. 
FT‐IR: ṽ = 3158, 2950, 1620, 1413, 1320, 1159, 1008 cm-1. 
HRMS: calc. for [M+H]
+
 C21H13N2OF6: 423.09266 found: 423.09283. 
 
2,3-Bis(4-fluorophenyl)-5-methylimidazo[1,2-a]pyridine 1-oxide (189f) 
Compound 189f was obtained by using the general procedure E 
and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (5:95 v/v); the product was 
obtained as light yellow solid; yield 91%. 
1
H NMR (500 MHz, CDCl3) δ 7.89 (d, J = 9.1 Hz, 1H), 7.62 – 
7.54 (m, 2H), 7.42 – 7.36 (m, 2H), 7.19 – 7.13 (m, 1H), 7.09 (t, J 
= 8.5 Hz, 2H), 6.95 (t, J = 8.7 Hz, 2H), 6.55 (d, J = 6.8 Hz, 1H), 
2.07 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) 163.63 (d, J = 251.80 Hz), 162.87 (d, J = 249.6 Hz), 136.28, 
135.49, 134.87 (d, J = 8.4 Hz), 133.31, 132.17 (d, J = 8.4 Hz), 125.46 (d, J = 3.7 Hz), 125.32, 
122.47 (d, J = 3.3 Hz), 117.10, 115.58, 115.52 (d, J = 21.8 Hz), 115.30 (d, J = 21.7 Hz), 
111.03ppm. 
FT‐IR: ṽ = 3093, 3051, 1637, 1595, 1517, 1493, 1377, 1222, 1158, 1070 cm-1. 
HRMS: calc. for [M+H]
+
 C20H15N2OF2: 337.11470 found: 337.11470. 
 
5-Methyl-2, 3-di (thiophen-2-yl)imidazo[1,2-a]pyridine 1-oxide (189g) 
Compound 189g was obtained by using the general procedure E and the 
product was isolated by column chromatography with silica gel. Eluent: 
MeOH/DCM (5:95 v/v); the product was obtained as brown solid; yield 
92%. 
1
H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 9.0 Hz, 1H), 7.68 (dd, J = 
5.3, 1.2 Hz, 1H), 7.38 (dd, J = 5.1, 1.1 Hz, 1H), 7.34 – 7.32 (m, 1H), 
7.22 (dd, J = 5.3, 3.5 Hz, 1H), 7.16 (dd, J = 9.0, 6.9 Hz, 1H), 7.11 (dd, J = 3.9, 1.0 Hz, 1H), 
6.93 (dd, J = 5.0, 3.9 Hz, 1H), 6.56 (d, J = 6.8 Hz, 1H), 2.28 ppm (s, 3H). 
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13
C NMR (126 MHz, CDCl3) δ 136.85, 135.90, 134.89, 131.54, 130.97, 129.70, 128.55, 
127.63, 127.41, 127.33, 126.25, 125.29, 116.28, 110.52, 106.36, 20.14 ppm. 
FT‐IR: ṽ = 3055, 2960, 1627, 1537, 1441, 1421, 1387, 1197, 1151, 1035 cm-1. 
HRMS: calc. for [M+H]
+
 C16H13N2OS2: 313.04638 found: 313.04711. 
 
2-(4-Nitrophenyl)-3-phenylimidazo[1,2-a]pyridine 1-oxide (189h) 
Compound 189h was obtained by using the general procedure 
E and the product was isolated by column chromatography 
with silica gel. Eluent: MeOH/DCM (5:95 v/v); the product 
was obtained as brown solid; yield 84%. 
1
H NMR (300 MHz, CDCl3) δ 8.28 (d, J = 8.8 Hz, 2H), 8.10 
(d, J = 7.0 Hz, 1H), 7.98 (d, J = 9.2 Hz, 1H), 7.61 (dd, J = 6.6, 
3.2 Hz, 2H), 7.56 (d, J = 8.8 Hz, 2H), 7.34 (dd, J = 5.3, 1.9 Hz, 3H), 7.31 – 7.26 (m, 1H), 6.91 
ppm (dd, J = 6.6, 1.9 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 147.87, 134.85, 134.21, 133.40, 131.09, 130.31, 129.69, 
128.66, 125.97, 125.63, 124.85, 122.34, 115.52, 114.86, 113.31, ppm. 
FT‐IR: ṽ = 3025, 2929, 1597, 1514, 1443, 1383, 1345, 1104 cm-1. 
HRMS: calc. for [M+H]
+
 C19H14N3O3: 332.10297 found: 332.10432. 
 
3-(4-Methoxyphenyl)-5-methyl-2-phenylimidazo[1,2-a]pyridine 1-oxide (189i) 
Compound 189i was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v); the product was obtained as brown 
solid; yield 85%. 
1
H NMR (300 MHz, CDCl3) δ 7.85 (d, J = 9.1 Hz, 1H), 7.62 – 7.55 
(m, 2H), 7.27 (d, J = 8.7 Hz, 2H), 7.22 (m, 3H), 7.11 (dd, J = 9.1, 6.8 
Hz, 1H), 6.85 (d, J = 8.7 Hz, 2H), 6.49 (d, J = 6.8 Hz, 1H), 3.79 (s, 
3H), 2.05 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 160.65, 136.57, 135.25, 133.78, 130.14, 128.64, 127.96, 
126.64, 125.10, 121.16, 118.38, 115.65, 113.45, 110.75, 55.36, 21.54 ppm. 
FT‐IR: ṽ = 2987, 2963, 1631, 1605, 1542, 1391, 1290, 1246, 1161, 1027 cm-1. 
HRMS: calc. for [M+H]
+
 C21H19N2O2: 331.14410 found: 331.14496. 
 
2-(4-Cyanophenyl)-3-(4-methoxyphenyl)-5-methylimidazo[1,2-a]pyridine 1-oxide (189j) 
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Compound 189g was obtained by using the general procedure E 
and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (5:95 v/v); the product was 
obtained as brown solid; yield 86%. 
1
H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 9.1 Hz, 1H), 7.79 (d, 
J = 8.6 Hz, 2H), 7.52 (d, J = 8.6 Hz, 2H), 7.30 (d, J = 8.7 Hz, 
2H), 7.16 (dd, J = 9.1, 6.8 Hz, 1H), 6.91 (d, J = 8.7 Hz, 2H), 6.55 
(d, J = 6.8 Hz, 1H), 3.84 (s, 3H), 2.08 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 161.16, 136.96, 135.80, 134.16, 131.79, 131.48, 130.52, 
126.12, 124.69, 120.35, 119.30, 118.68, 116.33, 113.94, 112.15, 110.91, 55.51, 21.58 ppm. 
FT‐IR: ṽ = 3006, 2967, 2839, 1912, 1609, 1546, 1333, 1291, 1253, 1180, 1071 cm-1. 
HRMS: calc. for [M+H]
+
 C22H18N3O2: 356.13935 found: 356.14013. 
 
2-Isopentyl-3-(4-methoxyphenyl)-5-methylimidazo[1,2-a]pyridine 1-oxide (191a) 
Compound 191a was obtained by using the general procedure E 
and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (2:98 v/v); the product was 
obtained as brown solid; yield 83%. 
1
H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 9.1 Hz, 1H), 7.33 – 
7.22 (m, 2H), 7.07 (dd, J = 9.1, 6.8 Hz, 1H), 6.98 – 6.81 (m, 2H), 
6.45 (d, J = 6.8 Hz, 1H), 3.85 (s, 3H), 2.69 – 2.56 (m, 2H), 2.03 (s, 
3H), 1.51-1.46 (m,  3H), 0.76 (s, 3H), 0.74 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 160.71, 136.74, 136.33, 134.91, 133.73, 124.63, 121.26, 
117.80, 114.96, 113.40, 110.08, 55.47, 36.91, 27.86, 22.30, 21.43, 20.61 ppm. 
FT‐IR: ṽ = 3056, 2949, 2866, 1638, 1580, 1505, 1310, 1247, 1142, 1033 cm-1. 
HRMS: calc. for [M+H]
+
 C20H25N2O2: 325.19105 found: 325.19229. 
 
2-(3-Hydroxypropyl)-3-(p-tolyl)imidazo[1,2-a]pyridine 1-oxide (191b) 
Compound 191b was obtained by using the general procedure E and the product was isolated 
by column chromatography with silica gel. Eluent: MeOH/DCM (5:95 v/v); the product was 
obtained as brown solid; yield 53%. 
 
1
H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 7.0 Hz, 1H), 7.89 (d, J 
= 9.2 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 
Experimental Section 
- 184 - 
 
7.31 – 7.26 (m, 1H), 6.83 (t, J = 7 Hz, 1H), 3.69 – 3.57 (m, 2H), 3.11 – 2.96 (m, 2H), 2.46 (s, 
3H), 1.95 – 1.77 ppm (m, 2H). 
13
C NMR (101 MHz, CDCl3) δ 140.34, 135.15, 133.56, 130.52, 129.94, 125.74, 123.07, 
122.98, 118.06, 114.43, 112.23, 60.80, 32.91, 21.58, 19.17 ppm. 
FT‐IR: ṽ = 2920, 1738, 1543, 1391, 1108, 1056, 1011 cm-1. 
HRMS: calc. for [M+H]
+
 C17H19N2O2: 383.14410 found: 283.14481. 
 
6-Bromo-2-(cyclopentylmethyl)-3-(4-nitrophenyl)imidazo[1,2-a]pyridine 1-oxide (191c) 
Compound 191c was obtained by using the general procedure E 
and the product was isolated by column chromatography with 
silica gel. Eluent: MeOH/DCM (5:95 v/v); The product was 
obtained as brown solid; yield 76%. 
1
H NMR (500 MHz, CDCl3) δ 8.42 (d, J = 8.8 Hz, 2H), 8.01 (s, 
1H), 7.81 (d, J = 9.6 Hz, 1H), 7.67 (d, J = 8.8 Hz, 2H), 7.28 – 
7.24 (m, 1H), 2.90 (d, J = 7.5 Hz, 2H), 2.39 (dt, J = 15.5, 7.8 Hz, 
1H), 1.60 (dt, J = 11.3, 6.5 Hz, 2H), 1.54 – 1.45 (m, 2H), 1.41 
(m, 2H), 1.01 ppm (m, 2H). 
13
C NMR (126 MHz, CDCl3) δ 148.37, 137.07, 132.88, 131.89, 130.91, 128.59, 125.10, 
122.11, 115.41, 113.44, 109.83, 38.29, 32.52, 28.23, 24.70 ppm. 
FT‐IR: ṽ = 3093, 2951, 2862, 1611, 1515, 1382, 1345, 1206, 1055 cm-1. 
HRMS: [M+H]
+
 C19H19
79
BrN3O3: 416.06043 found: 416.06132. HRMS: calc. for [M+H]
+
 
C19H19
81
BrN3O3: 418.05838 found: 418.05834. 
 
2-((1R,2S)-2-((3S,8S,9S,10R,13S,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-10,13-
dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-
cyclopenta[a]phenanthren-17-yl)-1-hydroxypropyl)-6-nitro-3-(p-tolyl)imidazo[1,2-
a]pyridine 1-oxide (191d) 
Compound 191d was obtained by using the general procedure E and the product was isolated 
by column chromatography with silica gel. Eluent: MeOH/DCM (1:99 v/v).The product was 
obtained as orange solid; yield 85%. 
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1
H NMR (600 MHz, CDCl3) δ 8.85 (d, J = 1.0 Hz, 1H), 7.93 (s, 2H), 7.43 (d, J = 8.0 Hz, 
2H), 7.38 (d, J = 8.0 Hz, 2H), 5.29 (dd, J = 2.9, 2.1 Hz, 1H), 4.90 (d, J = 4.9 Hz, 1H), 3.47 – 
3.42 (m, 1H), 2.49 (s, 3H), 2.26 – 2.21 (m, 1H), 2.17 – 2.10 (m, 2H), 1.94 – 1.83 (m, 1H), 
1.78 – 1.73 (m, 2H), 1.68 (d, J = 12.4 Hz, 1H), 1.54 – 1.47 (m, 1H), 1.47 – 1.39 (m, , 3H), 
1.38 – 1.31 (m, 2H), 1.26 – 1.18 (m, 2H), 1.10 – 1.04 (m, 1H), 0.98 (dd, J = 11.6, 5.4 Hz, 
5H), 0.94 (s, 3H), 0.87 (s, 9H), 0.69 (dd, J = 11.3, 4.1 Hz, 1H), 0.63 (s, 3H), 0.04 ppm (s, 6H). 
13
C NMR (50 MHz, CDCl3) δ 141.89, 141.77, 138.92, 136.43, 133.01, 130.96, 130.79, 
123.91, 121.17, 121.04, 120.58, 118.82, 112.24, 72.73, 72.06, 56.72, 53.26, 50.31, 45.56, 
43.08, 42.89, 39.85, 37.48, 36.61, 32.15, 31.97, 31.83, 28.23, 26.04, 24.61, 21.67, 21.06, 
19.49, 18.37, 15.10, 11.66, -4.48 ppm. 
FT‐IR: ṽ = 2928, 2855, 1525, 1509, 1515, 1460, 1332, 1249, 1195, 1078 cm-1. 
HRMS: calc. for [M+H]
+
 C42H60N2O5Si: 714.42967 found: 714.43019. 
 
5,5'-Dimethyl-3,3'-diphenyl-[2,2'-biimidazo[1,2-a]pyridine] 1,1'-dioxide (191e) 
Prepared according to the general procedure E using 1 equiv 
alkyne, 2 equiv 6-methyl-2-nitrosopyridine and the product 
could be isolated as light yellow solid by column 
chromatography with silica gel. Eluent: MeOH/DCM (5:95 v/v) 
in 65 % yield; 
1
H NMR (300 MHz, CDCl3) δ 8.02 (d, J = 9.0 Hz, 2H), 7.58 – 
7.49 (m, 4H), 7.33 – 7.23 (m, 8H), 6.74 (d, J = 6.9 Hz, 2H), 2.09 ppm (s, 6H). 
13
C NMR (75 MHz, CDCl3) δ 138.69, 137.33, 135.68, 130.11, 128.98, 128.78, 126.99, 
125.58, 117.79, 111.77, 104.13, 18.90 ppm. 
FT‐IR: ṽ = 3063, 2926, 2915, 1634, 1546, 1444, 1406, 1209, 1114 cm-1. 
HRMS: calc. for [M+H]
+
 C28H23N4O2: 447.18155 found: 447.18190. 
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3-Phenylimidazo[1,2-a]pyridine 1-oxide (192a)  
Compound 192a was obtained according to the general procedure E and the 
products were formed in 2:1 regioisomeric ratio in 76% combined yield and 
the major product could be isolated as light yellow solid by column 
chromatography with silica gel. Eluent: MeOH/DCM (3:97 v/v) in 40% 
yield in pure form which was fully characterized.  
1
H NMR (400 MHz, CDCl3+ CD3OD 10:1) δ 8.20 (d, J = 7.0 Hz, 1H), 7.93 (d, J = 9.2 Hz, 
1H), 7.79 (s, 1H), 7.60 – 7.48 (m, 5H), 7.34 – 7.27 (m, 1H), 6.90 ppm (t, J = 7.0 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 134.67, 130.01, 129.80, 128.82, 126.06, 125.93, 123.25, 
122.81, 121.12, 114.95, 112.93 ppm. 
FT‐IR: ṽ = 3052, 2954, 1641, 1474, 1416, 1327, 1147cm-1. 
HRMS: calc. for [M+H]
+
 C13H11N2O: 211.08659 found: 211.08659. 
 
3-(4-Fluorophenyl)imidazo[1,2-a]pyridine 1-oxide (192b)  
Compound 192b was obtained according to the general procedure E and the 
products were formed in 4:1 regioisomeric ratio in 78% combined yield and 
the major product could be isolated as light yellow solid by column 
chromatography with silica gel. Eluent: MeOH/DCM (3:97 v/v) in 51% 
yield in pure form which was fully characterized.  
1
H NMR (300 MHz, CDCl3+ CD3OD 10:1) 8.18 (d, J = 7.1 Hz, 1H), 7.92 
(d, J = 9.1 Hz, 1H), 7.78 (s, 1H), 7.60 – 7.50 (m, 2H), 7.42 (dd, J = 9.1, 6.9 Hz, 1H), 7.35 – 
7.27 (m, 2H), 7.00 (t, J = 6.9 Hz, 1H) ppm. 
13
C NMR (75 MHz, CDCl3) δ 163.61 (d, J = 251.7 Hz), 134.57, 131.06 (d, J = 8.6 Hz), 
127.06, 123.22, 122.27, 121.68 (d, J = 3.5 Hz), 120.53, 117.04 (d, J = 22.1 Hz), 115.32, 
112.34 ppm. 
FT‐IR: ṽ = 3037, 1719, 1495, 1413, 1335, 1225, 1088 cm-1. 
HRMS: calc. for [M+H]
+
 C13H10N2OF: 229.07717 found: 229.07791. 
  
3-(4-Bromo)imidazo[1,2-a]pyridine 1-oxide (3s) 
Compound 192b was obtained Eaccording to the general procedure E 
using 2 equiv of alkyne and the products were formed in 3:1 regioisomeric 
ratio in 65% combined yield and the major product could be isolated as 
light yellow semi-solid by column chromatography with silica gel. Eluent: 
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MeOH/DCM (5:95 v/v) in 43% yield in pure form which was fully characterized; 
1
H NMR (500 MHz, DMSO) δ 8.49 (d, J = 7.0 Hz, 1H), 8.18 (s, 1H), 7.76 (d, J = 8.4 Hz, 
2H), 7.74 (d, J = 9.4 Hz, 1H), 7.64 (d, J = 8.4 Hz, 2H), 7.34 (dd, J = 9.1, 6.7 Hz, 1H), 7.00 
ppm(t, J = 6.8 Hz, 1H). 
13
C NMR (126 MHz, DMSO) δ 133.90, 132.24, 130.26, 125.64, 125.30, 124.25, 122.81, 
122.24, 118.79, 114.76, 111.87 ppm. 
FT‐IR: ṽ = 3090, 2935, 2229, 1684, 1495, 1395, 1173, 1123 cm-1. 
HRMS: calc. for [M+H]
+
 C14H10N3O: 236.08184 found: 236.08252. 
 
3-(3,4-Dimethoxyphenyl)-5-methylimidazo[1,2-a]pyridine 1-oxide (192d) 
Compound 192d was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v). The product was obtained as light 
yellow solid; yield 74%. 
1
H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 9.1 Hz, 1H), 7.61 (s, 1H), 
7.17 (dd, J = 9.1, 6.8 Hz, 1H), 6.98 (dd, J = 8.2, 2.0 Hz, 1H), 6.89 (m, 
2H), 6.55 (d, J = 6.8 Hz, 1H), 3.92 (s, 3H), 3.85 (s, 3H), 2.15 ppm (s, 
3H). 
13
C NMR (126 MHz, CDCl3) δ 150.59, 148.25, 137.10, 135.59, 125.78, 125.21, 124.43, 
121.35, 120.69, 115.51, 115.12, 110.60, 110.31, 56.22, 56.10, 21.10 ppm. 
FT‐IR: ṽ = 2954, 2931, 1640, 1582, 1461, 1250, 1233, 1130 cm-1. 
HRMS: calc. for [M+H]
+
 C16H17N2O3: 285.12337 found: 285.12435. 
 
3-(6-Methoxynaphthalen-1-yl)imidazo[1,2-a]pyridine 1-oxide (192e) 
Compound 192d was obtained by using the general procedure E product 
was isolated by column chromatography with silica gel. Eluent: 
MeOH/DCM (5:95 v/v). The product was obtained as light yellow solid; 
yield 87%. 
1
H NMR (300 MHz, CDCl3) δ 8.22 (d, J = 7.1 Hz, 1H), 7.91-7,84 (m, 
3H), 7.82 – 7.73 (m, 2H), 7.48 (dd, J = 8.4, 1.5 Hz, 1H), 7.25 – 7.13 (m, 
3H), 6.84 (t, J = 6.8 Hz, 1H), 3.92 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3) δ 158.89, 134.92, 134.36, 129.71, 128.81, 128.34, 128.08, 
126.00, 125.12, 123.20, 122.92, 121.05, 121.00, 120.28, 114.64, 112.89, 105.84, 55.51 ppm. 
FT‐IR: ṽ = 3042, 2929, 1628, 1607, 1416, 1394, 1113, 1035 cm-1. 
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HRMS: calc. for [M+H]
+
 C18H15N2O2: 291.11280 found: 291.11361. 
 
7-Methyl-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194a) 
Compound 194a was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v). The product was obtained as light 
yellow solid; yield 67%. 
1
H NMR (400 MHz, CDCl3) 7.87 (d, J = 7.1 Hz, 1H), 7.68-7.65 (m, 3H), 7.47 – 7.41 (m, 
3H), 7.34 – 7.29 (m, 2H), 7.29 – 7.25 (m, 3H), 6.66 (dd, J = 7.1, 1.1 Hz, 1H), 2.40 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 137.39, 134.35, 132.51, 130.43, 130.07, 129.66, 128.90, 
128.20, 126.64, 126.45, 122.10, 117.37, 116.82, 110.70, 21.45 ppm. 
FT‐IR: ṽ = 2999, 1635, 1505, 1444, 1457, 1241, 1174, 1040 cm-1. 
HRMS: calc. for [M+H]
+
 C20H17N2O: 301.13354 found: 301.13354. 
 
6-Methyl-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194b) 
Compound 194b was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v). The product was obtained as light 
yellow solid; yield 82%. 
1
H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 9.2 Hz, 1H), 7.73 (s, 1H), 7.66 (dd, J = 6.7, 3.0 
Hz, 2H), 7.49 – 7.42 (m, 3H), 7.33 (dd, J = 6.7, 3.0 Hz, 2H), 7.30 – 7.24 (m, 3H), 7.10 (d, J = 
9.2 Hz, 1H), 2.25 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 133.30, 132.50, 130.57, 130.07, 129.71, 128.89, 128.63, 
128.21, 126.77, 126.49, 124.73, 119.97, 116.99, 112.05, 18.42 ppm. 
FT‐IR: ṽ = 3063, 2960, 1645, 1513, 1380, 1369, 1259, 1182, 1068 cm-1. 
HRMS: calc. for [M+H]
+
 C20H17N2O: 301.134354 found: 301.13439. 
 
6-Nitro-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194c) 
Compound 194c was obtained by using the general procedure E and the product was isolated 
by column chromatography with silica gel. Eluent: MeOH/DCM (10:90 v/v). The product was 
obtained as light yellow solid; yield 96%. 
1
H NMR (300 MHz, CDCl3) δ 8.99 (s, 1H), 8.00 (d, J = 10.0 Hz, 
1H), 7.84 (dd, J = 10.0, 1.6 Hz, 1H), 7.72 (dd, J = 7.1, 2.1 Hz, 2H), 
7.60 – 7.52 (m, 3H), 7.42-7.34 ppm (m, 5H). 
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13
C NMR (75 MHz, CDCl3) δ 138.84, 136.33, 133.33, 130.87, 130.42, 130.25, 130.06, 
129.92, 128.52, 125.33, 125.08, 123.65, 120.32, 117.83, 113.28 ppm. 
FT‐IR: ṽ = 3060, 2996, 1726, 1605, 1503, 1369, 1325, 1126, 1075 cm-1. 
HRMS: calc. for [M+H]
+
 C19H14N3O3: 332.10297 found: 332.10374. 
 
8-Chloro-2,3-diphenyl-6-(trifluoromethyl)imidazo[1,2-a]pyridine 1-oxide (3f) 
Compound 194b was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (3:97 v/v). The product was obtained as light 
yellow solid; yield 64%. 
1
H NMR (500 MHz, CDCl3) δ 8.10 (s, 1H), 7.72 – 7.68 (m, 2H), 7.58 
– 7.52 (m, 3H), 7.39 – 7.36 (m, 2H), 7.34 (dd, J = 5.7, 4.6 Hz, 3H), 7.15 ppm (s, 1H). 
13
C NMR (126 MHz, CDCl3) δ 136.44, 130.88, 130.52, 130.28, 130.24, 129.90, 129.79, 
128.37, 125.29, 125.25, 123.46, 123.12, 122.38 (q, J = 272.52 Hz), 120.69, 120.62 (q, J = 5.9 
Hz), 118.49, 118.21 ppm.   
FT‐IR: ṽ = 3050, 2940, 1636, 1531, 1416, 1309, 1231, 1121, 1074 cm-1. 
HRMS: calc. for [M+H]
+
 C21H12ClF3N2O: 389.05903 found: 389.06982. 
 
6,8-Dibromo-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194e) 
Compound 194e was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v). The product was obtained as light 
yellow solid; yield 81%. 
1
H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 1.3 Hz, 1H), 7.70 – 7.66 (m, 2H), 7.52 – 7.49 (m, 
3H), 7.36 – 7.32 (m, 3H), 7.31 – 7.27 ppm (m, 3H). 
13
C NMR (126 MHz, CDCl3) δ 134.97, 130.99, 130.55, 130.48, 130.15, 130.03, 129.37, 
129.00, 128.17, 125.70, 125.65, 121.75, 118.18, 108.12, 107.55 ppm. 
FT‐IR: ṽ = 3035, 2980, 1602, 1599, 1504, 1488, 1361, 1329, 1244, 1140, 1031 cm-1. 
HRMS: C19H13
79
Br2N2O [M+H]
+ 
calc.: 442.93891 found: 442.94002; C19H13
79
Br
81
BrN2O 
[M+H]
+ 
calc.: 444.94687 found: 444.93711, C19H13
81
Br2N2 [M+H]
+ 
calc.: 446.93482found : 
446.93442. 
 
6-Bromo-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194f) 
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Compound 194f was obtained by using the general procedure E and 
the product was isolated by column chromatography with silica gel. 
Eluent: MeOH/DCM (5:95 v/v). The product was obtained as light 
yellow solid; yield 95%. 
1
H NMR (300 MHz, CDCl3) δ 8.09 (s, 1H), 7.92 (d, J = 9.6 Hz, 1H), 
7.70 (dd, J = 6.7, 3.0 Hz, 2H), 7.51 (dd, J = 6.5, 3.6 Hz, 3H), 7.40 – 7.28 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 133.55, 132.85, 130.53, 130.32, 130.16, 130.01, 129.47, 
128.73, 128.46, 126.01, 125.82, 122.51, 117.87, 113.75, 109.76 ppm. 
FT‐IR: ṽ = 3096, 3004, 1625, 1510, 1376, 1355, 1175, 1078 cm-1. 
HRMS: calc. for [M+H]
+
 C19H14
79
BrN2O: 365.03004 found: 365.02840. HRMS: calc. for 
[M+H]
+
 C19H14
79
BrN2O: 367.02726 found: 367.02636. 
 
5-Methyl-2,3-diphenylimidazo[1,2-a]pyridine 1-oxide (194g) 
Compound 194g was obtained by using the general procedure E and the 
product was isolated by column chromatography with silica gel. Eluent: 
MeOH/DCM (5:95 v/v).The product was obtained as light yellow solid; 
yield 87%. 
1
H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 9.1 Hz, 1H), 7.56 (dd, J = 6.6, 3.0 Hz, 2H), 7.50 – 
7.30 (m, 5H), 7.28 – 7.14 (m, 4H), 6.57 (d, J = 6.8 Hz, 1H), 2.06 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 136.66, 135.45, 133.80, 133.01, 130.19, 130.00, 129.32, 
128.82, 128.12, 128.02, 126.32, 125.60, 118.63, 115.95, 110.71, 21.60 ppm. 
FT‐IR: ṽ = 3064, 2955, 1633, 1517, 1393, 1336, 1221, 1106 cm-1. 
HRMS: calc. for [M+H]
+
 C20H17N2O: 301.13354 found: 301.13353. 
 
N-(6-methylpyridin-2-yl)-N-(2-phenylallyl)hydroxylamine (198) 
To a screw cap reaction vial 6-methyl-2-nitrosopyridine (0.25 
mmol, 1 equiv), α-methyl-styrene (0.5 mmol, 2 equiv), and HFIP 
(1.0 mL) were added under air. The reaction mixture was stirred 
vigorously at RT for 3 h. The crude reaction mixture was 
concentrated under reduced pressure and subsequently purified by 
flash column chromatography over silica gel using ethyl acetate/petroleum ether (10:90 v/v) 
as an eluent system. The product was obtained as light yellow liquid in 93% yield  
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1
H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 7.2 Hz, 2H), 7.43 (t, J = 7.8 Hz, 1H), 7.34-7.26 
(m, 3H), 6.82 (d, J = 8.3 Hz, 1H), 6.63 (d, J = 7.2 Hz, 1H), 5.55 (s, 1H), 5.37 (s, 1H), 4.67 (s, 
2H), 2.45 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 161.52, 155.98, 143.65, 139.38, 138.13, 128.41, 127.84, 
126.45, 115.45, 115.40, 106.18, 59.12, 24.25 ppm. 
FT‐IR: ṽ = 3058, 2925, 2854, 1632, 1589, 1449, 1333, 1263, 1195, 1029 cm-1. 
 
5-Methyl-3,3-diphenyl-2,3-dihydroimidazo[1,2-a]pyridine 1-oxide (199) 
To a screw cap reaction vial 6-methyl-2-nitrosopyridine (0.25 mmol, 1 equiv), alpha-phenyl-
styrene (0.5 mmol, 2 equiv), and HFIP (1.0 mL) were added under air. The reaction mixture 
was stirred vigorously at RT for 12 h. The crude reaction mixture was 
concentrated under reduced pressure and subsequently purified by flash 
column chromatography over silica gel using methanol/ dichloromethane 
(2:98 v/v) as an eluent system. The product was obtained as light yellow 
solid in 85% yield; 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.36 (m, 6H), 7.27 – 7.23 (m, 4H), 6.61 (d, J = 6.4 Hz, 
2H), 5.77 – 5.69 (m, 1H), 4.65 (s, 2H), 2.14ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 151.39, 147.04, 140.63, 132.52, 129.25, 129.14, 127.53, 
109.00, 107.75, 73.45, 70.00, 21.97 ppm. 
FT‐IR: ṽ = 3059, 2955, 1655, 1538, 1493, 1446, 1356, 1130, 1081 cm-1. 
HRMS: calc. for [M+H]
+
 C19H17N2O: 289.13354 found: 289.13333. 
 
12.7.1 Synthesis of Imidazo[1,2-a]pyridine Scaffolds (201a-201c) 
 
2,3-Diphenylimidazo[1,2-a]pyridine (201a) 
To a screw cap reaction vial 2,3-diphenylimidazo[1,2-a]pyridine 1-oxide 
(189a, 0.25 mmol) and acetonitrile (2.0 mL) were added under air. The 
reaction mixture was stirred vigorously at 125-130 
o
C for 3 h. After 
completion the crude reaction mixture was concentrated under reduced 
pressure and subsequently purified by flash column chromatography over silica gel using 
acetone/petroleum ether (20:80) as an eluent system. The product was obtained as brown solid 
in 95% yield; 
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1
H NMR (500 MHz, CDCl3) δ 7.89 (dd, J = 6.8, 1.0 Hz, 1H), 7.68 (d, J = 9.1 Hz, 1H), 7.62-
7.57 (m, 2H), 7.50 – 7.44 (m, 2H), 7.44 – 7.42 (m, 1H), 7.41 – 7.37 (m, 2H), 7.24 – 7.19 (m, 
3H), 7.18 – 7.14 (m, 1H), 6.70 ppm (dd, J = 6.8, 1.0 Hz, 1H). 
13
C NMR (126 MHz, CDC3) δ 144.60, 133.73, 130.90, 129.75, 129.19, 128.47, 128.26, 
127.82, 125.32, 123.49, 121.24, 117.50, 112.76 ppm. 
FT‐IR: ṽ = 3058, 2925, 1666, 1600, 1505, 1442, 1344, 1212, 1027 cm-1. 
HRMS: calc. for [M+H]
+
 C19H15N2: 271.12298 found: 271.12367. 
 
3-Phenylimidazo[1,2-a]pyridine (201b) 
To a screw cap sealed reaction tube 3-phenylimidazo[1,2-a]pyridine 1-oxide 
(192a, 0.25 mmol) and acetonitrile (2.0 mL) were added under air. The 
reaction mixture was stirred vigorously at 140 
o
C for 12 h. After completion 
the crude reaction mixture was concentrated under reduced pressure and subsequently purified 
by flash column chromatography over silica gel using acetone/petroleum ether (15:85) as an 
eluent system. The product was obtained as brown liquid in 86% yield; 
1
H NMR (500 MHz, CDCl3) δ 8.38 – 8.31 (m, 1H), 7.72-7.70 (m, 2H), 7.58 – 7.54 (m, 2H), 
7.54 – 7.50 (m, 2H), 7.45 – 7.40 (m, 1H), 7.23 (s, 1H), 6.83 ppm (dd, J = 6.8, 1.0 Hz, 1H). 13C 
NMR (126 MHz, CDCl3) δ 146.01, 132.11, 129.42, 129.26, 128.46, 128.26, 124.72, 123.55, 
118.26, 112.89 ppm. 
FT‐IR: ṽ = 3055, 2936, 2851, 1643, 1499, 1353, 1297, 1148, 1010 cm-1. 
HRMS: calc. for [M+H]
+
 C13H11N2O: 195.09167 found: 195.0912. 
 
6-Bromo-2-isopentyl-3-(4-methoxyphenyl)imidazo[1,2-a]pyridine (201c) 
To a screw cap sealed reaction tube 6-bromo-2-isopentyl-3-(4-
methoxyphenyl)imidazo[1,2-a]pyridine 1-oxide (191f, 0.15 
mmol) and propionitrile (2.0 mL) were added under air. The 
reaction mixture was stirred vigorously at 150 
o
C for 12 h. After 
completion the crude reaction mixture was concentrated under 
reduced pressure and subsequently purified by flash column 
chromatography over silica gel using acetone/petroleum ether (10:90) as an eluent system. 
The product was obtained as black semi solid in 65% yield; 
1
H NMR (500 MHz, CDCl3) δ 8.08 (d, J = 1.0 Hz, 1H), 7.56 (d, J = 9.4 Hz, 1H), 7.38 – 7.31 
(m, 2H), 7.24 (dd, J = 9.4, 1.6 Hz, 1H), 7.11 – 7.06 (m, 2H), 3.90 (s, 3H), 2.78 – 2.69 (m, 
2H), 1.69 – 1.61 (m, 2H), 1.56 (td, J = 13.2, 6.6 Hz, 1H), 0.87 ppm (d, J = 6.5 Hz, 6H). 
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13
C NMR (75 MHz, CDCl3) δ 160.03, 142.10, 131.20, 127.88, 124.56, 123.25, 120.11, 
117.28, 114.88, 107.12, 55.38, 38.82, 27.92, 25.34, 22.33. 
FT‐IR: ṽ = 3060, 2966, 1656, 1538, 1493, 1446, 1355, 1278, 1130 cm-1. 
HRMS: calc. for [M+H]
+
 C19H22
79
BrN2O: 373.09100 found: 373.09266. HRMS: calc. for 
[M+H]
+
 C19H22
81
BrN2O: 375.08896 found: 375.08997. 
 
12.7.2 Radical Trapping Experiment 
 
 
To a screw cap reaction vial 2-nitrosopyridine (0.25 mmol, 1 equiv), diphenylacetylene (0.28 
mmol, 1.1 equiv), TEMPO (2 equiv) and HFIP (1.0 mL) were added. The reaction mixture 
was heated to 40 
o
C for 12 h. The crude reaction mixture was concentrated under reduced 
pressure and subsequently purified by flash column chromatography over silica gel using 
dichloromethane/methanol as an eluent system and isolated yield was 40%. 
 
12.7.3 Competition Study 
 
To a screw cap reaction vial, 2-aminosopyridine 184a (0.25 mmol, 1 equiv), 1,2-di-p-
tolylethyne 95c (0.24 mmol, 1.0 equiv), 1,2-bis(4-fluorophenyl)ethyne 95f (0.24 mmol, 1.0 
equiv), and HFIP (1.0 mL) were added. The reaction mixture was heated to 40 
o
C for 6 h. The 
crude reaction mixture was concentrated under reduced pressure and subsequently purified by 
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flash column chromatography over silica gel using dichloromethane/methanol as an eluent 
system. The ratio of the product was checked by 
1
H NMR analysis and it was 5:1. 
 
12.7.4. Crystallographic data for the compound 194f 
 
 
Crystal structure of the N–Oxide product. ORTEP of (194f) Crystallographic data have 
been deposited at the Cambridge Crystallographic Data Centre and copies can be obtained on 
request, free of charge, by quoting the publication citation and the deposition number  
CCDC 1018375. 
 
Table 12.7.4.1.  Crystal data and structure refinement for 194f. 
Identification code  CCDC 1018375 
Empirical formula  C19 H17 Br N2 O3 
Formula weight  401.25 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 5.6130(4) Å a= 90°. 
 b = 16.0480(14) Å b= 90°. 
B r
C 4
C 3
C 5
N 2
C 2
C 1
N 1
O 1
O 3
O 2
C 1 3
C 6
C 1 5
C 1 6
C 1 7
C 1 8
C 1 9
C 1 4
C 7
C 8
C 9
C 1 0
C 1 1
C 1 2
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 c = 18.9931(15) Å g = 90°. 
Volume 1710.8(2) Å3 
Z 4 
Density (calculated) 1.558 Mg/m3 
Absorption coefficient 2.424 mm-1 
F(000) 816 
Crystal size 0.401 x 0.043 x 0.023 mm3 
Theta range for data collection 2.492 to 25.997°. 
Index ranges -6<=h<=6, -19<=k<=19, -23<=l<=23 
Reflections collected 54577 
Independent reflections 3355 [R(int) = 0.1113] 
Completeness to theta = 25.242° 99.8 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3355 / 4 / 242 
Goodness-of-fit on F2 1.021 
Final R indices [I>2sigma(I)] R1 = 0.0358, wR2 = 0.0688 
R indices (all data) R1 = 0.0542, wR2 = 0.0753 
Absolute structure parameter -0.026(6) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.336 and -0.235 e.Å-3 
Table 12.7.4.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) 
for 5965.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
___________________________________________________________________________  
 x y z U(eq) 
___________________________________________________________________________  
Br 322(1) 10416(1) 6744(1) 34(1) 
O(1) 9155(6) 7405(2) 6644(2) 34(1) 
O(2) 10153(8) 7653(3) 5239(2) 46(1) 
O(3) 5984(8) 6143(3) 6554(2) 49(1) 
N(1) 8282(7) 8015(3) 7048(2) 26(1) 
N(2) 6009(7) 9032(3) 7417(2) 24(1) 
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C(1) 6468(8) 8508(3) 6861(3) 25(1) 
C(2) 5054(9) 8524(3) 6255(2) 28(1) 
C(3) 3207(9) 9075(3) 6222(3) 30(1) 
C(4) 2846(7) 9636(3) 6794(2) 28(1) 
C(5) 4233(8) 9625(3) 7376(2) 26(1) 
C(6) 7578(8) 8855(3) 7960(3) 25(1) 
C(7) 7452(8) 9324(3) 8632(2) 25(1) 
C(8) 5538(9) 9187(3) 9082(2) 30(1) 
C(9) 5399(8) 9617(3) 9718(2) 34(1) 
C(10) 7127(10) 10186(4) 9897(3) 39(1) 
C(11) 9005(9) 10334(4) 9445(3) 40(1) 
C(12) 9165(9) 9901(3) 8806(3) 34(1) 
C(13) 8979(8) 8210(3) 7735(2) 25(1) 
C(14) 10777(8) 7730(3) 8129(3) 25(1) 
C(15) 10537(9) 7653(3) 8863(2) 30(1) 
C(16) 12201(9) 7201(3) 9243(3) 33(1) 
C(17) 14100(9) 6821(3) 8914(3) 37(1) 
C(18) 14335(8) 6891(3) 8185(3) 34(1) 
C(19) 12679(9) 7332(3) 7797(3) 33(1) 
___________________________________________________________________________
Table 12.7.4.3.   Bond lengths [Å] and angles [°] for  5965. 
_____________________________________________________  
Br-C(4)  1.892(5) 
O(1)-N(1)  1.338(5) 
N(1)-C(1)  1.336(6) 
N(1)-C(13)  1.398(6) 
N(2)-C(1)  1.375(6) 
N(2)-C(5)  1.381(6) 
N(2)-C(6)  1.385(6) 
C(1)-C(2)  1.399(7) 
C(2)-C(3)  1.364(7) 
C(3)-C(4)  1.425(7) 
C(4)-C(5)  1.351(6) 
C(6)-C(13)  1.369(7) 
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C(6)-C(7)  1.483(7) 
C(7)-C(12)  1.376(7) 
C(7)-C(8)  1.391(7) 
C(8)-C(9)  1.392(6) 
C(9)-C(10)  1.375(7) 
C(10)-C(11)  1.380(7) 
C(11)-C(12)  1.402(7) 
C(13)-C(14)  1.473(6) 
C(14)-C(19)  1.394(7) 
C(14)-C(15)  1.407(7) 
C(15)-C(16)  1.385(7) 
C(16)-C(17)  1.377(7) 
C(17)-C(18)  1.395(7) 
C(18)-C(19)  1.381(7) 
 
C(1)-N(1)-O(1) 124.0(4) 
C(1)-N(1)-C(13) 109.2(4) 
O(1)-N(1)-C(13) 126.6(4) 
C(1)-N(2)-C(5) 120.9(4) 
C(1)-N(2)-C(6) 109.1(4) 
C(5)-N(2)-C(6) 130.0(4) 
N(1)-C(1)-N(2) 107.5(4) 
N(1)-C(1)-C(2) 131.5(4) 
N(2)-C(1)-C(2) 121.0(4) 
C(3)-C(2)-C(1) 118.7(4) 
C(2)-C(3)-C(4) 118.9(5) 
C(5)-C(4)-C(3) 122.2(4) 
C(5)-C(4)-Br 118.7(4) 
C(3)-C(4)-Br 119.1(3) 
C(4)-C(5)-N(2) 118.1(4) 
C(13)-C(6)-N(2) 106.7(4) 
C(13)-C(6)-C(7) 132.8(4) 
N(2)-C(6)-C(7) 120.4(4) 
C(12)-C(7)-C(8) 119.9(5) 
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C(12)-C(7)-C(6) 121.0(4) 
C(8)-C(7)-C(6) 119.1(4) 
C(7)-C(8)-C(9) 119.9(5) 
C(10)-C(9)-C(8) 120.3(5) 
C(9)-C(10)-C(11) 120.0(5) 
C(10)-C(11)-C(12) 120.2(5) 
C(7)-C(12)-C(11) 119.8(5) 
C(6)-C(13)-N(1) 107.4(4) 
C(6)-C(13)-C(14) 129.1(4) 
N(1)-C(13)-C(14) 123.3(4) 
C(19)-C(14)-C(15) 118.8(5) 
C(19)-C(14)-C(13) 122.3(4) 
C(15)-C(14)-C(13) 118.9(4) 
C(16)-C(15)-C(14) 119.8(5) 
C(17)-C(16)-C(15) 121.2(5) 
C(16)-C(17)-C(18) 119.2(5) 
C(19)-C(18)-C(17) 120.5(5) 
C(18)-C(19)-C(14) 120.6(5) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
Table 12.7.4.4.   Anisotropic displacement parameters  (Å2x 103) for 5965.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
___________________________________________________________________________
___  
 U11 U22  U33 U23 U13 U12 
___________________________________________________________________________
___  
Br 28(1)  34(1) 40(1)  5(1) -4(1)  2(1) 
O(1) 36(2)  31(2) 34(2)  -10(2) 4(2)  4(2) 
O(2) 44(3)  59(2) 34(2)  -8(2) -5(2)  2(2) 
O(3) 52(3)  41(2) 54(3)  5(2) -3(2)  -8(2) 
N(1) 27(2)  27(2) 24(2)  -2(2) 4(2)  -3(2) 
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N(2) 24(2)  26(2) 22(2)  0(2) 1(2)  -1(2) 
C(1) 24(2)  24(3) 27(3)  2(2) 7(2)  -2(2) 
C(2) 33(3)  28(3) 22(2)  -2(2) 3(2)  -2(2) 
C(3) 32(3)  32(3) 28(3)  6(2) -3(2)  -7(2) 
C(4) 23(2)  28(3) 31(3)  7(3) 1(2)  -4(2) 
C(5) 27(2)  25(3) 26(2)  1(2) 5(2)  2(3) 
C(6) 23(3)  26(3) 27(3)  2(2) 1(2)  -3(2) 
C(7) 21(2)  26(3) 26(3)  2(2) -4(2)  2(2) 
C(8) 30(3)  29(3) 30(3)  0(2) -1(2)  -4(3) 
C(9) 30(2)  41(3) 30(2)  -3(3) 4(2)  -3(3) 
C(10) 36(3)  49(4) 32(3)  -12(3) 4(2)  2(3) 
C(11) 31(3)  44(3) 45(3)  -12(3) -1(2)  -7(3) 
C(12) 31(3)  41(3) 29(3)  -5(2) 4(2)  -3(2) 
C(13) 26(3)  27(3) 22(3)  -2(2) 0(2)  -3(2) 
C(14) 22(2)  20(2) 34(3)  0(2) -2(2)  -4(2) 
C(15) 31(3)  29(3) 29(3)  1(2) 2(2)  -2(2) 
C(16) 36(3)  32(3) 31(3)  3(3) -6(2)  -7(3) 
C(17) 33(3)  30(3) 48(4)  6(3) -10(3)  -1(3) 
C(18) 22(2)  29(3) 52(3)  -1(3) 4(3)  1(2) 
C(19) 29(3)  30(3) 39(3)  -1(3) 2(2)  -1(2) 
___________________________________________________________________________
Table 12.7.4.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) 
for 5965. 
___________________________________________________________________________
_____  
 x  y  z  U(eq) 
___________________________________________________________________________
_____  
  
H(1O) 11720(70) 7450(50) 5140(40) 100(30) 
H(2O) 9890(140) 7530(50) 5721(17) 110(30) 
H(3O) 7160(110) 6580(40) 6540(40) 100(30) 
H(4O) 5070(120) 6190(50) 6130(20) 100(30) 
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H(2) 5375 8159 5873 33 
H(3) 2179 9085 5825 37 
H(5) 3994 10015 7745 32 
H(8) 4328 8800 8957 36 
H(9) 4106 9517 10029 40 
H(10) 7027 10478 10331 47 
H(11) 10192 10730 9568 48 
H(12) 10454 10006 8494 40 
H(15) 9238 7911 9098 36 
H(16) 12030 7151 9739 40 
H(17) 15236 6516 9180 44 
H(18) 15645 6635 7954 41 
H(19) 12836 7363 7300 39 
___________________________________________________________________________
Table 12.7.4.6.  Torsion angles [°] for 5965. 
________________________________________________________________  
O(1)-N(1)-C(1)-N(2) 177.4(4) 
C(13)-N(1)-C(1)-N(2) 1.1(5) 
O(1)-N(1)-C(1)-C(2) 1.0(8) 
C(13)-N(1)-C(1)-C(2) -175.3(5) 
C(5)-N(2)-C(1)-N(1) 179.1(4) 
C(6)-N(2)-C(1)-N(1) -0.2(5) 
C(5)-N(2)-C(1)-C(2) -4.1(7) 
C(6)-N(2)-C(1)-C(2) 176.7(4) 
N(1)-C(1)-C(2)-C(3) 176.3(5) 
N(2)-C(1)-C(2)-C(3) 0.3(7) 
C(1)-C(2)-C(3)-C(4) 2.5(7) 
C(2)-C(3)-C(4)-C(5) -1.8(7) 
C(2)-C(3)-C(4)-Br 178.8(4) 
C(3)-C(4)-C(5)-N(2) -1.9(7) 
Br-C(4)-C(5)-N(2) 177.5(3) 
C(1)-N(2)-C(5)-C(4) 4.8(6) 
C(6)-N(2)-C(5)-C(4) -176.2(5) 
C(1)-N(2)-C(6)-C(13) -0.9(5) 
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C(5)-N(2)-C(6)-C(13) 180.0(4) 
C(1)-N(2)-C(6)-C(7) -179.1(4) 
C(5)-N(2)-C(6)-C(7) 1.8(7) 
C(13)-C(6)-C(7)-C(12) 74.6(7) 
N(2)-C(6)-C(7)-C(12) -107.7(6) 
C(13)-C(6)-C(7)-C(8) -106.8(6) 
N(2)-C(6)-C(7)-C(8) 70.9(6) 
C(12)-C(7)-C(8)-C(9) -1.9(7) 
C(6)-C(7)-C(8)-C(9) 179.6(4) 
C(7)-C(8)-C(9)-C(10) 1.0(7) 
C(8)-C(9)-C(10)-C(11) 0.1(8) 
C(9)-C(10)-C(11)-C(12) -0.4(8) 
C(8)-C(7)-C(12)-C(11) 1.6(8) 
C(6)-C(7)-C(12)-C(11) -179.9(5) 
C(10)-C(11)-C(12)-C(7) -0.4(8) 
N(2)-C(6)-C(13)-N(1) 1.5(5) 
C(7)-C(6)-C(13)-N(1) 179.4(5) 
N(2)-C(6)-C(13)-C(14) -173.6(5) 
C(7)-C(6)-C(13)-C(14) 4.3(9) 
C(1)-N(1)-C(13)-C(6) -1.7(5) 
O(1)-N(1)-C(13)-C(6) -177.9(4) 
C(1)-N(1)-C(13)-C(14) 173.8(4) 
O(1)-N(1)-C(13)-C(14) -2.3(7) 
C(6)-C(13)-C(14)-C(19) -154.2(5) 
N(1)-C(13)-C(14)-C(19) 31.3(7) 
C(6)-C(13)-C(14)-C(15) 27.4(7) 
N(1)-C(13)-C(14)-C(15) -147.1(5) 
C(19)-C(14)-C(15)-C(16) 1.2(7) 
C(13)-C(14)-C(15)-C(16) 179.7(4) 
C(14)-C(15)-C(16)-C(17) 0.0(7) 
C(15)-C(16)-C(17)-C(18) -0.4(8) 
C(16)-C(17)-C(18)-C(19) -0.4(8) 
C(17)-C(18)-C(19)-C(14) 1.6(8) 
C(15)-C(14)-C(19)-C(18) -1.9(7) 
Experimental Section 
- 202 - 
 
C(13)-C(14)-C(19)-C(18) 179.6(5) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 12.7.4.7.  Hydrogen bonds for 5965  [Å and °]. 
___________________________________________________________________________
_  
D-H.A d(D-H) d(H...A) d(D...A) <(DHA) 
___________________________________________________________________________
_  
 C(2)–H(2)...O(2)#1 0.95 2.48 3.409(6) 164.4 
 C(5)–H(5)...O(3)#2 0.95 2.25 3.176(6) 165.4 
 O(3)–H(3O)...O(1) 0.97(3) 1.74(3) 2.701(5) 172(7) 
 O(3)–H(3O)...N(1) 0.97(3) 2.57(5) 3.402(6) 145(6) 
 O(2)–H(2O)...O(1) 0.95(3) 1.81(3) 2.754(5) 173(7) 
___________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1/2,-y+3/2,-z+1    #2 -x+1,y+1/2,-z+3/2       
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12.8 Metal-Free Oxidative Dehydrogenative Diels-Alder Reaction of Alkylarenes with 
Electron-Deficient Alkenes 
 
12.8.1 Characterization of Compounds (213a-216c) 
6,9-Dimethylphenanthrene-1,4-dione (213a) 
Compound 3a was prepared according to general procedure F and the 
product was isolated by column chromatography with silica gel using 
petroleum ether and ethyl acetate (98:2 v/v) as an orange amorphous 
in 72% yield.
 
1
H NMR (500 MHz, CDCl3) δ 9.38 – 9.36 (m, 1H), 7.95 (d, J = 8.6 Hz, 1H), 7.91 (d, J = 0.7 
Hz, 1H), 7.49 (dd, J = 8.6, 1.7 Hz, 1H), 6.89 (dd, J = 10.1 Hz, 2H), 2.77 (s, 3H), 2.59 ppm (s, 
3H).
 
13
C NMR (126 MHz, CDCl3) δ 188.05, 186.33, 142.57, 140.69, 139.93, 135.41, 133.93, 
131.78, 130.60, 130.40, 127.37, 125.08, 124.24, 121.89, 22.22, 20.42 ppm. 
FT‐IR: ṽ = 3303, 3110, 3012, 2920, 1664, 1647, 1614, 1589, 1372, 1295, 1082 cm-1. 
HRMS: calc. for [M+H]
+
 C16H13O2: 237.09077 found: 237.09101. 
 
9-Methylphenanthrene-1,4-dione (213b) 
Compound 213b was prepared according to general procedure F and the 
product was isolated by column chromatography with silica gel using 
petroleum ether and ethyl acetate (98:2 v/v) as an orange amorphous solid 
in 56% yield.
 
1
H NMR (500 MHz, CDCl3) δ 9.58 (d, J = 8.7 Hz, 1H), 8.07 (d, J = 8.3 Hz, 1H), 7.98 (s, 
1H), 7.77 – 7.70 (m, 1H), 7.69 – 7.64 (m, 1H), 6.91 (dd, J = 10.1 Hz, 2H), 2.80 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 188.20, 186.41, 142.96, 140.79, 135.72, 135.63, 131.75, 
130.21, 129.79, 128.66, 128.59, 125.79, 124.59, 122.76, 20.68 ppm. 
FT‐IR: ṽ = 3052, 2920, 2894, 1706, 1651, 1587, 1424, 1336, 1290, 1109, 1976 cm-1. 
MS-EI: m/z (%):) 222.1(100); 207.0 (31); 194.0 (31); 165.1 (38), 139.1 (36). 
 
6-Isopropyl-9-methylphenanthrene-1,4-dione (213c) 
Compound 213c was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and ethyl acetate (98:2) as an orange amorphous 
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in 46% yield. 
1
H NMR (500 MHz, CDCl3) δ 9.46 (d, J = 1.1 Hz, 1H), 8.00 (d, J = 8.7 Hz, 1H), 7.94 – 7.87 
(m, 1H), 7.59 (dd, J = 8.7, 1.6 Hz, 1H), 6.89 (dd, J = 10.1 Hz, 2H), 3.17 (sep, J = 6.9 Hz, 1H), 
2.77 (s, 3H), 1.38 ppm (d, J = 6.9 Hz, 6H).
 
13
C NMR (126 MHz, CDCl3) δ 188.32, 186.56, 150.75, 142.73, 140.85, 135.55, 134.46, 
131.87, 130.63, 128.25, 125.40, 125.09, 124.63, 122.11, 34.79, 23.99, 20.62 ppm. 
FT‐IR: ṽ = 3067, 2957, 2713, 1659, 1646, 1586, 1554, 1460, 1423, 1343, 1291, 1074 cm-1. 
HRMS: calc. for [M+H]
+
 C18H17O2: 265. 12231 found: 265.12207. 
 
5,7,9-Trimethylphenanthrene-1,4-dione (213d) 
Compound 213d was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and ethyl acetate (98:2 v/v) as an orange 
amorphous solid in 50% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.67 (s, 1H), 7.36 (s, 1H), 6.99 (d, J = 10.1 Hz, 
1H), 6.83 (d, J = 10.1 Hz, 1H), 2.75 (s, 3H), 2.53 (s, 3H), 2.47 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 187.64, 185.93, 141.63, 140.05, 138.81, 137.20, 137.15, 
135.37, 134.56, 132.33, 131.90, 128.05, 122.07, 121.77, 25.27, 21.91, 20.82 ppm. 
FT‐IR: ṽ = 3059, 2976, 2928, 1651, 1615, 1588, 1449, 1301, 1079 cm-1. 
HRMS: calc. for [M+H]
+
 C17H15O2: 251.1066 found: 251.10690. 
 
7-Isopropyl-9-methylphenanthrene-1,4-dione (213e) 
Compound 213e was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and ethyl acetate (98:2 v/v) as an orange 
amorphous in 56% yield. 
 
1
H NMR (500 MHz, CDCl3) δ 9.51 (d, J = 9.0 Hz, 1H), 7.97 (s, 1H), 7.84 (d, J = 1.3 Hz, 
1H), 7.65 (dd, J = 9.1, 1.8 Hz, 1H), 6.90 (dd, J = 10.1 Hz, 1H), 3.12 (sep, J = 6.8 Hz, 1H), 
2.80 (s, 3H), 1.37 ppm (d, J = 6.9 Hz, 6H).
 
13
C NMR (126 MHz, CDCl3) δ 188.35, 186.52, 149.47, 142.43, 140.70, 136.14, 135.74, 
131.10, 129.55, 128.70, 128.58, 125.77, 122.84, 121.06, 34.64, 23.89, 20.73 ppm. 
FT‐IR: ṽ = 3043, 2958, 2868, 1656, 1617, 1588, 1357, 1287, 1075, 1045 cm-1. 
HRMS: calc. for [M+H]
+
 C18H17O2: 12231 found: 265.12180. 
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6-Methylphenanthrene-1,4-dione (213f)
[270]
 
Compound 213f was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and ethyl acetate (98:2 v/v) as an orange 
amorphous in 38% yield.
 
1
H NMR (500 MHz, CDCl3) δ 9.33 (s, 1H), 8.15 – 8.05 (m, 2H), 7.78 (d, J = 8.3 Hz, 1H), 
7.47 (d, J = 8.3 Hz, 1H), 6.93 (dd, J = 10.1 Hz, 2H), 2.60 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 188.47, 186.24, 140.79, 140.72, 135.85, 135.05, 132.40, 
131.03, 130.28, 128.62, 126.84, 126.55, 121.16, 22.60 ppm. 
FT‐IR: ṽ = 2921, 1649, 1613, 1591, 1450, 1373, 1301, 1153, 1074 cm-1. 
MS-EI: m/z (%):) 222.1(100); 207.0 (31); 194.0 (31); 165.1 (38). 
 
6-Ethylphenanthrene-1,4-dione (213g) 
Compound 213g was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and ethyl acetate (98:2 v/v) as an orange 
amorphous in 43% yield.
 
1
H NMR (500 MHz, CDCl3) δ 9.38 (d, J = 0.6 Hz, 1H), 8.12 (dd, J = 8.5 Hz, 2H), 7.83 (d, J 
= 8.4 Hz, 1H), 7.53 (dd, J = 8.4, 1.5 Hz, 1H), 6.95 (dd, J = 10.1 Hz, 2H), 2.90 (q, J = 7.6 Hz, 
2H), 1.37 ppm (t, J = 7.6 Hz, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 188.51, 186.26, 147.01, 140.77, 135.91, 135.38, 135.05, 
132.48, 130.47, 130.02, 128.79, 126.80, 125.79, 121.26, 29.85, 15.67 ppm. 
FT‐IR: ṽ = 3115, 3081, 2856, 1777, 1707, 1597, 1548, 1498, 1377, 1346, 1162, 1070 cm-1. 
HRMS: calc. for [M+H]
+
 C16H13O2: 237.09101 found: 237.09072. 
 
rel-(3aS,9bS)-2,5,8-Trimethyl-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-dione (214a) 
Compound 214a was prepared according to general procedure F and 
the product compound was isolated by column chromatography with 
silica gel using petroleum ether and acetone (90:10 v/v) as a white 
amorphous solid in 64%) yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.39 (s, 1H), 7.20 (d, J = 7.9 Hz, 
1H), 7.11 (d, J = 7.9 Hz, 1H), 5.68 (d, J = 2.2 Hz, 1H), 4.10 (d, J = 10.5 Hz, 1H), 3.92 – 3.81 
(m, 1H), 3.01 (s, 3H), 2.39 (s, 3H), 2.07 – 2.05 ppm (m, 3H). 
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13
C NMR (126 MHz, CDCl3) δ 178.52, 178.01, 138.53, 133.10, 130.97, 129.89, 129.24, 
127.26, 124.37, 117.12, 43.05, 42.47, 25.66, 21.63, 20.07 ppm. 
FT‐IR: ṽ = 3045, 2962, 2856, 1769, 1686, 1504, 1430, 1375, 1282, 1157, 1092 cm-1. 
HRMS: calc. for [M+H]
+
 C15H16O2N: 242.11756 found: 242.11747. 
 
rel-(3aS,9bS)-2,5-Dimethyl-8-(2-nitroethyl)-3a,9b-dihydro-1H-benzo[e]isoindole-
1,3(2H)-dione (214b) 
Compound 214b was prepared according to general 
procedure F and the product was isolated by column 
chromatography with silica gel using petroleum ether: 
acetone (90:10) as an orange amorphous solid in 64% yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 1.1 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H), 7.15 (dd, J 
= 8.0, 1.8 Hz, 1H), 5.76 (dd, J = 3.7, 1.4 Hz, 1H), 4.77 – 4.36 (m, 2H), 4.13 (d, J = 10.6 Hz, 
1H), 3.89 (ddd, J = 10.6, 3.8, 2.1 Hz, 1H), 3.36 (dd, J = 15.2, 7.5 Hz, 2H), 3.02 (s, 3H), 2.07 
ppm (t, J = 1.6 Hz, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 177.93, 177.47, 135.74, 132.40, 131.57, 130.16, 128.50, 
127.87, 124.71, 118.06, 76.14, 42.54, 42.07, 33.18, 25.47, 19.78 ppm. 
FT‐IR: ṽ = 3050, 2919, 2855, 1774, 1692, 1547, 1432, 1377, 1285, 1094 cm-1. 
HRMS: calc. for [M+H]
+
 C16H16O4N: 323.10023 found: 323.10032. 
 
 rel-(3aS,9bS)-2,5-Dimethyl-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-dione (214c) 
Compound 214c was prepared according to general procedure F and the 
product was isolated by column chromatography (petroleum ether: acetone, 
90:10) as a light yellow amorphous solid in 61% yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.62 – 7.50 (m, 1H), 7.34 – 7.28 (m, 3H), 
5.75 (dd, J = 3.6, 1.4 Hz, 1H), 4.15 (d, J = 10.5 Hz, 1H), 3.94 – 3.83 (m, 
1H), 3.02 (s, 3H), 2.09 ppm (t, J = 1.8 Hz, 3H).
 
13
C NMR (151 MHz, CDCl3) δ 178.09, 177.60, 132.76, 132.11, 129.91, 128.26, 128.21, 
126.98, 124.06, 117.81, 42.61, 42.03, 25.34, 19.74 ppm. 
FT‐IR: ṽ = 3105, 3078, 2894, 1772, 1698, 1455, 1378, 1285, 1117, 1092 cm-1. 
HRMS: calc. for [M+H]
+
 C14H14O2N: 228.10191 found: 228.10210. 
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rel-(3aS,9bS)-8-Bromo-2,5-dimethyl-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-dione 
(214d) 
Compound 214d was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and acetone (90:10) as a yellow amorphous 
solid in 43% yield. 
 
1
H NMR (600 MHz, CDCl3) δ 7.72 (d, J = 1.5 Hz, 1H), 7.43 (dd, J = 8.3, 2.0 Hz, 1H), 7.16 
(d, J = 8.3 Hz, 1H), 5.77 (dd, J = 3.6, 1.3 Hz, 1H), 4.10 (d, J = 10.6 Hz, 1H), 3.98 – 3.71 (m, 
1H), 3.02 (s, 3H), 2.08 – 2.00 ppm (m, 3H). 
13
C NMR (126 MHz, CDCl3) δ 177.71, 177.03, 132.79, 132.13, 131.40, 131.22, 129.11, 
125.67, 122.00, 118.39, 42.25, 42.02, 25.54, 19.78 ppm. 
FT‐IR: ṽ = 3065, 2922, 2853, 1766, 1728, 1614, 1444, 1371, 1281, 1092 cm-1. 
HRMS: calc. for [M+H]
+
 C14H13O2N
79
Br: 306.01242 found: 306.01225; HRMS: calc. for 
[M+H]
+
 C14H14O2N
81
Br: 308.01037 found: 308.01035. 
 
 rel-(3aS,9bS)-2,5-Dimethyl-8-(o-tolyl)-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-
dione (214e) 
Compound 214e was prepared according to general procedure F 
and the product was isolated by column chromatography with 
silica gel using petroleum ether and ethyl acetate (95:5 v/v) as a 
yellow amorphous solid in 48% yield. 
 
1
H NMR (600 MHz, CDCl3) δ 7.57 (s, 1H), 7.37 (d, J = 7.9 Hz, 1H), 7.30 – 7.26 (m, 5H), 
5.78 (d, J = 2.3 Hz, 1H), 4.18 (d, J = 10.6 Hz, 1H), 3.99 – 3.68 (m, 1H), 3.03 (s, 3H), 2.35 (s, 
3H), 2.12 ppm (s, 3H).
 
13
C NMR (151 MHz, CDCl3) δ 178.25, 177.66, 141.92, 141.13, 135.62, 132.73, 131.10, 
130.83, 130.63, 129.88, 129.12, 127.65, 126.87, 126.02, 124.00, 117.8542.78, 42.21, 25.48, 
20.68, 19.87 ppm. 
FT‐IR: ṽ = 3059, 2958, 2851, 1708, 1654, 1417, 1398, 1244, 1112, 1073 cm-1. 
EIMS [M
+
] C14H14O2N: 317.24123. 
 
rel-(3aS,9bS)-5,8-Dimethyl-2-propyl-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-dione 
(214f) 
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Compound 214f was prepared according to general procedure F and the product was isolated 
by column chromatography with silica gel using petroleum ether and acetone (95:5 v/v) as a 
yellow amorphous solid in 72% yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.37 (s, 1H), 7.20 (d, J = 7.9 Hz, 1H), 7.13 – 7.09 (m, 1H), 
5.67 (dd, J = 3.5, 1.4 Hz, 1H), 4.07 (d, J = 10.5 Hz, 1H), 3.90 – 3.75 (m, 1H), 3.49 (t, J = 7.4 
Hz, 2H), 2.39 (s, 3H), 2.09 – 1.95 (m, 3H), 1.59 (ses, J = 7.4 Hz, 2H), 0.86 ppm(t, J = 7.4 Hz, 
3H).
 
13
C NMR (126 MHz, CDCl3) δ 178.32, 177.69, 138.21, 132.81, 130.78, 129.66, 128.95, 
127.13, 124.08, 117.05, 42.79, 42.24, 40.95, 21.37, 21.09, 19.80, 11.32 ppm. 
FT‐IR: ṽ = 2969, 2929, 2873, 1768, 1694, 1503, 1436, 1397, 1345, 1234, 1205, 1153, 1127, 
1056 cm
-1
. 
HRMS: calc. for [M+H]
+
 C17H22O2N: 270.14886 found: 270.14884. 
 
rel-(3aS,9bS)-5,8-Dimethyl-2-(2,2,2-trifluoroethyl)-3a,9b-dihydro-1H-benzo[e]isoindole-
1,3(2H)-dione (214g) 
Compound 214g was prepared according to general procedure F 
and the product was isolated by column chromatography with silica 
gel using petroleum ether and acetone (95:5) as a yellow 
amorphous solid in 38% yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.35 (s, 1H), 7.23 (d, J = 7.9 Hz, 
1H), 7.14 (d, J = 7.9 Hz, 1H), 5.65 (d, J = 1.9 Hz, 1H), 4.21 (d, J = 10.6 Hz, 1H), 4.14 (q, J = 
8.6 Hz, 2H), 3.98 (d, J = 10.0 Hz, 1H), 2.39 (s, 3H), 2.07 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 176.63, 176.22, 138.57, 133.64, 130.81, 129.54, 129.32, 
126.12, 124.30, 122.95 (q, J = 279.9 Hz), 115.96, 42.86, 42.19, 40.01 (q, J = 36.4 Hz), 21.38, 
19.84 ppm. 
FT‐IR: ṽ = 3020, 2979, 2927, 1787, 1796, 1503, 1412, 1385, 1267, 1153, 1127, 1104, 1026 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H25O2NF3: 310.10494 found: 10478. 
 
rel-(3aS,9bS)-5,8-Dimethyl-2-phenyl-3a,9b-dihydro-1H-benzo[e]isoindole-1,3(2H)-dione 
(214 h) 
Compound 214h was prepared according to general procedure F 
and the product was isolated by column chromatography with 
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silica gel using petroleum ether and ethyl acetate (95:5) as a yellow amorphous solid in 56% 
yield. 
 
1
H NMR (500 MHz, CDCl3) δ 7.90 – 7.82 (m, 3H), 7.81 – 7.75 (m, 1H), 7.71 (dd, J = 8.5, 
1.0 Hz, 2H), 7.69 – 7.64 (m, 1H), 7.59 – 7.51 (m, 1H), 6.21 – 6.14 (m, 1H), 4.69 (d, J = 10.7 
Hz, 1H), 4.47 – 4.36 (m, 1H), 2.81 (s, 3H), 2.54 – 2.52 ppm (t, J = 1.71H). 
13
C NMR (126 MHz, CDCl3) δ 177.17, 176.65, 138.38, 134.33, 133.40, 132.15, 130.88, 
129.75, 129.19, 129.13, 128.66, 126.90, 126.51, 124.18, 116.78, 43.04, 42.43, 21.38, 19.87 
ppm. 
FT‐IR: ṽ = 3062, 2920, 1773, 1703, 1548, 1498, 1377, 1186, 1176, 1073 cm-1. 
HRMS: calc. for [M+H]
+
 C20H18O2N: 304.13321 found: 304.13321. 
 
rel-(3aS,9bS)-2-(4-Bromophenyl)-5,8-dimethyl-3a,9b-dihydro-1H-benzo[e]isoindole-
1,3(2H)-dione (214i) 
Compound 214i was prepared according to general procedure A 
and the product was isolated by column chromatography with silica 
gel using petroleum ether: acetone (90:10) as a yellow amorphous 
solid in 62% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.7 Hz, 2H), 7.40 – 
7.37 (m, 1H), 7.25 (d, J = 7.9 Hz, 1H), 7.21 (d, J = 8.7 Hz, 2H), 
7.15 (d, J = 7.9 Hz, 1H), 5.76 – 5.66 (m, 1H), 4.27 (d, J = 10.6 Hz, 
1H), 4.06 – 3.98 (m, 1H), 2.40 (s, 3H), 2.11ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 176.82, 176.34, 138.50, 133.60, 132.38, 131.15, 130.86, 
129.71, 129.24, 128.01, 126.67, 124.26, 122.49, 116.52, 43.07, 42.43, 21.40, 19.88 ppm. 
FT‐IR: ṽ = 3098, 2919, 2855, 1774, 1709, 1491, 1378, 1184, 1118, 1069 cm-1. 
HRMS: calc. for [M+H]
+
 C20H17O2N
79
Br: 382.04372 found: 382.04332; HRMS: calc. for 
[M+H]
+
 C20H17O2N
81
Br: 384.04167 found: 384.04123. 
 
rel-(3aS,9bS)-2-(4-Chlorophenyl)-5,8-dimethyl-3a,9b-dihydro-1H-
benzo[e]isoindole-1,3(2H)-dione(214 j) 
Compound 214 j was prepared according to general procedure F and 
the product was isolated by column chromatography with silica gel 
using petroleum ether and acetone (90:10) as a light yellow 
amorphous solid in 53% yield. 
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1
H NMR (500 MHz, CDCl3) δ 7.43 – 7.39 (m, 3H), 7.26 (t, J = 8.1 Hz, 3H), 7.15 (d, J = 7.8 
Hz, 1H), 5.73 (d, J = 2.0 Hz, 1H), 4.28 (d, J = 10.7 Hz, 1H), 4.03 (d, J = 10.6 Hz, 1H), 2.40 
(s, 3H), 2.11 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 176.85, 176.35, 138.39, 134.34, 133.47, 130.74, 130.42, 
129.57, 129.31, 129.14, 127.62, 126.52, 124.15, 116.40, 42.90, 42.27, 21.30, 19.81 ppm. 
FT‐IR: ṽ = 3107, 3062, 2852, 1775, 1709, 1494, 1378, 1184, 1120, 1090 cm-1. 
HRMS: calc. for [M+H]
+
 C20H17O2N
35
Cl: 338.09423 found: 338.09395; calc. for [M+H]
+
 
C20H17O2N
37
Cl: 340.09128 found: 340.09118. 
 
rel-(3aS,9bS)-5,8-Dimethyl-2-(4-nitrophenyl)-3a,9b-dihydro-1H-benzo[e]isoindole-
1,3(2H)-dione (214k) 
Compound 214k was prepared according to general procedure 
F and the product was isolated by column chromatography 
with silica gel using petroleum ether and acetone (85:15) as a 
yellow amorphous solid in 66% yield 
 
1
H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 9.1 Hz, 2H), 7.61 
(d, J = 9.1 Hz, 2H), 7.40 (s, 1H), 7.29 – 7.23 (m, 1H), 7.17 (d, 
J = 7.8 Hz, 1H), 5.73 (d, J = 2.0 Hz, 1H), 4.32 (d, J = 10.7 Hz, 
1H), 4.08 (d, J = 10.6 Hz, 1H), 2.41 (s, 3H), 2.12 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 176.31, 175.93, 146.91, 138.57, 137.56, 133.87, 130.74, 
129.51, 129.33, 126.84, 126.18, 124.35, 124.27, 116.00, 43.02, 42.36, 21.32, 19.82 ppm. 
FT‐IR: ṽ = 3115, 3081, 2856, 1776, 1707, 1597, 1522, 1498, 1377, 1346, 1162, 1111, 1017 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C20H17O4N: 349.11828 found: 349.11828. 
 
(E)-1-Methyl-3-(2-nitrovinyl)benzene (216a) 
Compound 215a was obtained according to general procedure G and the 
product was isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (2:98 v/v); light yellow liquid with 62% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.89 (d, J = 13.7 Hz, 1H), 7.50 (d, J = 13.7 Hz, 1H), 7.31 – 
7.21 (m, 4H), 2.32 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 139.41, 139.31, 136.96, 133.15, 130.03, 129.82, 129.35, 
126.48, 77.41, 77.16, 76.91, 21.35 ppm. 
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FT‐IR: ṽ = 3110, 2972. 2921, 1652, 1633, 1515, 1425, 1338, 1289, 1265, 1108, 1076 cm-1. 
HRMS: calc. for [M+H]
+
 C9H10O2N: 164.07061 found: 164.07048. 
 
(E)-1-Methyl-4-(2-nitrovinyl)benzene (216b) 
Compound 215b was obtained according to general procedure B and 
the product was isolated by column chromatography with silica gel. 
Eluent: ethyl acetate/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 75% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 13.6 Hz, 1H), 7.56 (d, J = 13.6 Hz, 1H), 7.44 (d, J 
= 8.1 Hz, 2H), 7.25 (d, J = 8.1 Hz, 2H), 2.41 ppm (s, 3H).
 
13
C NMR (126 MHz, CDCl3) δ 143.22, 139.27, 136.45, 130.28, 129.31, 127.44, 21.79 ppm. 
FT‐IR: ṽ = 3107, 3029, 2854, 1631, 1605, 1516, 1495, 1333, 1264, 1185, 964 cm-1. 
HRMS: calc. for [M+H]
+
 C9H10O2N: 164.07061 found: 164.07020. 
 
(E)-1-Methyl-4-(1-nitroprop-1-en-2-yl)benzene (216c) and 1-methyl-4-(3-nitroprop-1-en-
2-yl)benzene (216c') (1:1)
[1]
 
Compounds 216c and 215c'were obtained 
according to general procedure B and the 
products were isolated by column 
chromatography with silica gel. Eluent: ethyl acetate/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 68% yield. 
Compound 215c:
 1
H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 8.2 Hz, 2H), 7.34 – 7.31 (m, 
3H), 2.40 (s, 3H), 2.36 ppm (s, 3H). 
Compound 215c':
 1
H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 7.9 Hz, 2H), 7.18 (d, J = 7.9 
Hz, 2H), 5.79 (s, 1H), 5.48 (s, 1H), 5.34 (d, J = 0.7 Hz, 2H), 2.40 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 150.10, 141.02, 138.87, 137.93, 135.92, 135.43, 134.07, 
129.86, 129.62, 126.90, 125.78, 120.91, 79.79, 21.40, 21.25, 18.54 ppm. 
FT‐IR: ṽ = 3101, 3030, 28580, 1617, 1607, 1553, 1509, 1334, 1258, 1190, 1037 cm-1. 
MS-EI: m/z (%):) 163.1(37); 146.1 (16); 115.1 (100); 91.1 (61), 78.1 (26). 
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12.9 Copper(I)-Catalyzed Oxidative (2+1) Annulation of Acetophenones with 
Maleimides in the Synthesis of Cyclopropanes 
 
12.9.1 Characterization of Cyclopropane Derivatives (229a-231l) 
(1R,5S,6s)-6-(2-Naphthoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229a) 
Compound 3a was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica 
gel. Eluent: acetone/petroleum ether (5:95 v/v); light yellow 
amorphous solid with 83% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.52 (s, 1H), 8.01-7.89 (m, 4H), 
7.70 – 7.56 (m, 2H), 3.53 (t, J = 2.8 Hz, 1H), 3.10 (d, J = 2.8 Hz, 2H), 2.97 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 191.86, 173.18, 136.17, 133.21, 132.50, 130.91, 129.86, 
129.40, 129.15, 128.04, 127.39, 123.70, 35.90, 28.38, 24.81 ppm. 
FT‐IR: ṽ = 3085, 2929, 1698, 1667, 1624, 1433, 1378, 1264, 1181, 1122, 1015 cm-1. 
HRMS: calc. for [M+H]
+
 C17H14O3N: 280.09682 found: 280.09643. 
 
(1R,5S,6s)-3-Methyl-6-(4-nitrobenzoyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (229b) 
Compound 229b was obtained by using the general procedure H and the 
product product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous solid 
with 62% yield.  
1
H NMR (200 MHz, CDCl3) δ 8.36 (d, J = 9.0 Hz, 2H), 8.15 (d, J = 9.0 
Hz, 2H), 3.35 (t, J = 2.8 Hz, 1H), 3.08 (d, J = 2.8 Hz, 2H), 2.94 ppm (s, 
3H). 
13
C NMR (50 MHz, CDCl3) δ 191.06, 172.45, 151.06, 140.12, 129.72, 124.30, 35.69, 28.66, 
24.89 ppm. 
FT‐IR: ṽ = 3087, 2955, 2857, 1695, 1665, 1603, 1522, 1435, 1381, 1347, 1321, 1222, 1181, 
1120, 1025 cm
-1
. 
HRMS: calc. for [M+H]
+
 C13H11O5N2: 275.06625 found: 275.06575. 
 
Methyl-4-(1R,5S,6s)-3-methyl-2,4-dioxo-3- azabicyclo[3.1.0]hexane-6-carbonyl)benzoate 
(229c) 
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Compound 229c was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (10:90 v/v); light yellow amorphous 
solid with 82% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.15 (d, J = 8.5 Hz, 2H), 8.03 (d, J = 
8.5 Hz, 2H), 3.96 (s, 3H), 3.37 (t, J = 2.8 Hz, 1H), 3.05 (d, J = 2.8 Hz, 
2H), 2.93 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 191.84, 172.80, 165.98, 138.89, 135.05, 130.23, 128.56, 
52.76, 35.77, 28.49, 24.81 ppm. 
FT‐IR: ṽ = 3092, 2970, 2898, 1695, 16177, 1514, 1453, 1435, 1383, 1290, 1257, 1042 cm-1. 
HRMS: calc. for [M+H]
+
 C15H14O5N: 288.08665 found: 288.08619. 
 
(1R,5S,6s)-6-(4-Acetylbenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229d) 
Compound 229d was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (10:90 v/v); light yellow amorphous 
solid with 56% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.06 (s, 4H), 3.37 (t, J = 2.8 Hz, 1H), 
3.06 (d, J = 2.8 Hz, 2H), 2.94 (s, 3H), 2.66 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 197.28, 191.80, 172.80, 141.10, 138.82, 128.88, 35.79, 28.51, 
27.08, 24.84 ppm. 
FT‐IR: ṽ = 3090, 2950, 1697, 1675, 1433, 1378, 1259, 1180, 1122, 1024 cm-1. 
HRMS: calc. for [M+H]
+
 C15H14O4N: 272.09173 found: 272.09147. 
 
(1R,5S,6s)-6-(4-Fluorobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229e) 
Compound 229e was obtained by using the general procedure H andtThe 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 72% 
yield.  
1
H NMR (300 MHz, CDCl3) δ 8.07 – 7.97 (m, 2H), 7.26-7.16 (m,2H), 3.31 
(t, J = 2.8 Hz, 1H), 3.03 (d, J = 2.8 Hz, 2H), 2.93 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 190.49, 172.99, 166.60 (d, J = 257.4 Hz), 132.24, 131.44 (d, J 
= 9.6 Hz), 116.40 (d, J = 22.1 Hz), 35.60, 28.27, 24.79 ppm. 
FT‐IR: ṽ = 3091, 2967, 2928, 1699, 1676, 1592, 1453, 1434, 1378, 1257, 1181, 1041 cm-1. 
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HRMS: calc. for [M+H]
+
 C13H11NO3F: 248.07175 found: 248.07164. 
4-(1R,5S,6s)-3-Methyl-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-carbonyl)phenyl 3-
chlorobenzoate (229f) 
Compound 229f was obtained by using the general procedure 
H and the product was isolated by column chromatography 
with silica gel. Eluent: acetone/petroleum ether (10:90 v/v); 
light yellow amorphous solid with 62% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.18 (t, J = 1.8 Hz, 1H), 8.11 – 
8.06 (m, 3H), 7.64 (ddd, J = 8.0, 2.1, 1.1 Hz, 1H), 7.48 (t, J = 
7.9 Hz, 1H), 7.42 – 7.35 (m, 2H), 3.36 (t, J = 2.8 Hz, 1H), 3.05 (d, J = 2.8 Hz, 2H), 2.93 ppm 
(s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 190.83, 172.97, 163.36, 155.44, 135.06, 134.22, 133.55, 
130.69, 130.45, 130.40, 130.19, 128.52, 122.42, 35.68, 28.30, 24.79 ppm. 
FT‐IR: ṽ = 3106, 3074, 2922, 1743, 1702, 1664, 1598, 1475, 1418, 1344, 1283, 1202, 1161, 
1061 cm
-1
. 
HRMS: calc. for [M+H]
+
 C20H15O5NCl: 384.06333 found: 384.06301. 
 
(1R,5S,6s)-6-Benzoyl-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229g) 
Compound 229g was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 65% 
yield.  
1
H NMR (300 MHz, CDCl3) δ 8.02 – 7.94 (m, 2H), 7.64 (ddd, J = 6.8, 4.0, 
1.3 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 3.37 (t, J = 2.8 Hz, 1H), 3.03 (d, J = 2.8 Hz, 2H), 2.93 
ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 192.08, 173.12, 135.82, 134.46, 129.12, 128.66, 35.80, 28.29, 
24.78 ppm. 
FT‐IR: ṽ = 3093, 2927, 1697, 1666, 1593, 1455, 1380, 1286, 1264, 1224, 1124, 1026 cm-
1
.HRMS: calc. for [M+H]
+
 C13H12NO3: 230.08117 found: 230.08116. 
 
(1R,5S,6s)-6-(4-Bromobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-
2,4-dione (229h)Compound 229h was obtained by using the general 
procedure H and the product was isolated by column chromatography 
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with silica gel. Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 
78% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.84 (d, J = 8.7 Hz, 2H), 7.65 (d, J = 8.7 Hz, 2H), 3.30 (t, J = 
2.8 Hz, 1H), 3.03 (d, J = 2.8 Hz, 2H), 2.93 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 190.99, 172.73, 134.33, 132.32, 129.90, 129.81, 35.35, 28.18, 
24.64 ppm. 
FT‐IR: ṽ = 3087, 2930, 1698, 1672, 1434, 1379, 1263, 1182, 1122, 1017 cm-1. 
HRMS: calc. for [M+H]
+
 C13H11
79
BrNO3: 307.99168 found: 307.99098 HRMS: calc. for 
[M+H]
+
 C13H11
81
BrNO3: 309.98964 found: 309.98864. 
 
(1R,5S,6s)-3-Methyl-6-(4-methylbenzoyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (229i)
[271]
 
Compound 229i was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 
52% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.87 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 
Hz, 2H), 3.34 (t, J = 2.8 Hz, 1H), 3.00 (d, J = 2.8 Hz, 2H), 2.92 (s, 3H), 
2.43 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 191.49, 173.20, 145.58, 133.37, 129.77, 128.77, 35.77, 28.19, 
24.72, 21.88 ppm. 
FT‐IR: ṽ = 3112, 3082, 2945, 1694, 1664, 1603, 1540, 1523, 1416, 1346, 1266, 1225, 1117, 
1010 cm
-1
. 
HRMS: calc. for [M+H]
+
 C14H14O3N: 244.09682 found: 244.09656. 
 
(1R,5S,6s)-6-(4-Chlorobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229j) 
Compound 229j was obtained by using the general procedure H and the product was isolated 
by column chromatography with silica gel. Eluent: acetone/petroleum ether (5:95 v/v); light 
yellow amorphous solid with 76% yield.  
1
H NMR (500 MHz,CDCl3) δ 7.91 (d, J = 8.5 Hz, 1H), 7.47 (d, J = 8.5 
Hz, 1H), 3.30 (t, J = 2.8 Hz, 1H), 3.01 (d, J = 2.8 Hz, 1H), 2.91 ppm (s, 
3H). 
13
C NMR (126 MHz, CDCl3) δ 190.89, 172.84, 141.12, 134.12, 129.99, 
129.46, 35.55, 28.29, 24.75 ppm. 
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FT‐IR: ṽ = 3093, 2965, 1696, 1664, 1600, 1527, 1456, 1435, 1417, 1348, 1226, 1160, 1042 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C13H11O3NCl: 264.04220 found: 264.04185. 
 
 (1R,5S,6s)-6-(3-Bromobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229k) 
Compound 229k was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid 
with76% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.08 (t, J = 1.8 Hz, 1H), 7.92 – 7.87 (m, 
1H), 7.78 – 7.72 (m, 1H), 7.38 (t, J = 7.9 Hz, 1H), 3.31 (t, J = 2.8 Hz, 
1H), 3.02 (d, J = 2.8 Hz, 2H), 2.92 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 190.95, 172.76, 137.44, 137.24, 131.57, 130.63, 127.14, 
123.42, 35.46, 28.39, 24.79 ppm. 
FT‐IR: ṽ = 3083, 2972, 1699, 1670, 1435, 1378, 1281, 1267, 1212, 1160, 1045 cm-1. 
HRMS: calc. for [M+H]
+
 C13H10
79
BrNO3: 307.99168 found: 307.99110: HRMS: calc. for 
[M+H]
+
 C13H11
81
BrNO3: 309.98964 found: 309.98897. 
 
3-(1R,5S,6s)]-3-Methyl-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-carbonyl)benzonitrile 
(229l) 
Compound 229l was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 
84% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.28 (t, J = 1.4 Hz, 1H), 8.24 – 8.18 (m, 
1H), 7.94 – 7.87 (m, 1H), 7.67 (t, J = 7.8 Hz, 1H), 3.34 (t, J = 2.8 Hz, 1H), 3.06 (d, J = 2.8 
Hz, 2H), 2.94 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 190.53, 172.50, 137.14, 136.55, 132.44, 132.29, 130.20, 
117.57, 113.83, 35.27, 28.52, 24.85 ppm. 
FT‐IR: ṽ = 3075, 2955, 2235, 1701, 1673, 1435, 1380, 1246, 1183, 1126, 1023 cm-1. 
HRMS: calc. for [M+H]
+
 C14H11O3N2: 255.07642 found: 255.07603. 
 
(1R,5S,6s)-3-Methyl-6-(3-(trifluoromethyl)benzoyl)-3-
azabicyclo[3.1.0]hexane-2,4-dione (229m) 
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Compound 229m was obtained by using the general procedure H and the product was isolated 
by column chromatography with silica gel. Eluent: acetone/petroleum ether (5:95 v/v); light 
yellow amorphous solid with 73% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.21 (s, 1H), 8.17 (d, J = 7.8 Hz, 1H), 7.89 (d, J = 7.8 Hz, 
1H), 7.66 (t, J = 7.8 Hz, 1H), 3.37 (t, J = 2.8 Hz, 1H), 3.05 (d, J = 2.8 Hz, 2H), 2.93 ppm (s, 
3H). 
13
C NMR (75 MHz, CDCl3) δ 191.11, 172.68, 136.30, 132.1.65 (q = J, 33.2 Hz) 131.74, 
130.61 (q, J = 3.5 Hz), 129.85, 125.30 (q, J = 3.8 Hz), 123.37 (q, J = 272.8 Hz), 35.36, 28.51, 
24.80 ppm. 
FT‐IR: ṽ = 3099, 2952, 1697, 1675, 1436, 1378, 1331, 1211, 1119, 1073 cm-1. 
HRMS: calc. for [M+H]
+
 C13H11O3NF3: 298.06855 found: 298.06805. 
 
(1R,5S,6s)-6-(4-Bromo-3-nitrobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione 
(229n) 
Compound 229n was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 
69% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.42 (d, J = 1.5 Hz, 1H), 8.01 (dd, J = 
8.4, 1.5 Hz, 1H), 7.92 (d, J = 8.4 Hz, 1H), 3.32 (t, J = 2.8 Hz, 1H), 3.05 
(d, J = 2.8 Hz, 2H), 2.93 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 189.65, 172.29, 150.34, 136.26, 135.68, 132.13, 125.42, 
121.33, 35.06, 28.67, 24.88 ppm. 
FT‐IR: ṽ = 3084, 2951, 1697, 1674, 1592, 1536, 1437, 1333, 1267, 1214, 1118, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C13H10
79
BrN2O5: 352.97676 found: 352.97616 HRMS: calc. for 
[M+H]
+
 C13H11
81
BrN2O5: 354.97471 found: 354.97402. 
 
(1R,5S,6s)-6-(2,4-Dichlorobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-
2,4-dione (229j) 
Compound 229j was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 48% yield.  
Experimental Section 
- 218 - 
 
1
H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 10.5 Hz, 1H), 7.49 (s, 1H), 7.36 (dd, J = 8.3, 2.0 
Hz, 1H), 3.21 (t, J = 2.8 Hz, 1H), 3.07 (d, J = 2.8 Hz, 2H), 2.90 ppm (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 193.69, 172.51, 139.32, 135.67, 133.16, 131.27, 130.83, 
127.93, 39.35, 29.24, 24.79 ppm. 
FT‐IR: ṽ = 3083, 2974, 1701, 1672, 1551, 1435, 1379, 1285, 1265, 1213, 1140, 1017 cm-1. 
HRMS: calc. for [M+H]
+
 C13H10NO3Cl2: 298.00323 found: 298.00289. 
 
 (1R,5S,6s)-6-(3,5-Difluorobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229p) 
Compound 229p was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 75% 
yield.  
1
H NMR (500 MHz, CDCl3) δ 7.52 – 7.46 (m, 2H), 7.09 (tt, J = 8.3, 2.2 
Hz, 1H), 3.24 (t, J = 2.7 Hz, 1H), 3.03 (d, J = 2.7 Hz, 2H), 2.93 ppm (s, 
3H). 
13
C NMR (126 MHz, CDCl3) δ 190.01, 172.50, 163.30 (dd, J = 252.5, 11.8 Hz), 138.54 (t, J 
= 7.8 Hz), 111.69 (dd, J = 19.9, 6.6 Hz), 109.75 (t, J = 25.3 Hz), 35.40, 28.48, 24.82 ppm. 
FT‐IR: ṽ = 3090, 2971, 2931, 1698, 1676, 1480, 1453, 1380, 1290, 1258, 1181, 1042 cm-1. 
HRMS: calc. for [M+H]
+
 C13H10NO3F2: 266.06233 found: 166.06198. 
 
 (1R,5S,6s)]-3-Methyl-6-picolinoyl-3-azabicyclo[3.1.0]hexane-2,4-dione (229q) 
Compound 229q was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (15:85 v/v); light yellow amorphous solid with 62% 
yield.  
1
H NMR (500 MHz, CDCl3) δ 8.73 – 8.69 (m, 1H), 8.04 (d, J = 7.7 Hz, 
1H), 7.87 (td, J = 7.7, 1.7 Hz, 1H), 7.56- 7.53 (m, 1H), 4.37 (t, J = 2.9 Hz, 
1H), 2.98 (d, J = 2.9 Hz, 2H), 2.92 ppm (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 193.30, 173.25, 151.88, 149.40, 137.36, 128.22, 122.64, 
34.14, 28.63, 24.71 ppm. 
FT‐IR: ṽ = 3092, 2971, 2899, 1698, 1678, 1582, 1567, 1481, 1433, 1377, 1260, 1026 cm-1. 
HRMS: calc. for [M+H]
+
 C12H15N2O3: 231.07642 found: 231.07652. 
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(1R,5S,6s)-6-(4-Bromobenzoyl)-3-propyl-3-azabicyclo[3.1.0]hexane-2,4-dione (231a) 
Compound 231a was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (3:97 v/v); light yellow amorphous 
solid with 61% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.7 Hz, 2H), 7.65 (d, J = 
8.7 Hz, 2H), 3.41 – 3.30 (m, 2H), 3.22 (t, J = 2.8 Hz, 1H), 3.00 (d, J 
= 2.8 Hz, 2H), 1.62 – 1.52 (m, 2H), 0.90 ppm (t, J = 7.4 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 191.17, 172.88, 138.46, 134.57, 132.46, 130.01, 129.87, 
77.41, 77.16, 76.91, 40.29, 35.57, 28.27, 21.35, 11.33 ppm. 
FT‐IR: ṽ = 3089, 2970, 2931, 1698, 1676, 1622, 1453, 1379, 1260, 1181, 1122 cm-1. 
HRMS: calc. for [M+H]
+
 C15H15
79
BrNO3: 336.02298 found: 336.02232: HRMS: calc. for 
[M+H]
+
 C15H15
81
BrNO3: 338.02094 found: 338.02054. 
 
(1R,5S,6s)-6-(4-Bromobenzoyl)-3-hexyl-3-azabicyclo[3.1.0]hexane-2,4-dione (231b) 
Compound 231b was obtained by using the general procedure 
and the product was isolated by column chromatography with 
silica gel. Eluent: acetone/petroleum ether (2:98 v/v); light 
yellow amorphous solid with 86% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.6 Hz, 2H), 7.66 
(d, J = 8.6 Hz, 2H), 3.44 – 3.37 (m, 2H), 3.20 (d, J = 2.8 Hz, 
1H), 3.01 (d, J = 2.8 Hz, 2H), 1.58 – 1.49 (m, 2H), 1.34 – 1.26 
(m, 6H), 0.89 ppm (t, J = 6.8 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 191.20, 172.88, 138.51, 134.62, 132.51, 130.03, 38.82, 
35.61, 31.42, 28.31, 27.99, 26.57, 22.63, 14.11 ppm. 
FT‐IR: ṽ = 3091, 2914, 1698, 1665, 1596, 1436, 1381, 1347, 1283, 1161, 1010 cm-1. 
HRMS: calc. for [M+H]
+
 C18H21
79
BrNO3: 378.06993 found: 378.06903: HRMS: calc. for 
[M+H]
+
 C18H21
81
BrNO3: 380.06789 found: 380.06789. 
 
(1R,5S,6s)-6-(4-Bromobenzoyl)-3-cyclohexyl-3-azabicyclo[3.1.0]hexane-2,4-dione (231c) 
Compound 231c was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (3:97 v/v); light yellow amorphous 
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solid with 77% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.6 Hz, 2H), 7.65 (d, J = 8.6 Hz, 2H), 3.97 – 3.61 
(m, 1H), 3.13 (t, J = 2.8 Hz, 1H), 2.95 (d, J = 2.8 Hz, 1H), 2.12 – 2.00 (m, 1H), 1.82 (d, J = 
13.5 Hz, 1H), 1.66-1.57 (m, 2H), 1.34 – 1.13 ppm (m, 4H). 
13
C NMR (126 MHz, CDCl3) δ 191.25, 172.98, 138.45, 134.64, 132.45, 130.01, 129.82, 
77.41, 77.16, 76.91, 51.64, 35.54, 29.16, 28.18, 25.94, 25.06 ppm. 
FT‐IR: ṽ = 3087, 2969, 1699, 1674, 1434, 1379, 1263, 1219, 1182, 1043 cm-1. 
 
(1R,5S,6s)-6-(4-Bromobenzoyl)-3-(2,2,2-trifluoroethyl)-3-azabicyclo[3.1.0]hexane-2,4-
dione (231d) 
Compound 231d was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 56% 
yield.  
1
H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 8.7 Hz, 2H), 7.68 (d, J = 8.7 
Hz, 2H), 4.09 (q, J = 8.6 Hz, 2H), 3.29 (t, J = 2.9 Hz, 1H), 3.10 ppm (d, J = 
2.9 Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ 190.63, 171.06, 138.61, 134.29, 132.62, 130.25, 123.03 (q, J = 
279.9 Hz), 24 (q, J = 36.4 Hz), 34.80, 28.07 ppm. 
HRMS: calc. for [M+H]
+
 C14H10
79
BrNO3F3: 375.97907 found: 375.97970: HRMS: calc. for 
[M+H]
+
 C14H10
81
BrNO3F3: 377.97702 found: 377.97754. 
 
Methyl 4-(1R,5S,6s)-3-(but-3-en-1-yl)-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-
carbonyl)benzoate (3231e) 
Compound 231e was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 59% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 8.6 Hz, 2H), 7.99 (d, J = 
8.6 Hz, 2H), 5.79-7.70 (m, 1H), 5.14 (s, 1H), 5.09 (dd, J = 6.9, 1.9 
Hz, 1H), 3,96 (s, 3s), 3.54 (t, J = 6.7 Hz, 2H), 3.33 (t, J = 2.8 Hz, 1H), 3.02 (d, J = 2.8 Hz, 
2H), 2.36 ppm (q, J = 6.8 Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ 191.92, 172.75, 165.99, 138.98, 135.07, 130.27, 128.48, 
117.86, 52.78, 37.18, 35.81, 32.29, 28.34 ppm. 
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FT‐IR: ṽ = 3083, 2952, 1698, 1670, 1579, 1436, 1379, 1267, 1212, 1106, 1014 cm-1. 
HRMS: calc. for [M+H]
+
 C18H18O4N: 328.11795 found: 328.11748. 
 
Methyl 4-(1R,5S,6s)-3-benzyl-2,4-dioxo-3-azabicyclo[3.1.0]hexane-6-carbonyl)benzoate 
(231f) 
Compound 231f was obtained by using the general procedure H and 
the product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 72% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.14 (d, J = 8.5 Hz, 2H), 7.97 (d, J = 
8.5 Hz, 2H), 7.37 – 7.28 (m, 5H), 4.57 (s, 2H), 3.95 (s, 3H), 3.23 (t, J 
= 2.8 Hz, 1H), 3.03 ppm (d, J = 2.8 Hz, 2H). 
13
C NMR (126 MHz, CDCl3) δ 191.73, 172.35, 165.94, 138.90, 135.77, 135.04, 130.21, 
128.93, 128.80, 128.51, 128.30, 52.72, 42.39, 35.38, 28.38 ppm. 
FT‐IR: ṽ = 3045, 2949, 2924, 1698, 1655, 1597, 1540, 1435, 1380, 1262, 1222, 1123, 1017 
cm
-1
 
HRMS: calc. for [M+H]
+
 C21H18NO5: 364.11795found: 364.11742. 
 
Methyl 4-(1R,5S,6s)-2,4-dioxo-3-((R)-1-phenylethyl)-3-azabicyclo[3.1.0]hexane-6-
carbonyl)benzoate (231g) 
Compound 231 was obtained by using the general procedure Hand the 
product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 87% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.15 (d, J = 8.6 Hz, 2H), 7.96 (d, J = 
8.6 Hz, 2H), 7.44 – 7.29 (m, 5H), 5.28 (q, J = 7.3 Hz, 1H), 3.96 (s, 
3H), 3.17 (t, J = 2.7 Hz, 1H), 2.98 (d, J = 2.8 Hz, 2H), 1.80 ppm (d, J = 7.4 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 191.80, 172.50, 172.46, 165.96, 139.50, 138.92, 134.96, 
130.20, 128.69, 128.48, 128.14, 127.47, 52.74, 50.31, 35.10, 28.31, 28.25, 16.74 ppm. 
FT‐IR: ṽ = 3084, 2951, 1697, 1674, 15736, 14367, 1351, 1267, 1214, 1118, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C22H20O5N: 378.13360 found: 378.13330. 
[α]RTD = -53.1 (CH2Cl2, c = 1.0). 
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(1R,5S,6s)-6-(4-bromobenzoyl)-3-((R)-1-cyclohexylethyl)-3-azabicyclo[3.1.0]hexane-2,4-
dione (231h) 
Compound 231h was obtained by using the general procedure H and the 
product was isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (3:97 v/v); light yellow amorphous solid with 
60% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.6 Hz, 2H), 7.66 (d, J = 8.6 
Hz, 2H), 3.66-3.76 (m, 1H), 3.18 (t, J = 2.7 Hz, 1H), 2.98 (dd, J = 2.7, 
1.4 Hz, 2H), 1.32 (d, J = 7.0 Hz, 4H). 
13
C NMR (126 MHz, CDCl3) δ 191.25, 173.13, 173.06, 134.67, 132.51, 129.99, 129.86, 
53.03, 39.23, 35.36, 30.60, 30.31, 28.23, 28.18, 26.18, 25.85, 25.79, 15.94 ppm. 
HRMS: calc. for [M+H]
+
 C20H23
79
BrNO3: 404.08558 found: 404.08474: HRMS: calc. for 
[M+H]
+
 C20H23
81
BrNO3: 406.08354 found: 406.08279. 
[α]RTD = -6.1 (CH2Cl2, c = 1.0). 
 
rel-Methyl 4-(1R,2R)-2-cyanocyclopropanecarbonyl)benzoate (231j) 
Compound 3z was obtained by using the general procedure from 
methyl 4-acetylbenzoate (0.25 mmol) and acrylonitrile (1.0 mmol). 
The product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 35% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 8.4 Hz, 2H), 8.07 (d, J = 8.4 Hz, 2H), 3.97 (s, 
3H), 3.27 (ddd, J = 8.7, 5.8, 4.3 Hz, 1H), 2.24 – 2.08 (m, 1H), 1.73-1.66 ppm (m, 2H). 
13
C NMR (126 MHz, CDCl3) δ 194.86, 166.08, 139.47, 134.90, 130.24, 128.41, 119.62, 
52.73, 24.54, 17.34, 7.89 ppm. 
HRMS: calc. for [M+H]
+
 C13H12O3N: 230.08117 found: 230.08087. 
FT‐IR: ṽ = 3091, 2970, 2929, 1697, 1678, 1481, 1453, 1376, 1258, cm-1. 
 
rel-Methyl (1R,2R)-2-(4-cyanobenzoyl)cyclopropane-1-carboxylate (231k) 
To a screw cap reaction vial charged with a magnetic stir-bar 4-cyanocetophenone (0.25 
mmol), CuI (10 mol%), dtbpy L5 (20 mol%) were added. The tube was then evacuated and 
back-filled with argon. This evacuation/backﬁll sequence was repeated three additional times. 
Under a counter flow of argon, solvent (2 mL of degased chlorobenzene), 10 equiv 
methylacraylate and di-tert-butyl peroxide (3 equiv) were added. The reaction mixture was 
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allowed to warm up to 90 °C and was stirred vigorously for completion of reaction (12 h). 
Then the reaction mixture was cooled to room temperature. To the reaction mixture was 
added dichloromethane (20 mL), washed by 1(N) HCl for two times, dried over Na2SO4 and 
evaporated in vacuum to afford the crude product and purified by column chromatography 
using silica. Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous solid with 
70% yield. 
 
rel-Methyl (1R,2R)-2-(4-cyanobenzoyl)cyclopropane-1-carboxylate (231k) 
1
H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 8.6 Hz, 1H), 7.79 
(d, J = 8.6 Hz, 1H), 3.73 (s, 2H), 3.24 – 3.01 (m, 1H), 2.47 – 
2.33 (m, 1H), 1.65 ppm (dd, J = 7.8, 6.4 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 196.02, 172.36, 139.94, 132.66, 128.77, 117.94, 116.72, 
52.47, 26.23, 25.13, 18.58 ppm. 
FT‐IR: ṽ = 3084, 2951, 1697, 1674, 15736, 14367, 1351, 1267, 1214, 1118, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C13H12O3N: 230.08117 found: 230.08076. 
 
Methyl 4-((2S, 3S)-2,3-bis(4-chlorobenzoyl)cyclopropane-1-carbonyl)benzoate (231l) 
Compound 231l was obtained by using the general 
procedure H from 0.25 mmol (E)-1,4-bis(4-
fluorophenyl)but-2-ene-1,4-dione. The product was 
isolated by column chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow 
amorphous solid with 61% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.6 Hz, 2H), 8.09 (d, J = 8.6 Hz, 2H), 8.03 (d, J = 
8.6 Hz, 2H), 7.92 (d, J = 8.6 Hz, 2H), 7.50 (d, J = 8.6 Hz, 2H), 7.40 (d, J = 8.6 Hz, 2H), 4.15 
(t, J = 5.6 Hz, 1H), 3.93 (s, 3H), 3.73 ppm (d, J = 5.6 Hz, 2H). 
13
C NMR (126 MHz, CDCl3) δ 194.47, 192.54, 191.70, 166.12, 140.89, 140.51, 139.53, 
134.75, 134.70, 134.56, 130.29, 130.09, 129.94, 129.41, 129.27, 128.45, 52.64, 36.45, 36.35, 
30.50 ppm. 
FT‐IR: ṽ = 3049, 2952, 1721, 1692, 1666, 1587, 1571, 1452, 1315, 1269, 1176, 1055, 1009 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C26H19O5Cl2: 481.06041 found: 481.05939. 
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12.9.2 Procedure for Reaction of 2,2,2-[
2
H3]-1-phenylethan-1-one (235a) 
 
To a screw cap reaction tube charged with a magnetic stir-bar N-methylmaleimide (0.25 
mmol), 2,2,2-[
2
H3]-1-phenylethan-1-one (0.75 mmol), CuI (20 mol%), bipy L4 (30 mol%) 
were added. The tube was then evacuated and back-filled with argon with the help of a 
syringe. This evacuation/backﬁll sequence was repeated three additional times. Under a 
counter flow of argon, solvent (2 mL degas chlorobenzene) and di-tert butyl peroxide (5 
equiv) were added. The reaction mixture was allowed to warm up to 110 °C and stirred 
vigorously for completion of reaction (18 h). Then the reaction mixture was cooled to room 
temperature. Dichloromethane (4 mL) and ethyl acetate (2 mL) were added for dilution of 
reaction mixture. Finally, the reaction mixture obtained upon filtration through a celite bed 
was concentrated and was purified by column chromatography using silica gel (100-200 
mesh) and petroleum-ether / acetone as the eluent and isolated yield was 41%. 
6-[
2
H]-(1R,5S,6s)-6-benzoyl-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione 
1H NMR (500 MHz, CDCl3) δ 7.98 (dd, J = 7.9, 0.5 Hz, 1H), 7.64 (t, J 
= 7.4 Hz, 1H), 7.51 (t, J = 7.8 Hz, 1H), 3.02 (s, 1H), 2.93 ppm (s, 2H). 
13
C NMR (126 MHz, CDCl3) δ 192.05, 173.07, 135.84, 134.43, 129.11, 
128.64, 28.27, 28.19, 24.76. 
FT‐IR: ṽ = 3092, 2946, 1768, 1694, 1675, 1437, 1382, 1229, 1125, 1017 cm-1. 
HRMS: calc. for [M+H]
+
 C13H11DO3N: 231.08745 found: 231.08669. 
 
12.9.3 Procedure for Kinetic Isotope Effect (KIE) study 
 
To a screw cap reaction tube charged with a magnetic stir-bar N-methylmaleimide (0.25 
mmol), acetophenone (0.375 mmol), 2,2,2-[
2
H3]-1-phenylethan-1-one (0.375 mmol), CuI (20 
mol%), L4 (30 mol%) were added. The tube was then evacuated and back-filled with argon 
with the help of a syringe. This evacuation/backﬁll sequence was repeated three additional 
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times. Under a counter flow of argon, solvent (2 mL degas chlorobenzene) and di-tert butyl 
peroxide (5 equiv) were added. The reaction mixture was allowed to warm up to 110 °C and 
 
stirred vigorously for completion of reaction (6 h). Then the reaction mixture was cooled to 
room temperature. Dichloromethane (4 mL) and ethyl acetate (2 mL) were added for dilution 
of reaction mixture. Finally, the reaction mixture obtained upon filtration through a celite bed 
was concentrated and purified by column chromatography using silica gel (100-200 mesh) 
and petroleum-ether / acetone as the eluent. KIE (KH/KD = 2.45) was determined from 
1
H 
NMR. 
12.9.4 Synthesis of Compound 234
[272]
 
 
To screw-capped pressure vial (10 ml) equipped with a magnetic stirring bar was charged 
with aromatic ketimine (1, 0.25 mmol), N-methylmaleimide 227a (2, 0.5 mmol), 2 mL 
toluene. The vial was closed and heated at 150 ℃ with a vigorous stirring for 3 hr. After 
cooling to room temperature, 10 mL 1 N HCl was added. The organic layer was extracted 
with Et2O, and dried over anhydrous Na2SO4. The crude traction mixture was concentrated 
under vacuum. The product 234 was purified by column chromatography (petroleum-ether 
/acetone 90:10) on silica gel. The desired product was obtained 35%.  
Methyl-3-(2-(naphthalen-2-yl)-2-oxoethyl)-pyrrolidine-2,5-dione (234) 
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1
H NMR (500 MHz, CDCl3) δ 8.44 (s, 1H), 7.99 – 7.89 (m, 2H), 7.90 – 7.84 (m, 2H), 7.60 (t, 
J = 7.4 Hz, 1H), 7.55 (t, J = 7.5 Hz, 1H), 3.79-3.74 (m, 1H), 3.55-3.50 (m, 1H), 3.33 – 3.24 
(m, 1H), 3.06 – 3.04 (m, 1H), 3.05 )s, 1H) 2.53-2.40 ppm (m, 1H). 
13
C NMR (126 MHz, CDCl3) δ 196.83, 179.86, 176.68, 135.90, 133.40, 132.50, 130.06, 
129.68, 128.92, 128.77, 127.91, 127.10, 123.52, 39.23, 36.01, 34.98, 25.10 ppm. 
12.9.5 Procedure for Control Experiment 
 
To a screw cap reaction tube charged with a magnetic stir-bar 1-methyl-3-(2-(naphthalen-2-
yl)-2-oxoethyl)pyrrolidine-2,5-dione 234 (0.25 mmol), CuI (20 mol%), bipy L4 (30 mol%) 
were added. The tube was then evacuated and back-filled with argon with the help of a 
syringe. This evacuation/backﬁll sequence was repeated three additional times. Under a 
counter flow of argon, solvent (2 mL degas chlorobenzene) and DTBP (5 equiv) were added. 
The reaction mixture was allowed to warm up to 110 °C and stirred vigorously for completion 
of reaction (18 h). Then the reaction mixture was cooled to room temperature. 
Dichloromethane (4 mL) and ethyl acetate (2 mL) were added for dilution of reaction mixture. 
Finally, the reaction mixture was analyzed by GC-MS and the desired product was not found.  
12.9.6 Procedure for Radical Inhibition Test  
 
To a screw cap reaction tube charged with a magnetic stir-bar maleimide (0.25 mmol), 2-
acetylnaphthalene (0.5 mmol), CuI (20 mol%), bipy (30 mol%) and TEMPO  (4 equiv) were 
added. The tube was then evacuated and back-filled with argon with the help of a syringe. 
This evacuation/backﬁll sequence was repeated three additional times. Under a counter flow 
of argon, solvent (2 mL degas chlorobenzene) and DTBP (5 equiv) were added. The reaction 
mixture was allowed to warm up to 110 °C and stirred vigorously for completion of reaction 
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(24 h). Then the reaction mixture was cooled to room temperature. Dichloromethane (4 mL) 
and ethyl acetate (2 mL) were added for dilution of reaction mixture. Finally, the reaction 
mixture was analyzed by GC-MS and the desired product was not found. 
12.9.7 Synthesis of Compound 242 
To a seal tube charged with a magnetic stir-bar; slowly LiAH4 (12 equiv) was added to a 
solution of amide in THF (3 mL) at 0 °C. The reaction mixture was stirred at reflux for 3h, 
then cooled to 0 °C and treated with water (1 mL) and 1N NaOH (2 mL). White solid was 
filtered out, the filtrate was extracted with ethyl acetate and further purified by column 
chromatography. The pure product was isolated with 75% yield.  
 
((1R,5S,6r)-3-Methyl-3-azabicyclo[3.1.0]hexan-6-yl)(phenyl)methanol (242) 
1
H NMR (500 MHz, CDCl3) δ 7.42 – 7.39 (m, 2H), 7.35 (t, J = 7.4 Hz, 2H), 7.29 (dd, J = 
7.9, 6.5 Hz, 1H), 4.08 (dd, J = 8.3, 4.3 Hz, 1H), 3.09 (dd, J = 8.8, 6.2 Hz, 1H), 2.97 – 2.91 (m, 
1H), 2.37 (dd, J = 9.0, 3.9 Hz, 1H), 2.28 (s, 3H), 1.67 (dd, J = 7.3, 4.1 Hz, 1H), 1.59 (dd, J = 
7.1, 3.5 Hz, 1H), 1.42 – 1.39 ppm (m, 1H). 
13
C NMR (126 MHz, CDCl3) δ 143.98, 128.44, 127.61, 126.33, 57.23, 56.88, 41.43, 27.56, 
22.52, 21.63 ppm. 
FT‐IR: ṽ = 3317, 2969, 2898, 1652, 1451, 1401, 1347, 1245, 1071 cm-1. 
HRMS: calc. for [M+H]
+
 C13H18ON: 204.13829 found: 204.13911. 
 
12.9.8 Synthesis of Compound 243 
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To a sled tube charged with a magnetic stir-bar was added (1R,5S,6s)-6-(4-bromobenzoyl)-3-
methyl-3-azabicyclo[3.1.0]hexane-2,4-dione 229h (0.25 mmol), 2 mL 6 N HCl aqueous 
solution were added. The reaction mixture was heated under refluxed for 8 h with the oil bath 
maintained at 150 °C. Then the reaction mixture was cooled to room temperature. To the 
reaction mixture was added dichloromethane (20 mL) and extracted by separating funnel. 
Finally, the reaction mixture was concentrated and crude product was used for second step. 
For the second step, to a round bottom flux charged with a magnetic stir-bar was added crude 
reaction mixture, 1 equiv PTSA, 1 mL isopropanol and 2 mL toluene were added. The 
reaction mixture was heated under refluxed for 10 h with a Dean–Stark trap, with the oil bath 
maintained at 120 °C. Then the reaction mixture was cooled to room temperature. Finally, the 
reaction mixture was concentrated and was purified by column chromatography using silica 
gel (100-200 mesh) and petroleum-ether / acetone as the eluent. The product was obtained as 
a white amorphous solid in 61% yield. 
Diisopropyl (1R,2S,3s)-3-(4-bromobenzoyl)cyclopropane-
1,2-dicarboxylate (243)1H NMR (300 MHz, CDCl3) δ 7.94 (d, 
J = 8.6 Hz, 1H), 7.64 (d, J = 8.6 Hz, 1H), 5.04 (hept, J = 6.3 Hz, 
1H), 3.66 (t, J = 5.6 Hz, 1H), 2.67 (d, J = 5.6 Hz, 1H), 1.25 ppm 
(dd, J = 6.3, 3.7 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 194.40, 167.47, 135.33, 
132.23, 130.16, 129.24, 69.39, 30.63, 29.06, 21.90, 21.85 ppm. 
FT‐IR: ṽ = 2979, 2934, 1723, 1674, 1583, 1373, 1416, 1296, 1211, 1181, 1106, 1037 cm-1. 
MS-EI: m/z (%): 155,0 (37); 156,9 (19); 182,9 (82); 184,9 (79); 294,9  (100); 296,9 (100); 
355,0 (18); 357,0 (17); 396,1 (4); 398,0 (4). 
 
12.9.9 Synthesis of Compound 244 
 
To a screw cap reaction tube charged with a magnetic stir-bar was added (1R,5S,6s)-6-(4-
bromobenzoyl)-3-methyl-3-azabicyclo[3.1.0]hexane-2,4-dione 229h,  1 equiv K2CO3 and 2 
mL isopropanol were added. The reaction mixture was allowed to warm up to 50 °C and was 
Experimental Section 
- 229 - 
 
stirred vigorously for completion of reaction (24 h). Then the reaction mixture was cooled to 
room temperature. Finally, the reaction mixture was concentrated and was purified by column 
chromatography using silica gel (100-200 mesh) and petroleum-ether / acetone as the eluent 
and isolated yield was 52%. 
rel-Isopropyl (1S,2R,3R)-2-(4-bromobenzoyl)-3-(methylcarbamoyl)cyclopropane-1-
carboxylate (244) 
1
H NMR (300 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H), 7.63 
(d, J = 8.5 Hz, 2H), 5.96 (s, 1H), 5.05 (hept, J = 5.6 Hz, 1H), 
3.69 (t, J = 5.6 Hz, 1H), 2.82 (d, J = 4.8 Hz, 3H), 2.54 (dd, J = 
9.8, 5.5 Hz, 1H), 1.25 ppm (t, J = 5.6 Hz, 6H). 
13
C NMR (126 MHz, CDCl3) δ 194.91, 167.88, 167.22, 
135.41, 132.26, 130.20, 129.26, 69.48, 32.21, 31.04, 29.01, 26.80, 21.91, 21.85 ppm. 
FT‐IR: ṽ = 3084, 2951, 1697, 1674, 15736, 14367, 1351, 1267, 1214, 1118, 1072 cm-1. 
HRMS: calc. for [M+H]
+
 C16H19
79
BrNO4: 368.04920 found: 375.97970: HRMS: calc. for 
[M+H]
+
 C14H10
81
BrNO3F3: 370.04715 found: 370.04770. 
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12.10 Copper(I)-Catalyzed Oxidative (1+1+1) Annulation of Acetophenone for 
Cyclopropane Synthesis 
 
12.10.1 Characterization of Cyclopropane Derivatives (245-248) 
(r)-Cyclo propane-1,2,3-triyltris((4-fluorophenyl)methanone 
Compound 245a was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: acetone/petroleum 
ether (3:97 v/v); light yellow amorphous solid with 86% 
yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.22 (dd, J = 8.4, 5.5 Hz, 2H), 8.03 (dd, J = 8.4, 5.5 Hz, 4H), 
7.20 (t, J = 8.4 Hz, 2H), 7.11 (t, J = 8.4 Hz, 4H), 4.15 (t, J = 5.6 Hz, 1H), 3.69 ppm (d, J = 5.6 
Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.23, 191.43, 166.50 (d, J = 256.7 Hz), 166.19 (d, J = 
256.2 Hz), 132.98 (d, J = 3.0 Hz), 132.95 (d, J = 3.4 Hz), 131.65 (d, J = 9.5 Hz), 131.24 (d, J 
= 9.5 Hz), 116.24 (d, J = 20.7 Hz), 116.07 (d, J = 22.0 Hz), 36.14, 30.40 ppm. 
FT‐IR: ṽ = 3069, 3018, 1727, 1631, 1594, 1505, 1366, 1223, 1154, 1037 cm-1. 
HRMS: calc. for [M+H]
+
 C24H16O3F3: 409.10461 found: 409.10452. 
 
(r)-Cyclopropane-1,2,3-triyltris((4-bchlorophenyl)methanone) (245b) 
Compound 245b was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: acetone/petroleum 
ether (3:97 v/v); light yellow amorphous solid with 66% 
yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.6 Hz, 2H), 7.93 (d, J = 8.6 Hz, 4H), 7.50 (d, J = 
8.6 Hz, 2H), 7.41 (d, J = 8.6 Hz, 4H), 4.13 (t, J = 5.6 Hz, 1H), 3.69 ppm (d, J = 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.57, 191.75, 140.89, 140.47, 134.76 (x
 
2), 130.30, 129.93, 
129.42, 129.27, 36.24, 30.45 ppm. 
FT‐IR: ṽ = 3050, 1693, 1665, 1586, 1400, 1368, 1296, 1231, 1092, 1008 cm-1. 
HRMS: calc. for [M+H]
+
 C24H16O3Cl3: 457.01595 found: 457.01529. 
 
(r)-Cyclopropane-1,2,3-triyltris((4-bromophenyl)methanone) (245c) 
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Compound 245c was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (5:95 v/v); light yellow 
amorphous solid with 73% yield, we carried out the 
reaction at 6 mmol scale using 2 equiv DTBP. Product 245c was obtained in 66% yield. 
1
H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.5 Hz, 4H), 7.67 (d, J = 
8.5 Hz, 2H), 7.58 (d, J = 8.5 Hz, 4H), 4.12 (t, J = 5.6 Hz, 1H), 3.68 ppm (d, J = 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.75, 191.94, 135.14, 132.42, 132.28, 130.35, 130.00, 
129.69, 129.27, 36.22, 30.42 ppm. 
FT‐IR: ṽ = 3053, 2925, 1695, 1664, 1585, 1486, 1370, 1297, 1204, 1073, 1007 cm-1. 
HRMS: calc. for [M+H]
+
 C24H16O3
79
Br3: 588.86441 found: 588.86293; HRMS: calc. for 
[M+H]
+
 C24H16O3
79
Br2
81
Br: 590.86236 found: 590.86129; HRMS: calc. for [M+H]
+
  
C24H16O3
79
Br
81
Br2: 592.86032 found: 592.85936; HRMS: calc. for [M+H]
+
 C24H16O3
81
Br3: 
594.85827 found: 594.85936. 
 
Trimethyl 4,4',4''-(cyclopropane-1,2,3-tricarbonyl)(r)-tribenzoate (245d) 
Compound 245d was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow 
amorphous solid with 88% yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.25 – 8.21 (m, 2H), 8.20 – 8.17 (m, 2H), 8.11 – 8.07 (m, 
4H), 8.06 – 8.02 (m, 4H), 4.24 (t, J = 5.6 Hz, 1H), 3.96 (s, 3H), 3.93 (s, 6H), 3.80 ppm (d, J = 
5.6 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 195.29, 192.39, 166.16, 166.12, 139.54, 139.47, 134.94, 
134.64, 130.24, 130.12, 128.83, 128.48, 52.70, 52.65, 36.79, 30.86 ppm. 
FT‐IR: ṽ = 2925, 1719, 1695, 1662, 1586, 1438, 1409, 1315, 1197, 1107, 1012 cm-1. 
HRMS: calc. for [M+H]
+
 C30H25O9: 529.14931 found: 529.14892. 
 
Triethyl 4,4',4''-(cyclopropane-1,2,3-tricarbonyl)(r)-tribenzoate (245e) 
Compound 245e was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
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acetone/petroleum ether (10:90 v/v); light yellow amorphous solid with 65% yield;
 
1
H NMR (300 MHz, CDCl3) δ 8.25 – 8.17 (m, 4H), 8.11 – 8.02 (m, 8H), 4.43 – 4.35 (m, 
6H), 4.24 (t, J = 5.6 Hz, 1H), 3.80 (d, J = 5.6 Hz, 1H), 1.44 – 1.34 ppm (m, 9H). 
13
C NMR (75 MHz, CDCl3) δ 195.36, 192.44, 165.68, 165.64, 139.40, 139.31, 135.23, 
134.95, 130.17, 130.06, 128.78, 128.43, 61.74, 61.68, 36.78, 30.79, 14.39 (x 2) ppm. 
FT‐IR: ṽ = 3051, 2978, 1713, 1668, 1504, 1438, 1408, 1368, 1271, 1102, 1014 cm-1. 
HRMS: calc. for [M+H]
+
 C33H31O9: 571.19626 found: 571.19629. 
 
Triallyl 4,4',4''-(cyclopropane-1,2,3-tricarbonyl)(r)-tribenzoate (245f) 
Compound 245f was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow 
amorphous solid with 43% yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.25-8.20 (m, 4H), 
8.11 (d, J = 8.5 Hz, 4H), 8.05 (d, J = 8.5 Hz, 4H), 6.09-5.58 (m,  3H), 5.45 – 5.38 (m, 3H), 
5.35 – 5.24 (m, 3H), 4.86 (d, J = 5.7 Hz, 2H), 4.83 (d, J = 5.7 Hz, 4H), 4.24 (t, J = 5.6 Hz, 
1H), 3.81 ppm (d, J = 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 195.26, 192.37, 165.31, 165.27, 139.56, 139.49, 134.95, 
134.66, 131.93 (x2), 130.27, 130.17, 128.82, 128.47, 118.93, 118.90, 66.26, 66.20, 36.77, 
30.87 ppm. 
FT‐IR: ṽ = 3082, 3031, 2933, 1716, 1670, 1681, 1576, 1456, 1364, 1315, 1266, 1102, 1017 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C36H31O9: 606.19626 found: 607.19636. 
 
(r)-Cyclopropane-1,2,3-triyltris((4-(trifluoromethyl)phenyl)methanone) (245g) 
Compound 245g was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (3:97 v/v); light yellow 
amorphous solid with 79% yield.
 
1
H NMR (500 MHz, Acetone) δ 8.41 (d, J = 8.1 Hz, 
2H), 8.30 (d, J = 8.1 Hz, 4H), 7.98 (d, J = 8.2 Hz, 2H), 7.85 (d, J = 8.2 Hz, 4H), 4.24 (t, J = 
5.7 Hz, 1H), 4.05 ppm (d, J = 5.7 Hz, 2H).
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13
C NMR (126 MHz, Acetone) δ 195.23, 193.33, 140.79, 140.68, 134.90 (q, J = 32.3 Hz), 
130.33, 130.20, 126.95 (q, J = 3.8 Hz), 126.74 (q, J = 3.7 Hz), 121.69, 110.66, 37.42, 32.01 
ppm.  
FT‐IR: ṽ = 3058, 3024, 2932, 1698, 1672, 1512, 1367, 1317, 1301, 1207, 1164, 1120, 1011 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C27H16O3F9: 559.09502 found: 559.09565. 
 
(r)-4,4',4''-(Cyclopropane-1,2,3-tricarbonyl)tribenzonitrile (245h) 
Compound 245h was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow 
amorphous solid with 62% yield.
 
1
H NMR (500 MHz, DMSO) δ 8.25 (d, J = 8.3 Hz, 2H), 8.16 (d, J = 8.3 Hz, 4H), 8.08 (d, J = 
8.4 Hz, 2H), 7.98 (d, J = 8.4 Hz, 4H), 4.08 (t, J = 5.8 Hz, 1H), 4.01 ppm (d, J = 5.8 Hz, 2H).
 
13
C NMR (126 MHz, DMSO) δ 194.03, 192.63, 139.24, 139.04, 132.97, 132.77, 128.96, 
128.88, 118.03, 117.98, 115.72, 115.54, 36.13, 31.10 ppm. 
FT‐IR: ṽ = 3080, 2958, 2231, 1670, 1596, 1512, 1579, 1373, 1307, 1242, 1196, 1173, 1122 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C27H16O3N3: 430.11862 found: 430.11837. 
 
(r)-Cyclopropane-1,2,3-triyltris((4-(pyrrolidin-1-ylsulfonyl)phenyl)methanone (245i) 
Compound 245i was obtained by using the 
general procedure I. The product was isolated by 
column chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light 
yellow amorphous solid with 35% yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 8.4 
Hz, 2H), 8.13 (d, J = 8.4 Hz, 4H), 7.98 (d, J = 8.4 Hz, 2H), 7.90 (d, J = 8.4 Hz, 4H), 4.20 (t, J 
= 5.6 Hz, 1H), 3.81 (d, J = 5.6 Hz, 2H), 3.29-3.23 (m, 12H), 1.85 – 1.63 ppm(m, 12H). 
13
C NMR (126 MHz, CDCl3) δ 194.61, 192.23, 142.63, 142.47, 139.30, 139.26, 129.75, 
129.40, 128.32, 128.22, 48.40, 48.36, 36.84, 31.38, 25.74, 25.72 ppm. 
FT‐IR: ṽ = 2975, 2880, 1674, 1595, 1569, 1398, 1343, 1291, 1208, 1157, 1092, 1005 cm-1. 
HRMS: calc. for [M+H]
+
 C36H40O9N3S3: 754.19212 found: 754.19293. 
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(r)-Cyclopropane-1,2,3-triyltris(p-tolylmethanone) (245j) 
Compound 245j was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 43% yield;
 
1
H NMR (500 MHz, CDCl3) δ 8.09 (d, J = 8.2 Hz, 2H), 
7.90 (d, J = 8.2 Hz, 4H), 7.31 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.0 Hz, 4H), 4.20 (t, J = 5.6 Hz, 
1H), 3.72 (d, J = 5.6 Hz, 2H), 2.44 (s, 3H), 2.38 ppm (s, 6H).
 
13
C NMR (126 MHz, CDCl3) δ 195.87, 192.74, 144.95, 144.44, 134.30, 134.26, 129.62, 
129.44, 129.01, 128.70, 36.41, 30.33, 21.87, 21.79 ppm. 
FT‐IR: ṽ = 3030, 2967, 1722, 1664, 1605, 1408, 1367, 1224, 1178, 1013 cm-1. 
HRMS: calc. for [M+H]
+
 C27H25O3: 397.17982 found: 397.17989. 
 
(r)-Cyclopropane-1,2,3-triyltris(phenylmethanone) (245k)
[273]
 
Compound 245k was obtained by using the general procedure I. 
The product was isolated by column chromatography with silica 
gel. Eluent: acetone/petroleum ether (3:97 v/v); light yellow 
amorphous solid with 65% yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.21 – 8.17 (m, 2H), 8.03 – 7.97 (m, 4H), 7.63 (t, J = 7.4 Hz, 
1H), 7.54 (q, J = 7.7 Hz, 4H), 7.43 (t, J = 7.7 Hz, 4H), 4.24 (t, J = 5.6 Hz, 1H), 3.76 ppm (d, J 
= 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 196.14, 193.11, 136.66, 134.06, 133.67 (x2), 129.00, 128.93, 
128.82, 128.61, 36.52, 30.55 ppm. 
FT‐IR: ṽ = 3066, 2999, 1684, 1661, 1595, 1578, 1446, 1328, 1303, 1216, 1153, 1014 cm-1. 
HRMS: calc. for [M+H]
+
 C27H16O3N3: 355.13287 found: 355.13336. 
 
(r)-Cyclopropane-1,2,3-triyltris((3-(trifluoromethyl)phenyl)methanone) (245l) 
Compound 245l was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow 
amorphous solid with 46% yield;
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1
H NMR (600 MHz, CDCl3) δ 8.41 (dd, J = 3.6, 2.9 Hz, 2H), 8.22 (s, 2H), 8.18 (d, J = 7.8 
Hz, 2H), 7.94 – 7.88 (m, 1H), 7.82 (d, J = 7.8 Hz, 2H), 7.74 – 7.68 (m, 1H), 7.60 (t, J = 7.8 
Hz, 2H), 4.26 (t, J = 5.6 Hz, 1H), 3.82 ppm(d, J = 5.6 Hz, 2H).
 
13
C NMR (75 MHz, CDCl3) δ 194.41, 191.51, 136.85, 136.71, 132.19, 131.66 (q, J = 33.2 
Hz), 131.88 (d, J = 33.3 Hz), 131.66, 130.75, 130.70, 130.66 (q, J = 3.5 Hz), (q, J = 3.5 Hz), 
129.86, 129.72, 129.57, 125.58 (q, J = 3.9 Hz), (q, J = 3.8 Hz) 124.73, 123.57 (q, J = 272.7 
Hz), 123.66 (q, J = 272.6 Hz), 121.75, 118.14, 36.44, 30.32 ppm.  
FT‐IR: ṽ = 3069, 2929, 1733, 1694, 1674, 1614, 1329, 1309, 1200, 1162, 1153, 1022 cm-1. 
HRMS: calc. for [M+H]
+
 C27H16O3F9: 559.09502 found: 559.09564. 
 
(r)-3,3',3''-(Cyclopropane-1,2,3-tricarbonyl)tribenzonitrile (245m) 
Compound 245m was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow 
amorphous solid with 68% yield.
 
1
H NMR (500 MHz, DMSO) δ 8.54 (s, 1H), 8.52 (s, 2H), 
8.39 (d, J = 7.9 Hz, 2H), 8.26 (d, J = 8.0 Hz, 1H), 8.18 (d, J = 7.8 Hz, 1H), 8.08 (d, J = 7.8 
Hz, 2H), 7.82 (t, J = 7.8 Hz, 1H), 7.70 (t, J = 7.8 Hz, 2H), 4.12 (t, J = 5.8 Hz, 1H), 4.01 
ppm(d, J = 5.8 Hz, 2H).
 
 13
C NMR (126 MHz, DMSO) δ 193.43, 191.91, 136.93, 136.77(x2), 136.73, 132.69, 132.45, 
132.28, 132.23, 130.32, 130.08, 118.00, 117.90, 112.19, 112.01, 35.99, 30.55 ppm. 
FT‐IR: ṽ = 3080, 2958, 2231, 1670, 1596, 1579, 1423, 1373, 1307, 1196, 1066, 1024 cm-1. 
HRMS: calc. for [M+H]
+
 C27H16O3N3: 430.11862 found: 430.11837. 
 
(r)-Cyclopropane-1,2,3-triyltris((3-bromophenyl)methanone) (245n) 
Compound 245n was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: acetone/petroleum 
ether (5:95 v/v); light yellow amorphous solid with 77% 
yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.27 (s, 1H), 8.17 – 8.06 (m, 
3H), 7.91 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.0 Hz, 1H), 7.68 (d, J = 8.0 Hz, 2H), 7.42 (t, J = 
7.9 Hz, 1H), 7.33 (t, J = 7.9 Hz, 2H), 4.14 (t, J = 5.6 Hz, 1H), 3.71 ppm (d, J = 5.6 Hz, 2H).
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13
C NMR (126 MHz, CDCl3) δ 194.44, 191.48, 138.10, 138.03, 137.08, 136.77, 131.71, 
131.61, 130.64, 130.49, 127.59, 127.09, 123.48, 123.30, 36.46, 30.37 ppm. 
FT‐IR: ṽ = 3065, 2926, 1686, 1662, 1565, 1418, 1343, 1294, 1197, 1064, 1034 cm-1. 
HRMS: calc. for [M+H]
+
 C24H16O3
79
Br3: 588.86441 found: 588.86293; HRMS: calc. for 
[M+H]
+
 C24H16O3Br2
81
Br: 590.86236 found: 590.86129; HRMS: calc. for [M+H]
+
  
C24H16O3
79
Br
81
Br2: 592.86032 found: 592.85936; HRMS: calc. for [M+H]
+
 C24H16O3
81
Br3: 
594.85827 found: 594.85936. 
 
(r)-Cyclopropane-1,2,3-triyltris((3,4-dimethylphenyl)methanone) (245o) 
Compound 245o was obtained by using the general 
procedure I from 3,4-dimethylacetophenone (0.5 mmol) in 
1 mL DMF for 18 h at 80 °C. The product was isolated by 
column chromatography with silica gel. Eluent: 
acetone/petroleum ether (3:97 v/v); light yellow 
amorphous solid with 53% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.95 – 7.91 (m, 2H), 7.77 (s, 2H), 7.75 (dd, J = 7.8, 1.7 Hz, 
2H), 7.26 (d, J = 7.7 Hz, 2H), 7.16 (d, J = 7.8 Hz, 1H), 4.19 (t, J = 5.6 Hz, 1H), 3.70 (d, J = 
5.6 Hz, 2H), 2.34 (s, 6H), 2.27 (s, 6H), 2.25 ppm (s, 6H).
 
13
C NMR (126 MHz, CDCl3) δ 196.17, 192.86, 143.52, 142.99, 137.17, 136.91, 134.58, 
134.55, 130.03, 129.81, 129.77, 129.59, 126.56, 126.23, 30.12, 28.18, 20.11, 20.02, 19.75, 
19.70 ppm. 
FT‐IR: ṽ = 3097, 2927, 1722, 1637, 1512, 1545, 1408, 1316, 1216, 1170, 1052 cm-1. 
HRMS: calc. for [M+H]
+
 C30H31O3: 439.22677 found: 439.22698. 
 
(r)-Cyclopropane-1,2,3-triyltris((4-fluoro-3-methylphenyl)methanone (245p) 
Compound 245p was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: acetone/petroleum 
ether (3:97 v/v); light yellow amorphous solid with 43% 
yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.04 (t, J = 7.1 Hz, 2H), 
7.89 – 7.72 (m, 4H), 7.13 (t, J = 8.7 Hz, 1H), 7.03 (t, J = 8.8 Hz, 2H), 4.13 (t, J = 5.6 Hz, 1H), 
3.67 (d, J = 5.6 Hz, 1H), 2.36 (s, 3H), 2.27 ppm (s, 6H).
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13
C NMR (151 MHz, CDCl3) δ 165.13 (d, J = 255.2 Hz), 164.81 (d, J = 254.6 Hz), 132.74, 
132.73, 132.71, 132.70, 132.42 (d, J = 6.8 Hz), 129.03 (d, J = 9.5 Hz), 128.60 (d, J = 9.5 Hz), 
125.99 (d, J = 18.0 Hz), 125.79 (d, J = 18.0 Hz), 115.77 (d, J = 23.2 Hz), 115.56 (d, J = 23.2 
Hz), 36.34, 30.27, 14.74, 14.71, 14.69, 14.67 ppm. 
FT‐IR: ṽ = 3064, 2958, 1741, 1684, 1661, 1584, 1545, 1496, 1411, 1317, 1246, 1155, 1067 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C27H22O3F3: 451.15156 found: 451.15137. 
 
(r)-Cyclopropane-1,2,3-triyltris(naphthalen-2-ylmethanone) (245q) 
Compound 245q was obtained by using the general 
procedure I. The product was isolated by column 
chromatography with silica gel. Eluent: acetone/petroleum 
ether (10:90 v/v); light yellow amorphous solid with 65% 
yield.
 
1
H NMR (500 MHz, CDCl3) δ 8.89 (s, 1H), 8.66 (s, 2H), 
8.29 – 8.22 (m, 1H), 8.10 – 8.06 (m, 3H), 7.99 (d, J = 8.6 
Hz, 1H), 7.92 (t, J = 8.5 Hz, 3H), 7.87 – 7.84 (m, 4H), 7.70 – 7.64 (m, 1H), 7.63 – 7.58 (m, 
4H), 7.52 (t, J = 7.5 Hz, 2H), 4.57 (t, J = 5.5 Hz, 1H), 4.08 ppm (d, J = 5.5 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 196.23, 193.12, 136.14, 135.91, 134.11, 134.05, 132.72, 
132.56, 131.42, 130.67, 130.11, 129.77, 129.11, 128.91, 128.83, 128.75, 127.93, 127.90, 
127.14, 126.97, 124.03, 36.94, 30.72 ppm. 
FT‐IR: ṽ = 3050, 2970, 2928, 1727, 1662, 1596, 1595, 1492, 1393, 1251, 1217, 1153, 1022, 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C27H16O3N3: 505.17982 found: 505.17932. 
 
(r)-Cyclopropane-1,2,3-triyltris((6-methoxynaphthalen-2-yl)methanone) (245r) 
Compound 245r was obtained by using the 
general procedure I from 1-(6-
methoxynaphthalen-2-yl)ethan-1-one (0.5 
mmol), CuI (20 mol%) and 4,4'-di-tert-butyl-
2,2'-bipyridine (30 mol%)  at 75 °C. The 
product was isolated by column 
chromatography with silica gel. Eluent: 
acetone/petroleum ether (10:90 v/v); light yellow amorphous solid with 46% yield.
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1
H NMR (500 MHz, CDCl3) δ 8.77 (s, 1H), 8.54 (s, 2H), 8.20 (dd, J = 8.6, 1.6 Hz, 1H), 8.03 
(dd, J = 8.6, 1.6 Hz, 2H), 7.93 (d, J = 8.9 Hz, 1H), 7.82 (d, J = 8.7 Hz, 1H), 7.76 (d, J = 9.0 
Hz, 2H), 7.70 (d, J = 8.7 Hz, 2H), 7.22 (dd, J = 8.9, 2.4 Hz, 1H), 7.18 (d, J = 2.0 Hz, 1H), 
7.14 (dd, J = 9.0, 2.4 Hz, 2H), 7.09 (d, J = 2.1 Hz, 2H), 4.49 (t, J = 5.6 Hz, 1H), 3.99 (d, J = 
5.6 Hz, 2H), 3.96 (s, 3H), 3.91 ppm(s, 6H).
 
13
C NMR (126 MHz, CDCl3) δ 196.01, 192.88, 160.29, 160.04, 137.90, 137.63, 132.31, 
132.20, 131.71, 131.34, 131.23, 130.50, 128.05, 127.89, 127.52, 127.35, 124.85, 120.00, 
119.86, 106.00, 105.90, 55.59, 55.53, 36.79, 30.51 ppm. 
FT‐IR: ṽ = 3029, 2929, 1713, 1679, 1574, 1512, 1410, 1362, 1264, 1213, 1099, 1173, 1031 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C39H31O6: 595.21152 found: 595.21133. 
 
(r)-Cyclopropane-1,2,3-triyltris((2-fluorophenyl)methanone) (245s) 
Compound 245s was obtained by using the general procedure I. 
The product was isolated by column chromatography with silica 
gel. Eluent: acetone/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 41% yield.
 
1
H NMR (500 MHz, CDCl3) δ 7.90 – 7.87 (m, 1H), 7.86-7.83 (m, 
2H), 7.59 – 7.48 (m, 3H), 7.28 – 7.24 (m, 1H), 7.23 – 7.18 (m, 2H), 7.15 (dd, J = 9.7, 1.2 Hz, 
1H), 7.11 (dd, J = 10.1, 8.5 Hz, 2H), 4.15 (ddd, J = 5.6, 4.6, 1.1 Hz, 1H), 3.76  ppm(d, J = 5.6 
Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.87, 191.62, 163.54, 163.43, 161.51, 161.38, 135.44, 
135.37, 131.26, 131.09, 126.36, 126.26, 125.82, 125.73, 124.85, 117.40, 117.22, 117.19, 
117.00, 41.20, 41.16, 41.12, 35.16, 35.09 ppm. 
FT‐IR: ṽ = 3079, 2928, 1726, 1665, 1607, 1577, 1480, 1452, 1315, 1269, 1206, 1120, 1014 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C24H16O3F3: 409.10461 found: 409.10487. 
 
(r)-Cyclopropane-1,2,3-triyltris(thiophen-2-ylmethanone) (245t) 
Compound 245t was obtained by using the general procedure I. The 
product was isolated by column chromatography with silica gel. 
Eluent: acetone/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 52% yield;
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1
H NMR (500 MHz, CDCl3) δ 8.07 (dd, J = 3.8, 0.8 Hz, 1H), 7.82 (dd, J = 3.8, 0.8 Hz, 2H), 
7.74 (dd, J = 4.9, 0.9 Hz, 1H), 7.62 (d, J = 0.9 Hz, 2H), 7.21 – 7.15 (m, 1H), 7.09 (dd, J = 4.9, 
3.9 Hz, 2H), 4.10 (t, J = 5.5 Hz, 1H), 3.64 ppm (d, J = 5.5 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 188.18, 184.97, 143.71, 143.64, 135.40, 134.54, 134.15, 
132.86, 128.78, 128.36, 36.39, 30.65 ppm. 
FT‐IR: ṽ = 3097, 2927, 1722, 1637, 1512, 1408, 1352, 1316, 1235, 1216, 1067, 1052 cm-1. 
HRMS: calc. for [M+H]
+
 C18H13O3S3: 373.00213 found: 373.00249. 
 
12.10.2 Synthesis of Compound 247
[216]
 
 
To a sealed tube (25 mL) was added 4-chloroacetophenone 228b (1 mmol), CuBr2 (0.2 
mmol), I2 (2 mmol) and dry DMF (1 mL). Then the mixture was heated to 80 ºC for 20 h. 
Afterward, the reaction mixture was cooled to room temperature, saturated Na2S2O4 (15 mL) 
was added. The resulting mixture was extracted with diethyl ether (3 × 10 mL). The combined 
organic phase was dried with Na2SO4. The reaction mixture was concentrated and purified by 
column chromatography using silica gel (100-200 mesh) and petroleum ether /ethyl acetate as 
eluent (95:5 v/v). 
 
 (E)-1,4-Bis(4-chlorophenyl)but-2-ene-1,4-dione  
1
H NMR (500 MHz, CDCl3) δ 8.0 (d, J = 8.7 Hz, 4H), 7.97 (s, 2H), 7.51 ppm (d, J = 8.7 Hz, 
4H).
 
13
C NMR (126 MHz, CDCl3) δ 188.48, 140.76, 135.28, 135.03, 130.40, 129.47 ppm. 
 
12.10.3. Synthesis of Compound 246
[274]
 
To a screw cap reaction tube with septum charged with a magnetic stir-bar, PBu3 (112 mg, 
0.55 mmol) was added into a mixture of (E)-1,4-Bis(4-chlorophenyl)but-2-ene-1,4-dione 249 
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 (152 mg, 0.5 mmol) and H2O (90 mg, 5.0 mmol) in 3 mL of acetone under argon. Reaction 
mixture stirred vigorously at room temperature for 24 h. The crude reaction mixture was 
concentrated under reduced pressure and subsequently purified by flash column 
chromatography over silica gel using petroleum ether/ethyl acetate as eluent system (150 mg, 
95%). 
 
 
1,4-Bis(4-chlorophenyl)butane-1,4-dione  
1
H NMR (300 MHz, CDCl3) δ 7.95 (d, J = 8.6 Hz, 4H), 7.38 (d, J = 8.6 Hz, 4H), 3.40 ppm 
(s, 4H).
 
13
C NMR (75 MHz, CDCl3) δ 197.41, 139.75, 135.05, 129.63, 129.04, 32.54 ppm. 
 
12.10.4. Synthesis of Compound 231l 
 
To a screw cap reaction vial charged with a magnetic stir-bar 1,4-bis(4-chlorophenyl)butane-
1,4-dionee 248 (0.25 mmol, 1 equiv), 4-acetylbenzoate (0.375 mmol, 1.5 equiv), CuI (10 
mol%), dtbpy L5 (20 mol%) were added. The vial was then evacuated and back-filled with 
argon. This evacuation/backﬁll sequence was repeated three additional times. Under a counter 
flow of argon, 2 mL of degased chlorobenzene and DTBP (3 equiv) were added by syringe. 
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The reaction mixture was allowed to warm up to 90 °C and was stirred vigorously for 8 h. 
Then the reaction mixture was cooled to room temperature. To the reaction mixture was 
added dichloromethane (15 mL), washed with HCl (1N) for two times, dried over Na2SO4 and 
evaporated in vacuum to afford the crude product, which was purified by column 
chromatography using silica gel (100-200 mesh) and petroleum ether / acetone as eluent. The 
pure isolated product was light yellow amorphous with 64% yield. 
 
Methyl 4-((2S,3S)-2,3-bis(4-chlorobenzoyl)cyclopropane-1-carbonyl)benzoate (247) 
1
H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.6 Hz, 2H), 8.09 (d, J = 8.6 Hz, 2H), 8.03 (d, J = 
8.6 Hz, 2H), 7.92 (d, J = 8.6 Hz, 2H), 7.50 (d, J = 8.6 Hz, 2H), 
7.40 (d, J = 8.6 Hz, 2H), 4.15 (t, J = 5.6 Hz, 1H), 3.93 (s, 3H), 
3.73 ppm (d, J = 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.47, 192.54, 191.70, 
166.12, 140.89, 140.51, 139.53, 134.75, 134.70, 134.56, 
130.29, 130.09, 129.94, 129.41, 129.27, 128.45, 52.64, 36.45, 36.35, 30.50 ppm. 
FT‐IR: ṽ = 3049, 2952, 1721, 1692, 1666, 1587, 1571, 1452, 1315, 1269, 1176, 1055, 1009 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C26H19O5Cl2: 481.06041 found: 481.05939. 
 
12.10.5 Control Experiment with 246 
 
 
To a screw cap reaction vial charged with a magnetic stir-bar, 1,4-bis(4-chlorophenyl)butane-
1,4-dione 248 (0.5 mmol), CuI (10 mol%), dtbpy L5 (20 mol%) were added. The vial was 
then evacuated and back-filled with argon. This evacuation/back-fill sequence was repeated 
three additional times. Under a counter flow of argon, 2 mL of degased chlorobenzene and 
DTBP (3 equiv) were added by syringe. The reaction mixture was allowed to warm up to 90 
°C and was stirred vigorously for 8 h. Then the reaction mixture was cooled to room 
temperature. To the reaction mixture was added dichloromethane (15 mL), washed with HCl 
(1M) for two times, dried over Na2SO4 and evaporated in vacuum to afford the crude product, 
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which was purified by flash column chromatography using silica gel (100-200 mesh) and 
petroleum-ether / acetone as eluent (95:5 v/v). The pure isolated product was light yellow 
amorphous and yield was 92%. 
 
(E)-1,4-Bis(4-chlorophenyl)but-2-ene-1,4-dione (247) 
1
H NMR (500 MHz, CDCl3) δ 8.02 – 7.98 (d, J = 8.7 Hz, 4H), 7.97 (s, 2H), 7.51 ppm (d, J = 
8.7 Hz, 4H).
 
13
C NMR (126 MHz, CDCl3) δ 188.48, 140.76, 135.28, 135.03, 130.40, 129.47 ppm. 
 
12.10.6 Synthesis of Compound231l with Probable Intermediate 247 
To a screw cap reaction vial charged with a magnetic stir-bar, (E)-1,4-bis(4-chlorophenyl)but-
2-ene-1,4-dione 247 (0.25 mmol, 1 equiv), 4-acetylbenzoate 228d (0.375 mmol, 1.5 equiv) 
CuI (10 mol%), dtbpy L5 (20 mol%) were added. The vial was then evacuated and back-filled 
with argon. This evacuation/back-fill sequence was repeated three additional times. Under a 
counter flow of argon, 2 mL of degassed chlorobenzene and DTBP (3 equiv) were added by  
 
syringe. The reaction mixture was allowed to warm up to 90 °C and was stirred vigorously for 
8 h. Then the reaction mixture was cooled to room temperature. To the reaction mixture was 
added dichloromethane (15 mL), washed by 1 M HCl for two times, dried over Na2SO4 and 
evaporated in vacuum to afford the crude product which was purified by column 
chromatography using silica gel (100-200 mesh) and petroleum-ether / acetone (95;5 v/v) as 
the eluent. The pure isolated product was light yellow amorphous and its yield was 82%. 
Methyl 4-((2S, 3S)-2,3-bis(4-chlorobenzoyl)cyclopropane-1-carbonyl)benzoate (231l) 
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1
H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 8.6 Hz, 2H), 8.09 (d, J = 8.6 Hz, 2H), 8.03 (d, J = 
8.6 Hz, 2H), 7.92 (d, J = 8.6 Hz, 2H), 7.50 (d, J = 8.6 Hz, 2H), 7.40 (d, J = 8.6 Hz, 2H), 4.15 
(t, J = 5.6 Hz, 1H), 3.93 (s, 3H), 3.73 ppm (d, J = 5.6 Hz, 2H).
 
13
C NMR (126 MHz, CDCl3) δ 194.47, 192.54, 191.70, 166.12, 140.89, 140.51, 139.53, 
134.75, 134.70, 134.56, 130.29, 130.09, 129.94, 129.41, 129.27, 128.45, 52.64, 36.45, 36.35, 
30.50 ppm. 
FT‐IR: ṽ = 3049, 2952, 1721, 1692, 1666, 1587, 1571, 1452, 1315, 1269, 1176, 1055, 1009 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C26H19O5Cl2: 481.06041 found: 481.05939. 
 
12.10.7 Procedure for Radical Inhibition Test 
 
To a screw cap reaction vial charged with a magnetic stir-bar, 4-fluoroacetophenone 228e (0.5 
mmol), CuI (10 mol%), dtbpy L5 (20 mol%) and 4 equiv TEMPO 16 were added. The vial 
was then evacuated and back-filled with argon. This evacuation/back-fill sequence was 
repeated three additional times. Under a counter flow of argon, 2 mL of degassed 
chlorobenzene and DTBP (3 equiv) were added. The reaction mixture was allowed to warm 
up to 90 °C and was stirred vigorously for 8 h. Then the reaction mixture was cooled to room 
temperature. Ethyl acetate (2 mL) was added for dilution of reaction mixture. Finally, the 
reaction mixture was checked by GC-MS analysis and we did not observe the desired product. 
 
12.10.8 Procedure for the Reaction of 2,2,2-[
2
H3]-1-Phenylethan-1-one (235a) 
To a screw cap reaction vial charged with a magnetic stir-bar, 2,2,2-[
2
H3]-1-phenylethan-1-
one (0.5 mmol), CuI (20 mol%), dtbpy L5 (30 mol%) were added. The vial was then 
evacuated and back-filled with argon. This evacuation/back-fill sequence was repeated three 
additional times. Under a counter flow of argon, 2 mL of degassed chlorobenzene and DTBP 
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 (3 equiv) were added. The reaction mixture was allowed to warm up to 75 °C and was stirred 
vigorously for 12 h. Then the reaction mixture was cooled to room temperature. To the 
reaction mixture was added dichloromethane (15 mL), washed with 1M HCl for two times, 
dried over Na2SO4 and evaporated in vacuum to afford the crude product which was purified 
by column chromatography using silica gel (100-200 mesh) and petroleum ether/acetone ( 
97:3 v/v). as the eluent and isolated yield was 55%. 
(r)-(Cyclopropane-1,2,3-triyl-(
2
H3)tris(phenylmethanone) (248) 
1
H NMR (500 MHz, CDCl3) δ 8.28 – 8.17 (m, 2H), 8.11 – 7.96 
(m, 4H), 7.63 (dd, J = 10.5, 4.3 Hz, 1H), 7.60 – 7.50 (m, 4H), 7.43 
ppm (t, J = 7.7 Hz, 4H).
 
13
C NMR (75 MHz, CDCl3) δ 196.01, 192.96, 136.41, 133.93, 
133.55, 128.83, 128.75, 128.67, 128.44, 36.10 (t, J = 25.1 Hz), 
30.10- (t, J = 25.1 Hz) ppm. 
FT‐IR: ṽ = 3061, 2969, 1727, 1684, 1663, 1580, 1476, 1320, 1272, 1176, 1046 cm-1. 
HRMS: calc. for [M+H]
+
 C26H16D3O3: 358.15170 found: 358.15210. 
 
12.10.9 Procedure for Kinetic Isotope Effect (KIE) Study 
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Two reaction vials were set up separately for acetophenone 235 (0.5 mmol) and 2,2,2-[
2
H3]-1-
phenylethan-1-one (0.5 mmol) and CuI (20 mol%), dtbpy L5 (30 mol%) were added to each 
vial. Then the vial was evacuated and back-filled with argon. This evacuation/back-fill 
sequence was repeated three additional times. Under a counter flow of argon, 2 mL of 
degassed chlorobenzene and DTBP (3 equiv) were added by syringe. Then the reaction 
mixtures were allowed to warm up to 75 °C and stirred vigorously for 6 h. Afterwards, the 
reaction mixtures were cooled to room temperature and mixed together in a single separation 
funnel. To the reaction mixture was added dichloromethane (20 mL), washed by 1M HCl for 
two times, dried over Na2SO4 and evaporated in vacuum to afford the crude product, which 
was purified by column chromatography using silica gel (100-200 mesh) and petroleum-ether/ 
acetone as the eluent. KIE (kH/kD = 1.4) was determined by 
1
H NMR analysis. 
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12.11 Copper(I)-Catalyzed (3+2) Oxidative Annulation of Acetophenone with Electron-
Deficient Alkyne 
12.11.1 Characterization of Furan Derivatives (266a-266w) 
Diethyl 5-(4-bromophenyl)furan-2,3-dicarboxylate (266a)
[275]
 
Compound 266a was obtained by using the general procedure 
J and isolated by column chromatography with silica gel. 
Eluent: ethyl acetate/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 70% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 8.7 Hz, 2H), 7.56 (d, J = 8.7 Hz, 2H), 6.97 (s, 
1H), 4.41 (q, J = 7.1 Hz, 2H), 4.38 (q, J = 7.1 Hz, 2H), 1.46 – 1.35 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 162.48, 157.96, 154.79, 142.96, 132.27, 127.74, 126.46, 
125.94, 123.67, 108.10, 61.80, 14.34, 14.29 ppm. 
FT‐IR: ṽ = 3069, 3018, 2985, 1711, 16981, 1594, 1505, 1410, 1322, 1298, 1223, 1154, 1011 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H16O5
79
Br: 367.01756 found: 367.01833 HRMS: calc. for 
[M+H]
+
 C16H16O5
81
Br: 369.01552 found: 369.01633. 
 
Diethyl 5-(4-chlorophenyl)furan-2,3-dicarboxylate (266b) 
Compound 266b was obtained by using the general procedure 
J and isolated by column chromatography with silica gel. 
Eluent: ethyl acetate/petroleum ether (2:98 v/v); white solid 
with 75% yield. 
1
H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 8.7 Hz, 2H), 7.43 (d, J = 8.7 Hz, 2H), 6.98 (s, 
1H), 4.44 (q, J = 7.1 Hz, 2H), 4.38 (q, J = 7.1 Hz, 2H), 1.46 – 1.37 ppm (m, 6H). 
13
C NMR (126 MHz, CDCl3) δ 162.50, 157.96, 154.79, 142.98, 135.46, 129.34, 127.37, 
126.28, 125.95, 108.01, 61.77, 61.74, 14.35, 14.30 ppm. 
FT‐IR: ṽ = 3067, 2958, 1716, 1664, 1593, 1542, 1449, 1409, 1368, 1304, 1240, 1183, 1140, 
1065 cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H16O5
35
Cl: 323.06808 found: 323.06863  HRMS: calc. for 
[M+H]
+
 C16H16O5
37
Br: 325.06513found: 325.06566. 
 
Diethyl 5-(4-fluorophenyl)furan-2,3-dicarboxylate (266c) 
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Compound 266c was obtained by using the general procedure J 
and isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (2:98 v/v); light yellow amorphous 
solid with 45% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.78 – 7.66 (m, 2H), 7.17 – 7.07 (m, 2H), 6.91 (s, 1H), 4.41 
(q, J = 7.1 Hz, 2H), 4.38 (q, J = 7.1 Hz, 2H), 1.44 – 1.34 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 163.24 (d, J = 250.1 Hz), 162.45, 157.84, 154.87, 142.51, 
126.86 (d, J = 8.4 Hz), 125.84, 125.04 (d, J = 3.3 Hz), 116.07 (d, J = 22.2 Hz), 107.20, 61.56 
(x2), 14.18, 14.12 ppm. 
FT‐IR: ṽ = 3066, 2980, 1692, 1602, 1542, 1492, 1424, 1314, 1248, 1141, 1072, 1010 cm-1. 
HRMS: calc. for [M+H]
+
 C16H16O5F: 307.09820 found: 307.09763. 
 
Diethyl 5-(4-cyanophenyl)furan-2,3-dicarboxylate (266d) 
 Compound 266d was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (4:96 v/v); 
white solid with 76% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 8.5 Hz, 2H), 7.72 (d, J = 8.5 Hz, 2H), 7.12 (s, 
1H), 4.47– 4.35 (m, 4H), 1.43– 1.37 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 162.12, 157.75, 153.40, 144.03, 132.90, 132.65, 125.81, 
125.30, 118.50, 112.66, 110.20, 62.04, 61.90, 14.32, 14.28 ppm. 
FT‐IR: ṽ = 3124, 2984, 2230, 1692, 1615, 1542, 1492, 1424, 1368, 1306, 1276, 1186, 1108, 
1074 cm
-1
. 
HRMS: calc. for [M+H]
+
 C17H16O5N: 314.10302 found: 314.10230. 
 
Diethyl 5-(4-(trifluoromethyl)phenyl)furan-2,3-dicarboxylate (266e) 
Compound 266e was obtained by using the general procedure 
J and isolated by column chromatography with silica gel. 
Eluent: ethyl acetate/petroleum ether (5:95 v/v); light yellow 
amorphous solid with 66% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.1 Hz, 2H), 7.68 (d, J = 8.3 Hz, 2H), 7.08 (s, 
1H), 4.43 (q, J = 7.1 Hz, 2H), 4.39 (q, J = 7.1 Hz, 2H), 1.41 (t, J = 4.8 Hz, 3H), 1.39 ppm (t, J 
= 4.8 Hz, 3H). 
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13
C NMR (126 MHz, CDCl3) δ 162.30, 157.87, 154.10, 143.67, 132.01, 131.10 (q, J = 32.7 
Hz), 126.07 (q, J = 3.7 Hz), 123.96 (q, J = 272.1 Hz), 125.04, 109.30, 61.90, 61.80, 14.31, 
14.27 ppm. 
FT‐IR: ṽ = 3119, 2985, 1699, 1619, 1541, 1497, 1423, 1322, 1309, 1164, 1108, 1065 cm-1. 
HRMS: calc. for [M+H]
+
 C17H16O5F3: 357.09443 found: 357.09548. 
 
Diethyl 5-(4-acetylphenyl)furan-2,3-dicarboxylate (3f) 
Compound 266f was obtained by using the general 
procedure J from 1,4-diacetylbenzene (0.75 mmol). The 
product was isolated by column chromatography with silica 
gel. Eluent: ethyl acetate/petroleum ether (5:95 v/v); white 
amorphous solid with 67% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 2H), 7.84 (d, J = 8.4 Hz, 2H), 7.09 (s, 
1H), 4.53 – 4.29 (m, 4H), 2.62 (s, 3H), 1.43 – 1.36 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 197.33, 162.32, 157.89, 154.44, 143.60, 137.25, 132.71, 
129.09, 125.86, 124.95, 109.57, 61.90, 61.79, 26.79, 14.31, 14.27 ppm. 
FT‐IR: ṽ = 3112, 2984, 1713, 1679, 1609, 1538, 1487, 1442, 1297, 1241, 1187, 1064, 1020 
cm
-1
. 
MS-EI: m/z (%):) 201,0(13); 243,0 (32); 285,0 (15); 330,0 (100); 331,0 (19). 
 
Diethyl 5-(4-nitrophenyl)furan-2,3-dicarboxylate (266g) 
Compound 266g was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (5:95 v/v); 
yellow amorphous solid with 78% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.31 – 8.19 (m, 2H), 7.94 – 7.77 (m, 2H), 7.16 (s, 1H), 4.43 
(q, J = 7.1 Hz, 2H), 4.39 (q, J = 7.1 Hz, 2H), 1.47 – 1.24 ppm (m, 6H). 
13
C NMR (126 MHz, CDCl3) δ 161.99, 157.70, 153.06, 147.93, 144.40, 134.37, 125.82, 
125.49, 124.50, 110.76, 62.06, 61.88, 14.29, 14.25 ppm. 
FT‐IR: ṽ = 3122, 2988, 1715, 1605, 1517, 1478, 1384, 1340, 1297, 1243, 1190, 1065, 1017 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H16O7N: 334.09303 found: 334.09213. 
 
Diethyl 5-(4-(methoxycarbonyl)phenyl)furan-2,3-dicarboxylate (266h) 
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Compound 2h was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (5:95 
v/v); light yellow amorphous solid with 65% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 8.3 Hz, 2H), 7.82 (d, J = 8.3 Hz, 2H), 7.08 (s, 
1H), 4.51 – 4.26 (m, 4H), 3.92 (s, 3H), 1.46 – 1.32 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 166.51, 162.33, 157.89, 154.55, 143.53, 132.65, 130.60, 
130.32, 125.85, 124.76, 109.43, 61.87, 61.77, 52.41, 14.32, 14.27 ppm. 
FT‐IR: ṽ = 3122, 2986, 1716, 1613, 1541, 1491, 1433, 1251, 1177, 1143, 1107, 1065 cm-1. 
HRMS: calc. for [M+H]
+
 C18H19O7: 347.11253 found: 347.11320. 
 
Diethyl 5-(3-nitrophenyl)furan-2,3-dicarboxylate (266i) 
Compound 266i was obtained by using the general procedure J 
and isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (5:95 v/v); light yellow amorphous 
solid with 56% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.57 – 8.40 (m, 1H), 8.21 – 8.12 (m, 1H), 8.04 (dd, J = 7.8, 
0.9 Hz, 1H), 7.60 (t, J = 8.0 Hz, 1H), 7.11 (s, 1H), 4.41 (q, J = 7.2 Hz, 2H), 4.36 (q, J = 7.2 
Hz, 2H), 1.39 (t, J = 5.8 Hz, 3H), 1.37 ppm (t, J = 5.8 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 161.96, 157.62, 152.92, 148.79, 143.82, 130.32, 130.18, 
125.72, 123.69, 119.65, 109.53, 61.92, 61.77, 14.23, 14.18 ppm. 
FT‐IR: ṽ = 3090, 2987, 1716, 1692, 1522, 1473, 1349, 1299, 1246, 1195, 1148, 1110, 1063 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H16O7N: 334.09213found: 334.09306. 
 
Diethyl 5-(3-cyanophenyl)furan-2,3-dicarboxylate (266j) 
Compound 266j was obtained by using the general procedure J and 
isolated by column chromatography with silica gel. Eluent: ethyl 
acetate/petroleum ether (5:95 v/v); white amorphous solid with 
72% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.02 (s, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.63 (d, J = 7.8 Hz, 
1H), 7.54 (t, J = 7.8 Hz, 1H), 7.05 (s, 1H), 4.46 – 4.31 (m, 4H), 1.43 – 1.34 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 162.11, 157.71, 153.07, 143.70, 136.11, 132.47, 129.99, 
128.83, 128.29, 125.78, 118.18, 113.53, 109.23, 61.98, 61.84, 14.30, 14.24 ppm. 
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FT‐IR: ṽ = 3112, 2984, 2230, 1709, 1597, 1535, 1471, 1438, 1259, 1190, 1148, 1064, 1023 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C17H16O5N: 314.10230 found: 314.10302. 
 
Diethyl 5-(2,4-dichlorophenyl)furan-2,3-dicarboxylate (266k) 
Compound 266k was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (5:95 v/v); 
light yellow amorphous solid with 52% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.88 (d, J = 8.6 Hz, 1H), 7.47 (d, J = 2.0 Hz, 1H), 7.40 (s, 
1H), 7.33 (dd, J = 8.6, 2.0 Hz, 1H), 4.41 (q, J = 7.1 Hz, 2H), 4.38 (q, J = 7.1 Hz, 2H), 1.42
 _ 
1.37 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 162.38, 157.86, 151.02, 142.82, 135.36, 131.85, 130.75, 
129.61, 127.68, 125.97, 125.53, 113.27, 61.88, 61.76, 14.30, 14.28 ppm. 
FT‐IR: ṽ = 2987, 2938, 1724, 1584, 1466, 1404, 1385, 1300, 1241, 1195, 1112, 1067 cm-1. 
HRMS: calc. for [M+H]
+
 C16H15O5
35
Cl2: 357.02911 found: 357.03020; calc. for [M+H]
+
 
C16H15O5
35
Cl
37
Cl: 359.02616 found: 359.02698 calc. for [M+H]
+
 C16H15O5
37
Cl2: 361.02321 
found: 361.02344. 
 
Diethyl 5-(4-fluoro-3-nitrophenyl)furan-2,3-dicarboxylate (266l) 
Compound 266l was obtained by using the general procedure J 
and isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (2:98 v/v); light yellow 
amorphous solid with 56% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.41 (dd, J = 6.8, 2.1 Hz, 1H), 
8.01 (ddd, J = 8.7, 3.9, 2.3 Hz, 1H), 7.44 – 7.33 (m, 1H), 7.07 (s, 1H), 4.46 – 4.34 (m, 4H), 
1.50 – 1.26 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 161.97, 157.65, 155.60 (d, J = 268.3 Hz), 152.02, 143.90, 
137.84, 131.49 (d, J = 8.8 Hz), 126.05 (d, J = 4.3 Hz), 125.82, 122.49, 119.54 (d, J = 21.7 
Hz), 109.36, 62.06, 61.91, 14.29, 14.24 ppm. 
FT‐IR: ṽ = 3113, 2995, 1716, 1601, 1533, 1487, 1423, 1360, 1318, 1249, 1195, 1162, 1018 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H15O7NF: 352.08324 found: 352.08271. 
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Diethyl 5-(3,5-difluorophenyl)furan-2,3-dicarboxylate (266m) 
Compound 266m was obtained by using the general procedure J 
and isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (2:98 v/v); yellow amorphous solid 
with 61% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.28 – 7.20 (m, 2H), 7.00 (s, 1H), 
6.85 – 6.74 (m, 1H), 4.44 – 4.33 (m, 4H), 1.42 – 1.33 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 163.54 (d, J = 249.2 Hz), 162.14, 163.37 (d, J = 249.2 Hz), 
157.72, 153.21, 143.54, 131.57 (t, J = 10.5 Hz), 125.72, 109.35, 108.13, 107.77, 104.73 (t, J = 
25.4 Hz), 61.93, 61.81, 14.28, 14.24 ppm. 
FT‐IR: ṽ = 3119, 2995, 1708, 1622, 1589, 1442, 1497, 1368, 1302, 1226, 1177, 1116, 1054 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C16H15O5F2: 325.08821 found: 325.08900. 
 
Diethyl 5-(thiophen-2-yl)furan-2,3-dicarboxylate (266n) 
Compound 2n was obtained by using the general procedure J and 
isolated by column chromatography with silica gel. Eluent: ethyl 
acetate/petroleum ether (3:97 v/v); reddish liquid with 48% yield.  
1
H NMR (300 MHz, CDCl3) δ 7.45 (dd, J = 3.7, 1.0 Hz, 1H), 7.36 
(dd, J = 5.0, 1.1 Hz, 1H), 7.07 (dd, J = 5.0, 3.7 Hz, 1H), 6.80 (s, 1H), 4.40 (q, J = 7.1 Hz, 2H), 
4.37 (q, J = 7.1 Hz, 2H), 1.45 – 1.34 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 162.47, 157.87, 151.44, 142.09, 131.31, 128.12, 126.99, 
126.03, 125.85, 107.41, 61.70, 14.32, 14.26 ppm. 
FT‐IR: ṽ = 3120, 2954, 2927, 1716, 1612, 1599, 1487, 1455, 1387, 1301, 1242, 1180, 1140, 
1063 cm
-1
. 
HRMS: calc. for [M+H]
+
 C14H15O5S: 295.06347 found: 295.06355. 
 
Dimethyl 5-(4-nitrophenyl)furan-2,3-dicarboxylate (266o) 
Compound 266o was obtained by using the general procedure J 
and isolated by column chromatography with silica gel. Eluent: 
ethyl acetate/petroleum ether (5:95 v/v); yellow amorphous 
solid with 66% yield.  
1
H NMR (300 MHz, CDCl3) δ 8.41 – 8.02 (m, 2H), 7.97 – 7.67 (m, 2H), 7.17 (s, 1H), 3.96 
(s, 3H), 3.91 ppm (s, 3H). 
Experimental Section 
- 252 - 
 
13
C NMR (75 MHz, CDCl3) δ 162.22, 157.98, 153.15, 147.90, 144.19, 134.20, 125.65, 
125.49, 124.51, 110.85, 52.83, 52.79 ppm. 
FT‐IR: ṽ = 3110, 2949, 1716, 1601, 1446, 1514, 1441, 1342, 1292, 1255, 1197, 1136, 1067 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C14H12O7N: 306.06083 found: 306.06150. 
 
Dipropyl 5-(4-nitrophenyl)furan-2,3-dicarboxylate (266s) 
Compound 266s was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (5:95 v/v); 
light yellow solid with 76% yield.  
1
H NMR (500 MHz, CDCl3) δ 8.33 – 8.26 (m, 2H), 7.95 – 7.88 (m, J = 9.0 Hz, 2H), 7.17 (s, 
1H), 4.34 (t, J = 6.7 Hz, 2H), 4.29 (t, J = 6.7 Hz, 2H), 1.85 – 1.72 (m, 4H), 1.05 – 1.00 ppm 
(m, 6H). 
13
C NMR (126 MHz, CDCl3) δ 162.08, 157.82, 153.06, 147.96, 144.43, 134.43, 125.82, 
125.51, 124.54, 110.75, 67.62, 67.50, 22.13, 22.09, 10.55, 10.51 ppm. 
FT‐IR: ṽ = 3115, 2966, 1708, 1604, 1619, 1514, 1341, 1315, 1293, 1245, 1178, 1149, 1069 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C18H20O7N: 362.12343 found: 362.12429. 
 
Dihexyl 5-(4-cyanophenyl)furan-2,3-dicarboxylate (266t) 
Compound 266t was obtained by using the general 
procedure J and isolated by column chromatography with 
silica gel. Eluent: ethyl acetate/petroleum ether (2:98 v/v); 
light yellow semi solid with 72% yield.  
1
H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 8.2 Hz, 2H), 7.72 (d, J = 8.2 Hz, 2H), 7.10 (s, 
1H), 4.36 (t, J = 6.8 Hz, 2H), 4.31 (t, J = 6.8 Hz, 2H), 1.81 – 1.67 (m, 4H), 1.44 – 1.40 (m, 
4H), 1.37 – 1.29 (m, 8H), 0.90 ppm (t, J = 6.0 Hz, 6H). 
13
C NMR (126 MHz, CDCl3) δ 162.16, 157.83, 153.37, 144.12, 132.90, 132.73, 125.80, 
125.30, 118.47, 112.71, 110.15, 66.18, 66.09, 31.57, 31.55, 28.66, 25.72, 25.65, 22.67, 14.12 
ppm. 
FT‐IR: ṽ = 2955, 2929, 2858, 2228, 1718, 1612, 1487, 1419, 1268, 1242, 1182, 1142, 1067 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C14H12O7N: 426.22750 found: 426.22830. 
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Diallyl 5-(4-cyanophenyl)furan-2,3-dicarboxylate (266u) 
Compound 266u was obtained by using the general 
procedure J and isolated by column chromatography 
with silica gel. Eluent: ethyl acetate/petroleum ether 
(5:95 v/v); yellow amorphous solid with 51% yield.  
1
H NMR (500 MHz, CDCl3) 7.86 (d, J = 8.6 Hz, 2H), 
7.72 (d, J = 8.6 Hz, 2H), 7.14 (s, 1H), 6.12 – 5.93 (m, 2H), 5.50 – 5.34 (m, 2H), 5.33 – 5.21 
(m, 2H), 4.88 – 4.84 (m, 2H), 7.95 – 7.78 ppm (m, 2H). 
13
C NMR (126 MHz, CDCl3) δ 161.62, 157.32, 153.64, 143.94, 132.92, 132.57, 131.63, 
131.46, 125.72, 125.35, 119.39, 119.27, 118.43, 112.84, 110.28, 66.49 ppm. 
FT‐IR: ṽ = 3123, 2948, 2227, 1716, 1693, 16539, 1488, 1419, 1363, 1301, 1271, 1181, 1145, 
1074 cm
-1
. 
HRMS: calc. for [M+H]
+
 C19H16O5N: 338.10230 found: 338.10324. 
 
Bis-((1S, 2R, 5S)-2-isopropyl-5-methylcyclohexyl)-5-(4-cyanophenyl)furan-2,3-
dicarboxylate (266u) 
Compound 266u was obtained by using the general 
procedure J from bis((1S, 2R, 5S)-2-isopropyl-5-
methylcyclohexyl) but-2-ynedioate (0.25 mmol) and 
4-cyanoacetophenone (1.0 mmol). The product was 
isolated by column chromatography with silica gel. 
Eluent: ethyl acetate/petroleum ether (5:95 v/v); 
white amorphous solid with 80% yield.  
1
H NMR (600 MHz, CDCl3) δ 7.85 (d, J = 8.6 Hz, 
2H), 7.72 (d, J = 8.6 Hz, 2H), 7.08 (s, 1H), 4.98 (td, J = 10.9, 4.5 Hz, 1H), 4.93 (td, J = 10.9, 
4.4 Hz, 1H), 2.20 – 2.11 (m, 2H), 2.01 – 1.91 (m, 2H), 1.73 (dt, J = 4.6, 3.2 Hz, 4H), 1.60 – 
1.51 (m, 5H), 1.22 – 1.08 (m, 5H), 0.96 – 0.93 (m, J = 6.5, 4.2 Hz, 6H), 0.92 (d, J = 1.5 Hz, 
3H), 0.91 (d, J = 1.5 Hz, 3H), 0.82 (d, J = 1.9 Hz, 3H), 0.81 ppm (d, J = 1.9 Hz, 3H). 
13
C NMR (151 MHz, CDCl3) δ 161.64, 157.47, 153.17, 144.19, 132.86, 132.82, 125.86, 
125.29, 118.52, 112.56, 110.20, 76.35, 76.00, 47.13, 47.11, 40.91, 40.77, 34.37, 31.62, 31.60, 
26.47, 26.41, 23.67, 23.61, 22.20, 22.17, 20.93, 20.89, 16.54, 16.53 ppm. 
FT‐IR: ṽ = 2954, 2226, 2869, 2228, 1719, 1612, 1541, 1487, 1418, 1243, 1180, 1142, 1066 
cm
-1
. 
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HRMS: calc. for [M+H]
+
 C33H44O5N: 534.32140 found: 534.32238. 
 
Bis((1R, 2S, 4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)-5-(4-cyanophenyl)furan-2,3-
dicarboxylate (266w) 
Compound 266w was obtained by using the general 
procedure J from bis((1R, 2S, 4R)-1,7,7-
trimethylbicyclo[2.2.1]heptan-2-yl) but-2-ynedioate 
(0.25 mmol) and 4-cyanoacetophenone (1.0 mmol). 
The product was isolated by column 
chromatography with silica gel. Eluent: ethyl 
acetate/petroleum ether (5:95 v/v); white amorphous solid with 47% yield.  
1
H NMR (600 MHz, CDCl3) δ 7.86 (d, J = 8.6 Hz, 2H), 7.73 (d, J = 8.7 Hz, 2H), 7.09 – 7.06 
(m, 1H), 5.16 (ddd, J = 10.0, 3.2, 2.2 Hz, 1H), 5.13 (ddd, J = 9.9, 3.2, 2.2 Hz, 1H), 2.53 – 2.43 
(m, 2H), 2.13 – 2.07 (m, 1H), 2.02 – 1.98 (m, 1H), 1.83 – 1.75 (m, 2H), 1.74 (d, J = 3.6 Hz, 
2H), 1.40 – 1.28 (m, 3H), 1.18 (ddd, J = 14.6, 7.1, 3.9 Hz, 3H), 0.96 (s, 6H), 0.93 (d, J = 6.4 
Hz, 6H), 0.91 ppm (d, J = 3.6 Hz, 6H). 
13
C NMR (151 MHz, CDCl3) δ 162.19, 158.10, 153.08, 144.67, 132.99, 132.94, 126.04, 
125.32, 118.61, 112.65, 110.04, 82.25, 81.82, 57.01, 49.38, 49.23, 48.19, 45.14, 45.13, 36.96, 
36.82, 28.24, 28.23, 27.48, 27.44, 19.94, 19.93, 19.13, 19.11, 13.82, 13.77 ppm. 
FT‐IR: ṽ = 2952, 2875, 2228, 1722, 1612, 1541, 1487, 1418, 1304, 1245, 1185, 1146, 1067 
cm
-1
. 
HRMS: calc. for [M+H]
+
 C33H40O5N: 530.29010 found: 530.29045. 
 
12.11.2 Synthesis of Acetylendicarboxylic Acid Esters
[276]
 
 
To the round bottom flask, acetylenedicarboxylic acid (1 mmol), corresponding alcohol (3 
equiv.) and p-toluenesulfonic acid (0.2 equiv) in benzene (4 mL) was refluxed using a Dean–
Stark trap apparatus for 12 h. The reaction mixture was concentrated and the products were 
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isolated by column chromatography using silica gel (100-200 mesh) and petroleum-ether/ 
acetone as eluent. 
 
Diallyl but-2-ynedioate 
1
H NMR (500 MHz, CDCl3) δ 4.31 (t, J = 6.8 Hz, 4H), 2.57 (td, J = 6.8, 2.7 Hz, 4H), 2.02 
ppm (t, J = 2.7 Hz, 2H). 
13
C NMR (126 MHz, CDCl3) δ 151.39, 79.00, 74.83, 70.72, 64.39, 18.76 ppm. 
 
 
Bis(2-isopropyl-5-methylcyclohexyl) but-2-ynedioate 
1
H NMR (300 MHz, CDCl3) δ 4.93 (dd, J = 3.3, 2.1 Hz, 1H), 4.90 (dd, J = 3.3, 2.0 Hz, 1H), 
2.36 – 2.18 (m, 2H), 1.94 – 1.79 (m, 2H), 1.72 – 1.60 (m, 2H), 1.55 – 1.48 (m, 2H), 1.26 – 
1.15 (m, 4H), 0.80 (s, 6H), 0.78 (s, 6H), 0.77 (s, 6H), 0.74 – 0.67 ppm (m, 6H). 
13
C NMR (75 MHz, CDCl3) δ 152.58, 83.60, 49.16, 48.14, 44.88, 36.56, 28.02, 27.10, 19.80, 
18.92, 13.57 ppm. 
 
 
Bis((2S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl) but-2-ynedioate 
1
H NMR (300 MHz, CDCl3) δ 4.93 – 4.74 (m, 2H), 2.02 (d, J = 11.9 Hz, 2H), 1.94 – 1.79 
(m, 2H), 1.69 (d, J = 11.6 Hz, 4H), 1.46 (d, J = 11.5 Hz, 3H), 1.16 – 1.02 (m, 3H), 0.93 – 0.8 
(m, 12H), 0.76 ppm (d, J = 6.9 Hz, 6H). 
13
C NMR (75 MHz, CDCl3) δ 151.80, 77.80, 75.00, 46.89, 40.55, 34.08, 31.59, 26.16, 23.31, 
22.05, 20.85, 16.19 ppm. 
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12.11.3 Procedure for Kinetic Isotope Effect (KIE) Study  
 
To a screw cap reaction tube with septum charged with a magnetic stir-bar, CuBr
.
SMe2 (20 
mol%) and bipy L4 (30 mol%) were added. The tube was then evacuated and back-filled with 
argon. This evacuation/backﬁll sequence was repeated three additional times. Under a counter 
flow of argon, diethyl but-2-ynedioate  (0.25 mmol), 2,2,2-[
2
H3]-1-(4-fluorophenyl)ethan-1-
one(1,5 equiv), 1-(4-fluorophenyl)ethan-1-one (1.5 equiv) and solvent (2 mL of degased 1,2-
dichloroethane) were added. The resulting mixture was then degassed by freezing in liquid 
nitrogen, replacing the atmosphere with argon and allowing warming to room temperature 
(repeated two times). Then DTBP (3 equiv) was added. The reaction mixture was allowed to 
warm up to 75 °C and stirred vigorously for completion of reaction (12 h). Then the reaction 
mixture was cooled to room temperature. Dichloromethane (4 mL) and ethyl acetate (2 mL) 
were added and the reaction mixture was filtered through celite. Afterwards, the reaction 
mixture was concentrated and purified by column chromatography using silica gel (100-200 
mesh) and petroleum-ether/ethyl acetate as eluent. KIE (kH/kD = 4.5) was determined from 
1
H 
NMR. 
12.11.4 Procedure for Radical Trapping Experiment 
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To a screw cap reaction tube with septum charged with a magnetic stir-bar, 4-bromo-
acetophenone 228h (0.75 mmol), radical quencher (0.5 mmol), CuBr
.
SMe2 (20 mol%) and 
bipy L4 (30 mol%) were added. The tube was then evacuated and back-filled with argon. This 
evacuation/backﬁll sequence was repeated three additional times. Under a counter flow of 
argon, diethyl but-2-ynedioate (0.25 mmol) and solvent (2 mL of degassed 1,2-
dichloroethane) were added. The resulting mixture was then degassed by freezing in liquid 
nitrogen, replacing the atmosphere with argon and allowing warming to room temperature 
(repeated two times). Then DTBP (3 equiv) was added. The reaction mixture was allowed to 
warm up to 75 °C and stirred vigorously for completion of reaction (12 h). Then the reaction 
mixture was cooled to room temperature and diluted with ethyl acetate (2 mL). Finally, the 
reaction mixture was analyzed by GC-MS and the desired product was not found. 
 
Entry Additive Yield (%) 
1 none 68 
2 TEMPO (16)  
3 (Z)-N-tert-butyl-1-phenylmethanimine oxide y (270) n.d. 
3 2,6-di-tert-butylphenol (271) n.d. 
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13 Biological Methods 
  
The hedgehog signaling inhibition and cell viability  
To assay the signal transduction through the Hh pathway mouse embryonic mesoderm 
fibroblast C3H10T1/2 cells were used. These multipotent mesenchymal progenitor cells can 
differentiate into osteoblasts upon treatment with the Smoothened agonist Purmorphamine. 
During differentiation osteoblast specific genes such as alkaline phosphatase (ALK), which 
plays an essential role in bone formation, are highly expressed. Activity of ALK can directly 
be monitored by following substrate hydrolysis yielding a highly luminescent product. 
Inhibition of the pathway results in reduction of luminescence.
[277-279]
 
 
The screening for small molecule inhibitors of the Hh pathway was carried out in 384 well 
formats. Shortly, 800 cells per well were seeded and allowed to grow overnight. The next day, 
compounds were added to a final concentration of 10μ M using the acoustic nanoliter 
dispenser ECHO 520. After one hour, Purmorphamine was added to a final concentration of 
1.5 μ M; control cells did not receive Purmorphamine. After four days, the cell culture 
medium was aspirated and a commercial luminogenic ALK substrate (CDP-Star, Roche) was 
added. After one hour, luminescence was read. To identify and exclude toxic compounds that 
also lead to a reduction in the luminescent signal, cell viability measurements were carried out 
in parallel. The cell viability assay followed the same workflow as the Hh assay, except that 
only 200 cells per well were seeded. Cell culture medium alone served as control for the cell 
viability assay. For the measurement of cell viability, Cell Titer Glo reagent (Promega) which 
determines the cellular ATP content was used. Hits were scored as showing at least a 50% 
reduction in the luminescent signal in the Hh assay, and a minimum of 80% cell viability. 
Dose-response analysis for hit compounds was done using a three-fold dilution curve starting 
from 30 μ M. IC50 values were calculated using the Quattro software suite  
(Quattro Research GmbH).  
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14 Selected NMR Spectra 
1-D NOE Spectra of Product 137h 
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1-D NOE Spectra of Product 137d 
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2-D COSY Spectra for the Product 137d 
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1-D NOE Spectra of Product 151i 
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1-D NOE Spectra of Product 151b 
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1-D NOE Spectra of Product 189j 
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1-D NOE Spectra of Product 191c 
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1-D NOE Spectra of Product 214i 
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1-D NOE Spectra of Product 229j 
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Å  Ångström  
Ac  acetyl  
Alk  alkyl  
aq.  aqueous  
Ar  aryl  
atm  atmospheric pressure  
BHT  2,6-di-tert-butyl-4-methylphenol  
bipy 2,2'-bipyridine 
Bn  benzyl  
Boc  tert-butyloxycarbonyl  
Bu  butyl  
BDE bond dissociation energy 
Bz  benzoyl  
BPO benzoyl peroxide 
BQ 1,4-benzoquinone 
c-  cyclo  
CDC  cross-dehydrogenative coupling  
calc.  calculated  
cat.  catalyst 
cod  1,5-cyclooctadien  
conv.  conversion  
COMAS Compound Management and Screening Center 
Cu copper 
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δ  chemical shift  
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DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DME  dimethoxyethane  
DMSO  dimethyl sulfoxide  
DTBP di-tert-butyl peroxide 
dt  doublet of triplet  
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Ed.  edition  
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EI  electron ionization  
equiv  equivalent  
ESI  electronspray ionization  
Et  ethyl  
FG  functional group  
g  gram  
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h hour  
Hal  halogen  
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HFIP 1,1,1,3,3,3-hexafluoro-2-propanol 
Hex  hexyl  
HPLC  high performance liquid chromatography  
HR-MS  high resolution mass spectrometry  
Hz  Hertz  
i  iso  
i
Pr isopropyl 
IC50 half maximal inhibitory concentration 
IR  infrared spectroscopy  
J  coupling constant  
KIE  kinetic isotope effect  
L  ligand  
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LED light-emitting diode 
m  multiplet  
m- meta 
M  molar  
[M]
+ 
 molecular ion peak  
Me  methyl  
mg  milligram  
MHz  megahertz  
m-CPBA meta-chloroperoxybenzoic acid 
min  minute  
mL  milliliter  
mmol  millimol  
MS  molecular sieve  
m/z  mass-to-charge ratio  
n  normal  
N normality 
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NMR  nuclear magnetic resonance  
NOE nucler overhauser effect 
Nu nucleophile 
o- ortho  
oct  octane  
p-  para  
pent  pentyl  
Ph  phenyl  
Piv  pivaloyl  
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SET  single electron transfer  
t  triplet  
T  temperature  
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